Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" ABCB10 "EST20237, M-ABC2, MTABC2" ENSG00000135776 "ATP binding cassette subfamily B member 10" Q9NRK6 1 229516582-229558695 "Plasma proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HL-60: 42.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB044063, CAB044065, HPA055175" Uncertain "CAB044063: AB_353262, CAB044065: AB_2220666, HPA055175: " "unprognostic (1.00e-1)" "unprognostic (1.29e-2)" "unprognostic (5.56e-3)" "unprognostic (5.64e-2)" "unprognostic (2.04e-1)" "unprognostic (8.06e-3)" "unprognostic (9.38e-2)" "unprognostic (2.05e-1)" "unprognostic (4.15e-2)" "unprognostic (5.61e-2)" "unprognostic (2.81e-1)" "unprognostic (3.13e-1)" "unprognostic (8.32e-2)" "unprognostic (2.58e-1)" "unprognostic (3.83e-1)" "unprognostic (5.29e-2)" "unprognostic (3.37e-2)" 13.2 6.4 5.5 6.7 6.0 37.1 14.0 15.1 6.1 7.9 18.8 5.4 3.7 12.6 9.9 6.9 10.7 6.1 11.9 8.3 5.5 5.4 10.9 24.7 9.8 15.5 5.2 3.8 6.3 8.2 9.0 4.2 11.4 4.9 9.9 8.6 5.3 7.1 5.9 13.9 6.0 30.1 14.7 5.0 15.0 7.8 4.0 4.2 9.4 9.6 8.3 12.1 10.0 9.1 2.4 3.2 2.9 2.7 1.3 4.1 1.3 10.4 6.2 5.2 4.2 8.9 7.7 22.6 9.6 7.3 8.8 8.0 6.4 8.0 11.5 8.8 8.8 9.1 11.1 8.0 8.9 7.8 14.0 12.6 5.5 8.1 6.3 42.2 7.0 5.3 6.9 5.3 6.2 9.4 26.8 26.5 9.0 3.3 10.7 24.2 6.9 5.3 9.8 10.2 12.2 7.1 6.8 3.8 5.8 7.5 8.4 11.8 6.5 14.8 7.2 9.5 6.0 5.9 13.1 6.5 4.8 10.0 5.0 7.4 5.9 1.7 2.4 2.9 2.8 2.7 3.6 1.8 3.3 4.1 2.8 2.4 3.0 4.0 0.4 1.3 1.9 3.2 2.7 1.3 5.5 6.0 15.1 6.1 5.5 5.4 5.2 3.8 4.9 4.2 ABCC4 "EST170205, MOAT-B, MOATB, MRP4" ENSG00000125257 "ATP binding cassette subfamily C member 4" O15439 13 95019829-95301475 "Plasma proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "prostate: 35.0" "Group enriched" "Detected in many" 4 "HEL: 60.4;HMC-1: 66.1;RPTEC TERT1: 17.8" "Cancer enriched" "Detected in all" 8 "prostate cancer: 90.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002476 Enhanced Approved "Nucleoli,Golgi apparatus,Plasma membrane" "Nucleoli, Plasma membrane" "Golgi apparatus" "HPA002476: AB_1844434" "unprognostic (8.77e-2)" "unprognostic (1.94e-2)" "unprognostic (1.48e-1)" "prognostic unfavourable (9.89e-4)" "unprognostic (2.83e-2)" "unprognostic (1.23e-1)" "unprognostic (7.45e-3)" "unprognostic (2.40e-2)" "unprognostic (9.96e-2)" "unprognostic (2.60e-2)" "unprognostic (1.28e-1)" "unprognostic (2.55e-2)" "prognostic favourable (2.25e-10)" "unprognostic (7.44e-3)" "unprognostic (1.67e-1)" "unprognostic (5.55e-2)" "unprognostic (2.35e-2)" 3.2 1.7 3.8 11.8 4.7 2.9 6.2 1.0 4.6 4.4 11.6 10.3 3.9 4.1 5.8 16.4 3.0 8.6 10.3 3.5 5.7 3.9 19.6 1.9 13.8 7.4 6.6 2.2 7.2 3.5 7.0 2.8 1.8 7.4 35.0 7.3 6.0 3.3 5.2 7.6 4.5 7.4 11.1 6.5 3.8 8.2 3.8 7.0 3.4 6.6 3.1 5.8 25.6 13.4 3.6 4.1 1.0 4.8 4.1 3.6 3.4 4.4 7.8 1.3 2.3 2.4 3.2 0.3 3.6 3.6 3.2 2.8 10.8 3.3 2.5 2.3 4.8 6.0 2.0 1.7 4.0 7.3 3.0 60.4 2.4 2.1 5.0 6.9 66.1 2.4 0.8 2.3 4.7 4.1 6.2 0.1 4.3 1.4 1.2 1.1 1.5 1.9 1.8 3.6 6.5 17.8 10.0 3.2 2.3 1.2 0.2 2.5 0.0 3.7 6.7 3.4 2.2 2.8 4.2 0.0 0.0 1.0 6.5 3.9 1.6 0.6 1.2 0.4 3.2 1.2 2.7 3.6 2.6 3.6 4.1 2.7 1.6 3.5 1.0 4.1 4.8 0.7 3.3 3.4 3.8 4.7 1.0 4.6 5.7 3.9 6.6 2.2 7.4 7.0 ABCG2 "ABCP, BCRP, CD338, EST157481, MXR" ENSG00000118777 "ATP binding cassette subfamily G member 2 (Junior blood group)" Q9UNQ0 4 88090264-88231322 "Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 49.6;intestine: 56.6;seminal vesicle: 61.0" "Cell line enhanced" "Detected in many" "A549: 19.9;BEWO: 34.7;MCF7: 11.5;RPMI-8226: 17.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 5.7" "Low lineage specificity" "Detected in many" "CAB037299, HPA054719" Enhanced Supported "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "CAB037299: AB_476804, HPA054719: " "unprognostic (5.04e-1)" "unprognostic (3.05e-2)" "unprognostic (2.01e-1)" "unprognostic (1.10e-1)" "unprognostic (1.01e-3)" "unprognostic (9.19e-2)" "unprognostic (1.09e-1)" "unprognostic (1.30e-1)" "unprognostic (9.14e-2)" "unprognostic (1.37e-1)" "unprognostic (3.01e-3)" "unprognostic (4.52e-2)" "unprognostic (1.67e-3)" "unprognostic (8.82e-3)" "unprognostic (7.04e-2)" "unprognostic (1.30e-1)" "unprognostic (1.92e-1)" 2.8 2.5 11.6 0.8 14.8 1.2 2.4 4.3 9.7 13.6 12.5 8.4 49.6 24.9 14.4 4.2 1.5 6.1 3.3 2.0 16.0 12.2 2.3 19.7 3.0 0.8 17.6 5.6 5.6 0.6 3.2 7.0 12.3 17.0 5.5 8.1 6.9 2.9 61.0 0.4 0.6 56.6 11.8 15.7 0.9 1.2 1.9 5.5 0.0 3.8 0.8 1.3 2.0 3.1 1.2 0.5 0.0 0.2 2.4 5.7 0.7 0.7 19.9 5.9 0.0 0.2 0.0 34.7 0.7 0.6 1.0 1.7 4.4 0.2 0.0 0.2 0.1 5.8 0.2 0.6 1.5 5.6 0.9 0.2 0.1 5.9 0.0 0.3 0.0 0.1 2.4 2.3 0.1 1.8 0.4 0.0 0.6 11.5 2.7 0.1 2.0 0.0 1.3 0.0 17.4 0.0 4.2 0.1 0.2 4.1 0.4 0.5 0.1 0.0 0.0 0.8 0.7 0.2 0.0 5.5 2.1 0.0 1.5 0.0 0.8 0.0 0.0 0.0 1.9 0.0 5.7 0.1 0.7 0.6 0.0 1.2 0.7 0.3 0.0 2.4 0.2 0.5 1.7 0.7 11.6 14.8 4.3 9.7 16.0 12.2 17.6 5.6 17.0 5.5 ABCG5 STSL ENSG00000138075 "ATP binding cassette subfamily G member 5" Q9H222 2 43812472-43838865 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 85 "intestine: 54.3;liver: 40.9" "Cell line enriched" "Detected in single" 47 "Hep G2: 14.4" "Cancer enriched" "Detected in some" 23 "liver cancer: 11.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "unprognostic (1.71e-1)" "unprognostic (5.47e-2)" "unprognostic (4.01e-1)" "unprognostic (6.92e-2)" "unprognostic (2.24e-1)" "unprognostic (9.97e-2)" "prognostic favourable (2.60e-5)" "unprognostic (4.59e-2)" "unprognostic (3.10e-1)" "unprognostic (1.38e-3)" "unprognostic (3.07e-4)" "unprognostic (1.86e-1)" "unprognostic (3.07e-1)" "unprognostic (5.52e-3)" "unprognostic (8.29e-2)" "unprognostic (5.31e-2)" "unprognostic (3.08e-2)" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 19.5 0.0 0.0 27.6 0.1 0.2 0.1 0.1 0.5 0.1 0.1 0.1 0.1 40.9 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 54.3 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 AC007040.2 ENSG00000258881 2 70939318-70995336 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "skin 1: 2.8;testis: 2.7" "Cell line enhanced" "Detected in many" "U-2 OS: 5.4" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "unprognostic (1.86e-1)" "unprognostic (2.94e-1)" "unprognostic (7.99e-4)" "unprognostic (1.36e-1)" "unprognostic (9.49e-2)" "unprognostic (1.78e-3)" "unprognostic (2.35e-1)" "unprognostic (1.34e-1)" "unprognostic (1.44e-1)" "unprognostic (1.95e-2)" "unprognostic (1.52e-1)" "unprognostic (2.93e-1)" "unprognostic (2.53e-9)" "unprognostic (6.54e-2)" "unprognostic (7.86e-2)" "unprognostic (2.07e-1)" "unprognostic (1.32e-1)" 0.4 0.1 0.9 0.3 0.7 1.0 0.5 1.5 0.8 0.3 0.3 0.4 0.4 0.4 0.3 0.5 0.3 0.2 0.6 0.4 0.6 0.0 0.2 0.4 0.2 0.5 0.4 0.0 0.1 0.2 0.6 0.1 1.6 0.1 0.7 2.8 0.1 0.1 0.3 0.2 0.0 2.7 0.5 0.0 0.2 0.3 0.7 0.4 1.5 0.5 1.0 1.3 0.1 2.7 0.3 0.2 1.5 0.3 0.3 1.1 0.2 0.1 0.5 0.7 0.3 0.3 3.9 0.4 0.5 0.6 1.1 0.1 0.8 3.1 2.8 2.4 0.4 0.9 0.0 0.1 1.0 0.3 0.1 0.8 0.1 1.5 0.2 1.0 0.5 0.7 0.3 0.3 0.3 0.4 3.1 1.0 0.1 0.8 0.3 0.3 0.3 0.6 0.6 1.2 1.0 0.1 1.1 3.0 5.4 0.8 2.5 0.4 0.1 0.1 3.3 1.4 2.9 0.7 0.5 1.5 0.7 0.3 0.8 0.6 0.5 0.3 0.2 0.7 1.3 0.8 1.1 1.0 0.3 0.4 0.4 0.1 ACER3 "APHC, FLJ11238, PHCA" ENSG00000078124 "Alkaline ceramidase 3" Q9NUN7 11 76860867-77026797 "Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" Hydrolase "Disease mutation, Leukodystrophy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA070087 Approved "HPA070087: " "unprognostic (1.32e-1)" "unprognostic (1.51e-1)" "unprognostic (9.54e-3)" "unprognostic (1.37e-1)" "unprognostic (4.06e-2)" "unprognostic (1.34e-1)" "prognostic unfavourable (2.49e-4)" "unprognostic (7.13e-2)" "unprognostic (2.35e-3)" "unprognostic (8.45e-3)" "unprognostic (1.30e-1)" "unprognostic (3.68e-3)" "prognostic unfavourable (2.73e-4)" "unprognostic (5.24e-2)" "unprognostic (3.37e-1)" "unprognostic (9.88e-2)" "unprognostic (7.97e-2)" 18.3 5.9 11.8 8.6 19.8 7.1 7.8 7.9 15.2 10.5 10.8 29.5 1.5 12.0 7.0 7.1 9.8 5.4 6.3 5.3 14.7 11.0 9.1 4.9 11.3 8.2 27.3 7.2 4.0 4.6 8.3 3.6 31.6 21.8 8.3 10.0 6.0 6.3 5.0 2.7 6.1 8.1 7.2 22.0 8.7 7.2 9.3 24.6 1.3 6.0 6.5 6.7 5.4 6.5 1.6 4.7 3.9 5.0 0.6 2.2 1.4 4.9 5.9 4.8 5.9 21.9 10.4 3.2 7.3 7.5 6.1 6.7 4.1 5.5 4.6 5.3 5.6 8.8 6.6 7.8 7.5 5.6 2.2 7.2 4.0 2.8 6.1 6.4 12.5 5.3 3.9 7.3 8.2 10.5 4.0 2.3 6.9 4.7 0.5 4.9 2.5 5.8 2.9 16.5 3.1 5.2 5.2 1.7 4.3 8.6 10.0 2.7 7.1 3.9 13.6 6.1 4.6 18.4 5.9 2.0 4.2 6.4 3.9 3.7 7.2 0.6 5.0 3.9 1.2 4.5 1.4 1.6 0.9 1.5 4.7 1.0 0.7 1.0 1.8 0.6 2.8 2.5 2.2 1.4 11.8 19.8 7.9 14.4 14.7 11.0 27.3 7.2 21.8 24.6 ADRA1A "ADRA1C, ADRA1L1" ENSG00000120907 "Adrenoceptor alpha 1A" P35348 8 26748150-26867273 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 45.1" "Group enriched" "Detected in some" 5 "ASC diff: 1.3;HAP1: 1.8;NTERA-2: 2.4;U-2 OS: 1.5" "Cancer enhanced" "Detected in some" "liver cancer: 0.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029678, HPA029679" Approved Supported "HPA029678: AB_10602108, HPA029679: " "unprognostic (1.27e-1)" "unprognostic (1.68e-2)" "unprognostic (1.99e-1)" "unprognostic (3.57e-1)" "unprognostic (5.04e-4)" "unprognostic (1.97e-1)" "unprognostic (9.55e-2)" "unprognostic (3.08e-1)" "unprognostic (1.58e-2)" "unprognostic (7.47e-2)" "unprognostic (1.71e-2)" "unprognostic (6.06e-3)" "unprognostic (7.41e-2)" "unprognostic (1.52e-2)" "unprognostic (1.30e-1)" 14.5 0.7 7.1 1.1 3.9 0.3 3.4 6.2 4.9 0.9 1.5 5.9 4.9 1.0 1.8 2.0 0.9 0.6 0.5 10.1 11.6 2.0 0.8 45.1 3.9 1.4 4.7 4.7 1.0 0.5 0.3 0.6 0.3 3.8 10.2 0.7 0.6 4.6 11.2 0.6 0.9 1.3 2.4 1.9 7.0 1.2 0.5 4.2 0.0 0.6 0.1 0.6 0.6 0.7 0.3 0.0 0.3 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.4 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.3 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.3 0.0 0.2 0.3 0.2 0.0 0.0 0.0 0.0 7.1 3.9 6.2 4.9 11.6 2.0 4.7 4.7 3.8 4.2 ADTRP "AIG1L, C6orf105, dJ413H6.1" ENSG00000111863 "Androgen dependent TFPI regulating protein" Q96IZ2 6 11712054-11807046 "Predicted membrane proteins" "Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 48.3;intestine: 61.2;retina: 38.0;seminal vesicle: 48.0" "Cell line enhanced" "Detected in some" "hTERT-HME1: 10.3;HUVEC TERT2: 35.2;RPMI-8226: 13.3;TIME: 19.0;U-138 MG: 12.7;U-266/84: 14.9" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 6 "pons and medulla: 12.4" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 10.5;T-reg: 9.8" "Lineage enriched" "Detected in many" 7 "T-cells: 10.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA048113 Uncertain Uncertain Nucleoli Nucleoli "HPA048113: " "unprognostic (6.82e-3)" "unprognostic (1.41e-1)" "unprognostic (1.58e-1)" "unprognostic (8.14e-3)" "unprognostic (3.04e-3)" "unprognostic (1.41e-2)" "unprognostic (4.00e-2)" "unprognostic (1.77e-1)" "unprognostic (1.85e-2)" "unprognostic (2.72e-1)" "unprognostic (5.41e-3)" "unprognostic (2.90e-1)" "prognostic unfavourable (1.13e-5)" "unprognostic (2.61e-2)" "unprognostic (1.40e-1)" "unprognostic (1.95e-2)" "unprognostic (1.26e-1)" 0.8 0.4 0.6 10.6 0.8 0.0 0.9 0.3 2.1 0.4 21.8 1.5 48.3 22.4 0.4 4.0 0.9 0.5 0.3 0.5 1.2 0.4 3.8 1.0 3.9 2.0 0.4 1.1 0.4 0.6 0.8 0.3 0.3 12.4 1.7 16.2 38.0 0.7 48.0 0.4 12.7 61.2 0.5 0.4 1.0 11.4 14.1 0.1 0.8 0.7 0.6 3.2 2.7 0.5 0.2 0.2 1.4 0.3 0.1 10.5 1.5 1.6 0.0 0.0 0.0 0.2 0.3 0.0 0.5 0.3 0.4 0.3 1.5 0.8 0.0 0.7 0.3 0.7 0.0 4.7 0.6 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.1 0.0 8.7 3.5 10.3 35.2 8.5 0.0 1.2 0.0 0.0 0.2 0.1 2.4 0.0 0.1 13.3 0.7 0.1 0.0 0.1 0.6 0.0 0.3 0.0 0.3 19.0 12.7 0.9 0.3 1.0 0.5 14.9 0.0 2.6 0.5 0.1 1.4 0.1 0.0 0.0 0.3 2.3 0.2 2.8 0.2 0.1 0.1 10.5 0.8 0.2 0.1 0.2 0.2 9.8 1.5 0.6 0.8 0.3 2.1 1.2 0.4 0.4 1.1 12.4 0.1 AL845331.2 ENSG00000259916 2 94588522-94604573 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 13 "adipose tissue: 12.1" "Cell line enriched" "Detected in single" 11 "ASC diff: 6.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (1.97e-1)" "unprognostic (1.24e-1)" "unprognostic (8.07e-3)" "unprognostic (1.39e-1)" "unprognostic (1.85e-1)" "unprognostic (1.45e-1)" "unprognostic (1.15e-1)" "unprognostic (9.15e-3)" "unprognostic (6.22e-2)" "unprognostic (4.66e-2)" 12.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ALG9 DIBD1 ENSG00000086848 "ALG9, alpha-1,2-mannosyltransferase" Q9H6U8 11 111782195-111871581 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA038575 Approved Approved "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA038575: AB_10672718" "unprognostic (1.48e-1)" "unprognostic (5.39e-2)" "unprognostic (6.22e-2)" "unprognostic (5.34e-3)" "unprognostic (8.72e-2)" "unprognostic (2.90e-1)" "unprognostic (2.43e-2)" "unprognostic (1.04e-2)" "unprognostic (7.07e-3)" "unprognostic (5.11e-2)" "unprognostic (8.75e-3)" "unprognostic (1.52e-2)" "prognostic unfavourable (7.29e-5)" "unprognostic (9.15e-2)" "unprognostic (7.76e-2)" "unprognostic (4.20e-2)" "unprognostic (1.10e-2)" 19.9 13.5 11.8 11.4 17.9 9.0 16.8 19.3 19.3 16.9 13.7 15.6 15.7 16.2 19.1 15.7 13.8 12.5 14.0 14.3 11.6 13.7 13.7 17.7 12.3 13.5 12.2 11.2 19.2 29.9 21.0 16.5 20.3 14.6 14.7 14.9 17.5 34.3 20.1 11.7 17.3 13.2 15.8 13.2 13.0 14.1 25.0 9.8 15.3 17.4 10.9 15.2 13.8 14.2 7.8 9.5 7.0 7.9 7.1 12.2 6.5 9.7 9.8 19.3 18.9 12.0 11.5 14.7 12.7 10.3 10.5 11.4 16.8 16.6 15.7 18.1 14.2 18.3 10.1 15.3 14.9 12.1 7.9 11.9 5.8 12.3 14.0 13.4 8.3 10.0 10.4 11.0 10.9 10.1 11.9 24.6 17.2 7.2 13.4 11.9 6.4 10.9 12.3 17.2 30.6 11.6 8.7 9.5 16.3 11.2 17.1 6.8 18.5 5.5 9.9 22.2 15.6 10.7 13.6 8.0 6.0 14.8 9.2 16.7 15.0 6.7 5.8 7.0 8.5 7.9 9.4 7.8 8.0 8.8 9.5 6.6 12.2 7.3 2.3 7.1 6.9 9.4 7.7 6.5 11.8 17.9 19.3 19.3 11.6 13.7 12.2 11.2 14.6 9.8 AMFR "gp78, RNF45" ENSG00000159461 "Autocrine motility factor receptor" Q9UKV5 16 56361452-56425538 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway, Wnt signaling pathway" "Receptor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026381, HPA029018, HPA077835" Approved Supported "Endoplasmic reticulum,Golgi apparatus" "Endoplasmic reticulum, Golgi apparatus" "CAB026381: , HPA029018: , HPA077835: " "unprognostic (1.72e-2)" "unprognostic (1.62e-1)" "unprognostic (1.62e-2)" "unprognostic (2.43e-2)" "unprognostic (3.60e-3)" "unprognostic (6.06e-2)" "unprognostic (1.04e-1)" "unprognostic (1.26e-3)" "unprognostic (1.28e-1)" "unprognostic (1.43e-1)" "unprognostic (2.97e-1)" "unprognostic (4.16e-2)" "unprognostic (5.52e-3)" "unprognostic (1.45e-1)" "unprognostic (1.68e-1)" "unprognostic (1.91e-1)" "unprognostic (2.28e-1)" 13.9 25.9 21.3 10.6 23.8 14.1 28.7 12.6 25.0 17.2 21.0 24.5 18.5 21.6 16.6 25.2 20.8 15.3 13.7 17.6 20.6 20.2 35.2 50.0 13.3 19.3 22.3 14.3 20.5 14.0 33.3 13.0 41.6 18.9 14.9 11.8 23.8 12.6 18.6 71.6 11.9 18.8 16.0 25.0 14.3 12.2 36.8 17.5 14.6 18.6 10.1 19.3 15.5 16.9 18.3 10.6 21.4 13.1 11.7 9.7 4.0 17.4 24.4 10.7 19.6 33.4 18.8 9.4 18.9 23.4 25.7 20.2 21.6 16.6 45.6 21.9 25.5 16.4 16.3 14.7 24.6 10.2 16.8 13.8 10.1 23.2 29.3 10.7 16.0 21.8 21.3 20.5 24.6 14.9 14.3 6.3 18.6 11.1 16.0 11.4 5.0 16.8 18.1 21.5 17.1 15.9 18.3 10.7 8.2 44.4 15.6 14.3 46.9 11.2 19.3 24.3 13.3 12.3 12.7 13.6 11.9 24.2 17.6 7.8 11.1 21.4 8.5 10.9 6.9 9.9 9.7 18.3 8.7 7.1 7.8 15.6 9.1 9.5 10.5 11.7 13.1 10.6 9.0 4.0 21.3 23.8 12.6 25.0 20.6 20.2 22.3 14.3 18.9 17.5 APH1B "APH-1B, DKFZp564D0372, PSFL" ENSG00000138613 "Aph-1 homolog B, gamma-secretase subunit" Q8WW43 15 63276018-63309126 "Predicted membrane proteins" "Notch signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 37.1;testis: 75.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "unprognostic (9.92e-2)" "unprognostic (1.03e-2)" "unprognostic (1.49e-1)" "unprognostic (1.75e-1)" "unprognostic (3.55e-2)" "unprognostic (3.57e-1)" "unprognostic (7.86e-2)" "unprognostic (1.78e-1)" "unprognostic (3.86e-1)" "unprognostic (4.56e-2)" "prognostic favourable (1.05e-4)" "unprognostic (8.44e-2)" "prognostic favourable (2.25e-4)" "unprognostic (4.29e-3)" "unprognostic (2.54e-1)" "unprognostic (1.01e-1)" "unprognostic (1.62e-1)" 6.7 8.0 5.3 5.9 7.8 4.5 6.9 6.1 7.1 5.0 3.4 12.6 4.8 2.4 6.3 8.0 3.0 10.4 5.1 5.6 5.6 5.8 5.1 2.2 5.8 15.0 6.8 6.2 9.6 2.9 4.3 5.6 5.0 7.4 7.7 2.9 8.6 5.0 5.4 2.5 3.4 4.5 4.6 7.5 9.2 3.2 75.6 3.4 8.0 12.3 2.0 5.0 5.3 4.2 8.4 5.7 16.6 37.1 2.3 4.9 6.5 0.7 4.7 5.2 4.2 12.0 21.1 1.8 6.2 12.7 4.7 8.0 4.4 6.9 6.1 3.0 6.8 0.7 8.8 2.4 8.9 4.1 1.3 10.6 1.1 0.1 9.9 2.3 17.6 13.2 4.0 7.0 4.7 9.9 3.6 4.6 14.7 2.1 3.1 7.2 5.0 2.5 3.1 2.9 0.1 2.4 4.8 4.6 2.5 2.5 2.1 0.0 7.7 13.8 6.6 14.1 5.5 2.3 0.9 11.2 18.6 8.3 10.2 13.9 8.2 10.6 12.0 14.8 4.2 22.9 3.4 8.4 4.4 3.8 5.7 6.4 4.8 4.9 16.6 2.3 37.1 2.1 4.2 6.5 5.3 7.8 6.1 7.1 5.6 5.8 6.8 6.2 7.4 3.4 AQP1 "CHIP28, CO" ENSG00000240583 "Aquaporin 1 (Colton blood group)" P29972 7 30911694-30925516 "Blood group antigen proteins, Predicted membrane proteins, Transporters" Transport "Blood group antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 156.5" "Cell line enhanced" "Detected in some" "EFO-21: 20.5;HeLa: 6.9;SH-SY5Y: 7.7;U-2 OS: 9.5;WM-115: 37.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "CAB001707, HPA019206" Enhanced Supported "Plasma membrane" 250000 "Plasma membrane" "CAB001707: , HPA019206: AB_1844965" "unprognostic (4.18e-2)" "unprognostic (7.82e-3)" "unprognostic (1.10e-2)" "unprognostic (1.08e-1)" "unprognostic (1.02e-1)" "prognostic favourable (6.52e-4)" "unprognostic (1.95e-3)" "unprognostic (1.66e-1)" "unprognostic (3.00e-2)" "unprognostic (3.80e-2)" "unprognostic (4.16e-1)" "unprognostic (2.05e-2)" "prognostic favourable (1.32e-8)" "unprognostic (3.43e-2)" "unprognostic (1.61e-1)" "unprognostic (2.09e-1)" "unprognostic (7.21e-2)" 68.2 8.0 9.9 8.7 17.1 9.4 51.9 10.7 13.0 46.5 18.1 62.1 7.7 10.8 28.0 20.8 58.8 29.0 36.3 46.7 18.1 15.4 156.5 4.2 103.2 9.1 36.9 17.8 16.4 49.9 12.9 4.0 9.1 63.2 32.4 10.6 8.3 19.8 22.7 35.2 24.8 18.2 41.2 56.4 2.9 18.2 15.0 17.8 1.9 21.3 33.5 12.5 36.0 76.7 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.2 0.1 0.6 0.4 1.8 0.4 1.2 0.4 0.0 0.0 0.2 0.3 0.0 20.5 1.1 0.2 0.0 0.0 0.0 0.1 0.2 0.2 6.9 0.0 0.4 0.1 0.0 3.2 0.0 0.1 0.0 2.8 1.1 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 5.0 0.1 0.7 0.0 0.1 7.7 1.2 0.6 0.0 0.1 0.1 0.0 0.0 9.5 0.7 0.3 0.5 0.3 0.0 0.1 0.0 37.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 9.9 17.1 10.7 13.0 18.1 15.4 36.9 17.8 63.2 17.8 AQP10 ENSG00000143595 "Aquaporin 10" Q96PS8 1 154321090-154325325 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "intestine: 59.9" "Cell line enhanced" "Detected in some" "HEL: 15.6;HMC-1: 6.5;K-562: 17.9;SH-SY5Y: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA062621, HPA065947" Enhanced Approved "Nuclear bodies,Vesicles,Plasma membrane" "Nuclear bodies, Vesicles, Plasma membrane" "HPA062621: , HPA065947: " "unprognostic (6.84e-2)" "unprognostic (4.97e-2)" "unprognostic (4.19e-2)" "unprognostic (1.87e-1)" "unprognostic (1.09e-1)" "unprognostic (8.45e-4)" "unprognostic (1.63e-1)" "unprognostic (3.07e-1)" "unprognostic (4.08e-2)" "unprognostic (3.99e-1)" "unprognostic (1.22e-1)" "unprognostic (1.43e-1)" "unprognostic (1.49e-1)" "unprognostic (1.68e-1)" "unprognostic (7.64e-3)" 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 36.0 0.0 0.0 37.2 0.2 0.3 0.1 4.3 0.5 0.7 0.4 0.0 0.0 0.1 2.2 0.4 0.1 0.0 0.4 0.1 0.0 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.3 59.9 0.0 0.0 2.7 0.3 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.9 0.1 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 15.6 0.0 0.0 0.0 0.0 6.5 0.0 0.1 0.0 0.0 0.0 17.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 7.6 0.0 0.2 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 AQP2 ENSG00000167580 "Aquaporin 2" P41181 12 49950741-49958881 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Diabetes insipidus, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 38 "ductus deferens: 178.6;kidney: 96.5;seminal vesicle: 108.2" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.6;EFO-21: 7.7;HEL: 2.2;HMC-1: 4.7;REH: 1.2" "Group enriched" "Detected in some" 6 "renal cancer: 1.7;stomach cancer: 1.8" "Not detected" "Not detected" "Group enriched" "Detected in some" 14 "intermediate monocyte: 1.4;non-classical monocyte: 1.3" "Lineage enriched" "Detected in single" 14 "monocytes: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA046834 Enhanced "HPA046834: " "unprognostic (2.10e-1)" "unprognostic (3.77e-2)" "unprognostic (6.96e-3)" "unprognostic (4.48e-3)" "unprognostic (3.60e-2)" "unprognostic (9.51e-2)" "unprognostic (2.21e-1)" "unprognostic (1.43e-2)" "unprognostic (2.65e-2)" "unprognostic (7.38e-3)" "unprognostic (5.92e-2)" "unprognostic (4.60e-2)" "unprognostic (2.01e-2)" "unprognostic (1.11e-1)" 0.1 1.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 178.6 0.0 0.1 3.3 0.1 0.1 0.0 0.6 0.1 0.1 96.5 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 2.9 0.0 0.0 0.2 108.2 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.6 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 AQP3 GIL ENSG00000165272 "Aquaporin 3 (Gill blood group)" Q92482 9 33441154-33447633 "Blood group antigen proteins, Plasma proteins, Predicted membrane proteins" Transport "Blood group antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 179.6;lymphoid tissue: 156.1;salivary gland: 194.2;tongue: 132.4" "Cell line enhanced" "Detected in many" "HaCaT: 28.0;HeLa: 50.9;RT4: 47.4;SK-BR-3: 32.8;U-266/70: 34.0;U-266/84: 44.0" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in some" 5 "hippocampal formation: 2.1;pons and medulla: 6.7" "Group enriched" "Detected in many" 6 "MAIT T-cell: 41.1;memory CD4 T-cell: 39.2;memory CD8 T-cell: 12.0;naive CD4 T-cell: 22.7;naive CD8 T-cell: 10.8;T-reg: 42.1" "Lineage enriched" "Detected in many" 16 "T-cells: 42.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA014924 Enhanced Supported "Nucleoplasm,Plasma membrane" "Plasma membrane" Nucleoplasm "HPA014924: " "unprognostic (4.29e-2)" "prognostic favourable (5.31e-4)" "unprognostic (1.15e-1)" "unprognostic (3.26e-2)" "unprognostic (1.84e-2)" "unprognostic (1.11e-2)" "unprognostic (9.95e-2)" "unprognostic (1.64e-1)" "unprognostic (3.46e-1)" "unprognostic (9.06e-2)" "unprognostic (4.87e-2)" "unprognostic (1.25e-1)" "unprognostic (1.54e-2)" "unprognostic (1.16e-2)" "unprognostic (2.59e-1)" "unprognostic (3.73e-2)" "unprognostic (4.51e-2)" 1.3 0.4 0.4 2.7 0.2 1.9 5.2 0.9 0.3 29.7 26.7 0.1 1.7 9.9 5.5 3.2 179.6 3.3 2.0 6.0 2.1 0.4 23.9 44.0 16.5 5.7 0.5 0.3 3.6 5.7 0.0 0.7 5.3 6.7 15.5 1.2 0.4 194.2 5.5 0.9 65.2 33.2 5.1 0.3 17.2 3.9 1.2 0.0 70.6 0.6 132.4 156.1 37.6 60.2 2.6 2.4 0.5 0.1 0.5 42.1 10.3 0.1 8.4 0.4 0.0 15.5 2.8 0.2 0.0 0.2 0.2 0.2 4.4 2.6 0.1 2.0 0.0 28.0 1.3 0.1 0.0 13.3 1.3 0.9 50.9 0.4 0.0 0.2 0.3 0.4 1.4 0.1 0.0 0.1 14.3 13.0 1.5 6.2 12.7 4.9 1.1 0.1 0.2 21.2 2.3 0.2 47.4 0.4 1.0 7.1 32.8 0.0 0.2 2.2 0.2 0.0 0.2 0.0 0.0 34.0 44.0 3.1 0.1 0.0 0.0 0.3 0.1 0.0 4.5 0.0 41.1 2.6 39.2 12.0 0.0 0.5 22.7 10.8 0.5 0.5 0.1 2.4 42.1 10.3 0.4 0.2 0.9 0.3 2.1 0.4 0.5 0.3 6.7 0.0 AQP4 MIWC ENSG00000171885 "Aquaporin 4" P55087 18 26852038-26865818 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 185.1;lung: 53.5" "Cell line enhanced" "Detected in some" "AF22: 6.7;Karpas-707: 2.0;RPTEC TERT1: 3.8;U-87 MG: 1.7" "Cancer enriched" "Detected in some" 22 "glioma: 223.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005079, HPA014784, CAB058689" Enhanced Supported Approved "Plasma membrane,Cell Junctions" "Plasma membrane" "Cell Junctions" "CAB005079: AB_2274338, CAB058689: , HPA014784: AB_1844967" "unprognostic (7.23e-5)" "unprognostic (1.55e-1)" "unprognostic (3.19e-8)" "unprognostic (3.68e-1)" "unprognostic (1.96e-1)" "unprognostic (2.69e-2)" "unprognostic (1.74e-1)" "unprognostic (2.34e-1)" "unprognostic (5.38e-3)" "unprognostic (1.64e-3)" "unprognostic (8.98e-2)" "unprognostic (1.22e-1)" "unprognostic (4.14e-2)" "unprognostic (1.35e-1)" "unprognostic (4.10e-2)" 1.7 1.7 60.7 1.6 57.1 1.6 1.8 21.8 185.1 1.9 1.6 41.3 0.0 1.6 1.6 2.0 1.9 2.1 1.6 2.7 64.3 27.1 2.7 2.0 53.5 1.7 39.8 36.4 2.8 1.7 2.9 0.8 1.6 39.1 1.8 1.6 0.0 1.8 1.7 25.4 1.6 1.6 1.6 67.2 1.8 6.1 1.7 42.2 0.0 8.4 0.1 1.6 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.5 0.2 0.9 0.0 0.0 0.0 0.0 3.8 0.0 1.3 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.7 57.1 21.8 31.7 64.3 27.1 39.8 36.4 39.1 42.2 AQP5 ENSG00000161798 "Aquaporin 5" P55064 12 49961870-49965681 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease mutation, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "salivary gland: 217.9;testis: 76.2" "Group enriched" "Detected in some" 9 "CAPAN-2: 11.2;REH: 12.8" "Cancer enhanced" "Detected in many" "endometrial cancer: 87.5" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA065008 Enhanced Approved "Plasma membrane" "Plasma membrane" "HPA065008: " "unprognostic (4.67e-3)" "unprognostic (5.00e-2)" "unprognostic (3.30e-1)" "unprognostic (6.00e-3)" "unprognostic (1.92e-3)" "prognostic favourable (1.75e-5)" "unprognostic (4.13e-3)" "unprognostic (1.02e-2)" "unprognostic (9.39e-2)" "unprognostic (3.70e-3)" "unprognostic (2.88e-3)" "unprognostic (2.46e-3)" "unprognostic (1.69e-4)" "unprognostic (2.53e-1)" "unprognostic (5.28e-2)" "unprognostic (2.51e-3)" "unprognostic (9.11e-3)" 0.2 0.1 0.4 0.2 1.1 0.0 3.8 0.4 0.3 3.0 0.3 0.4 0.3 3.2 0.6 0.8 3.8 0.1 15.6 1.0 0.3 0.3 0.2 0.2 2.3 0.2 0.7 0.2 0.2 0.8 0.1 0.4 0.2 0.3 0.5 0.0 0.4 217.9 0.6 0.9 23.5 0.3 0.6 0.2 0.2 12.0 76.2 0.3 0.2 0.3 2.8 11.5 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 11.2 0.0 1.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.5 0.9 0.0 12.8 0.0 0.0 0.4 0.0 0.3 0.1 1.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.4 0.3 0.3 0.3 0.7 0.2 0.3 0.3 AQP6 AQP2L ENSG00000086159 "Aquaporin 6" Q13520 12 49967194-49977139 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 25 "kidney: 40.1" "Cell line enhanced" "Detected in some" "A549: 2.5;SH-SY5Y: 2.6" "Cancer enriched" "Detected in many" 9 "renal cancer: 9.1" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Region enriched" "Detected in some" 7 "cerebellum: 23.5" "Low region specificity" "Detected in all" HPA015278 Enhanced "HPA015278: AB_10600982" "unprognostic (1.23e-1)" "unprognostic (1.32e-2)" "unprognostic (9.53e-2)" "unprognostic (2.02e-2)" "unprognostic (6.46e-2)" "unprognostic (4.60e-3)" "unprognostic (3.45e-2)" "unprognostic (1.46e-2)" "unprognostic (1.36e-1)" "unprognostic (8.68e-3)" "unprognostic (1.71e-1)" "unprognostic (2.00e-1)" "unprognostic (1.74e-1)" "unprognostic (6.85e-2)" "unprognostic (9.22e-2)" "unprognostic (9.03e-2)" "unprognostic (1.77e-1)" 0.1 0.2 0.6 0.1 1.1 0.0 0.1 0.3 1.6 0.1 0.1 0.1 0.1 0.2 0.1 0.2 0.1 0.0 0.1 0.1 0.7 0.5 40.1 0.2 0.1 0.1 1.2 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.2 0.0 0.1 1.0 0.3 0.1 0.0 0.1 0.1 0.4 0.1 0.2 0.7 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.8 0.5 1.2 0.2 0.2 0.4 0.2 0.4 2.5 0.1 0.3 0.1 0.0 0.0 0.5 0.3 0.0 0.0 1.4 1.6 0.0 1.1 0.0 0.3 0.4 0.0 0.1 0.2 1.7 0.0 0.1 0.9 0.4 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.5 0.7 0.0 1.2 0.0 0.7 0.5 1.3 1.2 0.2 0.7 1.2 0.0 0.6 2.6 0.8 0.0 0.8 0.0 0.1 0.0 0.7 1.1 0.0 0.7 0.2 0.2 0.0 0.3 0.3 0.5 1.2 0.2 0.1 0.4 0.1 0.1 0.3 0.1 0.2 0.5 0.8 0.2 0.3 1.1 0.2 0.2 0.2 0.3 0.2 0.6 1.1 0.3 0.3 0.7 0.5 1.2 0.1 0.3 0.1 AQP7 "AQP7L, AQP9, AQPap" ENSG00000165269 "Aquaporin 7" O14520 9 33383179-33402682 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 72.7;breast: 25.6;heart muscle: 21.5" "Cell line enriched" "Detected in some" 52 "ASC diff: 77.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 6 "T-reg: 2.7" "Lineage enriched" "Detected in single" 15 "T-cells: 2.7" "unprognostic (3.25e-2)" "unprognostic (3.81e-3)" "unprognostic (1.25e-5)" "unprognostic (7.22e-3)" "unprognostic (1.50e-1)" "unprognostic (3.32e-1)" "unprognostic (4.67e-2)" "unprognostic (3.06e-2)" "unprognostic (9.99e-2)" "unprognostic (4.65e-2)" "unprognostic (8.56e-4)" "unprognostic (1.21e-1)" "prognostic favourable (9.21e-8)" "unprognostic (2.42e-1)" "unprognostic (1.28e-1)" "unprognostic (1.61e-1)" "unprognostic (2.12e-3)" 72.7 1.2 0.6 1.3 0.8 0.0 25.6 2.4 0.9 0.6 3.9 0.6 0.6 3.9 0.6 1.1 1.2 1.2 2.3 21.5 0.6 0.0 5.3 5.9 0.6 0.6 0.6 0.6 1.0 3.0 10.2 0.6 0.9 1.2 1.2 0.8 0.8 2.7 0.6 8.8 0.9 5.7 0.6 1.0 0.6 0.3 5.5 0.6 0.8 1.0 3.0 1.6 1.7 0.6 0.0 0.0 0.0 0.1 0.0 2.7 0.0 0.0 0.5 0.0 0.0 77.5 1.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 2.7 0.0 0.6 0.8 2.4 0.9 0.6 0.0 0.6 0.6 1.2 0.6 AQP9 "HsT17287, SSC1" ENSG00000103569 "Aquaporin 9" O43315 15 58138169-58185911 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "blood: 127.8;liver: 147.0" "Cell line enriched" "Detected in single" 27 "U-87 MG: 25.3" "Cancer enriched" "Detected in many" 30 "liver cancer: 132.4" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in some" 20 "neutrophil: 127.8" "Lineage enriched" "Detected in many" 20 "granulocytes: 127.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA074762, CAB075684" Enhanced "CAB075684: , HPA074762: " "unprognostic (1.91e-1)" "unprognostic (1.92e-1)" "unprognostic (7.30e-2)" "unprognostic (2.67e-1)" "unprognostic (1.24e-2)" "unprognostic (4.15e-2)" "unprognostic (1.36e-3)" "unprognostic (2.28e-2)" "unprognostic (3.82e-2)" "unprognostic (2.03e-1)" "unprognostic (4.80e-3)" "unprognostic (6.98e-2)" "prognostic unfavourable (5.72e-11)" "unprognostic (8.78e-2)" "unprognostic (1.13e-2)" "unprognostic (1.25e-1)" "unprognostic (8.39e-2)" 7.8 0.3 0.6 12.9 0.7 9.8 0.6 0.7 1.4 0.2 0.3 0.1 1.0 0.0 0.2 7.8 0.7 3.0 0.8 2.0 0.4 0.2 0.8 147.0 8.6 12.0 2.4 0.4 1.2 0.3 2.8 0.4 1.4 0.6 0.4 0.0 0.5 0.4 0.8 0.4 6.9 0.3 1.0 0.5 15.8 0.7 2.5 0.4 0.4 0.5 0.1 0.4 1.3 0.6 0.0 0.2 127.8 6.2 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 25.3 0.1 0.0 0.0 6.2 0.1 0.0 1.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 127.8 0.0 2.3 0.0 0.0 1.7 0.6 0.7 0.7 1.4 0.4 0.2 2.4 0.4 0.6 0.4 ARL6IP1 "AIP1, ARL6IP, ARMER, KIAA0069, SPG61" ENSG00000170540 "ADP ribosylation factor like GTPase 6 interacting protein 1" Q15041 16 18791667-18801678 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA045307 Uncertain Approved "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA045307: AB_10961042" "unprognostic (2.42e-1)" "unprognostic (3.47e-2)" "unprognostic (4.07e-3)" "unprognostic (1.12e-1)" "unprognostic (1.54e-1)" "unprognostic (2.60e-3)" "unprognostic (2.58e-2)" "unprognostic (1.76e-2)" "unprognostic (3.88e-2)" "unprognostic (6.83e-2)" "unprognostic (1.91e-3)" "unprognostic (3.33e-2)" "unprognostic (1.13e-2)" "unprognostic (7.09e-2)" "unprognostic (4.60e-2)" "unprognostic (6.32e-3)" "unprognostic (5.36e-3)" 29.6 40.9 75.9 16.5 62.0 40.2 26.2 76.5 93.0 19.5 31.5 28.6 13.8 31.4 16.7 29.7 19.8 20.5 30.2 8.8 65.7 70.1 35.1 80.7 18.0 27.0 65.2 44.6 24.7 18.6 45.1 13.4 20.3 68.6 18.1 29.0 40.9 18.6 17.4 8.3 14.8 27.5 16.0 43.0 20.4 27.8 28.1 20.4 33.1 26.2 11.3 24.9 27.8 14.2 41.2 57.2 40.1 32.4 44.1 67.7 63.0 47.3 43.3 57.7 45.0 20.7 13.3 51.6 27.7 26.8 43.1 34.5 26.6 114.9 41.4 50.9 26.5 52.0 41.3 19.5 50.2 53.0 18.7 29.4 26.8 72.2 16.4 41.5 31.5 11.1 19.0 29.8 31.2 43.0 32.0 43.3 82.9 42.9 29.2 31.4 70.7 14.8 49.8 72.3 35.2 46.2 26.7 35.1 39.9 60.9 38.2 27.3 78.4 42.0 23.7 28.4 26.7 20.1 49.5 14.7 26.0 50.0 25.3 28.4 54.7 40.1 32.4 20.9 48.7 30.0 44.7 41.2 43.2 52.4 32.0 38.3 38.5 45.8 27.7 44.1 30.9 57.2 67.7 63.0 75.9 62.0 76.5 93.0 65.7 70.1 65.2 44.6 68.6 20.4 ATG9A "APG9L1, FLJ22169" ENSG00000198925 "Autophagy related 9A" Q7Z3C6 2 219219380-219229717 "Predicted membrane proteins, Transporters" "Autophagy, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA059551 Uncertain Supported Vesicles Vesicles "HPA059551: " "unprognostic (1.53e-2)" "unprognostic (4.03e-1)" "unprognostic (1.46e-2)" "unprognostic (5.04e-2)" "unprognostic (4.80e-1)" "unprognostic (1.92e-1)" "prognostic unfavourable (2.18e-5)" "unprognostic (8.99e-3)" "unprognostic (2.07e-1)" "unprognostic (3.55e-3)" "unprognostic (4.67e-2)" "unprognostic (4.21e-1)" "unprognostic (2.23e-2)" "unprognostic (4.84e-2)" "unprognostic (3.15e-1)" "unprognostic (5.61e-2)" "unprognostic (1.95e-2)" 13.9 14.3 15.2 9.0 26.1 23.3 13.2 26.7 37.9 12.2 15.0 23.8 10.0 17.1 14.9 9.4 17.6 10.4 13.3 23.4 14.2 13.2 12.6 21.0 13.6 10.2 18.5 14.0 12.9 16.7 27.0 10.8 20.3 20.6 12.8 14.3 12.5 14.0 14.9 61.3 17.5 19.8 18.0 14.3 13.0 13.0 47.0 16.3 7.8 13.1 16.6 12.6 14.7 12.3 5.0 6.6 8.8 16.8 8.4 7.6 8.5 9.5 12.6 9.9 22.7 20.4 21.4 12.7 17.9 21.1 25.1 22.9 19.1 13.4 2.4 14.4 29.3 21.3 16.0 20.6 19.2 7.7 24.4 19.2 32.5 21.8 20.2 5.1 14.7 21.4 34.2 26.1 24.5 25.7 26.1 9.8 17.3 12.5 4.1 10.7 6.9 10.1 5.6 13.1 9.7 14.7 14.1 15.2 8.8 18.1 16.8 15.8 6.2 12.4 17.4 25.0 11.6 10.1 16.1 5.3 5.0 3.9 20.3 12.0 13.5 4.8 9.4 4.3 6.2 14.4 6.6 5.0 4.9 7.6 6.6 3.4 4.7 5.5 8.8 8.4 16.8 2.9 5.6 8.5 15.2 26.1 26.7 37.9 14.2 13.2 18.5 14.0 20.6 16.3 ATG9B "APG9L2, FLJ14885, NOS3AS, SONE" ENSG00000181652 "Autophagy related 9B" Q674R7 7 151012209-151024499 "Predicted membrane proteins, Transporters" Autophagy "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "placenta: 67.1" "Group enriched" "Detected in some" 6 "BEWO: 16.6;CAPAN-2: 5.4" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 4 "memory CD4 T-cell: 6.0;naive CD4 T-cell: 11.0;naive CD8 T-cell: 4.1;T-reg: 5.9" "Lineage enriched" "Detected in many" 7 "T-cells: 11.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "unprognostic (1.59e-1)" "unprognostic (2.18e-2)" "unprognostic (1.31e-1)" "unprognostic (5.03e-2)" "unprognostic (1.53e-3)" "unprognostic (1.05e-3)" "unprognostic (2.79e-3)" "unprognostic (6.66e-2)" "unprognostic (2.38e-3)" "unprognostic (6.76e-2)" "unprognostic (2.02e-1)" "unprognostic (5.06e-2)" "unprognostic (2.08e-6)" "unprognostic (2.82e-2)" "unprognostic (2.70e-2)" "unprognostic (6.34e-2)" "unprognostic (2.63e-1)" 0.0 0.5 0.0 0.2 8.8 0.1 0.1 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.5 1.2 15.4 1.1 0.1 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 6.1 67.1 0.3 0.0 0.0 0.0 0.4 0.0 0.0 13.7 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 8.8 10.5 0.0 0.1 1.6 0.8 0.2 0.1 0.4 11.0 1.9 0.7 0.0 0.9 0.2 0.0 0.0 16.6 0.0 0.0 0.0 0.0 0.1 5.4 0.4 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.7 1.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.2 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.3 1.9 0.5 0.7 0.0 0.4 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.2 1.3 0.0 1.2 1.1 6.0 1.6 0.0 1.6 11.0 4.1 0.0 0.4 0.1 0.8 5.9 1.9 ATP11A "ATPIH, ATPIS, KIAA1021" ENSG00000068650 "ATPase phospholipid transporting 11A" P98196 13 112690329-112887168 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035583, HPA035584" Approved Enhanced Vesicles Vesicles "HPA035583: AB_10671106, HPA035584: AB_10672096" "unprognostic (1.67e-1)" "unprognostic (5.06e-3)" "unprognostic (1.58e-1)" "unprognostic (5.27e-2)" "unprognostic (6.58e-2)" "unprognostic (8.84e-2)" "unprognostic (5.87e-3)" "unprognostic (1.80e-2)" "unprognostic (6.97e-2)" "unprognostic (1.54e-3)" "unprognostic (3.93e-2)" "unprognostic (4.23e-1)" "prognostic favourable (7.44e-4)" "unprognostic (3.85e-2)" "unprognostic (3.69e-1)" "unprognostic (3.26e-2)" "unprognostic (7.40e-3)" 11.1 11.5 7.2 8.3 16.4 15.7 7.9 5.0 12.5 13.6 5.8 24.4 8.7 9.5 13.7 9.2 8.5 10.8 14.6 19.6 7.2 5.4 12.9 12.3 36.9 7.5 17.7 6.9 8.6 13.2 36.1 17.8 11.2 12.8 5.0 3.6 10.0 12.0 9.0 11.2 11.4 8.7 9.1 12.5 10.2 6.1 9.7 16.2 2.1 16.4 6.4 6.0 5.7 11.3 4.2 1.1 6.4 3.1 0.0 1.0 0.6 13.8 7.1 9.0 10.6 4.6 6.2 16.1 6.6 3.9 5.7 4.6 22.3 16.1 7.0 8.1 5.6 11.8 8.1 5.5 5.5 7.0 7.6 8.1 5.9 11.6 7.3 15.2 13.3 4.2 4.2 6.8 4.2 14.8 5.6 1.2 3.9 5.2 6.9 9.6 3.9 5.1 6.0 3.6 4.0 30.9 3.2 14.5 4.0 6.4 8.4 5.5 3.2 20.3 9.7 0.0 12.3 7.3 5.0 3.8 7.5 2.9 2.5 14.3 6.2 0.0 2.3 3.1 1.0 3.1 0.6 1.3 0.6 0.5 1.1 4.2 0.7 0.4 6.4 0.0 2.7 1.1 0.1 0.6 7.2 16.4 5.0 12.5 7.2 5.4 17.7 6.9 12.8 16.2 ATP2B2 PMCA2 ENSG00000157087 "ATPase plasma membrane Ca2+ transporting 2" Q01814 3 10324023-10708007 "Enzymes, Plasma proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 55.1;liver: 15.2;salivary gland: 28.6;skeletal muscle: 30.3" "Group enriched" "Detected in some" 4 "EFO-21: 5.3;RPMI-8226: 15.0;SCLC-21H: 5.7" "Cancer enhanced" "Detected in some" "liver cancer: 7.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB005606 Enhanced "CAB005606: AB_2243199" "unprognostic (2.04e-1)" "unprognostic (1.26e-2)" "unprognostic (6.84e-2)" "unprognostic (1.59e-2)" "unprognostic (3.59e-1)" "unprognostic (3.62e-1)" "unprognostic (4.09e-2)" "unprognostic (4.65e-1)" "unprognostic (5.61e-2)" "unprognostic (1.93e-1)" "unprognostic (2.32e-4)" "unprognostic (2.70e-1)" "unprognostic (1.46e-3)" "unprognostic (1.08e-3)" "unprognostic (1.33e-2)" "unprognostic (8.34e-2)" "unprognostic (7.95e-3)" 1.0 1.5 7.6 1.0 23.0 0.9 1.0 39.9 55.1 3.0 1.0 2.4 0.0 1.0 3.2 1.1 1.1 4.3 1.0 1.0 10.0 6.2 1.1 15.2 1.0 1.0 7.9 14.7 1.0 1.1 0.9 1.7 0.9 15.5 1.0 1.0 0.7 28.6 0.9 30.3 1.3 1.0 2.3 2.5 1.0 1.0 1.5 4.2 0.0 0.9 0.0 1.0 0.9 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.3 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 15.0 0.0 0.0 5.7 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 7.6 23.0 39.9 55.1 10.0 6.2 7.9 14.7 15.5 4.2 ATP7A MNK ENSG00000165240 "ATPase copper transporting alpha" Q04656 X 77910656-78050395 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Copper transport, Ion transport, Transport" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012887, HPA048107" Approved Supported "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA012887: AB_1845205, HPA048107: " "unprognostic (3.14e-2)" "unprognostic (3.48e-1)" "unprognostic (4.90e-2)" "unprognostic (1.49e-2)" "unprognostic (1.26e-1)" "unprognostic (1.03e-1)" "unprognostic (7.17e-3)" "unprognostic (2.59e-2)" "unprognostic (3.17e-2)" "unprognostic (2.47e-1)" "unprognostic (2.30e-2)" "unprognostic (1.14e-1)" "prognostic favourable (8.38e-4)" "unprognostic (1.06e-1)" "unprognostic (2.16e-1)" "unprognostic (3.69e-1)" "unprognostic (2.52e-1)" 9.8 7.4 2.6 8.6 4.6 6.4 8.5 2.3 2.9 8.2 7.7 5.9 9.6 4.8 9.5 7.6 10.0 5.7 4.5 5.1 2.9 2.8 9.0 3.3 9.3 9.3 4.1 1.7 7.3 6.3 13.2 15.9 5.0 4.3 8.2 4.4 5.2 12.3 10.3 6.1 15.9 8.5 7.8 6.3 10.8 7.0 2.7 6.0 15.6 6.0 7.1 11.7 11.8 7.0 2.3 1.4 10.7 2.4 1.7 3.0 1.2 2.5 6.7 4.5 4.6 4.3 4.5 0.8 3.9 5.4 2.3 4.8 0.9 3.0 3.7 5.8 3.8 3.1 5.8 3.1 4.4 5.5 4.0 1.9 6.5 0.7 5.4 3.3 3.5 4.8 1.3 5.0 1.5 6.1 15.3 14.4 4.3 2.2 3.5 1.1 1.3 1.4 2.9 7.5 12.6 3.9 7.2 1.4 17.1 9.6 2.4 4.9 1.8 1.1 7.7 3.1 3.1 4.3 1.5 4.7 8.3 4.3 5.1 2.0 4.7 8.3 2.0 5.5 2.4 1.9 1.2 2.0 1.7 1.7 1.3 2.3 2.1 3.0 10.7 1.7 2.4 1.4 0.6 1.2 2.6 4.6 2.3 2.9 2.9 2.8 4.1 1.7 4.3 6.0 AVPR2 "DIR, DIR3, V2R" ENSG00000126895 "Arginine vasopressin receptor 2" P30518 X 153902531-153907166 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Diabetes insipidus, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 8.9" "Cell line enhanced" "Detected in some" "EFO-21: 5.5;SCLC-21H: 6.5;U-266/84: 5.8;U-698: 6.1" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 26 "intermediate monocyte: 6.2;non-classical monocyte: 5.3" "Lineage enriched" "Detected in single" 28 "monocytes: 6.2" "Not detected" "Not detected" "Region enriched" "Detected in single" 18 "cerebellum: 7.9" "unprognostic (3.05e-2)" "unprognostic (5.62e-2)" "unprognostic (1.99e-4)" "unprognostic (2.50e-4)" "unprognostic (2.76e-1)" "unprognostic (7.10e-6)" "unprognostic (3.80e-3)" "unprognostic (1.17e-1)" "unprognostic (2.20e-1)" "unprognostic (2.56e-2)" "unprognostic (4.21e-2)" "unprognostic (1.91e-1)" "unprognostic (1.33e-1)" "unprognostic (1.08e-2)" "unprognostic (1.87e-1)" "unprognostic (4.38e-1)" "unprognostic (9.83e-2)" 8.9 0.1 0.0 0.1 0.0 0.9 7.1 1.2 0.0 2.1 1.5 0.7 2.7 0.0 0.8 2.6 1.4 6.3 0.0 0.0 4.7 0.0 1.9 1.1 0.0 0.1 0.6 0.2 0.0 0.1 1.1 0.0 1.2 0.8 4.3 2.2 1.3 1.0 0.0 0.0 1.2 0.0 1.9 0.2 1.8 2.1 0.0 0.2 0.0 6.2 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.3 2.8 5.5 0.0 0.0 0.0 0.0 0.0 1.9 0.2 2.1 0.9 0.0 0.1 2.7 2.2 0.0 0.0 0.0 0.0 0.1 0.0 2.6 0.0 0.1 1.4 1.6 0.2 0.1 2.4 1.0 2.5 0.1 0.0 6.5 1.2 0.1 0.0 0.1 0.0 2.4 0.0 0.0 0.0 0.0 0.2 1.1 5.8 6.1 0.0 1.6 0.1 0.0 0.1 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.2 BDKRB1 "B1BKR, BKR1, bradyb1" ENSG00000100739 "Bradykinin receptor B1" P46663 14 96255824-96268967 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 16.1;lymphoid tissue: 17.1" "Cell line enhanced" "Detected in some" "BJ hTERT+: 11.6;HHSteC: 11.9;hTEC/SVTERT24-B: 11.1;U-2197: 12.3;U-87 MG: 40.9" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "cerebellum: 2.1" "Cell type enriched" "Detected in single" 19 "T-reg: 1.8" "Lineage enriched" "Detected in single" 19 "T-cells: 1.8" "Low region specificity" "Detected in single" HPA002935 Approved "HPA002935: AB_1078274" "unprognostic (6.15e-2)" "unprognostic (2.78e-2)" "unprognostic (9.40e-2)" "unprognostic (3.06e-3)" "unprognostic (6.76e-2)" "unprognostic (1.11e-2)" "unprognostic (3.31e-2)" "unprognostic (2.34e-3)" "unprognostic (2.23e-2)" "unprognostic (2.96e-2)" "unprognostic (4.80e-3)" "unprognostic (2.36e-1)" "unprognostic (9.96e-6)" "unprognostic (2.33e-1)" "unprognostic (8.82e-2)" "unprognostic (2.33e-3)" "unprognostic (4.66e-2)" 7.3 0.0 0.2 17.1 0.2 0.0 0.8 2.1 0.6 5.4 3.7 0.2 0.2 1.8 0.7 2.8 10.4 4.8 16.1 2.3 0.2 0.0 2.4 0.6 3.7 0.2 0.2 0.2 4.5 7.9 0.0 0.2 3.0 0.4 2.2 2.8 0.7 1.5 1.1 0.4 2.4 3.7 5.7 0.2 0.6 3.3 2.3 0.2 0.2 0.8 4.6 2.0 13.7 5.6 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.2 0.6 0.0 0.4 1.1 3.9 0.0 1.0 11.6 1.2 0.2 0.0 0.2 0.0 0.0 6.7 1.1 0.0 0.1 1.9 0.1 0.0 0.0 1.1 0.0 11.9 0.0 0.0 0.4 0.9 11.1 0.2 0.0 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.1 0.0 3.5 0.0 0.1 0.0 0.4 0.0 3.2 1.1 0.0 0.0 0.0 0.0 4.4 0.2 12.3 0.6 2.1 4.0 0.0 40.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.2 0.2 2.1 0.6 0.2 0.0 0.2 0.2 0.4 0.2 CACNA1A "APCA, CACNL1A4, Cav2.1, EA2, FHM, HPCA, MHP, MHP1, SCA6" ENSG00000141837 "Calcium voltage-gated channel subunit alpha1 A" O00555 19 13206442-13633025 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 77.9" "Group enriched" "Detected in some" 5 "SCLC-21H: 30.5;U-87 MG: 17.2" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in all" 4 "cerebellum: 77.9" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064258, HPA071902" Enhanced Supported Uncertain "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA064258: , HPA071902: " "unprognostic (1.09e-1)" "unprognostic (3.73e-3)" "unprognostic (2.27e-1)" "unprognostic (2.78e-4)" "unprognostic (4.00e-2)" "unprognostic (2.29e-3)" "unprognostic (5.47e-2)" "unprognostic (3.13e-1)" "unprognostic (2.86e-1)" "unprognostic (1.14e-2)" "prognostic favourable (4.32e-4)" "unprognostic (5.31e-3)" "unprognostic (5.03e-6)" "unprognostic (6.29e-2)" "unprognostic (1.59e-1)" "unprognostic (2.61e-2)" "unprognostic (6.25e-2)" 2.2 5.3 7.6 1.0 12.2 0.7 0.9 77.9 19.7 0.8 1.5 1.8 0.0 3.9 1.2 2.8 0.7 2.2 0.8 1.1 5.7 5.1 0.7 0.5 0.7 1.3 3.9 7.3 1.1 3.0 0.7 1.5 0.6 7.2 0.8 1.7 1.2 0.9 0.8 1.3 0.7 2.8 0.9 3.3 1.3 7.7 1.9 2.8 0.0 0.7 0.0 1.0 0.8 0.3 2.8 0.8 1.9 1.1 0.8 0.8 0.4 0.0 0.1 0.0 3.8 0.1 0.3 0.0 1.6 1.5 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 2.0 0.0 1.2 0.0 0.0 0.0 4.5 0.1 0.0 0.0 0.1 0.9 0.2 0.4 0.0 0.1 0.0 0.1 30.5 0.0 0.0 0.0 0.2 0.0 1.2 0.1 0.1 0.6 0.1 0.0 0.0 0.0 0.0 17.2 0.0 0.4 1.9 0.4 0.7 0.5 0.5 0.8 2.8 0.5 0.3 0.4 1.7 0.6 0.7 1.6 0.8 1.1 0.8 0.6 0.4 7.6 12.2 77.9 17.4 5.7 5.1 3.9 7.3 7.2 2.8 CACNA1E "BII, CACH6, CACNL1A6, Cav2.3" ENSG00000198216 "Calcium voltage-gated channel subunit alpha1 E" Q15878 1 181317690-181808084 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 30.8" "Cell line enhanced" "Detected in some" "CACO-2: 4.0;NB-4: 2.5;NTERA-2: 2.9;SCLC-21H: 2.3;U-266/70: 7.0" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "neutrophil: 1.8" "Lineage enriched" "Detected in single" 8 "granulocytes: 1.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042515, CAB079032" Approved Approved "Plasma membrane,Actin filaments,Cytosol" "Plasma membrane" "Actin filaments, Cytosol" "CAB079032: , HPA042515: " "unprognostic (3.96e-3)" "unprognostic (1.89e-1)" "unprognostic (1.05e-2)" "unprognostic (1.54e-5)" "unprognostic (6.56e-2)" "unprognostic (3.16e-2)" "unprognostic (4.30e-3)" "unprognostic (1.18e-1)" "unprognostic (2.40e-1)" "unprognostic (9.48e-3)" "unprognostic (1.04e-1)" "unprognostic (2.06e-1)" "unprognostic (9.85e-7)" "unprognostic (1.74e-2)" "unprognostic (2.07e-2)" "unprognostic (1.16e-1)" "unprognostic (3.75e-2)" 0.6 3.0 17.9 2.1 19.7 3.1 0.5 3.9 22.5 0.6 0.8 1.3 0.0 0.6 0.6 4.4 1.1 2.3 0.6 0.6 30.8 5.8 3.8 0.6 0.6 1.4 2.4 10.6 0.5 0.6 0.5 0.2 0.8 4.2 0.5 0.8 0.5 0.5 0.5 0.6 0.5 1.1 1.0 5.2 0.9 0.8 2.8 2.4 0.0 0.6 0.0 1.0 0.6 0.1 0.2 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 1.4 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 2.9 0.0 0.0 0.0 1.0 1.3 0.0 2.3 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.1 0.0 0.0 7.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 17.9 19.7 3.9 22.5 30.8 5.8 2.4 10.6 4.2 2.4 CATSPER2 ENSG00000166762 "Cation channel sperm associated 2" Q96P56 15 43628503-43668118 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Calcium transport, Differentiation, Ion transport, Spermatogenesis, Transport" "Calcium channel, Developmental protein, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 43.7" "Cell line enhanced" "Detected in many" "HeLa: 12.6" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 6 "cerebellum: 9.0" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "unprognostic (6.88e-3)" "unprognostic (6.79e-2)" "unprognostic (2.08e-2)" "unprognostic (2.65e-2)" "unprognostic (4.05e-1)" "unprognostic (1.05e-2)" "unprognostic (7.11e-3)" "unprognostic (1.48e-2)" "unprognostic (6.35e-2)" "unprognostic (1.15e-2)" "unprognostic (1.09e-2)" "unprognostic (3.37e-2)" "unprognostic (3.74e-3)" "unprognostic (1.15e-1)" "unprognostic (6.04e-2)" "unprognostic (8.87e-2)" "unprognostic (8.23e-5)" 1.1 0.9 1.1 1.1 1.4 3.2 1.3 9.0 1.1 1.1 1.7 1.1 1.1 2.7 1.1 5.2 1.9 1.1 1.1 1.1 1.1 1.3 1.1 1.1 1.1 1.3 1.1 1.1 1.4 1.1 4.0 3.0 1.1 1.1 1.3 1.9 1.1 1.1 1.9 1.1 4.8 3.1 1.1 1.6 1.1 1.3 43.7 1.1 1.1 1.7 1.1 1.1 1.2 1.1 3.3 1.8 2.3 1.2 1.8 2.9 0.2 2.4 3.5 1.5 5.5 0.0 0.0 2.5 0.9 2.1 1.5 3.7 0.8 1.3 2.9 1.3 0.6 5.4 1.4 4.8 1.5 2.5 6.7 8.4 12.6 1.2 2.3 1.9 2.8 0.3 3.8 2.1 5.4 1.9 3.3 3.1 0.5 0.6 1.6 3.4 0.5 1.5 2.3 1.7 1.4 3.1 3.9 3.3 1.1 1.4 2.1 0.1 4.1 1.9 0.5 3.9 1.6 0.0 2.3 0.6 0.3 5.8 2.7 6.0 1.4 0.4 1.2 0.5 1.3 0.5 1.6 3.3 1.1 1.8 0.8 1.7 1.5 2.9 2.3 1.8 1.2 1.8 0.5 0.2 1.1 1.4 9.0 1.1 1.1 1.3 1.1 1.1 1.1 1.1 CATSPER4 ENSG00000188782 "Cation channel sperm associated 4" Q7RTX7 1 26190561-26202968 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Differentiation, Ion transport, Spermatogenesis, Transport" "Calcium channel, Developmental protein, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 34 "testis: 13.5" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.1;hTCEpi: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045257 Enhanced "HPA045257: AB_10968995" "unprognostic (7.20e-2)" "unprognostic (2.06e-2)" "unprognostic (4.56e-2)" "unprognostic (2.69e-2)" "unprognostic (3.49e-1)" "unprognostic (3.86e-2)" "unprognostic (1.52e-2)" "unprognostic (2.16e-1)" "unprognostic (3.06e-1)" "unprognostic (6.78e-2)" "unprognostic (6.98e-2)" "unprognostic (6.67e-5)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.5 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCR2 "CC-CKR-2, CD192, CKR2, CMKBR2, FLJ78302, MCP-1-R" ENSG00000121807 "C-C motif chemokine receptor 2" P41597 3 46353734-46360928 "CD markers, G-protein coupled receptors, Predicted membrane proteins" "Host-virus interaction, Inflammatory response" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 96.3;lymphoid tissue: 36.1" "Cell line enhanced" "Detected in some" "Karpas-707: 47.4;THP-1: 22.5;U-266/70: 109.2;U-266/84: 43.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "basophil: 96.3" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in single" CAB003793 Approved "CAB003793: AB_344889" "unprognostic (1.09e-2)" "unprognostic (6.28e-4)" "unprognostic (3.49e-2)" "unprognostic (6.35e-4)" "unprognostic (1.89e-2)" "unprognostic (4.16e-4)" "unprognostic (8.06e-2)" "prognostic favourable (5.87e-4)" "unprognostic (6.33e-2)" "unprognostic (3.27e-2)" "unprognostic (3.12e-1)" "unprognostic (1.56e-1)" "unprognostic (5.52e-3)" "unprognostic (1.29e-1)" "unprognostic (3.35e-2)" "unprognostic (4.88e-2)" "unprognostic (4.19e-1)" 2.5 1.3 0.6 20.7 0.8 0.9 1.9 0.5 0.8 4.3 5.8 0.5 1.5 5.6 2.6 2.4 6.1 2.2 2.5 1.8 0.6 0.6 3.7 1.8 8.6 30.1 1.6 0.1 1.7 1.7 0.0 0.8 2.1 1.8 3.7 4.0 2.6 10.2 3.5 0.8 1.3 7.3 5.6 1.5 36.1 3.7 1.5 0.5 3.6 2.0 3.5 5.9 5.8 1.7 1.6 29.0 96.3 28.4 2.5 19.3 13.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 22.5 0.0 0.0 0.0 0.0 0.0 109.2 43.5 0.0 0.0 0.8 0.0 96.3 28.4 0.4 2.5 2.6 19.3 1.6 5.2 4.2 29.0 0.3 0.1 0.1 0.7 2.5 0.0 23.0 2.3 13.5 0.6 0.8 0.5 0.8 0.6 0.6 1.6 0.1 1.8 0.5 CD47 "IAP, MER6, OA3" ENSG00000196776 "CD47 molecule" Q08722 3 108043094-108091862 "CD markers, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016055, HPA044659" Approved Supported "Vesicles,Plasma membrane" 2000000 "Plasma membrane" Vesicles "CAB016055: AB_627086, HPA044659: AB_2679040" "unprognostic (3.54e-2)" "unprognostic (4.74e-2)" "unprognostic (3.19e-2)" "prognostic unfavourable (2.44e-4)" "unprognostic (4.49e-2)" "unprognostic (2.14e-1)" "unprognostic (2.05e-3)" "unprognostic (8.77e-3)" "unprognostic (7.35e-2)" "unprognostic (1.53e-1)" "unprognostic (1.69e-2)" "unprognostic (2.87e-1)" "prognostic unfavourable (1.69e-4)" "unprognostic (7.37e-2)" "unprognostic (3.78e-1)" "prognostic favourable (7.29e-5)" "unprognostic (1.83e-1)" 16.2 24.3 23.0 28.8 46.5 58.0 29.0 44.0 55.5 20.5 25.7 42.5 13.4 19.8 16.2 30.4 46.7 31.7 26.0 26.7 24.1 24.4 19.1 22.1 49.6 35.1 27.4 28.8 16.2 25.7 11.5 34.8 23.3 43.6 40.2 29.0 15.7 43.8 18.9 18.1 19.3 21.2 21.0 37.7 29.0 33.4 20.6 25.0 34.4 30.1 22.0 42.5 25.1 29.1 40.1 35.6 44.1 64.4 45.1 65.3 51.7 45.4 8.2 16.4 9.3 23.6 25.4 21.7 17.2 26.9 13.4 22.9 0.4 25.7 20.9 27.9 16.5 31.2 9.1 17.3 17.5 12.3 6.3 53.1 7.6 0.7 13.7 37.8 71.8 16.3 10.6 12.8 10.3 13.2 12.5 49.6 19.9 23.3 45.9 14.2 6.8 20.9 24.5 12.1 29.5 34.0 18.1 12.5 7.8 10.2 20.4 17.4 36.9 12.4 12.7 34.7 6.4 19.4 11.6 19.2 13.0 29.3 25.3 19.0 9.5 31.7 24.7 44.1 40.2 48.1 35.0 40.1 47.0 42.0 35.6 39.2 35.4 38.3 30.1 45.1 64.4 27.7 65.3 51.7 23.0 46.5 44.0 55.5 24.1 24.4 27.4 28.8 43.6 25.0 CEPT1 ENSG00000134255 "Choline/ethanolamine phosphotransferase 1" Q9Y6K0 1 111139627-111185102 "Enzymes, Predicted membrane proteins, Transporters" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (1.16e-1)" "unprognostic (2.42e-1)" "unprognostic (1.47e-3)" "unprognostic (1.83e-2)" "prognostic favourable (4.96e-4)" "unprognostic (5.52e-2)" "unprognostic (1.10e-1)" "unprognostic (5.61e-2)" "unprognostic (1.54e-3)" "unprognostic (1.84e-1)" "unprognostic (9.20e-3)" "unprognostic (1.03e-1)" "unprognostic (4.60e-2)" "unprognostic (3.58e-2)" "unprognostic (1.10e-1)" "unprognostic (5.88e-2)" "unprognostic (1.27e-2)" 22.4 22.9 16.0 22.2 19.5 5.6 20.1 20.7 19.8 14.9 13.7 22.2 17.5 19.0 18.3 19.1 21.3 16.6 15.3 12.2 17.9 16.0 22.6 39.4 16.5 31.7 22.9 15.1 22.9 17.8 19.6 25.5 22.5 18.2 13.9 18.1 16.9 19.2 12.0 11.2 17.8 20.2 16.3 23.3 34.5 17.5 12.5 21.3 22.3 19.4 11.5 24.7 19.5 17.8 14.6 9.0 4.2 19.1 5.3 9.0 5.5 13.9 5.2 6.2 6.0 24.8 12.3 15.2 15.5 8.8 7.2 8.8 4.6 15.9 16.6 17.2 8.0 17.3 9.0 12.1 10.4 12.3 14.1 7.2 9.5 10.1 16.6 17.0 10.4 9.9 23.4 5.3 25.3 9.6 15.6 10.9 9.4 10.1 17.4 16.8 9.6 10.9 9.5 19.8 13.5 11.8 8.8 8.2 4.4 14.3 21.8 16.5 11.7 18.5 8.3 11.8 7.4 25.6 10.4 10.0 10.9 13.0 15.9 15.3 22.3 3.2 7.6 4.2 6.4 13.6 8.4 14.5 7.2 6.7 9.0 14.6 8.4 9.0 1.9 5.3 19.1 7.0 6.2 5.5 16.0 19.5 20.7 19.8 17.9 16.0 22.9 15.1 18.2 21.3 CERS1 "LAG1, LASS1, UOG1" ENSG00000223802 "Ceramide synthase 1" P27544 19 18868545-18896727 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" Transferase "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 86.3" "Cell line enhanced" "Detected in many" "AN3-CA: 17.4;EFO-21: 12.7;HEK 293: 17.7;NB-4: 19.0;NTERA-2: 13.0" "Cancer enhanced" "Detected in many" "glioma: 13.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 9 "neutrophil: 1.7" "Lineage enriched" "Detected in single" 9 "granulocytes: 1.7" HPA045724 Enhanced Approved "Endoplasmic reticulum" "Intracellular and membrane" "Endoplasmic reticulum" "HPA045724: AB_10969762" "unprognostic (8.25e-2)" "unprognostic (8.91e-2)" "unprognostic (2.12e-2)" "unprognostic (2.14e-1)" "unprognostic (3.59e-2)" "unprognostic (6.47e-2)" "unprognostic (1.15e-2)" "unprognostic (1.13e-1)" "unprognostic (4.02e-1)" "unprognostic (7.04e-3)" "unprognostic (3.52e-3)" "unprognostic (1.92e-1)" "unprognostic (4.59e-2)" "unprognostic (2.99e-2)" "unprognostic (3.15e-2)" "unprognostic (9.15e-2)" "unprognostic (3.49e-1)" 2.4 4.7 28.9 2.3 32.9 1.7 1.7 12.5 86.3 2.2 2.1 40.5 0.0 1.6 2.0 2.1 2.5 2.1 3.9 3.4 29.5 23.2 1.6 1.6 1.9 1.6 31.9 20.5 4.3 2.4 1.7 3.2 1.9 33.8 2.0 1.8 1.8 2.3 2.1 17.8 2.0 1.9 3.0 37.8 1.7 1.8 15.7 22.2 0.0 2.4 0.0 1.6 2.6 0.4 0.0 0.0 1.7 0.1 0.0 0.1 0.0 0.1 1.7 10.7 17.4 0.6 0.2 0.3 1.1 0.1 3.0 2.2 8.5 0.6 0.0 12.7 0.8 0.1 7.8 0.3 1.2 0.0 17.7 0.1 0.4 6.4 1.4 1.7 0.2 0.6 0.1 1.0 0.3 0.7 1.1 0.1 2.0 4.4 0.1 19.0 13.0 0.3 0.0 0.3 0.3 2.3 0.0 9.1 9.1 0.4 0.0 7.7 2.9 10.6 0.2 0.0 2.4 1.7 2.5 0.3 0.2 0.0 0.0 0.6 6.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 28.9 32.9 12.5 35.7 29.5 23.2 31.9 20.5 33.8 22.2 CERS2 "FLJ10243, LASS2, SP260" ENSG00000143418 "Ceramide synthase 2" Q96G23 1 150960583-150975004 "Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 142.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027262 Approved Supported "Nuclear membrane,Endoplasmic reticulum" 24000 "Nuclear membrane, Endoplasmic reticulum" "HPA027262: AB_1852717" "unprognostic (1.01e-1)" "unprognostic (2.70e-3)" "unprognostic (3.72e-2)" "unprognostic (1.29e-2)" "unprognostic (8.23e-2)" "unprognostic (2.03e-2)" "unprognostic (7.05e-2)" "unprognostic (1.60e-1)" "unprognostic (2.34e-1)" "unprognostic (4.05e-2)" "unprognostic (8.17e-3)" "unprognostic (1.11e-1)" "unprognostic (2.63e-2)" "unprognostic (1.56e-1)" "unprognostic (7.21e-2)" "unprognostic (1.09e-1)" "unprognostic (1.85e-1)" 19.4 65.5 17.0 10.5 36.1 13.9 22.6 9.6 21.3 19.8 21.1 59.3 22.1 19.6 16.9 19.0 12.5 21.1 21.6 14.4 23.0 16.1 60.9 142.3 28.6 14.0 50.1 14.5 21.8 29.7 28.7 17.6 24.0 25.5 18.5 18.8 16.5 12.3 19.2 7.1 9.1 33.3 21.2 63.7 13.2 23.4 10.2 38.7 10.2 35.5 8.8 14.0 17.5 25.6 12.3 23.5 56.6 27.0 19.3 33.6 26.2 25.7 28.2 23.8 51.0 71.1 43.7 17.8 26.4 38.8 50.3 34.6 29.5 45.7 22.7 44.1 41.4 29.4 33.0 28.1 41.4 30.8 26.9 31.3 19.8 35.8 51.5 35.5 38.8 39.7 36.3 44.4 55.4 31.3 33.5 52.0 62.8 38.8 23.2 20.5 36.5 50.5 26.5 16.2 36.2 54.5 21.9 22.0 34.3 29.1 51.7 30.1 61.6 53.9 24.3 36.5 16.4 32.9 46.4 33.7 37.8 142.5 41.0 15.2 36.9 56.6 27.0 44.0 28.0 14.6 33.6 12.3 25.7 28.4 23.4 11.4 22.9 22.2 29.2 19.3 10.2 23.5 28.8 26.2 17.0 36.1 9.6 21.3 23.0 16.1 50.1 14.5 25.5 38.7 CERS4 "FLJ12089, LASS4, Trh1" ENSG00000090661 "Ceramide synthase 4" Q9HA82 19 8206736-8262421 "Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 21.2;NB-4: 38.2;U-937: 23.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033734, HPA054729" Uncertain Supported Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "CAB033734: AB_2132977, HPA054729: " "unprognostic (5.96e-2)" "prognostic favourable (2.71e-4)" "unprognostic (2.46e-2)" "unprognostic (2.82e-2)" "unprognostic (1.30e-1)" "prognostic favourable (7.83e-4)" "unprognostic (1.74e-1)" "prognostic favourable (3.45e-5)" "unprognostic (1.48e-2)" "unprognostic (3.32e-1)" "prognostic favourable (8.05e-4)" "unprognostic (1.77e-1)" "prognostic favourable (9.63e-5)" "unprognostic (6.08e-3)" "unprognostic (2.69e-2)" "unprognostic (2.91e-2)" "unprognostic (8.08e-3)" 6.2 6.7 17.5 10.5 22.9 2.5 21.6 14.5 19.3 13.2 6.8 24.3 7.8 4.6 9.9 41.8 26.4 11.9 7.7 9.7 16.1 10.8 16.5 32.4 12.9 12.2 26.9 13.3 13.8 56.7 11.6 10.1 2.2 16.8 22.4 3.2 26.2 34.8 12.8 2.1 20.9 6.1 8.5 20.3 8.6 9.9 8.4 29.0 6.4 38.1 9.5 15.9 9.3 13.2 13.3 2.7 16.9 4.4 13.5 5.2 3.5 0.1 0.9 0.9 10.0 0.3 0.0 0.7 1.3 3.3 1.5 0.7 7.5 0.8 15.6 11.1 0.0 5.3 6.5 0.1 0.7 13.7 5.1 3.0 0.1 21.2 12.9 0.0 8.5 5.0 8.4 3.5 7.6 0.1 2.2 0.5 0.0 0.3 1.2 38.2 10.2 3.7 18.8 0.2 1.2 2.5 0.0 3.8 5.1 1.6 0.3 5.4 7.4 3.5 0.0 1.1 3.2 7.5 0.0 9.8 7.8 11.9 0.0 23.9 1.1 5.9 4.4 16.9 5.2 2.3 3.9 13.3 3.0 3.1 2.7 12.1 2.8 2.6 14.0 13.5 1.5 2.6 3.5 3.5 17.5 22.9 14.5 19.3 16.1 10.8 26.9 13.3 16.8 29.0 CLCN3 "ClC-3, CLC3" ENSG00000109572 "Chloride voltage-gated channel 3" P51790 4 169612633-169723673 "Predicted intracellular proteins, Predicted membrane proteins" "Antiport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044723 Approved Supported Vesicles Vesicles "HPA044723: AB_10959733" "unprognostic (1.92e-1)" "unprognostic (3.92e-2)" "unprognostic (1.95e-3)" "unprognostic (1.38e-2)" "unprognostic (1.64e-1)" "unprognostic (1.52e-1)" "unprognostic (1.99e-1)" "unprognostic (2.25e-1)" "unprognostic (3.32e-1)" "unprognostic (1.79e-1)" "unprognostic (5.40e-2)" "unprognostic (1.30e-1)" "prognostic favourable (1.10e-4)" "unprognostic (2.49e-2)" "unprognostic (2.49e-1)" "unprognostic (1.45e-1)" "unprognostic (6.38e-3)" 11.6 21.1 27.6 10.9 29.9 5.9 18.4 24.9 37.7 15.0 26.7 32.4 15.5 17.1 11.1 17.7 26.6 15.6 22.0 19.6 29.3 29.7 22.2 14.7 11.9 9.0 32.7 22.7 14.0 23.4 29.4 38.7 14.5 36.1 19.5 30.8 20.6 48.5 13.5 14.6 18.0 16.5 10.4 46.1 9.0 23.2 18.4 25.4 10.8 21.7 18.4 13.5 20.5 16.7 8.6 11.9 6.2 8.1 6.9 11.5 7.9 11.8 12.2 18.3 23.3 37.4 31.5 9.0 15.9 19.9 10.7 13.1 8.6 26.8 14.6 9.9 13.2 10.1 22.8 9.8 18.0 12.9 8.9 12.2 19.9 9.9 25.5 14.6 20.5 21.9 22.6 19.0 18.9 19.3 30.2 33.5 18.9 4.2 20.0 3.4 7.5 8.3 9.0 8.1 11.4 22.4 24.4 19.9 19.6 14.1 15.5 24.8 10.5 6.9 16.3 8.6 9.7 13.8 12.3 14.9 22.4 13.0 25.9 5.6 22.7 6.2 6.5 4.7 9.0 8.1 11.5 8.6 6.7 8.2 9.5 7.4 10.4 9.2 5.3 6.9 6.5 11.9 8.1 7.9 27.6 29.9 24.9 36.8 29.3 29.7 32.7 22.7 36.1 25.4 CLN3 "BTN1, BTS, JNCL" ENSG00000188603 "CLN3, battenin" Q13286 16 28474111-28495575 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Disease mutation, Neurodegeneration, Neuronal ceroid lipofuscinosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 52.7;SK-BR-3: 51.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA063280 Uncertain "HPA063280: " "unprognostic (2.38e-3)" "unprognostic (2.41e-2)" "unprognostic (7.06e-2)" "unprognostic (8.83e-2)" "unprognostic (1.04e-1)" "unprognostic (1.68e-1)" "unprognostic (2.36e-2)" "unprognostic (1.69e-2)" "unprognostic (6.38e-3)" "unprognostic (8.16e-2)" "unprognostic (6.27e-2)" "unprognostic (5.26e-1)" "unprognostic (9.90e-2)" "unprognostic (1.06e-1)" "unprognostic (4.45e-2)" "unprognostic (1.62e-1)" "unprognostic (2.05e-2)" 14.0 23.8 10.6 15.7 11.8 9.0 15.8 14.5 10.3 12.5 27.1 14.6 61.5 14.8 11.7 23.0 15.2 10.6 10.1 9.2 10.8 7.1 18.2 22.3 20.6 15.3 14.4 8.0 14.6 18.4 22.2 6.7 26.0 11.4 13.3 20.4 11.9 22.6 45.3 9.3 16.9 17.4 9.6 13.1 15.8 18.6 7.5 16.5 8.9 19.1 9.4 10.0 15.4 14.8 11.6 28.2 39.6 25.0 15.3 24.1 17.6 6.2 10.7 4.4 10.6 11.9 5.9 52.7 3.9 12.1 8.9 10.8 5.2 15.5 4.6 13.2 7.1 6.6 7.6 7.3 3.8 11.3 10.2 4.4 7.3 15.7 18.4 6.6 19.2 8.0 17.5 6.9 4.4 9.8 7.8 14.1 8.9 14.9 5.9 10.9 6.8 6.9 10.2 4.3 14.4 8.6 14.1 6.0 6.2 1.9 51.8 5.0 16.7 9.1 5.3 5.2 3.0 7.3 6.5 16.0 17.9 4.4 8.5 13.7 3.7 18.1 25.0 39.6 24.1 19.5 18.0 9.6 19.4 23.3 27.2 11.6 16.1 18.2 9.4 15.3 14.3 28.2 19.7 17.6 10.6 11.8 14.5 10.3 10.8 7.1 14.4 8.0 11.4 16.5 CLN8 "C8orf61, EPMR, FLJ39417" ENSG00000182372 "CLN8, transmembrane ER and ERGIC protein" Q9UBY8 8 1755778-1801711 "Disease related genes, Predicted membrane proteins" "Disease mutation, Epilepsy, Mental retardation, Neurodegeneration, Neuronal ceroid lipofuscinosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 35.5" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 5 "plasmacytoid DC: 35.5" "Lineage enriched" "Detected in all" 5 "dendritic cells: 35.5" "unprognostic (5.86e-2)" "unprognostic (1.95e-2)" "unprognostic (6.40e-2)" "unprognostic (1.23e-2)" "unprognostic (1.57e-1)" "unprognostic (4.05e-3)" "unprognostic (1.21e-1)" "unprognostic (3.45e-1)" "unprognostic (3.03e-1)" "unprognostic (6.66e-2)" "unprognostic (9.69e-3)" "unprognostic (1.83e-1)" "prognostic favourable (4.36e-8)" "unprognostic (1.36e-1)" "unprognostic (1.70e-1)" "unprognostic (6.24e-2)" "unprognostic (8.38e-2)" 6.4 4.6 10.3 5.2 11.5 12.8 4.2 5.5 11.4 4.2 6.1 22.8 5.1 8.3 5.0 7.7 14.6 5.6 13.3 8.1 12.2 8.7 6.2 12.0 7.5 8.2 21.3 6.1 3.3 11.5 2.2 4.0 8.9 12.1 4.2 5.2 3.0 6.1 7.2 4.8 10.3 6.2 6.8 24.1 8.9 7.3 7.3 14.6 3.9 6.1 6.4 7.6 11.3 4.5 6.8 35.5 2.6 6.0 2.1 3.4 2.7 3.1 7.0 1.7 3.1 3.5 3.3 8.2 5.4 4.2 3.4 5.0 5.1 8.3 4.3 2.5 2.8 5.9 3.4 6.1 7.0 2.0 1.6 3.5 2.4 1.7 1.4 2.0 11.8 2.0 3.5 3.8 2.0 6.9 4.0 2.1 6.8 3.1 6.2 1.9 3.4 6.6 4.2 2.5 2.4 4.4 5.5 1.0 1.5 2.2 1.7 2.3 13.3 2.9 9.6 7.3 2.8 0.8 4.0 0.8 4.1 6.1 3.7 4.6 8.5 2.6 4.7 1.9 3.2 6.0 3.4 4.8 3.3 2.1 4.7 6.8 3.3 2.2 1.3 2.1 5.0 35.5 3.2 2.7 10.3 11.5 5.5 11.4 12.2 8.7 21.3 6.1 12.1 14.6 CLPTM1 ENSG00000104853 "CLPTM1, transmembrane protein" O96005 19 44954585-44993341 "Predicted intracellular proteins, Predicted membrane proteins" Differentiation "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA068702, HPA068767" Approved Approved "Nuclear membrane,Centriolar satellite" "Nuclear membrane, Centriolar satellite" "HPA068702: , HPA068767: " "unprognostic (1.40e-1)" "unprognostic (1.32e-1)" "unprognostic (4.07e-1)" "unprognostic (2.19e-1)" "unprognostic (1.81e-1)" "unprognostic (3.25e-1)" "unprognostic (1.94e-1)" "unprognostic (5.93e-2)" "unprognostic (6.60e-3)" "unprognostic (2.67e-2)" "unprognostic (1.46e-3)" "unprognostic (2.62e-1)" "unprognostic (1.02e-2)" "unprognostic (3.30e-1)" "unprognostic (2.56e-1)" "unprognostic (7.46e-2)" "unprognostic (1.59e-1)" 29.7 53.4 39.4 20.3 56.2 14.7 20.2 26.7 66.4 25.8 26.6 36.8 17.3 31.5 20.3 24.0 23.7 25.6 22.1 32.2 35.7 35.7 40.6 62.5 23.1 19.1 36.0 33.7 26.9 36.2 53.8 21.1 34.3 37.7 27.1 21.3 30.2 38.0 29.6 37.6 32.9 27.6 23.7 27.2 22.6 25.1 26.7 30.7 13.9 27.3 16.1 26.3 19.5 18.6 18.4 24.1 25.5 28.8 12.5 24.4 11.8 26.4 59.8 13.9 27.5 46.4 18.7 14.8 26.2 28.9 30.9 33.3 25.9 26.8 26.3 29.3 34.6 31.3 24.7 23.7 21.0 19.3 34.2 20.4 22.6 21.7 32.8 16.2 23.9 29.3 25.2 29.5 19.1 21.5 21.1 36.9 27.3 23.8 17.0 9.5 12.5 19.9 17.7 15.1 25.5 28.7 37.1 16.4 18.1 32.4 48.2 14.2 26.3 13.0 19.9 34.8 21.7 18.2 32.4 25.9 56.6 20.5 28.8 16.1 31.8 10.4 16.7 25.5 17.0 23.6 14.3 17.5 18.3 24.4 15.4 18.4 14.5 12.2 15.7 12.5 28.8 24.1 15.1 11.8 39.4 56.2 26.7 66.4 35.7 35.7 36.0 33.7 37.7 30.7 CLPTM1L "CRR9, FLJ14400" ENSG00000049656 "CLPTM1 like" Q96KA5 5 1317744-1345099 "Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/84: 82.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014791 Approved Approved "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA014791: AB_1847250" "unprognostic (2.92e-2)" "unprognostic (1.34e-1)" "unprognostic (9.53e-2)" "unprognostic (8.43e-2)" "unprognostic (5.16e-3)" "unprognostic (1.17e-1)" "prognostic unfavourable (3.75e-4)" "unprognostic (3.42e-2)" "unprognostic (1.41e-1)" "unprognostic (5.47e-3)" "unprognostic (9.14e-3)" "unprognostic (1.06e-1)" "unprognostic (5.77e-3)" "unprognostic (8.57e-2)" "unprognostic (4.92e-2)" "unprognostic (4.54e-2)" "unprognostic (4.17e-2)" 15.8 14.1 10.6 20.5 12.4 13.5 16.3 6.7 16.9 13.8 19.0 11.1 12.1 24.6 12.0 10.6 15.7 11.7 20.7 13.1 11.3 12.2 29.4 56.1 20.0 17.6 14.8 8.3 11.3 57.6 10.0 14.6 15.8 11.6 13.9 11.0 13.1 33.3 14.5 8.3 12.3 23.6 12.1 9.2 22.5 25.6 20.0 9.8 37.2 30.9 11.3 21.1 13.8 9.8 10.4 12.3 12.3 9.6 12.8 9.7 5.2 12.5 21.3 7.3 19.7 11.8 5.1 19.3 12.9 8.6 11.6 11.5 23.2 20.1 12.0 39.9 12.0 11.1 9.8 10.7 5.3 48.8 27.0 6.3 49.9 15.3 13.4 16.5 16.3 8.2 12.3 10.7 10.0 9.4 14.3 41.2 8.7 20.6 18.2 21.8 13.5 23.2 15.4 11.9 36.8 9.0 12.0 7.7 15.3 22.5 19.6 9.8 32.9 24.9 6.9 13.9 40.1 9.6 18.5 74.5 82.2 19.4 10.4 25.0 15.9 4.6 6.7 12.3 7.9 6.2 9.3 9.7 8.4 7.8 6.0 10.4 8.0 9.6 5.2 12.8 9.6 12.3 9.7 5.2 10.6 12.4 6.7 16.9 11.3 12.2 14.8 8.3 11.6 9.8 CTNS "CTNS-LSB, PQLC4" ENSG00000040531 "Cystinosin, lysosomal cystine transporter" O60931 17 3636468-3661542 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Melanin biosynthesis, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 46.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046947 Supported "Vesicles,Intermediate filaments" "Vesicles, Intermediate filaments" "HPA046947: " "unprognostic (1.64e-1)" "unprognostic (1.70e-1)" "unprognostic (1.21e-1)" "unprognostic (8.25e-2)" "unprognostic (8.39e-2)" "prognostic favourable (7.33e-4)" "unprognostic (1.28e-2)" "unprognostic (8.02e-2)" "unprognostic (1.94e-1)" "unprognostic (6.62e-3)" "prognostic favourable (6.39e-5)" "unprognostic (8.40e-2)" "unprognostic (2.25e-1)" "unprognostic (1.80e-1)" "unprognostic (5.64e-2)" "unprognostic (1.96e-1)" "unprognostic (1.52e-1)" 9.6 19.0 8.5 8.2 11.9 8.3 12.1 5.0 9.9 18.8 8.2 16.1 34.8 10.8 10.3 7.2 7.3 8.3 10.6 9.3 7.7 5.9 23.9 16.4 11.4 9.1 12.1 5.6 12.6 32.7 11.3 14.5 13.2 8.5 10.2 6.4 11.4 10.5 46.2 22.6 18.0 9.2 7.9 10.2 12.2 12.9 27.0 13.0 11.7 9.0 6.5 9.0 10.1 9.1 3.5 19.6 13.7 5.6 2.5 3.3 3.7 6.1 13.8 8.1 6.9 13.2 6.7 5.1 6.0 10.1 6.9 8.7 7.7 6.1 3.7 6.4 4.0 15.8 7.1 4.1 5.3 46.0 12.5 4.2 10.4 6.2 17.8 2.8 28.8 8.3 5.2 7.3 5.9 7.6 4.3 5.8 6.5 5.6 2.8 2.7 3.6 6.1 6.2 3.3 8.7 6.2 6.3 1.6 5.9 7.0 9.4 7.0 6.6 2.8 8.9 6.8 4.3 15.4 4.9 4.7 6.0 1.7 10.5 3.0 4.6 13.7 5.6 12.1 1.9 3.7 2.7 3.5 2.3 3.3 5.4 3.1 2.9 3.1 2.0 2.5 3.8 19.6 2.6 3.7 8.5 11.9 5.0 9.9 7.7 5.9 12.1 5.6 8.5 13.0 CYB561 "CYB561A1, FRRS2" ENSG00000008283 "Cytochrome b561" P49447 17 63432304-63446378 "Predicted membrane proteins, Transporters" "Electron transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 86.9" "Cell line enhanced" "Detected in many" "SH-SY5Y: 89.0;SK-BR-3: 42.6;T-47d: 34.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014753 Approved "HPA014753: AB_1847364" "prognostic unfavourable (8.89e-5)" "unprognostic (2.90e-1)" "unprognostic (4.01e-1)" "prognostic favourable (2.95e-5)" "unprognostic (1.81e-3)" "unprognostic (3.82e-1)" "unprognostic (1.37e-2)" "unprognostic (8.47e-2)" "unprognostic (2.07e-1)" "unprognostic (3.91e-2)" "unprognostic (8.97e-2)" "unprognostic (6.38e-2)" "unprognostic (8.09e-3)" "unprognostic (1.16e-3)" "unprognostic (8.17e-2)" "unprognostic (1.50e-2)" "unprognostic (2.89e-1)" 4.7 46.3 7.0 5.6 12.4 1.0 16.6 2.4 12.3 16.6 11.8 3.7 43.7 12.4 5.2 20.9 16.8 19.8 13.2 9.9 7.1 14.5 10.1 12.0 14.6 9.1 4.7 7.8 8.8 86.9 21.8 26.3 12.2 9.9 22.8 7.3 6.2 26.0 32.0 2.7 11.9 13.7 3.4 3.7 2.8 16.9 4.7 1.8 1.2 17.1 8.3 8.3 5.3 8.6 0.4 1.2 3.4 4.4 12.6 16.2 3.1 19.2 6.5 0.5 4.1 2.4 11.1 8.8 1.8 2.4 2.5 1.0 5.9 19.5 0.0 4.5 15.0 16.8 4.1 1.6 1.0 4.9 1.6 2.4 4.1 0.3 4.5 0.2 0.8 1.8 17.1 2.3 0.3 4.8 7.6 3.6 0.8 27.5 0.0 0.9 4.1 9.7 0.0 0.0 6.0 8.1 9.9 15.1 89.0 5.0 42.6 1.9 34.4 1.2 0.7 5.4 5.9 12.5 0.6 0.0 0.1 0.0 4.7 1.0 2.8 0.1 1.1 0.1 12.6 3.4 16.2 0.4 9.6 8.5 1.2 0.4 0.8 2.8 3.4 12.6 4.4 0.0 0.0 3.1 7.0 12.4 2.4 12.3 7.1 14.5 4.7 7.8 9.9 1.8 CYB561A3 CYBASC3 ENSG00000162144 "Cytochrome b561 family member A3" Q8NBI2 11 61348745-61362299 "Predicted membrane proteins" "Electron transport, Transport" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 113.7;blood: 98.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 8 "memory B-cell: 40.5;naive B-cell: 50.1;plasmacytoid DC: 98.8" "Group enriched" "Detected in all" 10 "B-cells: 50.1;dendritic cells: 98.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045674, HPA052548" Approved Approved Nucleoplasm,Nucleoli,Vesicles,Cytosol "Nucleoli, Vesicles" "Nucleoplasm, Cytosol" "HPA045674: , HPA052548: AB_2681866" "unprognostic (2.61e-1)" "unprognostic (8.78e-2)" "unprognostic (4.16e-1)" "unprognostic (3.62e-2)" "unprognostic (1.37e-1)" "unprognostic (9.41e-3)" "unprognostic (7.41e-3)" "unprognostic (2.48e-1)" "unprognostic (1.90e-1)" "unprognostic (2.12e-1)" "unprognostic (2.22e-2)" "unprognostic (3.73e-1)" "unprognostic (2.53e-1)" "unprognostic (2.83e-1)" "unprognostic (3.71e-2)" "unprognostic (1.19e-1)" "unprognostic (1.80e-3)" 10.0 113.7 4.0 22.5 6.4 7.1 7.5 4.7 6.9 6.6 10.9 10.9 14.4 6.1 10.9 9.9 8.8 11.0 11.0 5.7 5.1 4.1 9.7 30.6 12.4 21.7 8.3 3.5 14.5 17.9 9.0 6.6 21.0 6.8 9.2 9.6 10.7 10.9 8.1 10.2 24.8 15.8 7.6 5.6 24.0 8.5 8.0 7.0 16.8 10.0 8.4 33.3 10.7 7.3 50.1 98.8 3.8 7.4 3.3 3.8 8.7 18.0 30.5 4.9 14.1 23.2 15.4 4.1 9.1 13.9 11.0 11.0 8.3 20.2 35.2 16.4 16.0 25.3 4.6 25.4 6.7 23.5 10.4 6.0 20.6 5.6 10.9 8.3 15.8 21.6 35.9 23.9 11.0 16.3 19.8 21.1 18.5 19.4 15.7 3.6 9.1 17.5 19.0 4.7 26.3 12.7 17.9 6.0 10.0 18.6 26.9 21.0 21.8 9.7 10.9 13.0 6.7 12.6 13.1 13.2 17.4 19.7 17.8 14.6 16.3 1.6 7.4 3.8 3.8 6.0 3.4 40.5 2.7 3.4 7.4 50.1 2.8 3.0 2.5 3.3 6.4 98.8 2.6 8.7 4.0 6.4 4.7 6.9 5.1 4.1 8.3 3.5 6.8 7.0 CYB561D1 "FLJ39035, FLJ44753" ENSG00000174151 "Cytochrome b561 family member D1" Q8N8Q1 1 109494052-109502932 "Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027028 Uncertain "HPA027028: AB_1847365" "unprognostic (2.15e-2)" "unprognostic (3.49e-1)" "unprognostic (1.04e-2)" "unprognostic (1.98e-1)" "unprognostic (2.27e-1)" "prognostic favourable (4.68e-4)" "unprognostic (4.53e-4)" "unprognostic (1.32e-1)" "unprognostic (3.45e-1)" "unprognostic (5.29e-2)" "prognostic favourable (5.16e-6)" "unprognostic (4.30e-1)" "prognostic favourable (2.22e-4)" "unprognostic (1.20e-3)" "unprognostic (2.75e-1)" "unprognostic (4.95e-3)" "unprognostic (5.82e-2)" 6.1 10.5 8.7 10.7 12.0 9.1 7.0 21.7 13.4 4.2 8.4 7.9 13.4 7.1 6.9 14.8 9.3 7.0 6.7 4.6 9.6 5.6 8.2 4.2 7.4 12.8 9.7 10.2 9.4 19.4 11.1 11.2 7.0 8.8 6.8 7.7 4.6 10.8 8.4 7.8 22.5 12.2 6.8 7.8 12.1 9.0 3.9 11.1 10.6 10.3 6.6 12.8 7.0 12.2 4.5 3.0 10.8 4.5 8.7 8.3 3.5 8.2 4.8 3.6 4.2 12.3 9.1 9.1 7.2 5.6 8.2 5.9 4.8 3.7 7.4 7.7 9.2 9.5 4.7 5.9 5.4 6.1 4.3 5.0 6.7 3.7 5.8 10.1 15.6 9.7 14.7 8.1 4.3 5.9 3.1 3.4 5.3 10.4 3.6 5.4 1.7 7.5 6.0 14.5 2.9 7.6 14.0 5.3 4.6 8.1 8.0 7.5 5.5 5.5 7.6 8.2 9.7 11.1 5.8 4.0 2.8 3.7 8.3 8.4 9.0 3.8 3.8 5.6 6.3 4.2 5.5 3.5 6.6 5.6 2.7 4.5 8.3 5.8 10.8 8.7 4.5 3.0 4.7 3.5 8.7 12.0 21.7 13.4 9.6 5.6 9.7 10.2 8.8 11.1 CYB561D2 "101F6, TSP10" ENSG00000114395 "Cytochrome b561 family member D2" O14569 3 50350695-50358460 "Predicted membrane proteins" "Electron transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 58.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA042817 Uncertain "HPA042817: AB_10795762" "unprognostic (4.89e-2)" "unprognostic (3.25e-1)" "unprognostic (2.02e-1)" "unprognostic (6.98e-2)" "unprognostic (5.15e-2)" "unprognostic (2.72e-2)" "unprognostic (2.28e-3)" "unprognostic (2.47e-2)" "unprognostic (1.76e-1)" "unprognostic (5.41e-2)" "prognostic favourable (1.86e-4)" "unprognostic (3.26e-1)" "prognostic favourable (6.16e-5)" "unprognostic (4.33e-2)" "unprognostic (1.89e-1)" "unprognostic (2.18e-1)" "unprognostic (7.57e-2)" 8.7 16.6 9.8 11.9 11.6 14.8 12.0 10.9 12.2 8.5 14.6 11.5 12.8 16.4 6.3 20.5 11.1 7.8 16.0 7.6 8.8 6.9 15.2 42.2 11.2 16.6 12.2 10.0 5.9 27.3 13.6 14.8 12.2 8.0 12.6 13.9 8.9 15.2 18.2 7.1 6.9 19.0 6.2 11.5 19.7 16.4 7.4 12.4 12.3 16.1 6.5 11.2 9.7 6.9 29.9 31.0 58.3 46.9 34.4 53.2 33.8 7.4 16.4 4.2 7.9 8.8 7.6 9.8 13.3 9.9 12.3 14.1 11.5 12.2 11.8 14.0 16.5 8.0 6.2 12.3 5.4 17.7 15.4 10.9 19.3 10.4 12.7 12.0 25.7 11.5 5.6 14.7 7.0 10.2 4.8 15.7 9.7 14.1 7.6 10.8 6.6 25.9 5.4 2.9 23.5 12.8 12.7 4.2 11.7 6.5 27.0 8.1 9.6 14.3 11.0 11.1 9.5 18.5 16.4 12.0 11.2 7.5 15.4 15.0 11.9 42.4 41.1 58.3 53.2 46.9 34.8 29.9 36.1 42.0 30.0 27.4 25.6 38.0 39.0 34.4 44.1 31.0 37.1 33.8 9.8 11.6 10.9 12.2 8.8 6.9 12.2 10.0 8.0 12.4 CYBRD1 "CYB561A2, DCYTB, FLJ23462, FRRS3" ENSG00000071967 "Cytochrome b reductase 1" Q53TN4 2 171522247-171558133 "Predicted membrane proteins" "Electron transport, Transport" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 141.9;ASC TERT1: 61.7;BJ hTERT+: 53.4;HSkMC: 43.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 12.0;intermediate monocyte: 12.4;myeloid DC: 11.7;neutrophil: 6.7;non-classical monocyte: 9.4" "Group enriched" "Detected in many" 4 "dendritic cells: 11.7;granulocytes: 6.7;monocytes: 12.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA014757, HPA056736" Approved Approved "Golgi apparatus,Cytosol" "Golgi apparatus, Cytosol" "HPA014757: AB_1847374, HPA056736: " "unprognostic (1.35e-1)" "unprognostic (1.57e-1)" "unprognostic (2.89e-2)" "unprognostic (4.87e-2)" "unprognostic (2.97e-2)" "unprognostic (3.11e-2)" "unprognostic (2.86e-1)" "unprognostic (5.44e-3)" "unprognostic (8.90e-3)" "unprognostic (3.57e-3)" "unprognostic (1.74e-1)" "unprognostic (1.71e-1)" "unprognostic (1.02e-3)" "unprognostic (1.93e-2)" "unprognostic (8.48e-2)" "unprognostic (2.77e-2)" "unprognostic (1.51e-2)" 75.2 26.0 10.1 9.3 13.2 4.0 78.9 6.1 8.0 44.5 56.3 14.7 16.3 49.5 44.3 28.5 29.6 26.1 38.8 43.1 12.1 5.5 8.6 6.2 35.6 10.6 11.0 11.2 49.5 5.4 2.0 9.5 9.5 11.4 41.7 10.2 32.0 21.5 21.1 17.5 26.7 111.3 41.1 12.8 7.3 18.1 20.1 11.7 2.1 103.8 23.9 10.0 43.8 56.0 0.0 11.7 6.7 12.4 2.5 1.2 4.4 3.1 2.3 1.3 2.5 141.9 61.7 0.1 11.6 53.4 6.1 7.7 0.1 4.4 0.0 2.0 27.2 1.6 1.1 0.9 7.2 2.4 0.3 2.6 3.6 0.0 29.8 2.8 0.2 43.7 9.0 9.4 1.8 3.8 0.8 0.0 16.6 0.0 0.9 2.5 0.6 0.6 0.3 16.8 0.1 0.9 0.1 0.1 0.6 13.5 0.0 7.2 4.7 1.7 7.6 13.7 1.9 12.7 4.9 0.0 0.0 0.0 6.5 2.3 7.3 0.0 12.0 0.5 1.2 12.4 0.2 0.0 0.2 0.1 11.7 0.0 0.0 0.0 6.7 2.5 9.4 0.5 0.0 4.4 10.1 13.2 6.1 8.0 12.1 5.5 11.0 11.2 11.4 11.7 DAGLA "C11orf11, DAGLALPHA, KIAA0659, NSDDR" ENSG00000134780 "Diacylglycerol lipase alpha" Q9Y4D2 11 61680433-61747001 "Disease related genes, Predicted membrane proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.0" "Cell line enhanced" "Detected in many" "CAPAN-2: 11.0;T-47d: 12.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 1.4;intermediate monocyte: 1.9;non-classical monocyte: 1.6" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062497, CAB078793" Approved Supported "CAB078793: , HPA062497: " "unprognostic (2.53e-3)" "unprognostic (1.85e-1)" "unprognostic (1.26e-2)" "prognostic unfavourable (1.13e-7)" "unprognostic (1.23e-1)" "unprognostic (1.70e-1)" "unprognostic (1.14e-4)" "unprognostic (2.22e-2)" "unprognostic (2.29e-3)" "unprognostic (3.99e-3)" "unprognostic (1.55e-1)" "unprognostic (1.09e-1)" "unprognostic (1.11e-3)" "unprognostic (1.53e-1)" "unprognostic (1.52e-1)" "unprognostic (1.08e-1)" "unprognostic (1.14e-2)" 3.7 2.5 7.2 2.8 13.3 1.1 3.0 12.0 22.0 3.1 6.0 3.6 3.1 4.4 2.7 3.8 4.7 3.8 2.9 3.8 8.6 6.0 2.3 0.5 3.2 1.3 3.7 7.4 1.2 8.8 1.7 3.3 1.7 4.5 3.5 3.7 2.5 7.9 4.0 3.1 1.1 5.2 3.2 1.4 3.4 2.9 3.3 2.7 0.0 1.6 2.0 1.0 1.7 1.4 0.0 0.8 0.0 1.9 0.0 0.1 0.3 5.3 6.1 4.7 0.9 1.1 1.7 0.8 2.5 0.7 2.8 3.0 3.5 11.0 0.0 2.6 2.2 3.2 0.8 0.0 1.2 0.0 3.1 0.0 4.5 5.4 1.8 0.0 1.0 0.9 0.3 3.6 0.0 0.8 0.0 0.0 1.3 2.5 0.0 0.0 9.7 5.9 0.0 0.7 0.0 1.0 1.3 9.8 5.4 1.4 2.3 1.7 12.1 3.1 3.3 1.9 8.5 5.1 3.0 0.0 0.0 0.0 5.1 1.4 2.9 0.0 1.4 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 1.6 0.1 0.0 0.3 7.2 13.3 12.0 21.5 8.6 6.0 3.7 7.4 4.5 2.7 DCST1 FLJ32785 ENSG00000163357 "DC-STAMP domain containing 1" Q5T197 1 155033824-155050930 "Enzymes, Predicted membrane proteins" "Immunity, Innate immunity, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "retina: 18.2;skin 1: 6.8;testis: 10.7" "Cell line enhanced" "Detected in some" "HaCaT: 4.8;HeLa: 4.0;RPMI-8226: 5.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA060314 Uncertain "HPA060314: " "unprognostic (1.44e-1)" "unprognostic (7.66e-2)" "unprognostic (3.77e-2)" "unprognostic (1.05e-4)" "unprognostic (3.58e-2)" "unprognostic (8.75e-4)" "unprognostic (1.46e-2)" "unprognostic (2.66e-1)" "unprognostic (6.01e-3)" "unprognostic (2.22e-1)" "unprognostic (6.62e-2)" "unprognostic (1.89e-2)" "unprognostic (8.33e-15)" "unprognostic (7.77e-2)" "unprognostic (2.22e-1)" "unprognostic (2.38e-1)" "unprognostic (1.23e-1)" 0.2 0.0 0.1 0.1 0.1 0.0 0.3 0.1 0.1 0.2 0.1 0.1 0.1 1.7 0.1 0.1 0.4 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.2 0.0 18.2 0.7 0.1 0.1 6.8 1.6 0.1 0.1 0.2 0.4 10.7 0.1 0.1 0.1 0.1 0.1 0.1 0.5 0.8 0.8 0.9 1.2 0.0 1.0 0.1 1.5 0.7 2.7 1.5 0.1 0.0 1.0 0.5 0.0 0.0 0.0 0.7 3.2 1.5 0.5 0.0 4.8 0.0 0.0 0.0 1.2 0.4 0.4 4.0 0.3 0.0 1.1 0.6 0.0 0.2 0.0 0.0 0.0 1.1 2.3 0.0 1.0 0.0 0.3 0.2 2.2 0.0 1.1 5.4 0.0 0.8 0.9 1.8 0.6 1.8 0.2 3.4 0.1 0.0 0.3 0.2 0.8 0.4 0.9 0.8 0.3 0.7 1.6 0.0 0.0 0.2 0.9 0.1 0.0 0.0 0.8 0.4 0.2 0.3 0.0 1.0 0.2 0.2 0.0 1.2 0.8 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 DERL2 "CGI-101, derlin-2, F-LAN-1, F-LANa, FLANa" ENSG00000072849 "Derlin 2" Q9GZP9 17 5471251-5486811 "Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction, Unfolded protein response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037287, HPA048957, HPA056551" Enhanced Supported "Endoplasmic reticulum" "Endoplasmic reticulum" "CAB037287: AB_1078641, HPA048957: , HPA056551: " "unprognostic (2.54e-1)" "unprognostic (5.30e-2)" "unprognostic (5.83e-2)" "prognostic favourable (7.26e-4)" "unprognostic (1.51e-2)" "unprognostic (4.70e-2)" "unprognostic (1.36e-1)" "unprognostic (2.63e-1)" "unprognostic (2.17e-1)" "unprognostic (1.12e-3)" "unprognostic (1.73e-3)" "unprognostic (5.23e-2)" "prognostic unfavourable (6.49e-4)" "unprognostic (1.91e-1)" "unprognostic (1.82e-1)" "unprognostic (3.73e-1)" "unprognostic (2.91e-2)" 12.2 18.9 8.8 11.6 10.7 22.4 13.5 8.1 9.7 11.9 10.7 10.5 17.0 10.9 12.4 23.6 13.4 11.5 13.2 9.6 10.6 6.8 18.1 28.7 12.8 18.8 12.5 4.4 13.1 49.1 12.2 14.7 16.6 11.5 11.0 9.5 10.7 30.3 19.4 9.5 9.5 15.9 11.3 11.0 14.9 13.5 21.0 11.3 11.4 22.1 7.6 16.7 13.8 10.5 33.4 36.6 39.3 36.3 29.5 40.6 53.3 16.5 21.5 10.1 17.0 17.4 13.2 13.0 23.6 19.3 16.3 19.9 14.6 14.9 11.5 21.5 15.0 18.6 7.0 13.6 16.3 15.2 14.8 5.6 14.1 15.7 24.1 4.1 13.8 12.2 11.4 22.0 19.1 16.8 6.1 20.2 22.0 8.6 8.8 6.4 9.8 8.6 10.8 14.4 8.5 17.5 8.5 4.3 12.6 14.4 10.0 24.8 13.3 6.2 12.6 19.4 13.0 11.8 22.5 14.1 15.6 10.2 20.3 10.4 15.2 31.4 34.4 39.3 36.5 36.3 37.8 33.4 35.4 38.6 25.7 29.3 28.1 34.8 32.3 29.5 27.8 36.6 40.6 53.3 8.8 10.7 8.1 9.7 10.6 6.8 12.5 4.4 11.5 11.3 DNAJC22 "FLJ13236, wus" ENSG00000178401 "DnaJ heat shock protein family (Hsp40) member C22" Q8N4W6 12 49346917-49357546 "Predicted membrane proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 10.0;intestine: 10.0;liver: 18.9" "Cell line enhanced" "Detected in many" "AN3-CA: 11.2;CACO-2: 17.5;CAPAN-2: 11.0;EFO-21: 18.9;MCF7: 15.4;T-47d: 13.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Region enhanced" "Detected in single" "midbrain: 1.4" "Low region specificity" "Detected in many" HPA039953 Approved Vesicles Vesicles "HPA039953: " "unprognostic (5.23e-2)" "unprognostic (1.24e-1)" "unprognostic (9.01e-2)" "prognostic favourable (4.56e-5)" "unprognostic (4.77e-3)" "unprognostic (2.74e-1)" "unprognostic (1.28e-1)" "unprognostic (4.05e-2)" "prognostic unfavourable (7.54e-4)" "unprognostic (6.14e-2)" "unprognostic (1.23e-2)" "unprognostic (2.49e-1)" "unprognostic (1.49e-2)" "unprognostic (3.18e-2)" "unprognostic (9.35e-2)" "unprognostic (1.58e-1)" "unprognostic (3.83e-2)" 1.1 0.3 0.5 0.4 1.0 0.0 0.4 0.4 2.2 1.5 5.4 0.8 0.4 10.0 2.2 1.3 0.4 0.8 10.0 0.4 0.7 0.5 5.2 18.9 0.4 0.4 1.0 1.2 0.4 5.2 2.7 0.4 0.9 4.6 0.4 5.2 0.8 1.2 0.4 0.4 0.2 8.3 0.4 0.8 0.4 4.4 0.6 0.4 0.4 6.6 0.4 0.4 0.4 0.7 0.7 0.8 2.7 0.5 0.5 0.5 0.4 1.6 10.4 0.0 11.2 0.0 0.0 3.7 0.4 3.3 1.1 2.4 17.5 11.0 0.0 18.9 0.4 0.1 1.6 0.0 1.9 0.1 2.5 0.3 0.2 8.7 2.7 0.0 1.9 0.1 0.0 1.7 0.3 1.6 0.1 0.3 0.8 15.4 0.0 0.0 0.0 5.4 0.0 5.4 0.1 0.3 0.0 1.8 0.9 0.3 0.5 3.5 13.9 0.2 0.2 1.2 3.5 0.1 1.5 0.0 0.0 0.0 2.6 0.0 2.3 2.3 0.5 0.5 0.5 0.3 0.3 0.4 0.4 0.3 0.1 0.7 0.3 0.3 2.7 0.5 0.4 0.8 0.2 0.4 0.5 1.0 0.4 2.2 0.7 0.5 1.0 1.2 4.6 0.4 DRAM1 "DRAM, FLJ11259" ENSG00000136048 "DNA damage regulated autophagy modulator 1" Q8N682 12 101877351-102012130 "Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Autophagy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "breast: 52.5;lung: 73.9" "Cell line enriched" "Detected in many" 4 "BJ hTERT+: 101.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "unprognostic (8.82e-2)" "unprognostic (1.80e-1)" "unprognostic (7.19e-2)" "prognostic favourable (6.52e-8)" "unprognostic (1.15e-2)" "unprognostic (2.35e-3)" "unprognostic (1.29e-3)" "unprognostic (1.23e-2)" "unprognostic (1.47e-1)" "unprognostic (2.35e-1)" "unprognostic (6.17e-3)" "unprognostic (5.02e-2)" "prognostic unfavourable (3.91e-4)" "unprognostic (1.54e-1)" "unprognostic (3.21e-3)" "unprognostic (3.58e-2)" "unprognostic (2.07e-2)" 13.1 11.0 3.6 9.9 3.8 16.7 52.5 1.2 2.6 9.2 8.3 2.3 3.6 3.4 8.0 9.2 8.1 6.9 11.2 13.8 3.6 3.6 16.7 7.2 73.9 20.9 4.3 2.3 10.9 13.7 4.3 6.6 15.2 4.4 13.2 4.8 5.4 8.8 5.4 6.6 4.6 6.4 10.8 4.4 14.8 10.0 8.6 2.2 4.9 10.4 4.3 6.4 12.4 22.1 2.6 3.0 9.2 9.8 3.5 2.2 2.5 1.9 3.9 1.4 0.4 18.4 4.2 7.8 14.6 101.3 14.7 23.1 1.3 3.8 0.3 1.7 24.0 2.9 0.3 6.0 20.5 2.1 1.2 0.5 3.5 5.0 8.5 0.5 1.1 5.0 2.7 5.1 5.6 7.9 1.7 0.7 3.8 1.5 0.3 1.7 1.0 0.9 0.6 1.0 0.3 15.6 9.3 0.3 0.3 8.1 0.9 3.8 2.8 2.2 4.8 10.4 1.8 1.8 2.6 2.1 0.9 0.2 3.5 5.0 2.7 9.2 8.8 5.8 1.9 9.8 2.2 2.6 1.4 2.0 3.0 1.7 1.1 1.3 8.8 3.5 5.6 0.8 1.9 2.5 3.6 3.8 1.2 2.4 3.6 3.6 4.3 2.3 4.4 2.2 DRAM2 "MGC54289, PRO180, RP5-1180E21.1, TMEM77, WWFQ154" ENSG00000156171 "DNA damage regulated autophagy modulator 2" Q6UX65 1 111117333-111140216 "Predicted membrane proteins" "Apoptosis, Autophagy" "Cone-rod dystrophy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-MEL-30: 17.6;THP-1: 19.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018036, HPA061701" Supported Enhanced "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA018036: AB_1858134, HPA061701: " "unprognostic (9.38e-3)" "unprognostic (1.58e-2)" "unprognostic (2.16e-3)" "unprognostic (5.22e-2)" "unprognostic (1.12e-2)" "unprognostic (2.65e-2)" "prognostic unfavourable (3.45e-5)" "unprognostic (6.57e-3)" "prognostic unfavourable (6.43e-4)" "unprognostic (2.69e-1)" "unprognostic (4.37e-3)" "unprognostic (2.66e-1)" "prognostic unfavourable (7.45e-4)" "unprognostic (1.10e-1)" "unprognostic (1.63e-1)" "unprognostic (2.29e-1)" "unprognostic (1.77e-3)" 21.8 10.1 5.9 14.4 6.6 7.9 18.4 13.5 6.9 8.4 12.0 7.5 5.7 10.6 8.6 11.1 10.0 12.7 9.1 11.7 5.3 6.0 13.0 9.2 11.5 19.9 9.3 4.2 12.3 8.2 5.7 9.9 14.1 8.4 10.1 8.7 8.8 10.7 7.1 10.6 7.0 15.2 10.1 15.1 24.9 9.5 6.1 8.3 15.0 10.6 6.7 14.7 16.8 7.7 16.1 11.2 3.0 10.9 6.2 10.4 11.4 2.0 0.1 3.4 2.0 8.5 7.2 6.0 8.1 3.1 2.0 4.6 2.5 1.1 7.3 5.4 4.0 2.3 4.8 1.3 3.9 8.8 3.4 4.1 2.5 1.2 6.4 0.6 1.8 5.0 6.1 3.3 1.3 1.0 2.3 3.3 2.4 1.4 3.9 5.3 6.5 4.1 3.8 3.8 3.1 7.3 2.1 6.5 2.4 0.9 2.7 17.6 4.7 19.3 3.5 0.6 0.8 4.1 5.4 4.2 1.2 12.5 1.5 8.1 1.3 2.7 10.3 3.0 6.5 10.9 10.4 13.6 9.0 8.1 11.2 16.1 9.5 7.9 2.1 6.2 7.6 11.2 5.4 11.4 5.9 6.6 13.5 5.4 5.3 6.0 9.3 4.2 8.4 8.3 EI24 "EPG4, PIG8, TP53I8" ENSG00000149547 "EI24, autophagy associated transmembrane protein" O14681 11 125569216-125584687 "Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Autophagy" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 164.6" "Cell line enhanced" "Detected in all" "HEL: 117.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047165, HPA051029" Approved Supported "Endoplasmic reticulum,Golgi apparatus,Cytosol" "Endoplasmic reticulum, Cytosol" "Golgi apparatus" "HPA047165: AB_2679965, HPA051029: AB_2681317" "unprognostic (2.04e-3)" "unprognostic (2.69e-2)" "unprognostic (1.25e-2)" "unprognostic (3.43e-2)" "unprognostic (1.68e-1)" "unprognostic (2.78e-2)" "unprognostic (5.02e-2)" "unprognostic (6.38e-2)" "unprognostic (6.74e-2)" "unprognostic (1.17e-2)" "prognostic unfavourable (9.28e-4)" "unprognostic (3.50e-2)" "unprognostic (1.35e-1)" "unprognostic (4.58e-2)" "unprognostic (8.35e-2)" "unprognostic (2.07e-1)" "unprognostic (3.01e-1)" 13.4 10.2 13.3 8.9 16.2 4.6 16.7 11.2 22.1 12.7 17.0 14.4 13.8 11.3 13.6 12.9 22.7 12.1 15.8 16.4 10.6 10.7 14.6 55.5 12.1 11.2 12.0 11.1 13.1 34.2 164.6 9.2 11.9 11.0 13.7 18.9 13.2 20.9 14.3 26.5 17.2 16.1 15.9 9.2 10.5 17.7 10.4 10.5 9.9 12.0 14.2 13.0 16.2 12.9 8.5 15.5 5.4 7.3 6.5 10.0 4.9 24.5 18.7 21.4 25.8 35.2 26.8 26.8 25.2 19.1 17.4 15.7 28.4 49.6 24.7 42.9 23.7 28.4 32.5 53.0 22.6 6.5 20.6 117.8 13.4 26.6 26.2 26.5 12.8 25.0 48.6 26.1 38.6 36.7 53.4 10.1 24.4 17.3 12.1 13.6 28.2 20.5 17.8 25.3 21.0 29.0 44.0 20.0 19.2 29.5 35.2 9.5 71.9 26.5 30.5 22.4 15.2 15.6 20.3 6.3 12.7 32.2 9.8 40.8 29.8 4.1 7.3 5.4 8.2 7.0 8.1 8.5 6.5 10.0 11.6 7.3 9.4 7.6 0.9 6.5 5.1 15.5 9.0 4.9 13.3 16.2 11.2 22.1 10.6 10.7 12.0 11.1 11.0 10.5 ELOVL1 Ssc1 ENSG00000066322 "ELOVL fatty acid elongase 1" Q9BW60 1 43363397-43368074 "Enzymes, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 101.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033426, HPA056557" Approved Approved "Endoplasmic reticulum" "Endoplasmic reticulum" "CAB033426: AB_2099896, HPA056557: " "unprognostic (5.23e-2)" "prognostic unfavourable (3.63e-5)" "unprognostic (8.00e-2)" "unprognostic (8.45e-2)" "unprognostic (7.60e-2)" "unprognostic (7.40e-2)" "prognostic unfavourable (2.79e-7)" "unprognostic (4.74e-2)" "unprognostic (1.33e-1)" "unprognostic (4.37e-1)" "prognostic unfavourable (8.51e-4)" "unprognostic (1.83e-1)" "unprognostic (2.88e-2)" "unprognostic (1.41e-2)" "unprognostic (1.28e-1)" "unprognostic (1.73e-1)" "unprognostic (9.00e-2)" 21.2 15.6 16.2 15.3 25.3 18.3 24.1 6.8 32.5 16.1 23.6 101.5 11.7 20.7 14.1 13.0 46.6 15.1 17.3 11.5 30.3 18.3 26.6 23.8 22.9 22.7 51.4 14.1 9.3 18.3 16.7 8.4 20.9 45.6 21.6 20.1 8.6 20.6 21.6 6.8 54.0 21.7 20.7 99.5 17.2 22.8 8.4 37.2 7.2 23.9 15.6 21.7 20.4 22.6 30.9 61.1 46.9 54.8 30.5 32.3 48.8 23.5 26.6 5.2 10.2 35.2 33.1 16.1 27.9 35.3 35.7 28.8 23.6 41.5 16.3 21.8 43.8 27.2 18.2 34.4 21.9 20.9 12.3 21.2 18.4 17.0 30.6 18.2 22.6 25.3 39.2 42.2 46.6 35.6 14.6 12.4 40.8 17.4 4.2 15.3 7.6 27.5 9.6 13.7 19.9 45.0 28.8 6.3 6.6 16.5 59.1 23.6 27.7 18.2 29.5 30.3 19.1 36.6 35.4 6.2 6.7 7.8 29.4 18.7 27.2 29.0 54.8 46.9 32.3 50.6 28.6 30.9 30.7 31.4 61.1 25.5 20.1 28.1 38.2 30.5 48.1 42.9 31.4 48.8 16.2 25.3 6.8 32.5 30.3 18.3 51.4 14.1 45.6 37.2 FADS3 "CYB5RP, LLCDL3" ENSG00000221968 "Fatty acid desaturase 3" Q9Y5Q0 11 61873519-61892051 "Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Transport" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 63.1" "Cell line enhanced" "Detected in many" "ASC diff: 62.2;HHSteC: 53.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 8.9;naive B-cell: 10.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045224 Approved Approved "Nucleoli fibrillar center" "Nucleoli fibrillar center" "HPA045224: AB_10967570" "unprognostic (4.69e-3)" "unprognostic (1.31e-2)" "unprognostic (5.55e-3)" "unprognostic (1.20e-1)" "unprognostic (2.91e-2)" "prognostic unfavourable (9.54e-5)" "unprognostic (1.76e-3)" "unprognostic (3.46e-1)" "unprognostic (6.45e-2)" "unprognostic (1.49e-1)" "unprognostic (1.28e-3)" "unprognostic (2.04e-1)" "prognostic unfavourable (1.50e-9)" "unprognostic (1.14e-1)" "unprognostic (3.92e-2)" "unprognostic (1.53e-1)" "unprognostic (2.37e-1)" 63.1 25.9 15.7 17.5 17.9 4.1 23.5 8.7 16.5 9.3 8.3 13.8 5.9 4.3 9.8 25.4 7.4 9.0 9.9 22.7 14.4 11.6 16.6 8.5 16.3 15.4 16.9 10.0 12.7 12.1 12.4 5.0 48.2 15.1 7.1 4.4 16.8 5.5 11.3 15.7 4.2 9.0 14.9 13.3 9.7 8.3 6.0 15.6 1.1 6.1 7.3 15.7 10.4 9.9 10.6 0.7 5.7 1.2 0.6 2.4 0.7 7.6 2.4 0.7 4.8 62.2 12.6 15.5 15.5 37.8 16.6 16.1 3.4 2.8 5.7 10.1 30.8 4.2 2.9 42.1 8.8 1.6 1.6 4.7 10.1 6.7 53.9 0.4 0.9 13.8 18.3 19.9 38.1 19.1 4.5 10.8 28.2 8.8 1.7 2.3 2.2 6.3 9.6 30.7 15.8 18.5 2.7 1.2 1.5 17.7 2.4 15.7 3.4 1.0 12.9 16.2 11.2 4.7 6.7 3.3 1.6 6.8 13.5 2.3 11.7 0.0 0.7 5.7 1.8 1.2 1.6 8.9 1.6 2.4 0.7 10.6 0.1 0.6 0.3 0.6 0.8 0.0 0.4 0.7 15.7 17.9 8.7 15.4 14.4 11.6 16.9 10.0 15.1 15.6 FITM1 FIT1 ENSG00000139914 "Fat storage inducing transmembrane protein 1" A5D6W6 14 24131275-24132849 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "heart muscle: 56.1;skeletal muscle: 94.7;tongue: 79.9" "Cell line enriched" "Detected in some" 17 "RH-30: 26.4" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA019842 Uncertain "HPA019842: AB_1853025" "unprognostic (1.81e-2)" "unprognostic (4.29e-7)" "unprognostic (2.77e-1)" "unprognostic (2.02e-3)" "unprognostic (2.24e-2)" "unprognostic (6.68e-2)" "prognostic favourable (1.00e-3)" "unprognostic (1.20e-4)" "unprognostic (4.57e-1)" "unprognostic (2.12e-2)" "unprognostic (2.84e-2)" "unprognostic (3.68e-2)" "unprognostic (2.47e-1)" "unprognostic (2.86e-2)" "unprognostic (5.62e-1)" "unprognostic (1.96e-1)" "unprognostic (2.12e-3)" 0.8 1.7 0.0 0.2 0.0 0.6 0.3 0.4 0.2 0.2 0.3 0.0 0.0 0.5 0.2 2.2 1.2 0.2 0.2 56.1 0.0 0.0 0.2 13.1 0.2 0.3 0.0 0.0 0.2 11.9 0.2 0.2 0.2 0.0 0.7 0.2 0.1 2.9 0.3 94.7 0.5 0.4 0.2 0.0 2.5 0.3 0.3 0.0 0.0 0.5 79.9 3.6 0.3 0.0 0.8 0.3 0.0 1.1 0.4 1.5 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 1.5 0.1 0.0 0.7 0.7 0.2 0.0 0.1 0.0 0.0 0.3 0.3 0.0 0.2 0.3 0.0 0.3 0.2 26.4 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.5 0.0 0.5 1.1 0.3 0.2 1.1 1.5 0.3 0.8 0.6 0.6 0.0 0.4 0.4 0.0 0.1 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FLVCR2 "C14orf58, FLJ20371, MFSD7C" ENSG00000119686 "Feline leukemia virus subgroup C cellular receptor family member 2" Q9UPI3 14 75578617-75663214 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 45.7" "Cell line enhanced" "Detected in many" "ASC diff: 26.5;ASC TERT1: 11.5;BEWO: 35.4;MCF7: 12.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 7 "classical monocyte: 11.3;intermediate monocyte: 12.1;myeloid DC: 6.2;non-classical monocyte: 8.9" "Group enriched" "Detected in many" 7 "dendritic cells: 6.2;monocytes: 12.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037984 Enhanced "HPA037984: AB_10672733" "unprognostic (2.42e-1)" "unprognostic (4.85e-2)" "unprognostic (4.19e-2)" "unprognostic (2.32e-1)" "unprognostic (1.24e-1)" "unprognostic (4.44e-2)" "unprognostic (8.72e-2)" "unprognostic (2.78e-1)" "unprognostic (3.64e-1)" "unprognostic (1.91e-1)" "unprognostic (2.22e-1)" "unprognostic (4.80e-2)" "prognostic favourable (2.53e-5)" "unprognostic (6.69e-2)" "unprognostic (9.94e-2)" "unprognostic (9.38e-2)" "unprognostic (1.16e-1)" 5.6 11.6 1.4 6.5 2.6 3.0 2.4 0.7 2.4 2.5 24.1 1.9 0.9 12.5 1.4 2.9 2.4 2.0 2.6 3.0 1.7 1.0 8.3 19.0 11.5 7.7 4.8 0.7 2.4 0.8 0.8 4.1 25.6 5.0 2.3 5.2 30.9 8.7 2.5 7.6 5.1 45.7 2.8 6.0 17.5 1.1 15.6 2.6 1.1 3.2 5.6 3.3 2.2 4.2 0.1 6.2 0.5 12.1 0.3 1.3 3.0 1.7 1.3 0.4 1.9 26.5 11.5 35.4 0.3 1.4 1.5 1.2 2.9 0.2 0.0 0.1 0.1 0.2 4.6 0.1 0.6 8.9 0.3 0.0 1.3 6.1 2.1 0.0 0.3 5.3 3.7 1.9 1.1 0.3 0.1 0.2 4.8 12.2 0.0 0.9 0.8 2.1 0.0 1.2 0.0 1.7 2.4 0.0 0.0 0.9 3.9 0.7 2.1 4.7 4.1 1.9 0.7 1.0 0.0 0.3 0.5 0.0 5.5 1.1 0.3 0.0 11.3 0.5 0.3 12.1 1.0 0.0 0.9 0.3 6.2 0.1 0.7 0.1 0.3 0.3 8.9 0.1 1.3 3.0 1.4 2.6 0.7 2.1 1.7 1.0 4.8 0.7 5.0 2.6 FRRS1 "SDFR2, SDR2" ENSG00000156869 "Ferric chelate reductase 1" Q6ZNA5 1 99708632-99766631 "Predicted membrane proteins" "Electron transport, Transport" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 27.1" "Cell line enhanced" "Detected in many" "HEL: 27.6;K-562: 18.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 7 "eosinophil: 5.5" "Lineage enriched" "Detected in single" 7 "granulocytes: 5.5" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA017883 Approved "HPA017883: AB_2294223" "unprognostic (3.97e-2)" "unprognostic (8.02e-2)" "unprognostic (1.25e-1)" "unprognostic (2.07e-2)" "unprognostic (6.63e-2)" "unprognostic (8.34e-2)" "unprognostic (1.68e-1)" "unprognostic (8.54e-3)" "unprognostic (7.00e-2)" "unprognostic (2.64e-1)" "unprognostic (8.25e-3)" "unprognostic (1.06e-1)" "prognostic unfavourable (6.53e-4)" "unprognostic (2.65e-2)" "unprognostic (1.83e-2)" "unprognostic (3.56e-2)" "unprognostic (3.54e-2)" 10.3 6.2 0.6 2.7 1.2 1.5 5.1 0.5 1.2 6.4 6.1 1.2 14.5 2.6 10.7 6.5 11.2 2.0 3.4 2.9 0.6 0.6 1.9 27.1 3.8 1.7 2.1 0.0 5.3 2.0 1.5 2.3 9.8 0.9 4.4 4.0 1.6 8.4 13.4 2.0 7.2 8.0 3.3 3.1 1.5 4.2 2.9 1.3 1.4 5.6 5.4 6.0 5.1 7.0 0.3 0.5 5.5 0.8 0.0 0.1 0.1 5.5 1.0 2.4 2.1 7.6 4.1 12.2 1.4 2.7 1.7 6.5 6.7 7.3 3.2 5.7 1.6 12.7 3.8 5.9 2.1 6.5 2.4 27.6 2.7 7.2 1.1 3.1 7.4 6.1 7.5 3.4 1.3 0.3 18.5 0.1 1.4 1.7 1.0 1.2 1.7 5.1 0.0 9.0 1.3 1.1 13.8 0.5 0.1 2.3 10.4 5.4 3.8 3.9 0.6 3.0 4.1 2.6 1.5 2.3 0.0 5.4 6.6 1.3 1.4 0.5 0.4 5.5 0.0 0.8 0.0 0.3 0.0 0.0 0.5 0.1 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.1 0.6 1.2 0.5 1.2 0.6 0.6 2.1 0.0 0.9 1.3 GCGR GGR ENSG00000215644 "Glucagon receptor" P47871 17 81804132-81814013 "FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Diabetes mellitus, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "liver: 68.8" "Cell line enhanced" "Detected in some" "HeLa: 3.8;MCF7: 6.0;SK-BR-3: 5.2;U-87 MG: 6.0" "Cancer enhanced" "Detected in many" "liver cancer: 10.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 5 "cerebellum: 0.9" "Low region specificity" "Detected in all" HPA071228 Approved "Golgi apparatus" "Golgi apparatus" "HPA071228: " "unprognostic (3.28e-4)" "unprognostic (9.30e-2)" "unprognostic (2.20e-1)" "unprognostic (1.53e-4)" "unprognostic (1.11e-1)" "unprognostic (2.30e-3)" "unprognostic (4.38e-2)" "unprognostic (1.79e-3)" "unprognostic (2.18e-1)" "unprognostic (2.77e-1)" "unprognostic (3.09e-1)" "unprognostic (2.61e-1)" "unprognostic (6.42e-2)" "unprognostic (5.99e-3)" "unprognostic (1.71e-1)" "unprognostic (1.17e-3)" "unprognostic (8.36e-3)" 0.2 3.9 0.1 0.6 0.3 0.0 0.1 0.1 0.3 0.2 0.2 0.1 0.1 0.2 0.1 0.2 0.2 0.0 0.1 0.1 0.1 0.0 11.4 68.8 0.1 0.1 0.1 0.1 0.1 0.5 3.9 0.1 0.1 0.5 0.2 0.0 1.4 0.3 0.1 0.1 0.9 0.2 0.1 0.1 0.1 0.0 0.2 0.1 0.2 0.2 0.6 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 3.8 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 1.5 0.0 5.2 0.0 0.0 0.6 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.3 0.1 0.0 0.1 0.1 0.5 0.1 GDPD2 "FLJ20207, GDE3, OBDPF" ENSG00000130055 "Glycerophosphodiester phosphodiesterase domain containing 2" Q9HCC8 X 70423031-70433390 "Enzymes, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 22.5;intestine: 19.5;lymphoid tissue: 37.5;skin 1: 33.2" "Group enriched" "Detected in some" 7 "AF22: 9.2;NTERA-2: 19.7" "Cancer enhanced" "Detected in many" "glioma: 10.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.4" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "unprognostic (1.53e-3)" "unprognostic (5.79e-2)" "unprognostic (5.37e-2)" "unprognostic (5.00e-7)" "unprognostic (3.15e-3)" "unprognostic (3.65e-2)" "unprognostic (2.86e-2)" "unprognostic (4.66e-2)" "unprognostic (1.19e-1)" "unprognostic (8.40e-2)" "unprognostic (8.45e-2)" "unprognostic (1.06e-1)" "unprognostic (1.35e-2)" "unprognostic (5.41e-2)" "unprognostic (5.52e-2)" "unprognostic (2.22e-1)" "unprognostic (8.91e-2)" 0.4 0.4 6.8 0.6 5.7 0.4 1.0 1.1 4.0 0.3 13.0 8.2 8.3 8.0 0.4 22.5 0.4 0.5 0.5 0.8 7.6 4.0 0.6 0.3 0.4 0.4 4.3 5.6 0.4 0.4 0.3 2.6 0.4 8.4 0.3 3.0 0.2 1.1 0.6 0.6 33.2 19.5 0.4 1.5 37.5 1.6 0.3 4.9 0.0 0.4 0.6 0.3 1.0 0.3 0.4 0.1 1.4 0.2 0.1 0.2 0.0 0.0 0.0 9.2 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.2 19.7 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.2 0.2 0.2 0.0 0.1 0.1 0.2 0.2 0.1 0.1 0.0 0.4 0.1 0.1 1.4 0.1 0.1 0.1 0.0 0.0 6.8 5.7 1.1 4.0 7.6 4.0 4.3 5.6 8.4 4.9 GDPD5 "GDE2, PP1665" ENSG00000158555 "Glycerophosphodiester phosphodiesterase domain containing 5" Q8WTR4 11 75434640-75525903 "Predicted membrane proteins" Neurogenesis Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 37.2;placenta: 41.7" "Cell line enhanced" "Detected in many" "EFO-21: 17.0;fHDF/TERT166: 16.2;HDLM-2: 33.2;U-2 OS: 15.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 9.3" "Group enriched" "Detected in many" 5 "granulocytes: 9.3;T-cells: 3.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065257, HPA066762, HPA069281" Uncertain Approved "Golgi apparatus" "Golgi apparatus" "HPA065257: , HPA066762: , HPA069281: " "unprognostic (1.66e-1)" "unprognostic (1.09e-1)" "unprognostic (2.37e-1)" "prognostic unfavourable (1.29e-4)" "unprognostic (1.48e-1)" "unprognostic (6.12e-2)" "unprognostic (9.97e-3)" "unprognostic (4.05e-1)" "unprognostic (1.44e-1)" "unprognostic (3.49e-1)" "unprognostic (3.07e-2)" "unprognostic (1.19e-1)" "prognostic unfavourable (6.59e-9)" "unprognostic (8.64e-2)" "unprognostic (1.30e-1)" "unprognostic (4.39e-2)" "unprognostic (1.65e-1)" 16.5 6.0 3.3 3.3 4.6 7.8 8.0 23.2 7.9 3.3 3.0 3.3 1.6 2.0 6.4 3.1 1.6 3.2 3.6 2.8 3.0 1.8 2.3 2.7 5.4 4.3 3.0 2.6 2.9 13.4 0.4 7.0 41.7 4.2 3.1 1.3 18.8 15.5 4.1 5.9 2.3 3.2 4.9 3.4 37.2 1.4 11.9 5.5 2.0 2.6 1.4 3.4 3.5 11.5 1.1 1.1 9.3 1.2 0.0 3.1 0.7 1.0 3.8 1.6 1.9 1.1 0.6 5.7 1.2 1.6 0.5 0.4 5.0 2.2 7.1 17.0 16.2 2.3 2.0 1.9 0.3 33.2 1.5 1.3 5.8 10.3 1.7 0.8 5.6 1.3 1.0 0.4 0.8 13.6 2.3 3.2 0.7 2.2 1.9 3.5 2.9 5.4 2.2 0.4 1.9 0.4 1.8 0.9 0.6 2.4 9.3 4.5 1.3 3.1 4.0 3.9 15.8 3.0 1.2 0.8 0.1 1.3 0.9 4.2 0.4 9.3 1.2 0.7 2.0 0.6 2.9 1.1 2.3 1.6 0.3 0.4 1.2 1.5 0.1 0.0 0.0 1.1 3.1 0.7 3.3 4.6 23.2 7.9 3.0 1.8 3.0 2.6 4.2 5.5 GGCX VKCFD1 ENSG00000115486 "Gamma-glutamyl carboxylase" P38435 2 85544723-85561547 "Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins" Lyase "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "liver: 74.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018284 Approved "HPA018284: AB_1849641" "unprognostic (4.88e-3)" "unprognostic (1.13e-2)" "unprognostic (1.22e-2)" "prognostic unfavourable (1.82e-6)" "unprognostic (5.67e-2)" "unprognostic (1.85e-3)" "unprognostic (2.96e-2)" "unprognostic (3.77e-2)" "unprognostic (5.64e-2)" "unprognostic (2.18e-2)" "unprognostic (6.45e-3)" "unprognostic (5.23e-2)" "unprognostic (8.17e-3)" "unprognostic (7.85e-2)" "unprognostic (2.59e-1)" "unprognostic (7.63e-3)" "unprognostic (9.38e-2)" 7.1 7.8 4.8 4.2 6.3 1.6 10.8 6.3 6.6 6.4 4.9 5.4 8.3 4.0 6.3 8.1 6.5 5.9 7.0 6.8 5.4 3.6 9.0 74.8 8.1 5.4 5.4 5.0 7.0 11.4 15.1 5.6 13.8 5.9 6.3 5.5 5.8 7.4 7.9 6.8 4.9 5.5 7.2 5.1 4.5 6.0 3.6 5.7 3.4 8.5 5.3 5.4 7.3 6.0 0.9 4.9 6.0 7.2 2.2 3.2 3.2 6.8 11.1 7.9 8.8 40.0 11.4 17.6 12.2 14.4 9.0 12.8 19.0 8.4 2.4 12.5 20.0 11.1 5.6 15.4 10.0 4.3 7.7 4.4 7.4 18.0 14.9 2.7 4.2 14.1 9.1 18.2 12.5 12.7 5.3 3.6 26.1 8.9 1.4 2.1 3.7 9.6 2.6 18.6 6.1 12.5 13.1 3.0 5.0 10.9 21.6 11.3 10.5 2.7 11.6 11.6 10.2 11.2 8.3 2.8 7.8 2.0 11.1 2.8 16.2 6.0 7.2 3.6 3.2 7.2 3.0 0.7 1.3 1.2 4.9 0.9 3.2 3.0 3.2 2.2 4.4 4.0 1.9 3.2 4.8 6.3 6.3 6.6 5.4 3.6 5.4 5.0 5.9 5.7 GHITM "DERP2, HSPC282, My021, PTD010, TMBIM5" ENSG00000165678 "Growth hormone inducible transmembrane protein" Q9H3K2 10 84139440-84153245 "Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016464, HPA061664" Approved Supported Mitochondria Mitochondria "HPA016464: AB_1849656, HPA061664: " "unprognostic (6.26e-3)" "unprognostic (1.85e-1)" "unprognostic (2.75e-2)" "unprognostic (1.51e-1)" "unprognostic (4.61e-2)" "prognostic unfavourable (1.76e-4)" "unprognostic (5.71e-2)" "unprognostic (4.56e-2)" "unprognostic (1.76e-1)" "unprognostic (1.28e-1)" "unprognostic (8.14e-2)" "unprognostic (5.71e-2)" "prognostic favourable (2.32e-10)" "unprognostic (2.46e-2)" "unprognostic (2.09e-1)" "unprognostic (3.56e-2)" "unprognostic (1.25e-1)" 28.7 50.7 46.0 21.9 53.3 25.3 26.0 30.9 62.7 21.4 45.5 20.2 23.9 43.3 21.2 24.5 30.0 19.9 21.8 94.9 40.8 42.8 80.5 71.6 19.2 23.2 45.2 42.4 20.7 25.1 29.9 24.0 20.9 62.8 22.6 46.0 24.3 26.0 24.5 87.6 19.9 35.6 28.9 24.6 20.1 30.1 41.7 17.5 21.5 29.3 47.6 26.6 26.1 19.1 46.8 63.7 60.6 67.5 44.4 51.6 106.0 41.2 43.0 18.4 42.1 31.6 28.2 32.7 28.5 50.3 37.1 34.7 52.2 34.4 32.7 32.1 37.7 37.3 39.0 37.3 35.9 32.6 29.6 23.2 44.9 51.3 59.9 72.2 38.1 31.7 73.4 38.2 111.5 32.0 53.8 61.2 34.0 36.0 25.5 57.8 18.5 38.3 23.3 16.9 49.1 51.4 33.3 15.1 17.6 28.8 25.3 57.6 51.6 46.4 27.0 18.0 24.3 26.2 45.8 43.3 47.1 36.7 47.4 67.0 12.5 52.6 64.3 60.6 42.2 67.5 47.1 46.8 44.2 44.9 63.7 37.2 41.5 44.4 51.3 44.4 59.6 33.0 51.6 106.0 46.0 53.3 30.9 62.7 40.8 42.8 45.2 42.4 62.8 17.5 GHSR ENSG00000121853 "Growth hormone secretagogue receptor" Q92847 3 172445133-172448456 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 2.4;blood: 2.4;pituitary gland: 7.4" "Cell line enriched" "Detected in single" 4 "HMC-1: 1.7" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 25 "NK-cell: 2.4" "Lineage enriched" "Detected in single" 25 "NK-cells: 2.4" "Region enhanced" "Detected in some" "hypothalamus: 3.8" "Low region specificity" "Detected in all" "unprognostic (1.27e-1)" "unprognostic (3.31e-2)" 0.0 2.4 0.0 0.8 0.5 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 1.8 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 7.4 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.1 GPAA1 "GAA1, hGAA1" ENSG00000197858 "Glycosylphosphatidylinositol anchor attachment 1" O43292 8 144082590-144086216 "Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 69.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077224 Approved "HPA077224: " "unprognostic (2.53e-3)" "unprognostic (1.39e-1)" "unprognostic (3.06e-2)" "unprognostic (2.57e-2)" "unprognostic (2.49e-2)" "unprognostic (4.05e-2)" "unprognostic (1.73e-3)" "unprognostic (2.64e-1)" "unprognostic (8.92e-2)" "unprognostic (1.67e-2)" "unprognostic (2.04e-3)" "unprognostic (4.72e-2)" "unprognostic (1.15e-1)" "unprognostic (1.03e-1)" "unprognostic (3.89e-1)" "unprognostic (1.27e-1)" "unprognostic (2.73e-2)" 25.2 35.3 23.0 15.9 25.5 32.1 20.0 19.9 43.7 23.6 24.4 27.1 32.3 28.2 26.3 38.3 23.2 24.0 31.1 35.0 20.3 17.4 29.3 47.2 24.9 31.4 19.9 19.0 23.8 46.6 36.4 17.1 32.9 25.1 23.1 10.7 27.4 46.0 35.4 28.5 23.3 31.0 16.3 22.3 21.9 23.0 24.6 16.1 24.0 29.0 22.2 18.6 19.3 18.6 17.2 41.0 21.7 33.3 24.7 34.5 26.1 16.2 28.7 6.7 21.0 15.6 13.3 23.3 16.6 16.6 14.0 14.6 11.9 26.9 8.8 24.3 18.0 20.2 4.4 16.5 2.0 14.9 15.1 13.9 13.4 8.7 15.1 6.8 20.9 14.6 15.5 14.3 10.0 11.5 10.1 31.4 13.4 57.1 13.1 6.3 6.7 69.8 9.2 8.5 42.2 12.1 11.4 11.6 16.0 21.8 28.1 12.2 18.0 19.2 7.6 13.0 22.6 7.3 18.6 17.5 13.5 5.9 23.0 8.4 17.7 11.8 24.8 21.7 34.5 29.9 23.7 15.5 17.4 27.1 23.1 17.2 17.3 24.1 5.8 24.7 33.3 41.0 15.0 26.1 23.0 25.5 19.9 43.7 20.3 17.4 19.9 19.0 25.1 16.1 GPER1 "CEPR, CMKRL2, DRY12, FEG-1, GPCR-Br, GPER, GPR30, LERGU, LERGU2, LyGPR" ENSG00000164850 "G protein-coupled estrogen receptor 1" Q99527 7 1082208-1093815 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Cell cycle, Differentiation, Immunity, Inflammatory response, Innate immunity, Neurogenesis" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 9.9;Daudi: 10.4;Hep G2: 19.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 4.3;intermediate monocyte: 4.2;myeloid DC: 8.4" "Group enriched" "Detected in many" 18 "dendritic cells: 8.4;monocytes: 4.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA027052 Approved "HPA027052: AB_10612112" "unprognostic (4.74e-2)" "unprognostic (1.32e-1)" "unprognostic (3.09e-2)" "prognostic favourable (1.17e-4)" "unprognostic (2.17e-1)" "unprognostic (6.17e-2)" "unprognostic (3.45e-1)" "unprognostic (6.38e-2)" "unprognostic (2.40e-1)" "unprognostic (1.23e-1)" "unprognostic (1.42e-2)" "unprognostic (2.49e-1)" "unprognostic (2.37e-2)" "unprognostic (1.79e-2)" "unprognostic (1.58e-1)" "unprognostic (7.26e-2)" "unprognostic (7.78e-2)" 14.2 10.9 12.1 3.6 13.2 1.2 11.5 5.1 11.1 6.4 7.1 5.6 3.5 2.0 5.4 1.8 5.5 4.8 3.2 6.0 8.3 6.2 7.4 19.5 25.6 6.4 8.6 8.7 3.3 4.0 1.8 4.7 13.3 6.1 6.8 3.7 5.2 4.2 11.8 8.6 2.8 2.6 5.5 4.1 6.5 23.9 2.2 8.6 1.3 16.5 2.3 2.8 6.4 7.2 0.3 8.4 0.0 4.3 0.0 0.0 1.6 0.9 0.3 0.2 9.9 2.4 2.4 1.0 5.7 3.8 1.8 3.3 0.2 0.2 10.4 0.9 7.1 0.5 0.1 0.0 0.2 2.1 1.8 0.0 1.2 19.0 0.3 0.1 0.6 1.3 0.0 1.1 0.0 0.5 0.1 0.1 0.4 0.6 0.0 0.3 1.9 6.8 0.9 0.0 0.0 0.2 0.0 0.1 3.9 0.0 0.4 2.1 0.2 0.1 1.4 0.4 2.6 6.0 1.8 0.0 0.0 3.6 3.3 0.1 0.2 0.0 4.3 0.0 0.0 4.2 0.0 0.3 0.0 0.0 8.4 0.1 0.0 0.0 0.0 0.0 1.1 0.2 0.0 1.6 12.1 13.2 5.1 11.1 8.3 6.2 8.6 8.7 6.1 8.6 GPR137 "C11orf4, GPR137A, TM7SF1L1" ENSG00000173264 "G protein-coupled receptor 137" Q96N19 11 64270062-64289500 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 64.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 15.7" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062871 Uncertain Approved "Nucleoplasm,Nucleoli,Actin filaments" "Nucleoplasm, Nucleoli" "Actin filaments" "HPA062871: " "unprognostic (2.25e-1)" "unprognostic (4.21e-2)" "unprognostic (6.81e-2)" "unprognostic (1.06e-1)" "unprognostic (1.29e-3)" "unprognostic (6.37e-2)" "prognostic unfavourable (5.34e-4)" "unprognostic (5.68e-2)" "unprognostic (1.83e-2)" "unprognostic (7.61e-3)" "prognostic favourable (6.18e-4)" "unprognostic (4.95e-2)" "unprognostic (8.66e-3)" "unprognostic (3.67e-3)" "unprognostic (2.28e-1)" "unprognostic (2.13e-1)" "unprognostic (5.41e-1)" 10.3 12.2 18.6 12.8 21.8 10.4 12.0 20.0 23.1 8.9 10.5 13.2 13.8 11.2 9.0 10.4 10.5 13.3 10.3 9.7 18.5 14.3 14.0 14.1 9.3 10.8 15.4 9.1 7.3 9.4 16.4 10.1 28.9 16.5 10.5 5.8 12.4 13.9 12.8 9.9 15.9 11.4 7.1 12.7 11.3 13.6 64.8 14.4 9.9 14.3 5.5 9.3 9.5 16.2 3.9 3.4 15.7 3.0 1.9 3.4 1.4 8.9 20.0 6.9 20.0 13.5 7.2 29.3 10.7 9.0 10.7 6.9 14.7 12.6 9.2 18.6 6.7 18.0 9.6 5.9 3.1 29.1 12.1 8.7 20.5 9.4 7.7 5.8 17.0 9.0 9.4 9.3 7.1 5.7 7.8 22.5 6.4 22.7 6.5 15.6 9.4 20.0 13.0 7.4 14.9 7.4 12.2 11.0 13.4 13.0 17.7 11.5 19.4 2.4 9.2 29.6 20.5 22.3 7.7 18.0 33.1 7.7 21.2 4.9 18.0 1.7 3.0 5.3 2.7 2.8 3.4 2.8 2.3 2.0 3.1 3.9 2.6 2.2 15.7 1.9 2.3 3.4 1.6 1.4 18.6 21.8 20.0 23.1 18.5 14.3 15.4 9.1 16.5 14.4 GPR137C "DKFZp762F0713, TM7SF1L2" ENSG00000180998 "G protein-coupled receptor 137C" Q8N3F9 14 52553148-52637713 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 31.1;epididymis: 16.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "granulocytes: 2.4;NK-cells: 3.9;T-cells: 4.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003640, HPA030763" Uncertain Approved Vesicles Vesicles "HPA003640: , HPA030763: AB_10602352" "unprognostic (1.39e-1)" "unprognostic (1.45e-1)" "unprognostic (1.23e-1)" "unprognostic (6.84e-2)" "unprognostic (8.50e-3)" "unprognostic (7.34e-3)" "unprognostic (5.95e-3)" "unprognostic (2.32e-2)" "unprognostic (4.41e-2)" "unprognostic (8.42e-4)" "unprognostic (2.20e-2)" "unprognostic (1.04e-1)" "unprognostic (7.88e-2)" "unprognostic (4.08e-1)" "unprognostic (1.38e-2)" "unprognostic (2.83e-1)" "unprognostic (2.60e-1)" 1.4 2.2 7.1 1.0 11.0 3.3 1.9 31.1 20.2 1.4 1.2 7.5 0.2 2.0 2.5 16.6 1.7 1.2 2.8 2.4 5.9 10.6 1.2 1.3 1.7 2.1 6.3 7.5 1.6 0.7 2.3 1.8 1.8 13.3 1.6 1.5 3.2 1.7 1.5 1.3 1.8 1.2 1.5 7.0 2.5 1.4 6.5 8.3 0.0 2.1 0.0 1.2 2.1 0.7 0.7 0.5 2.4 0.5 3.9 4.1 0.8 0.8 0.3 8.1 7.4 2.3 0.7 3.2 3.4 2.3 3.5 8.6 1.5 1.6 0.8 2.5 2.8 1.9 2.7 0.5 5.3 1.2 1.8 0.9 2.3 0.9 0.3 0.5 1.9 0.4 0.0 3.3 0.2 1.8 1.2 3.5 5.1 3.9 0.3 1.1 2.0 4.7 1.8 5.1 0.3 1.0 5.7 8.3 10.4 1.7 0.5 0.2 5.1 0.0 0.3 8.1 8.7 5.9 2.8 0.8 2.0 1.8 2.0 0.4 2.4 1.2 0.5 0.5 3.1 0.1 4.1 0.3 2.0 3.9 0.2 0.7 1.5 1.8 2.4 3.9 0.4 0.5 1.4 0.8 7.1 11.0 31.1 14.1 5.9 10.6 6.3 7.5 13.3 8.3 GPR149 "IEDA, PGR10, R35" ENSG00000174948 "G protein-coupled receptor 149" Q86SP6 3 154337672-154429715 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 11 "brain: 23.5;pituitary gland: 6.5;seminal vesicle: 8.7" "Cell line enhanced" "Detected in single" "SCLC-21H: 2.1" "Not detected" "Not detected" "Group enriched" "Detected in many" 7 "basal ganglia: 23.5;pons and medulla: 6.5" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in many" "basal ganglia: 15.0" "Low region specificity" "Detected in all" HPA018020 Uncertain "HPA018020: AB_1849334" 0.2 0.3 0.2 0.2 23.5 0.2 0.2 0.0 0.8 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 1.9 0.2 0.2 0.2 0.2 0.8 0.0 0.2 0.2 0.2 6.5 0.2 6.5 0.3 0.3 0.4 0.2 8.7 0.2 0.3 0.3 0.2 0.6 0.2 0.5 1.1 2.1 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 23.5 0.0 0.8 0.2 1.9 0.8 0.0 6.5 2.1 GPR153 PGR1 ENSG00000158292 "G protein-coupled receptor 153" Q6NV75 1 6247346-6260975 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 13.9;PC-3: 35.5;RH-30: 16.8;SCLC-21H: 17.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 4 "granulocytes: 1.3;monocytes: 1.0;T-cells: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007159 Approved "HPA007159: AB_1849268" "unprognostic (1.02e-2)" "unprognostic (2.40e-2)" "unprognostic (4.95e-2)" "prognostic unfavourable (3.07e-4)" "unprognostic (5.74e-3)" "unprognostic (3.33e-1)" "unprognostic (1.20e-1)" "prognostic unfavourable (3.75e-4)" "unprognostic (8.54e-2)" "unprognostic (1.02e-2)" "unprognostic (1.31e-1)" "unprognostic (1.51e-2)" "unprognostic (1.53e-3)" "unprognostic (2.00e-1)" "unprognostic (2.93e-1)" "unprognostic (1.35e-1)" "unprognostic (1.05e-1)" 11.0 2.9 11.9 3.8 5.2 0.5 16.1 1.3 10.6 16.1 19.9 3.7 4.6 5.4 8.3 15.9 7.0 7.1 5.8 7.7 5.8 5.1 2.7 6.3 12.6 2.3 2.0 2.7 14.8 2.1 5.9 10.2 9.2 4.2 6.8 7.1 7.2 2.6 4.9 1.4 8.7 18.3 6.6 1.2 8.8 3.0 2.9 2.5 1.8 1.6 5.5 3.5 6.1 9.6 0.0 0.3 1.3 1.0 0.3 1.7 0.1 3.0 0.5 7.5 9.0 13.9 5.5 0.6 2.0 1.9 0.8 0.9 1.3 1.2 0.0 3.1 2.1 3.9 0.4 8.8 0.3 2.0 1.8 0.0 1.2 0.2 2.7 0.3 1.2 3.4 2.3 0.6 0.4 0.6 0.4 0.0 2.6 3.3 1.0 2.3 0.6 35.5 3.7 16.8 0.2 0.3 1.7 17.1 6.1 1.3 5.2 4.2 2.0 1.6 1.7 1.8 1.7 0.2 0.9 0.1 0.1 0.6 0.8 4.1 0.7 1.3 0.0 0.9 1.4 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.7 0.0 0.3 1.0 0.3 0.0 0.1 11.9 5.2 1.3 10.6 5.8 5.1 2.0 2.7 4.2 2.5 GPR26 ENSG00000154478 "G protein-coupled receptor 26" Q8NDV2 10 123666355-123694607 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 10 "brain: 8.6" "Cell line enriched" "Detected in single" 16 "SCLC-21H: 5.3" "Cancer enriched" "Detected in single" 13 "breast cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA062736 Enhanced "HPA062736: " "unprognostic (4.15e-2)" "unprognostic (5.75e-2)" "unprognostic (3.42e-1)" "unprognostic (2.12e-1)" "unprognostic (9.09e-2)" "unprognostic (9.98e-2)" "unprognostic (2.12e-2)" "unprognostic (1.16e-2)" "unprognostic (1.12e-1)" 0.0 0.0 1.0 0.1 0.2 0.1 0.0 0.0 8.6 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.1 2.6 2.4 0.0 0.3 0.0 0.1 4.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 GPR31 "12-HETER, HETER1" ENSG00000120436 "G protein-coupled receptor 31" O00270 6 167156271-167158329 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.7;epididymis: 2.5;lymphoid tissue: 4.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 28 "myeloid DC: 2.7" "Lineage enriched" "Detected in single" 28 "dendritic cells: 2.7" "Not detected" "Not detected" "HPA014014, HPA027108" Uncertain "HPA014014: AB_1849292, HPA027108: AB_10601474" "unprognostic (9.92e-2)" "unprognostic (1.52e-1)" "unprognostic (1.69e-3)" "unprognostic (1.02e-1)" "unprognostic (1.03e-1)" "unprognostic (1.42e-3)" "unprognostic (2.20e-3)" "unprognostic (5.95e-3)" "unprognostic (4.03e-2)" "unprognostic (3.64e-2)" "unprognostic (2.54e-1)" "unprognostic (1.54e-2)" "unprognostic (2.86e-1)" "unprognostic (8.10e-4)" "unprognostic (2.45e-1)" "unprognostic (6.01e-2)" 0.0 0.0 0.1 0.9 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.5 0.0 2.5 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.0 0.1 4.5 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.9 0.0 0.2 2.1 0.3 1.1 0.1 1.4 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPR39 ENSG00000183840 "G protein-coupled receptor 39" O43194 2 132416574-132646559 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 22.0" "Cell line enhanced" "Detected in many" "A-431: 17.2;CAPAN-2: 14.7;hTEC/SVTERT24-B: 17.7;RT4: 15.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 6 "plasmacytoid DC: 4.3" "Lineage enriched" "Detected in single" 44 "dendritic cells: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA022111 Approved "HPA022111: AB_1849298" "unprognostic (4.06e-2)" "unprognostic (2.49e-1)" "unprognostic (2.23e-1)" "unprognostic (1.50e-2)" "unprognostic (5.19e-2)" "unprognostic (1.85e-1)" "unprognostic (8.54e-3)" "unprognostic (3.81e-2)" "unprognostic (2.12e-1)" "unprognostic (1.20e-1)" "prognostic unfavourable (7.50e-4)" "unprognostic (2.28e-1)" "unprognostic (1.64e-1)" "unprognostic (3.72e-1)" "unprognostic (4.69e-2)" "unprognostic (1.25e-1)" "unprognostic (6.58e-3)" 0.5 0.1 0.6 4.9 1.1 0.0 2.2 0.4 0.3 4.8 14.4 0.1 3.5 4.7 3.2 1.8 1.5 3.4 10.0 0.7 0.5 0.5 8.7 8.6 9.3 0.0 0.6 0.0 1.4 22.0 14.1 0.4 1.3 0.6 3.0 6.0 1.6 1.3 8.7 0.1 1.0 14.4 0.8 0.3 0.1 6.5 0.8 0.0 0.6 4.1 0.0 1.0 6.5 1.9 0.0 4.3 0.0 0.0 0.0 0.0 0.0 17.2 8.2 0.1 0.0 0.3 2.3 0.0 1.2 6.2 3.3 1.9 9.4 14.7 0.0 3.3 1.0 8.2 0.0 7.1 3.2 0.0 0.0 0.0 0.9 0.3 0.3 0.0 0.0 0.6 5.4 17.7 1.7 0.0 0.0 0.0 2.3 1.4 0.0 0.0 0.1 5.3 0.0 0.2 0.0 11.3 15.5 0.0 0.1 1.0 5.8 0.0 3.3 0.0 3.0 7.1 5.3 1.5 5.2 0.0 0.0 0.0 8.4 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.6 1.1 0.4 0.3 0.5 0.5 0.6 0.0 0.6 0.0 GPR55 ENSG00000135898 "G protein-coupled receptor 55" Q9Y2T6 2 230907318-230961066 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 7.8;intestine: 8.2;lymphoid tissue: 13.2;testis: 7.7" "Cell line enriched" "Detected in some" 5 "Karpas-707: 26.4" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in some" 6 "basal ganglia: 7.8" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (9.88e-4)" "unprognostic (2.60e-2)" "unprognostic (2.27e-1)" "unprognostic (4.24e-3)" "unprognostic (5.93e-2)" "unprognostic (1.12e-4)" "unprognostic (3.79e-1)" "unprognostic (2.98e-2)" "unprognostic (1.08e-1)" "unprognostic (2.34e-1)" "unprognostic (4.37e-2)" "unprognostic (3.18e-1)" "unprognostic (1.20e-2)" "unprognostic (1.15e-1)" "unprognostic (1.13e-1)" "unprognostic (2.42e-2)" "unprognostic (4.26e-1)" 0.4 0.1 0.4 6.9 7.8 0.2 0.7 0.1 1.2 0.6 4.8 0.7 0.1 2.1 0.9 0.5 0.8 0.2 1.6 0.1 0.5 0.7 0.9 0.1 0.8 8.8 0.2 0.1 0.1 0.1 0.1 0.5 0.1 0.3 1.2 1.5 0.1 1.9 2.1 0.1 0.6 8.2 0.1 0.3 6.6 0.9 7.7 0.1 7.0 0.4 1.2 13.2 2.2 0.4 3.0 1.9 0.5 0.2 2.2 3.1 4.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 1.7 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.1 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.6 26.4 0.0 0.0 0.2 0.7 0.5 0.8 0.0 0.0 2.5 0.0 0.0 1.0 0.0 0.0 0.0 4.8 0.0 1.8 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.0 0.0 0.1 0.0 0.0 0.1 0.3 1.2 1.2 0.9 0.4 3.0 0.5 2.3 0.5 2.2 0.2 1.9 3.1 4.6 0.4 7.8 0.1 1.2 0.5 0.7 0.2 0.1 0.3 0.1 GPR78 ENSG00000155269 "G protein-coupled receptor 78" Q96P69 4 8558725-8619761 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "placenta: 53.3" "Cell line enriched" "Detected in single" 202 "BEWO: 21.2" "Cancer enhanced" "Detected in single" "urothelial cancer: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA013209 Uncertain "HPA013209: AB_10601657" "unprognostic (6.41e-2)" "unprognostic (1.77e-2)" "unprognostic (1.17e-2)" "unprognostic (2.51e-1)" "unprognostic (1.81e-2)" "unprognostic (3.70e-2)" "unprognostic (3.82e-4)" "unprognostic (6.46e-3)" "unprognostic (1.20e-1)" "unprognostic (3.80e-2)" "unprognostic (2.29e-1)" "unprognostic (4.88e-15)" "unprognostic (5.55e-3)" "unprognostic (3.93e-2)" "unprognostic (9.90e-3)" "unprognostic (8.15e-2)" 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.5 0.1 0.0 0.0 0.0 0.0 0.0 GPR83 GPR72 ENSG00000123901 "G protein-coupled receptor 83" Q9NYM4 11 94377311-94401419 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 5 "brain: 20.0;thyroid gland: 9.3" "Cell line enhanced" "Detected in some" "CACO-2: 5.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 61.1" "Low region specificity" "Detected in all" "unprognostic (6.74e-2)" "unprognostic (7.78e-3)" "unprognostic (8.58e-2)" "unprognostic (2.60e-1)" "unprognostic (1.82e-1)" "unprognostic (2.88e-1)" "unprognostic (6.36e-3)" "unprognostic (6.89e-2)" "unprognostic (6.03e-2)" "unprognostic (1.47e-1)" "unprognostic (8.86e-3)" "unprognostic (6.17e-2)" "unprognostic (1.47e-12)" "unprognostic (3.16e-1)" "unprognostic (1.64e-1)" "unprognostic (1.33e-2)" "unprognostic (8.28e-3)" 0.6 2.6 3.3 0.8 6.1 2.0 0.6 20.0 11.7 0.8 0.7 0.9 0.0 0.7 0.8 1.2 0.5 0.8 0.8 1.2 19.8 6.7 1.2 1.2 0.7 1.1 1.0 3.7 0.7 0.7 0.5 0.6 0.5 1.7 0.5 0.6 0.3 0.6 0.6 1.3 1.4 0.8 0.6 1.8 1.1 0.8 1.1 1.0 0.0 9.3 0.0 0.7 0.5 0.3 0.7 0.5 2.6 0.6 1.6 0.6 0.2 0.3 0.4 0.8 1.1 0.0 0.2 0.9 0.7 0.1 0.1 0.2 5.6 1.0 1.1 0.5 0.1 1.2 0.3 0.2 0.1 0.8 0.5 1.2 1.2 0.7 0.0 1.6 2.9 0.1 0.5 0.4 0.2 0.0 1.1 1.3 0.1 0.8 0.4 2.4 1.1 0.7 1.0 0.2 0.8 0.1 0.9 0.7 0.7 0.5 0.8 0.2 0.9 0.1 0.4 0.8 1.3 0.8 0.8 1.2 1.5 0.5 0.5 1.0 1.1 2.6 0.6 0.5 0.5 0.3 0.4 0.4 0.5 0.6 0.2 0.7 0.4 0.4 1.4 1.6 0.6 0.5 0.3 0.2 3.3 6.1 20.0 11.7 19.8 6.7 1.0 3.7 1.7 1.0 GRINA "HNRGW, LFG1, NMDARA1, TMBIM3" ENSG00000178719 "Glutamate ionotropic receptor NMDA type subunit associated protein 1" Q7Z429 8 143990058-143993415 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036980, HPA036981" Approved Approved "Nucleoli fibrillar center,Cytosol" "Nucleoli fibrillar center" Cytosol "HPA036980: AB_10696791, HPA036981: AB_10962980" "unprognostic (2.73e-3)" "unprognostic (2.18e-3)" "unprognostic (1.79e-2)" "unprognostic (1.12e-1)" "unprognostic (7.01e-3)" "unprognostic (3.72e-2)" "unprognostic (1.69e-1)" "unprognostic (1.35e-2)" "unprognostic (2.32e-1)" "unprognostic (6.70e-2)" "unprognostic (8.19e-2)" "unprognostic (3.13e-3)" "unprognostic (1.01e-3)" "unprognostic (1.55e-1)" "unprognostic (9.43e-2)" "unprognostic (6.75e-2)" "unprognostic (5.72e-2)" 76.4 48.8 46.6 52.3 61.0 89.0 70.2 73.8 85.8 37.1 28.4 34.5 37.1 35.6 33.1 42.1 30.5 41.4 37.5 35.2 54.2 45.1 61.7 143.7 49.7 67.4 47.4 51.5 46.1 32.0 66.8 29.3 42.4 46.5 42.6 17.7 49.3 44.4 99.4 32.8 37.4 33.5 38.0 43.3 82.0 23.2 52.2 24.3 24.3 54.7 19.2 26.8 43.2 31.3 4.5 12.4 10.2 19.3 1.6 2.6 6.4 12.6 24.8 12.7 21.5 67.7 34.2 18.8 18.1 42.9 30.9 28.6 15.0 10.6 9.1 20.0 40.8 11.4 22.6 26.8 12.7 12.9 15.5 9.4 14.4 17.8 71.7 1.9 15.2 44.0 74.2 22.4 32.7 14.9 8.8 12.8 26.5 76.4 5.3 5.1 8.9 37.5 7.2 6.4 17.5 15.8 35.9 8.6 14.0 26.4 29.7 35.2 57.1 12.5 15.0 19.6 21.5 26.1 13.1 20.8 11.9 6.8 24.8 12.5 11.1 0.9 16.6 4.6 1.4 19.3 2.0 4.5 1.4 1.6 7.1 4.3 2.6 2.3 10.2 1.6 18.0 12.4 1.2 6.4 46.6 61.0 73.8 85.8 54.2 45.1 47.4 51.5 46.5 24.3 HACD2 PTPLB ENSG00000206527 "3-hydroxyacyl-CoA dehydratase 2" Q6Y1H2 3 123490820-123585185 "Enzymes, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SiHa: 64.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB019282 Approved "CAB019282: " "unprognostic (3.04e-2)" "unprognostic (2.51e-1)" "unprognostic (6.11e-2)" "unprognostic (2.65e-3)" "unprognostic (5.36e-2)" "unprognostic (6.04e-2)" "unprognostic (1.32e-2)" "unprognostic (1.95e-2)" "unprognostic (1.96e-1)" "unprognostic (1.22e-1)" "prognostic unfavourable (9.59e-5)" "unprognostic (6.90e-2)" "unprognostic (7.03e-3)" "unprognostic (1.48e-1)" "unprognostic (3.85e-2)" "unprognostic (1.94e-2)" "unprognostic (2.59e-2)" 43.2 9.7 18.0 11.2 30.0 5.7 16.6 20.5 18.7 14.1 20.4 28.6 7.4 21.2 12.4 13.5 18.8 9.9 12.2 9.9 20.7 13.4 20.7 34.3 13.8 14.1 29.4 12.0 13.8 13.4 15.6 12.5 11.1 18.5 22.1 20.4 7.3 15.5 10.2 5.6 23.2 30.8 12.3 24.9 9.6 15.3 13.3 25.7 9.1 16.0 10.5 19.7 10.9 16.6 4.9 6.4 2.4 3.5 2.9 5.3 2.4 19.4 11.0 7.6 5.5 23.9 5.3 28.3 13.9 5.8 14.5 10.5 22.5 17.2 11.2 10.1 13.3 42.5 13.6 17.5 15.3 7.1 4.5 7.8 10.4 17.4 7.8 10.3 7.8 7.3 45.1 7.0 19.7 7.5 1.5 11.2 8.7 15.1 4.9 3.1 9.8 9.8 7.5 8.3 11.9 17.5 12.5 13.4 4.2 64.8 13.8 8.8 14.4 5.4 5.8 15.2 11.4 15.2 13.5 6.7 8.5 9.2 6.8 7.3 8.1 1.5 3.5 2.4 3.6 2.8 5.3 3.4 4.8 4.6 6.4 4.9 4.4 4.3 1.1 2.9 2.2 3.7 5.3 2.4 18.0 30.0 20.5 18.7 20.7 13.4 29.4 12.0 18.5 25.7 HACD3 "B-ind1, HSPC121, PTPLAD1" ENSG00000074696 "3-hydroxyacyl-CoA dehydratase 3" Q9P035 15 65530418-65578352 "Enzymes, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014837, HPA060347" Enhanced Enhanced "Endoplasmic reticulum" 27000 "Endoplasmic reticulum" "HPA014837: AB_1855914, HPA060347: " "unprognostic (1.51e-2)" "unprognostic (2.89e-1)" "unprognostic (2.29e-1)" "unprognostic (2.18e-1)" "unprognostic (3.52e-1)" "unprognostic (1.92e-2)" "unprognostic (1.67e-1)" "unprognostic (2.28e-1)" "unprognostic (3.36e-2)" "unprognostic (1.09e-1)" "unprognostic (1.73e-1)" "unprognostic (2.57e-1)" "prognostic favourable (3.09e-5)" "unprognostic (3.44e-2)" "unprognostic (5.33e-2)" "unprognostic (1.10e-2)" "unprognostic (2.04e-2)" 9.6 37.4 31.0 7.4 36.0 6.2 33.3 28.6 37.6 18.5 12.5 24.2 10.1 12.2 13.1 19.4 8.4 14.3 14.7 5.9 29.2 44.8 35.0 50.0 12.7 7.2 36.5 26.0 21.7 12.6 22.5 33.9 15.9 45.9 18.5 15.1 17.9 11.6 15.8 3.3 11.7 12.0 12.2 41.5 8.5 29.0 13.9 19.7 8.9 30.7 5.6 8.3 18.8 10.4 13.0 9.0 2.7 6.1 11.7 19.9 11.2 19.6 44.0 49.0 24.4 30.9 18.7 23.2 21.8 18.9 24.8 28.1 33.7 29.5 24.8 19.1 23.6 54.4 78.9 18.2 22.3 13.7 44.0 19.6 22.1 36.8 15.7 24.3 15.1 19.1 13.6 17.0 12.3 24.1 25.7 9.4 40.0 23.4 18.0 19.0 41.7 15.0 20.4 41.5 27.9 35.4 34.2 29.6 26.1 23.5 26.5 24.6 26.9 12.9 19.1 31.6 27.8 15.5 30.2 18.4 54.5 34.9 21.0 23.8 18.9 2.7 3.9 1.2 17.6 5.8 19.9 13.0 16.1 16.6 6.8 13.0 18.9 18.5 0.4 11.7 6.1 9.0 12.4 11.2 31.0 36.0 28.6 34.1 29.2 44.8 36.5 26.0 45.9 19.7 HCN2 "BCNG-2, BCNG2, HAC-1" ENSG00000099822 "Hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2" Q9UL51 19 589893-617159 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Sodium transport, Transport" "Ion channel, Ligand-gated ion channel, Potassium channel, Sodium channel, Voltage-gated channel" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 38.1;heart muscle: 16.8" "Cell line enhanced" "Detected in many" "A549: 17.6;MCF7: 16.4;U-138 MG: 12.3;U-87 MG: 25.4" "Group enriched" "Detected in many" 6 "glioma: 8.7;melanoma: 5.7;renal cancer: 2.8;testis cancer: 4.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (8.69e-2)" "unprognostic (3.97e-3)" "unprognostic (3.31e-4)" "unprognostic (1.44e-1)" "unprognostic (2.44e-1)" "unprognostic (3.07e-2)" "unprognostic (1.57e-2)" "unprognostic (1.97e-2)" "unprognostic (1.55e-1)" "unprognostic (5.32e-2)" "unprognostic (1.19e-3)" "unprognostic (8.00e-2)" "prognostic unfavourable (6.99e-5)" "unprognostic (1.07e-1)" "unprognostic (1.41e-1)" "unprognostic (5.53e-4)" "unprognostic (9.72e-3)" 1.1 4.8 12.0 1.4 29.1 1.5 1.0 8.5 38.1 1.1 1.2 8.2 0.0 1.2 1.0 1.3 2.2 1.0 1.1 16.8 18.3 11.7 1.5 1.1 1.1 1.5 22.0 6.6 1.0 1.5 1.2 3.0 1.1 11.4 1.2 1.1 0.6 1.4 1.2 1.1 1.7 1.2 1.2 24.5 1.3 1.3 3.7 7.3 0.0 1.1 0.0 1.4 1.2 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 17.6 0.2 0.6 1.9 1.3 0.6 1.2 1.4 0.5 0.1 2.5 0.1 0.0 3.9 1.7 0.1 0.4 0.1 0.0 2.9 7.5 0.0 9.4 0.2 1.4 0.2 3.4 3.4 0.3 0.1 0.0 0.1 1.0 0.1 1.3 16.4 0.0 0.0 0.8 0.5 0.1 0.1 0.4 0.3 0.5 6.8 3.5 4.3 0.0 1.3 3.5 0.6 1.6 12.3 1.8 0.2 4.8 0.3 0.2 0.1 25.4 0.8 3.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 12.0 29.1 8.5 19.6 18.3 11.7 22.0 6.6 11.4 7.3 HGSNAT "FLJ32731, HGNAT, TMEM76" ENSG00000165102 "Heparan-alpha-glucosaminide N-acetyltransferase" Q68CP4 8 43140455-43202855 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters" "Acyltransferase, Transferase" "Disease mutation, Mucopolysaccharidosis, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029578 Approved "HPA029578: AB_10602423" "unprognostic (5.35e-2)" "unprognostic (4.61e-2)" "unprognostic (4.31e-2)" "unprognostic (1.36e-1)" "prognostic unfavourable (5.46e-4)" "unprognostic (3.94e-3)" "unprognostic (1.10e-1)" "unprognostic (6.54e-3)" "unprognostic (5.02e-2)" "prognostic favourable (6.33e-5)" "unprognostic (2.55e-2)" "unprognostic (5.48e-3)" "unprognostic (2.03e-1)" "unprognostic (1.27e-2)" "unprognostic (1.55e-1)" "unprognostic (1.72e-1)" "unprognostic (3.45e-2)" 24.8 16.9 21.4 16.0 18.8 16.0 29.6 18.5 20.6 28.5 17.8 20.3 24.5 15.4 27.5 29.7 20.4 24.0 22.1 18.7 18.0 16.5 16.9 19.9 21.8 14.9 12.9 19.8 31.1 28.8 26.5 24.8 25.6 15.7 21.6 14.7 20.9 20.7 20.7 11.9 29.5 18.1 25.3 18.2 14.9 18.6 8.5 11.7 9.1 21.9 18.4 18.2 21.1 23.2 2.3 14.5 8.3 8.0 8.2 3.1 4.0 11.5 15.6 3.9 7.9 32.3 24.4 5.9 13.2 15.7 9.6 8.6 2.2 17.0 7.0 9.2 18.4 6.7 1.7 8.0 5.6 2.8 3.2 6.9 9.9 3.9 10.4 1.5 1.1 16.3 11.5 5.3 11.1 17.0 3.1 9.9 17.5 5.2 6.2 3.0 3.7 2.3 0.7 7.2 3.4 15.8 9.8 2.1 6.2 17.2 5.5 7.6 19.1 8.9 19.9 14.8 2.5 9.2 5.4 8.0 7.5 2.6 11.9 2.7 9.0 0.2 8.0 8.3 2.8 5.0 3.1 1.8 2.3 2.8 14.5 2.3 1.7 1.9 3.0 8.2 7.2 1.9 1.5 4.0 21.4 18.8 18.5 20.6 18.0 16.5 12.9 19.8 15.7 11.7 HM13 "dJ324O17.1, H13, IMP1, IMPAS, PSENL3, PSL3, SPP, SPPL1" ENSG00000101294 "Histocompatibility minor 13" Q8TCT9 20 31514428-31577923 "Enzymes, Plasma proteins, Predicted membrane proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045089, HPA056062" Enhanced Supported "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA045089: AB_10962054, HPA056062: " "unprognostic (8.03e-2)" "unprognostic (2.11e-2)" "unprognostic (5.03e-2)" "unprognostic (1.59e-1)" "unprognostic (2.82e-1)" "unprognostic (5.87e-3)" "prognostic unfavourable (1.95e-5)" "unprognostic (2.66e-2)" "unprognostic (2.14e-2)" "unprognostic (2.55e-1)" "unprognostic (2.30e-1)" "unprognostic (8.10e-2)" "prognostic unfavourable (4.64e-12)" "unprognostic (3.77e-2)" "unprognostic (1.57e-1)" "unprognostic (1.85e-1)" "unprognostic (8.17e-2)" 25.2 34.3 9.2 20.1 11.1 19.8 36.4 10.2 17.5 37.9 17.0 13.2 64.7 18.1 23.3 40.7 39.2 21.4 24.1 17.9 9.3 13.0 30.2 121.3 25.5 38.7 10.8 9.8 20.8 132.3 24.4 28.6 45.9 14.5 22.4 16.3 15.4 149.6 84.3 13.1 15.0 17.8 17.9 11.0 22.0 25.3 11.7 9.0 15.5 33.5 21.5 30.5 18.1 21.4 16.7 48.2 50.1 65.3 19.4 29.8 52.6 24.6 26.0 10.5 15.5 47.9 30.8 36.2 42.2 39.5 28.9 29.8 51.6 29.7 15.9 56.9 46.0 45.1 14.7 28.4 19.0 8.0 19.9 35.2 19.0 31.0 53.3 20.0 14.1 28.1 18.5 24.4 33.4 22.3 15.5 63.3 26.7 29.1 17.1 14.4 12.1 44.6 10.9 49.5 74.2 27.8 13.2 13.8 16.7 43.2 41.6 34.1 32.3 19.1 27.0 43.9 23.4 44.2 23.7 40.9 24.3 12.6 59.9 72.2 38.7 18.4 65.3 31.8 21.7 64.0 29.8 16.7 20.5 20.9 46.0 12.6 13.8 16.2 50.1 19.4 58.6 48.2 18.1 52.6 9.2 11.1 10.2 17.5 9.3 13.0 10.8 9.8 14.5 9.0 HTT "HD, IT15" ENSG00000197386 Huntingtin P42858 4 3074681-3243960 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Disease mutation, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002756, HPA026114" Uncertain Supported Nucleoplasm,Cytosol Nucleoplasm Cytosol "CAB002756: , HPA026114: AB_1851330" "unprognostic (2.05e-1)" "unprognostic (1.09e-1)" "unprognostic (8.79e-3)" "unprognostic (1.08e-1)" "unprognostic (1.66e-1)" "prognostic favourable (3.26e-4)" "unprognostic (1.52e-2)" "unprognostic (8.33e-2)" "unprognostic (8.06e-2)" "unprognostic (2.15e-1)" "unprognostic (1.87e-2)" "unprognostic (6.04e-2)" "prognostic favourable (2.41e-12)" "unprognostic (9.46e-3)" "unprognostic (1.99e-1)" "unprognostic (6.53e-2)" "unprognostic (3.84e-2)" 12.9 13.8 19.4 16.6 18.3 14.1 12.3 24.7 32.3 10.0 13.6 11.6 11.0 10.5 11.5 15.9 16.3 11.6 9.4 8.9 19.7 12.1 11.3 13.1 21.5 18.1 11.8 19.5 13.0 27.0 29.5 13.0 12.0 12.8 10.5 11.4 13.3 10.2 11.4 19.1 25.4 12.8 12.0 10.4 17.4 12.0 14.9 10.4 17.4 13.3 7.3 15.6 11.7 9.6 2.9 3.5 2.8 4.5 2.9 4.3 1.9 12.3 8.6 12.1 7.1 22.3 12.7 12.3 5.8 7.1 8.7 8.3 11.4 8.1 19.0 6.2 13.9 7.1 14.3 10.5 8.8 5.0 10.5 18.1 12.3 12.2 5.2 12.1 26.5 8.8 6.5 17.1 8.0 10.1 11.8 6.8 7.7 11.9 12.9 11.5 14.8 14.0 11.6 11.6 3.7 9.3 12.8 13.3 9.4 10.3 3.9 10.1 10.7 7.6 14.0 12.2 7.7 8.4 12.9 5.3 6.2 15.1 9.1 11.2 8.7 0.0 2.6 2.8 3.5 3.4 2.4 2.9 2.7 4.3 3.5 2.4 2.0 2.4 0.4 2.9 4.5 2.6 3.5 1.9 19.4 18.3 24.7 32.3 19.7 12.1 11.8 19.5 12.8 10.4 ICMT "HSTE14, PCCMT, PPMT" ENSG00000116237 "Isoprenylcysteine carboxyl methyltransferase" O60725 1 6221193-6235972 "Enzymes, Plasma proteins, Predicted membrane proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 126.5" "Low region specificity" "Detected in all" "HPA032024, HPA032025" Uncertain "HPA032024: AB_2674115, HPA032025: AB_10601819" "unprognostic (1.95e-3)" "unprognostic (3.83e-2)" "unprognostic (7.34e-2)" "unprognostic (4.40e-2)" "unprognostic (5.53e-2)" "unprognostic (9.30e-2)" "prognostic unfavourable (1.79e-4)" "unprognostic (2.30e-2)" "unprognostic (7.05e-2)" "unprognostic (2.15e-1)" "unprognostic (1.87e-1)" "unprognostic (6.58e-2)" "unprognostic (2.11e-2)" "unprognostic (4.11e-1)" "unprognostic (5.27e-1)" "unprognostic (8.97e-2)" "unprognostic (1.99e-3)" 19.0 20.9 11.2 11.4 22.6 3.2 37.4 20.1 19.8 19.8 16.6 12.9 13.3 17.3 18.0 19.7 19.0 15.1 17.7 28.5 11.5 10.3 23.5 14.5 17.2 13.9 13.9 8.4 8.7 20.2 26.2 24.0 20.3 12.7 16.2 16.0 21.5 15.4 18.2 41.3 16.9 22.8 19.8 11.1 11.3 13.5 9.1 7.8 13.0 18.1 30.3 17.2 15.4 13.6 4.1 6.2 4.1 5.1 4.6 7.4 3.9 12.5 11.7 16.1 15.7 49.4 19.7 6.9 30.3 20.4 18.0 13.8 12.5 10.2 13.8 11.6 23.9 17.1 18.3 12.8 19.2 27.4 17.7 9.4 17.2 9.5 9.7 14.8 13.4 12.6 8.6 18.9 7.2 14.0 9.1 10.9 20.3 7.9 14.8 10.3 10.8 16.3 12.5 22.7 8.0 21.7 9.3 21.9 10.7 14.9 35.3 12.9 9.2 12.5 17.3 20.6 8.1 24.0 21.7 10.2 19.7 11.0 10.1 34.4 10.6 4.1 4.2 3.6 7.4 5.1 6.5 2.7 6.0 7.3 3.9 4.1 5.4 4.5 1.8 4.6 4.0 6.2 3.4 3.9 11.2 22.6 20.1 19.8 11.5 10.3 13.9 8.4 12.7 7.8 INSIG1 "CL-6, MGC1405" ENSG00000186480 "Insulin induced gene 1" O15503 7 155297776-155310235 "Plasma proteins, Predicted membrane proteins" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 81.4;liver: 143.2" "Cell line enhanced" "Detected in many" "Karpas-707: 152.5;RPMI-8226: 71.5" "Cancer enhanced" "Detected in all" "liver cancer: 142.8" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "intermediate monocyte: 45.7;non-classical monocyte: 81.4" "Lineage enriched" "Detected in all" 6 "monocytes: 81.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071524 Approved Vesicles Vesicles "HPA071524: " "unprognostic (8.11e-2)" "unprognostic (3.22e-1)" "unprognostic (2.91e-1)" "unprognostic (1.47e-1)" "unprognostic (9.23e-2)" "unprognostic (3.83e-2)" "unprognostic (2.05e-2)" "unprognostic (3.06e-1)" "unprognostic (1.60e-2)" "unprognostic (1.52e-1)" "unprognostic (4.64e-2)" "unprognostic (2.12e-1)" "unprognostic (1.26e-1)" "unprognostic (1.85e-1)" "unprognostic (1.91e-1)" "prognostic unfavourable (9.62e-4)" "unprognostic (4.97e-2)" 18.4 9.2 8.5 8.3 8.8 9.7 14.1 10.1 14.3 6.0 7.4 21.8 7.5 12.5 5.2 8.3 15.6 4.6 8.0 5.6 10.8 11.6 6.4 143.2 18.5 6.9 8.6 8.3 16.4 27.2 4.6 5.2 17.5 23.9 15.9 6.7 11.9 31.4 3.1 2.4 10.5 14.2 5.1 19.2 4.5 13.4 8.2 8.3 10.7 3.3 6.1 6.9 11.2 5.6 10.0 13.6 10.7 81.4 4.0 12.7 12.5 18.9 3.5 9.4 5.9 25.0 33.4 5.2 1.5 21.6 4.5 30.1 2.1 27.5 12.4 4.4 11.7 10.3 6.4 11.2 5.4 3.8 18.9 3.3 6.5 0.0 12.3 5.7 56.0 20.8 6.2 34.9 3.2 6.0 6.2 152.5 5.8 9.8 28.0 15.1 9.8 2.2 5.2 0.0 71.5 35.7 9.4 7.0 5.6 5.0 3.6 7.9 3.5 19.3 6.8 5.0 1.5 9.5 3.9 37.2 6.5 11.0 22.2 22.5 4.6 3.1 4.9 2.1 8.7 45.7 4.4 7.7 6.0 7.4 13.6 10.0 5.9 6.7 10.7 4.0 81.4 7.7 12.7 12.5 8.5 8.8 10.1 14.3 10.8 11.6 8.6 8.3 23.9 8.3 INSIG2 ENSG00000125629 "Insulin induced gene 2" Q9Y5U4 2 118088452-118110997 "Predicted membrane proteins" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" CAB033861 Uncertain "CAB033861: AB_2249149" "unprognostic (3.84e-3)" "unprognostic (4.54e-3)" "unprognostic (1.84e-1)" "unprognostic (7.00e-2)" "unprognostic (6.24e-2)" "prognostic unfavourable (7.10e-4)" "unprognostic (1.80e-1)" "unprognostic (7.30e-2)" "unprognostic (7.41e-2)" "unprognostic (2.37e-1)" "prognostic unfavourable (2.19e-6)" "unprognostic (2.40e-1)" "prognostic unfavourable (4.11e-6)" "unprognostic (1.40e-1)" "unprognostic (2.65e-1)" "unprognostic (1.42e-1)" "unprognostic (3.75e-2)" 12.3 8.2 14.3 7.1 16.5 3.2 13.5 24.4 22.5 10.0 9.6 8.9 7.8 11.6 12.1 16.8 8.1 8.3 9.4 11.0 12.2 10.6 16.0 38.6 12.9 10.2 12.0 13.1 11.8 14.5 16.9 15.8 11.0 17.5 11.8 8.3 8.9 9.4 10.1 8.8 12.1 14.7 10.1 13.9 14.1 13.5 7.3 11.6 18.5 13.2 1.8 9.6 10.0 9.8 11.8 11.4 17.5 17.6 15.4 15.4 9.2 23.4 4.2 6.3 2.7 16.2 8.0 6.9 6.7 7.2 5.3 9.4 3.9 22.5 4.6 22.4 8.4 8.7 4.7 11.1 10.0 8.6 5.8 4.4 5.4 26.6 6.3 5.4 7.1 12.7 10.1 4.8 11.4 12.4 2.3 8.6 8.7 2.5 6.9 7.3 3.1 5.8 4.5 5.5 5.0 12.1 7.3 5.1 6.7 3.9 6.9 3.8 3.5 5.4 13.2 6.7 4.9 6.1 3.4 15.9 8.5 4.1 13.7 4.4 4.4 10.2 10.3 17.5 11.9 15.2 13.9 11.8 13.0 11.4 11.4 10.8 14.2 15.4 10.8 15.4 17.6 10.6 11.6 9.2 14.3 16.5 24.4 22.5 12.2 10.6 12.0 13.1 17.5 11.6 ITPR2 "CFAP48, IP3R2" ENSG00000123104 "Inositol 1,4,5-trisphosphate receptor type 2" Q14571 12 26336515-26833198 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 47.1" "Cell line enhanced" "Detected in many" "TIME: 35.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059144, HPA062260" Uncertain Supported "Nucleoplasm,Endoplasmic reticulum" "Endoplasmic reticulum" Nucleoplasm "HPA059144: , HPA062260: " "unprognostic (5.65e-2)" "unprognostic (1.46e-1)" "unprognostic (1.22e-1)" "unprognostic (4.53e-1)" "unprognostic (2.25e-1)" "unprognostic (2.37e-2)" "unprognostic (3.59e-3)" "unprognostic (8.70e-2)" "unprognostic (1.66e-1)" "unprognostic (8.61e-2)" "unprognostic (2.06e-2)" "unprognostic (1.63e-1)" "unprognostic (1.54e-2)" "unprognostic (2.82e-1)" "unprognostic (9.13e-2)" "unprognostic (3.99e-2)" "unprognostic (3.76e-1)" 8.8 20.6 12.8 14.5 13.8 6.1 18.5 9.3 15.0 7.9 9.9 7.8 3.7 6.0 7.2 7.8 12.0 7.3 8.0 7.1 14.2 6.0 14.4 47.1 6.5 8.1 12.8 4.6 8.0 9.2 17.4 9.9 11.9 13.0 6.6 7.8 4.8 17.6 3.8 4.7 13.3 8.9 5.4 20.3 12.5 5.9 3.4 15.3 35.3 5.3 6.6 10.7 5.5 8.1 4.3 9.0 17.3 5.2 3.6 3.1 0.7 2.6 1.1 1.6 2.6 4.9 5.0 1.7 2.5 3.4 1.7 1.8 0.1 1.4 9.2 1.6 3.3 2.9 8.6 5.2 2.3 2.2 2.8 7.4 2.4 14.8 4.5 6.6 3.3 4.7 0.7 3.7 6.8 16.3 3.2 2.9 2.2 2.2 4.6 8.8 7.1 0.8 1.5 3.8 5.8 4.0 4.2 0.5 2.6 11.2 2.0 6.2 4.2 3.3 35.6 3.5 1.3 3.4 3.1 2.7 2.1 17.2 3.2 3.0 2.2 17.3 5.2 7.1 2.4 2.2 2.0 4.2 2.1 1.9 1.0 4.3 2.5 2.2 13.5 3.6 3.0 9.0 3.1 0.7 12.8 13.8 9.3 15.0 14.2 6.0 12.8 4.6 13.0 15.3 JKAMP "C14orf100, CDA06, HSPC213, HSPC327, JAMP" ENSG00000050130 "JNK1/MAPK8 associated membrane protein" Q9P055 14 59484443-59505410 "Cancer-related genes, Predicted membrane proteins" "Unfolded protein response" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031172, HPA071650" Supported Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA031172: AB_10670563, HPA071650: " "unprognostic (1.48e-1)" "unprognostic (2.19e-2)" "unprognostic (4.95e-2)" "unprognostic (5.88e-2)" "unprognostic (2.54e-1)" "unprognostic (1.49e-3)" "prognostic unfavourable (3.09e-6)" "unprognostic (2.68e-1)" "unprognostic (3.52e-1)" "unprognostic (1.16e-1)" "unprognostic (3.09e-1)" "unprognostic (3.14e-1)" "prognostic favourable (1.36e-4)" "unprognostic (1.76e-1)" "unprognostic (2.27e-1)" "unprognostic (1.36e-1)" "unprognostic (1.73e-1)" 19.0 29.5 19.3 13.0 25.5 15.7 24.2 16.7 28.4 17.5 21.3 25.0 18.1 13.8 22.8 19.6 18.6 23.2 21.7 18.3 18.8 29.4 38.9 26.1 22.2 16.2 29.5 19.5 19.7 18.7 42.3 44.5 24.1 36.9 22.9 22.5 22.8 24.9 20.3 15.9 17.5 25.0 20.7 30.3 22.1 18.7 24.6 27.0 18.6 24.6 18.0 14.7 21.0 16.7 14.9 29.0 37.0 31.7 18.0 18.3 21.5 19.7 23.3 20.1 16.4 15.0 19.9 15.3 31.0 26.5 18.3 21.8 7.3 36.2 9.8 27.8 28.6 14.4 14.7 19.1 24.7 29.3 8.4 9.8 15.0 14.5 20.0 16.5 19.4 21.7 21.7 17.1 11.8 18.6 8.9 19.7 34.4 17.8 9.0 12.7 11.0 20.6 10.6 24.4 9.0 31.5 19.6 8.6 15.0 28.1 22.5 16.4 22.7 12.7 24.4 19.3 25.3 17.6 20.3 9.2 16.3 11.4 27.3 11.2 24.2 28.2 25.2 32.5 15.1 29.8 14.6 14.9 16.5 15.9 21.2 13.6 17.7 16.6 37.0 18.0 31.7 29.0 18.3 21.5 19.3 25.5 16.7 28.4 18.8 29.4 29.5 19.5 36.9 27.0 KCNA1 "AEMK, HUK1, Kv1.1, MBK1, RBK1" ENSG00000111262 "Potassium voltage-gated channel subfamily A member 1" Q09470 12 4909893-4918256 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 24.1" "Group enriched" "Detected in some" 11 "LHCN-M2: 2.3;NTERA-2: 2.0;SCLC-21H: 3.8;U-2 OS: 3.7" "Not detected" "Not detected" "Group enriched" "Detected in all" 4 "basal ganglia: 13.7;cerebellum: 23.8;cerebral cortex: 21.1;pons and medulla: 24.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074471 Approved "HPA074471: " "unprognostic (6.39e-3)" "unprognostic (2.64e-1)" "unprognostic (1.09e-1)" "unprognostic (8.44e-2)" "unprognostic (1.33e-1)" "unprognostic (1.79e-2)" "unprognostic (4.69e-3)" "unprognostic (2.48e-1)" "unprognostic (8.77e-5)" "unprognostic (6.30e-2)" "unprognostic (1.08e-4)" 0.8 0.7 1.5 0.7 13.7 0.7 1.3 23.8 21.1 1.6 0.9 0.9 0.0 0.9 1.0 0.7 0.7 0.7 0.9 0.7 4.6 1.1 0.7 0.7 0.8 0.7 2.2 3.5 0.7 0.7 4.0 0.6 0.7 24.1 0.7 0.9 0.0 1.9 0.8 0.7 0.8 0.8 1.1 1.1 0.7 1.0 0.7 1.4 0.2 2.0 0.0 0.7 0.9 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 13.7 23.8 21.1 4.6 1.1 2.2 3.5 24.1 1.4 KCNA10 Kv1.8 ENSG00000143105 "Potassium voltage-gated channel subfamily A member 10" Q16322 1 110517217-110519175 "FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "testis: 3.2" "Cell line enhanced" "Detected in some" "U-2 OS: 1.4;U-87 MG: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 4 "basal ganglia: 0.2" "HPA015061, CAB022564" Uncertain Nucleoplasm,Cytosol "Nucleoplasm, Cytosol" "CAB022564: , HPA015061: AB_1855573" "unprognostic (2.96e-2)" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 3.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.4 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KCNA2 "HK4, Kv1.2" ENSG00000177301 "Potassium voltage-gated channel subfamily A member 2" P16389 1 110519837-110631474 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 28.0" "Cell line enhanced" "Detected in some" "Karpas-707: 10.6;SCLC-21H: 2.7;U-2 OS: 2.4;U-266/70: 3.5;U-266/84: 5.3;WM-115: 2.9" "Cancer enhanced" "Detected in some" "glioma: 1.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 4.1" "Lineage enriched" "Detected in single" 8 "T-cells: 4.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB001976 Enhanced "CAB001976: " "unprognostic (1.84e-2)" "unprognostic (9.70e-3)" "unprognostic (1.97e-1)" "unprognostic (2.98e-1)" "unprognostic (7.17e-3)" "unprognostic (6.68e-3)" "unprognostic (5.05e-3)" "unprognostic (2.02e-1)" "unprognostic (1.29e-1)" "unprognostic (4.50e-3)" "unprognostic (3.08e-3)" "unprognostic (2.93e-4)" "unprognostic (2.15e-1)" "unprognostic (3.55e-1)" "unprognostic (6.41e-2)" "unprognostic (2.83e-1)" 3.2 1.4 7.1 2.2 13.1 0.8 1.2 17.2 28.0 1.2 1.6 3.1 0.0 1.4 1.0 1.3 1.7 1.1 1.6 1.6 7.2 6.1 0.9 0.9 1.0 1.9 7.2 14.5 1.1 1.9 0.8 1.4 0.7 21.1 1.8 2.0 1.4 1.8 2.4 2.1 1.6 1.6 1.6 2.8 1.3 1.3 2.5 3.8 0.3 5.3 0.0 3.5 1.4 0.5 0.5 0.0 0.0 0.0 0.0 4.1 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.9 0.0 0.5 0.0 1.4 0.0 0.0 2.7 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 2.4 0.0 0.0 3.5 5.3 0.2 0.1 0.0 2.9 0.0 0.0 0.0 0.4 0.0 0.3 0.5 1.8 1.3 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 4.1 0.1 7.1 13.1 17.2 26.3 7.2 6.1 7.2 14.5 21.1 3.8 KCNA3 "HLK3, HPCN3, Kv1.3, MK3" ENSG00000177272 "Potassium voltage-gated channel subfamily A member 3" P22001 1 110672465-110675033 "FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 59.4" "Cell line enhanced" "Detected in some" "HDLM-2: 12.4;Karpas-707: 25.6;U-266/70: 18.5;U-266/84: 16.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 7 "B-cells: 3.3;T-cells: 11.5" "Low region specificity" "Detected in all" HPA016625 Approved "HPA016625: " "unprognostic (2.17e-2)" "unprognostic (5.07e-3)" "unprognostic (3.92e-3)" "unprognostic (1.20e-2)" "unprognostic (2.35e-1)" "unprognostic (1.76e-5)" "unprognostic (1.70e-4)" "unprognostic (8.48e-2)" "unprognostic (1.49e-2)" "unprognostic (5.92e-4)" "unprognostic (1.81e-2)" "unprognostic (3.96e-2)" "unprognostic (1.39e-1)" "unprognostic (3.13e-2)" "unprognostic (2.99e-2)" "unprognostic (1.73e-1)" "unprognostic (1.40e-1)" 1.9 1.3 4.0 7.8 5.7 5.6 1.3 5.0 5.6 1.7 3.1 0.5 0.0 3.2 1.1 0.4 1.1 1.3 2.3 1.4 3.5 4.3 1.5 1.3 7.8 14.5 1.5 3.1 1.3 0.9 0.4 1.8 0.9 3.1 1.1 2.6 0.5 3.7 0.3 0.5 0.8 5.9 0.7 1.9 7.7 5.3 1.4 1.5 59.4 2.1 0.3 10.9 5.8 1.3 3.3 1.0 0.0 0.7 0.9 11.5 2.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.6 0.0 0.0 5.3 0.0 0.5 0.0 0.0 0.0 5.1 0.0 0.0 3.6 0.3 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.4 0.0 0.0 18.5 16.6 6.4 0.0 1.5 0.0 0.0 0.7 0.0 7.2 0.0 8.2 2.3 10.8 11.5 1.0 3.3 8.5 6.4 0.0 0.9 0.1 0.5 9.5 2.9 4.0 5.7 5.0 5.6 3.5 4.3 1.5 3.1 3.1 1.5 KCNA4 "HK1, HPCN2, KCNA4L, Kv1.4" ENSG00000182255 "Potassium voltage-gated channel subfamily A member 4" P22459 11 30009741-30017023 "FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Cataract, Disease mutation, Dystonia, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "adrenal gland: 16.5;brain: 39.0" "Cell line enhanced" "Detected in some" "U-2 OS: 1.6;WM-115: 2.1" "Not detected" "Not detected" "Region enhanced" "Detected in many" "basal ganglia: 39.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB001977, HPA016422" Approved "CAB001977: , HPA016422: AB_1855574" "unprognostic (1.12e-2)" "unprognostic (1.80e-2)" "unprognostic (1.31e-2)" "unprognostic (2.73e-2)" "unprognostic (1.00e-1)" "unprognostic (4.09e-3)" "unprognostic (2.24e-1)" "unprognostic (1.15e-2)" "unprognostic (6.71e-2)" "unprognostic (1.17e-1)" 2.2 16.5 9.8 0.6 39.0 0.6 0.6 0.2 12.2 0.6 0.6 0.8 1.8 0.7 1.1 0.9 0.6 0.8 0.6 5.9 6.1 2.7 1.2 0.6 2.4 0.6 1.6 6.2 0.6 0.6 0.6 2.8 1.2 10.5 0.6 0.6 0.0 0.6 1.7 0.6 0.8 0.6 0.8 0.6 0.6 1.0 0.7 5.9 0.0 0.6 0.0 0.6 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.1 0.0 0.0 0.6 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 39.0 0.2 12.2 6.1 2.7 1.6 6.2 10.5 5.9 KCNB1 Kv2.1 ENSG00000158445 "Potassium voltage-gated channel subfamily B member 1" Q14721 20 49293394-49484297 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Exocytosis, Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.9;retina: 22.4" "Cell line enhanced" "Detected in some" "ASC diff: 3.5;CACO-2: 5.0;hTCEpi: 3.1;U-2 OS: 4.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB001979, HPA042434" Enhanced "CAB001979: , HPA042434: " "unprognostic (4.51e-1)" "unprognostic (1.72e-1)" "unprognostic (6.54e-3)" "unprognostic (4.87e-2)" "unprognostic (1.94e-1)" "unprognostic (1.82e-1)" "unprognostic (8.09e-2)" "unprognostic (6.22e-2)" "unprognostic (5.31e-1)" "unprognostic (8.32e-2)" "unprognostic (1.87e-3)" "unprognostic (1.37e-1)" "unprognostic (1.31e-2)" "unprognostic (2.07e-3)" "unprognostic (8.17e-2)" "unprognostic (9.35e-2)" "unprognostic (5.25e-4)" 16.9 3.6 11.4 1.3 14.6 0.8 2.4 8.1 25.9 2.3 5.1 1.8 0.7 1.2 6.8 2.3 3.9 9.0 1.9 1.9 6.6 5.3 1.3 3.5 1.2 0.8 3.3 12.5 1.2 1.2 0.9 2.5 1.0 2.5 4.8 1.9 22.4 1.7 6.5 6.2 1.1 1.8 9.6 1.2 1.2 3.9 1.5 2.4 0.0 1.0 0.1 0.8 4.0 0.9 0.4 0.3 1.2 0.2 0.3 0.7 0.0 0.0 0.1 0.8 0.0 3.5 0.3 0.1 0.0 0.4 0.4 0.0 5.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.3 0.1 0.2 0.0 0.1 0.0 0.0 2.5 0.0 0.6 3.1 0.0 0.1 0.0 0.0 1.9 1.1 0.3 0.0 2.3 0.1 0.9 0.0 0.9 0.0 0.0 0.0 2.3 1.8 1.6 2.3 0.0 1.6 0.0 0.0 2.2 4.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.2 0.0 0.1 0.1 0.3 0.2 0.0 0.4 0.7 0.2 1.2 0.3 0.1 0.3 0.1 0.0 11.4 14.6 8.1 25.9 6.6 5.3 3.3 12.5 2.5 2.4 KCNB2 Kv2.2 ENSG00000182674 "Potassium voltage-gated channel subfamily B member 2" Q92953 8 72537391-72938349 "FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.7;lymphoid tissue: 8.6;pituitary gland: 9.2" "Group enriched" "Detected in some" 5 "HaCaT: 3.2;HDLM-2: 3.0;HEK 293: 7.4;SCLC-21H: 6.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA065970 Approved "Nucleoli,Plasma membrane,Midbody" "Plasma membrane" "Nucleoli, Midbody" "HPA065970: " "unprognostic (9.87e-3)" "unprognostic (1.71e-1)" "unprognostic (7.57e-2)" "unprognostic (1.10e-3)" "unprognostic (1.22e-1)" "unprognostic (1.34e-1)" "unprognostic (1.44e-2)" "unprognostic (2.72e-1)" "unprognostic (6.93e-5)" "unprognostic (5.53e-3)" "unprognostic (3.30e-2)" "unprognostic (1.62e-1)" "unprognostic (3.35e-2)" "unprognostic (3.26e-1)" 0.8 1.9 3.8 0.6 5.3 0.4 0.7 0.3 9.7 0.5 0.7 0.0 0.0 1.2 0.4 0.4 1.1 2.1 0.5 0.4 7.1 3.1 0.5 0.4 0.6 0.5 0.9 7.8 0.4 2.4 0.4 9.2 0.5 3.2 0.7 0.7 4.2 0.5 0.5 0.4 0.4 1.6 0.5 1.6 8.6 2.4 1.7 0.4 0.9 0.4 0.0 0.9 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 3.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 5.3 0.3 9.7 7.1 3.1 0.9 7.8 3.2 0.4 KCNC1 Kv3.1 ENSG00000129159 "Potassium voltage-gated channel subfamily C member 1" P48547 11 17734774-17856804 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 67.5" "Cell line enhanced" "Detected in some" "RH-30: 7.4;SCLC-21H: 7.0;SH-SY5Y: 4.3" "Cancer enhanced" "Detected in some" "glioma: 1.1" "Region enhanced" "Detected in all" "cerebellum: 67.5" "Cell type enhanced" "Detected in some" "basophil: 5.8" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047634, HPA048249" Enhanced Approved "Nucleoplasm,Nuclear membrane,Vesicles,Cytosol" "Nucleoplasm, Nuclear membrane" "Vesicles, Cytosol" "HPA047634: , HPA048249: " "unprognostic (1.79e-2)" "unprognostic (2.68e-1)" "unprognostic (1.33e-1)" "unprognostic (4.09e-3)" "unprognostic (1.12e-1)" "unprognostic (8.02e-2)" "unprognostic (2.40e-1)" "unprognostic (1.27e-1)" "unprognostic (8.37e-2)" "unprognostic (2.14e-1)" "unprognostic (7.04e-5)" "unprognostic (5.89e-2)" "unprognostic (7.32e-4)" "unprognostic (1.29e-1)" "unprognostic (5.44e-2)" "unprognostic (1.05e-2)" "unprognostic (7.83e-2)" 0.7 2.3 8.2 1.0 10.0 2.9 0.9 67.5 33.3 3.0 1.0 1.0 0.0 1.4 1.5 0.6 1.1 0.9 1.3 0.6 5.6 4.9 0.9 1.1 1.0 1.2 3.3 12.6 1.1 0.9 0.6 1.4 0.7 19.5 1.2 0.8 0.7 1.2 0.7 1.7 1.8 1.2 0.8 1.9 1.0 1.3 2.9 2.0 0.0 1.5 0.0 0.8 2.4 0.5 1.7 0.8 5.8 0.8 0.7 1.1 0.3 0.4 0.1 3.0 1.2 0.5 0.0 0.1 0.0 0.0 0.1 0.0 0.2 1.0 0.0 0.2 0.0 1.1 1.8 0.0 0.3 0.3 2.1 0.6 2.9 0.2 0.3 0.5 0.2 0.0 0.0 0.0 0.1 0.0 0.5 1.4 0.0 0.5 0.5 1.1 1.5 0.0 0.7 7.4 0.9 0.0 0.4 7.0 4.3 0.4 0.4 0.0 0.6 0.5 0.1 0.2 2.3 0.3 0.3 0.5 0.6 1.0 0.5 0.3 0.9 5.8 0.7 1.1 1.1 0.7 0.7 0.7 0.9 0.5 0.2 1.7 0.7 0.8 3.8 0.7 0.8 0.8 0.4 0.3 8.2 10.0 67.5 33.3 5.6 4.9 3.3 12.6 19.5 2.0 KCNC2 Kv3.2 ENSG00000166006 "Potassium voltage-gated channel subfamily C member 2" Q96PR1 12 75040077-75209868 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 39.3" "Cell line enhanced" "Detected in single" "Karpas-707: 1.0" "Group enriched" "Detected in some" 8 "breast cancer: 1.5;prostate cancer: 4.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA019664, CAB022571" Uncertain Supported "Plasma membrane,Cytosol" Cytosol "Plasma membrane" "CAB022571: , HPA019664: AB_1855578" "unprognostic (2.01e-1)" "unprognostic (1.14e-1)" "unprognostic (2.68e-1)" "unprognostic (5.58e-3)" "unprognostic (4.46e-2)" "unprognostic (3.39e-2)" 0.7 0.7 8.7 0.7 12.9 0.7 3.3 0.4 39.3 0.7 0.8 1.9 0.0 0.7 0.9 0.9 0.7 0.7 0.7 0.7 7.4 10.4 0.7 0.9 0.7 0.7 4.7 13.5 0.7 0.7 0.7 6.0 0.7 19.1 4.4 0.8 1.3 1.1 0.7 0.7 0.7 0.8 0.7 1.0 0.7 0.7 1.0 0.6 0.0 0.7 0.0 0.7 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 8.7 12.9 0.4 27.3 7.4 10.4 4.7 13.5 19.1 0.6 KCNC3 "Kv3.3, SCA13" ENSG00000131398 "Potassium voltage-gated channel subfamily C member 3" Q14003 19 50311937-50333515 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Disease mutation, FDA approved drug targets, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.1;parathyroid gland: 31.1;thyroid gland: 23.9" "Cell line enhanced" "Detected in some" "CACO-2: 8.7;CAPAN-2: 7.6;HDLM-2: 7.9;HMC-1: 20.9;K-562: 7.7;SK-BR-3: 14.2;T-47d: 13.5;U-2 OS: 9.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.1" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018041 Approved "HPA018041: AB_1855579" "unprognostic (8.05e-2)" "unprognostic (2.34e-2)" "unprognostic (3.01e-4)" "unprognostic (4.41e-2)" "unprognostic (3.84e-2)" "unprognostic (1.91e-2)" "unprognostic (2.79e-2)" "unprognostic (1.12e-2)" "unprognostic (1.46e-1)" "unprognostic (1.59e-1)" "unprognostic (3.94e-3)" "unprognostic (2.10e-5)" "prognostic unfavourable (1.23e-4)" "unprognostic (1.68e-2)" "unprognostic (1.45e-1)" "unprognostic (2.85e-2)" "unprognostic (1.19e-1)" 1.4 2.2 7.2 5.4 9.4 1.4 2.3 32.1 31.2 3.1 1.1 3.4 3.0 1.8 4.5 5.8 1.1 12.8 1.4 1.7 6.9 4.2 10.6 2.5 4.5 4.7 4.0 6.6 0.6 3.7 31.1 9.7 2.4 15.6 2.4 1.4 3.0 2.3 15.1 1.2 2.1 1.8 1.7 3.8 6.5 2.1 2.4 2.9 1.1 23.9 0.0 3.4 1.8 1.0 0.4 1.1 0.0 0.8 0.0 0.0 0.0 0.0 0.4 0.0 1.4 0.0 0.0 4.1 0.0 0.0 0.0 0.0 8.7 7.6 0.7 1.0 0.0 1.1 0.2 0.0 0.0 7.9 1.8 0.0 0.0 1.7 0.0 0.0 20.9 0.1 0.0 0.0 0.0 0.1 7.7 0.0 0.0 2.7 0.1 0.0 1.1 3.3 0.0 0.1 0.0 0.5 0.2 0.0 1.4 1.6 14.2 0.0 13.5 2.1 0.1 0.0 9.3 0.0 0.0 0.0 0.1 0.4 0.3 1.7 0.0 0.0 0.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 7.2 9.4 32.1 31.2 6.9 4.2 4.0 6.6 15.6 2.9 KCND1 Kv4.1 ENSG00000102057 "Potassium voltage-gated channel subfamily D member 1" Q9NSA2 X 48961378-48971569 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.8" "Cell line enhanced" "Detected in many" "HSkMC: 13.6;NB-4: 10.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 1.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000524, HPA001066" Approved Uncertain Nucleoplasm Nucleoplasm "HPA000524: , HPA001066: AB_1079662" "unprognostic (6.00e-2)" "unprognostic (2.58e-1)" "unprognostic (1.01e-4)" "unprognostic (2.19e-4)" "unprognostic (1.41e-1)" "unprognostic (3.79e-2)" "unprognostic (2.79e-1)" "unprognostic (8.13e-3)" "unprognostic (1.13e-2)" "unprognostic (2.41e-3)" "prognostic favourable (2.66e-6)" "unprognostic (2.61e-1)" "unprognostic (4.30e-11)" "unprognostic (3.13e-2)" "unprognostic (3.49e-1)" "unprognostic (7.64e-2)" "unprognostic (2.22e-3)" 4.9 2.4 4.2 3.4 4.7 6.0 2.2 16.8 7.8 5.1 2.2 6.3 1.9 2.0 5.0 3.8 1.4 7.4 6.3 2.9 6.9 2.5 2.5 1.8 3.0 3.1 3.1 3.5 4.6 1.4 1.8 3.0 2.5 10.4 3.3 2.1 2.6 1.2 6.0 0.7 1.6 2.6 6.6 6.5 4.2 2.5 3.0 2.7 1.1 2.3 0.5 3.6 3.0 3.0 0.6 1.3 1.4 0.1 0.0 0.8 0.1 0.4 2.0 0.8 4.8 6.6 5.2 1.6 1.0 4.2 2.9 1.9 1.3 0.6 1.6 3.5 3.2 0.6 0.8 0.4 2.8 2.7 3.2 1.5 2.0 0.1 2.4 0.4 3.0 13.6 1.8 5.3 0.6 1.0 1.1 3.7 2.1 3.6 0.4 10.8 2.6 0.7 1.3 0.9 1.6 3.2 1.5 0.5 2.2 0.9 0.0 2.2 2.1 1.6 2.5 0.6 2.7 0.6 0.2 3.0 3.9 3.9 1.8 3.9 2.1 0.0 0.1 0.0 0.5 0.0 0.3 0.6 0.2 0.8 0.0 0.1 0.2 0.0 1.4 0.0 0.0 1.3 0.0 0.1 4.2 4.7 16.8 7.8 6.9 2.5 3.1 3.5 10.4 2.7 KCND2 "KIAA1044, Kv4.2, RK5" ENSG00000184408 "Potassium voltage-gated channel subfamily D member 2" Q9NZV8 7 120273668-120750331 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Autism, Autism spectrum disorder, Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 41.1" "Cell line enhanced" "Detected in some" "ASC TERT1: 6.4;HSkMC: 4.0;NTERA-2: 3.1;RT4: 3.2;SCLC-21H: 16.2" "Cancer enhanced" "Detected in many" "glioma: 6.2" "Region enhanced" "Detected in all" "cerebellum: 41.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029068 Enhanced "HPA029068: AB_10601436" "unprognostic (4.22e-1)" "unprognostic (2.79e-4)" "unprognostic (3.79e-2)" "unprognostic (3.40e-1)" "unprognostic (1.23e-1)" "unprognostic (3.91e-2)" "unprognostic (4.98e-3)" "unprognostic (9.07e-3)" "unprognostic (1.03e-1)" "unprognostic (1.14e-1)" "unprognostic (9.77e-3)" "unprognostic (1.51e-1)" "unprognostic (4.51e-4)" "unprognostic (4.07e-5)" "unprognostic (2.71e-2)" "unprognostic (2.92e-2)" "unprognostic (1.83e-3)" 2.9 1.0 3.9 1.0 6.7 0.3 1.9 41.1 20.6 2.4 0.7 1.5 0.0 0.7 5.6 0.5 0.5 1.7 7.0 0.5 3.7 5.4 0.3 0.4 0.6 0.5 4.2 3.6 5.9 0.6 2.5 6.6 0.8 12.1 0.5 0.6 0.0 0.7 1.7 0.5 0.3 0.5 3.7 3.7 0.3 0.5 2.9 4.5 0.0 0.8 1.1 0.3 2.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.7 6.4 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.1 2.5 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.6 0.0 0.0 4.0 0.0 0.0 0.0 0.1 0.0 0.4 0.2 0.0 0.0 0.0 3.1 0.2 0.0 0.0 0.0 0.0 3.2 16.2 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 6.7 41.1 5.3 3.7 5.4 4.2 3.6 12.1 4.5 KCND3 "KSHIVB, Kv4.3, SCA19, SCA22" ENSG00000171385 "Potassium voltage-gated channel subfamily D member 3" Q9UK17 1 111770662-111989155 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Brugada syndrome, Disease mutation, FDA approved drug targets, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.9" "Cell line enriched" "Detected in some" 4 "SCLC-21H: 16.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029452 Approved "HPA029452: AB_10602239" "unprognostic (1.11e-2)" "unprognostic (1.73e-3)" "unprognostic (1.71e-1)" "unprognostic (2.60e-2)" "unprognostic (1.37e-1)" "unprognostic (2.42e-1)" "unprognostic (1.41e-1)" "unprognostic (9.48e-2)" "unprognostic (1.15e-1)" "unprognostic (9.17e-2)" "unprognostic (1.86e-2)" "unprognostic (1.40e-1)" "unprognostic (7.44e-2)" "unprognostic (3.64e-1)" "unprognostic (1.23e-1)" "unprognostic (2.51e-3)" "unprognostic (6.64e-3)" 3.3 0.8 6.8 3.1 6.9 0.0 2.1 25.9 11.9 1.3 2.5 1.3 1.3 0.3 4.1 9.6 3.2 3.4 4.2 5.5 5.6 5.6 1.3 11.6 1.3 1.3 8.9 5.7 1.3 2.2 4.1 1.5 1.3 1.6 9.2 1.6 1.9 1.3 10.0 2.8 5.1 1.3 7.7 1.3 2.0 1.7 1.3 1.3 1.3 1.3 2.3 1.3 3.7 1.3 0.5 0.4 1.2 0.3 0.9 0.3 0.7 0.0 0.0 0.3 0.0 0.5 0.1 0.1 0.4 0.0 0.0 0.0 0.8 0.1 0.0 1.6 0.6 0.5 0.6 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 1.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.3 16.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.5 0.2 0.1 0.3 0.1 0.1 0.1 0.1 0.3 0.4 0.5 0.3 0.2 1.2 0.9 0.3 0.3 0.1 0.7 6.8 6.9 25.9 9.3 5.6 5.6 8.9 5.7 1.6 1.3 KCNH1 "eag, eag1, h-eag, Kv10.1" ENSG00000143473 "Potassium voltage-gated channel subfamily H member 1" O95259 1 210676823-211134180 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Calmodulin-binding, Ion channel, Potassium channel, Voltage-gated channel" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 20.2" "Cell line enhanced" "Detected in some" "LHCN-M2: 4.2;RH-30: 7.1;RPTEC TERT1: 4.1;SH-SY5Y: 9.0;SK-MEL-30: 8.5;T-47d: 6.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA014551, HPA019445" Enhanced Supported Vesicles Vesicles "HPA014551: , HPA019445: AB_1852118" "unprognostic (9.12e-2)" "unprognostic (4.82e-3)" "unprognostic (2.63e-1)" "unprognostic (6.70e-2)" "unprognostic (3.56e-1)" "unprognostic (3.63e-2)" "unprognostic (1.73e-1)" "unprognostic (9.36e-2)" "unprognostic (1.41e-1)" "unprognostic (1.98e-1)" "unprognostic (1.46e-2)" "unprognostic (2.77e-2)" "unprognostic (1.42e-3)" "unprognostic (1.17e-1)" "unprognostic (8.89e-2)" "unprognostic (1.36e-1)" "unprognostic (9.70e-2)" 0.9 2.3 6.3 1.3 13.3 0.7 0.6 19.1 20.2 1.0 1.3 3.3 0.2 1.2 1.5 1.0 0.9 1.2 1.0 0.7 3.8 1.7 1.0 0.7 0.7 0.7 1.1 7.5 0.8 0.9 0.9 0.8 1.1 1.7 1.3 1.3 0.0 0.8 0.9 0.7 0.9 1.0 1.0 2.1 0.6 1.5 2.4 1.5 0.0 0.8 0.0 0.7 0.9 0.7 0.1 0.7 0.7 0.1 0.1 0.3 0.0 0.0 1.4 0.3 0.0 0.0 0.0 0.1 0.6 0.1 1.4 1.7 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 4.2 0.1 0.0 0.0 0.1 0.0 0.0 7.1 0.0 4.1 0.0 0.3 9.0 1.6 0.1 8.5 6.3 0.0 0.0 1.1 0.1 1.3 0.8 0.0 0.0 0.0 0.2 0.0 0.5 0.7 0.1 0.1 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.2 0.3 0.1 0.0 0.7 0.1 0.0 6.3 13.3 19.1 20.2 3.8 1.7 1.1 7.5 1.7 1.5 KCNH3 "BEC1, elk2, Kv12.2" ENSG00000135519 "Potassium voltage-gated channel subfamily H member 3" Q9ULD8 12 49539157-49558308 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.7" "Cell line enhanced" "Detected in some" "A549: 9.4;AN3-CA: 4.4;HMC-1: 4.5;RPTEC TERT1: 11.6;U-2 OS: 12.3" "Cancer enhanced" "Detected in many" "endometrial cancer: 9.8" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "MAIT T-cell: 3.6" "Lineage enriched" "Detected in single" 5 "T-cells: 3.6" "Group enriched" "Detected in many" 11 "amygdala: 60.0;basal ganglia: 42.5;cerebral cortex: 73.6;hippocampal formation: 46.6;olfactory region: 50.0" "Low region specificity" "Detected in many" HPA051088 Approved Nucleoplasm,Mitochondria "Nucleoplasm, Mitochondria" "HPA051088: " "unprognostic (5.69e-3)" "unprognostic (1.36e-1)" "unprognostic (8.87e-4)" "unprognostic (8.24e-3)" "unprognostic (7.54e-2)" "unprognostic (2.38e-2)" "unprognostic (3.63e-2)" "unprognostic (2.66e-1)" "unprognostic (9.91e-3)" "unprognostic (5.28e-2)" "unprognostic (6.39e-5)" "unprognostic (1.68e-1)" "unprognostic (1.07e-4)" "unprognostic (5.52e-3)" "unprognostic (2.67e-1)" "unprognostic (1.27e-1)" "unprognostic (2.86e-1)" 0.9 3.8 24.3 1.5 18.5 1.4 1.0 5.8 30.7 0.9 0.8 0.5 0.0 0.9 1.3 0.9 0.7 8.7 1.7 1.2 22.0 3.0 1.6 0.7 1.2 1.9 1.9 13.0 0.8 1.4 6.3 9.3 0.8 0.0 1.2 0.7 0.0 1.1 1.6 0.8 1.1 1.0 1.0 0.6 1.4 1.4 2.6 2.1 0.0 1.7 0.0 1.4 0.9 0.0 0.0 0.1 0.6 0.8 0.4 3.6 0.5 1.0 9.4 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.0 0.6 0.0 2.2 0.7 0.2 0.0 0.1 0.4 0.0 0.5 0.1 0.1 0.0 4.5 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 1.6 0.0 0.1 0.1 0.1 0.0 0.0 0.6 11.6 0.0 1.8 0.3 0.3 0.0 0.3 1.0 0.2 0.1 0.0 12.3 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.8 0.0 1.7 0.0 3.6 0.0 0.3 1.1 0.1 0.0 1.1 2.6 0.6 0.4 0.1 0.0 0.4 0.5 24.3 18.5 5.8 30.7 22.0 3.0 1.9 13.0 0.0 2.1 KCNH4 "elk1, Kv12.3" ENSG00000089558 "Potassium voltage-gated channel subfamily H member 4" Q9UQ05 17 42156891-42181278 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 11.2" "Cell line enhanced" "Detected in some" "HDLM-2: 6.2;K-562: 5.8;RPMI-8226: 11.1;RT4: 4.2;U-266/70: 6.0" "Not detected" "Not detected" "Region enhanced" "Detected in many" "basal ganglia: 11.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "unprognostic (3.07e-3)" "unprognostic (1.02e-2)" "unprognostic (4.02e-2)" "unprognostic (1.70e-1)" "unprognostic (9.30e-2)" "unprognostic (2.08e-3)" "unprognostic (4.59e-3)" "unprognostic (1.56e-1)" "unprognostic (2.41e-1)" "unprognostic (9.92e-2)" "unprognostic (4.77e-3)" "unprognostic (1.58e-1)" "unprognostic (1.36e-6)" "unprognostic (9.52e-2)" "unprognostic (2.66e-1)" "unprognostic (6.47e-2)" "unprognostic (1.72e-3)" 1.2 1.0 0.7 2.4 11.2 0.7 0.3 0.0 7.9 0.7 0.3 0.1 0.0 0.7 0.2 0.1 0.1 0.4 0.5 0.7 0.4 0.9 0.2 0.2 0.3 1.0 0.3 1.0 0.2 0.3 0.0 0.4 0.3 0.0 0.5 0.3 0.0 0.8 0.5 0.2 0.4 0.5 0.3 0.1 0.8 0.6 0.9 2.6 0.0 0.2 0.0 1.1 3.1 0.1 0.4 0.6 0.6 0.4 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 1.4 0.0 0.0 1.1 0.0 0.0 0.0 6.2 0.5 0.9 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 5.8 1.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 11.1 0.0 4.2 2.5 1.4 0.4 0.1 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 6.0 0.8 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.6 0.0 0.0 0.7 11.2 0.0 7.9 0.4 0.9 0.3 1.0 0.0 2.6 KCNH5 "eag2, H-EAG2, Kv10.2" ENSG00000140015 "Potassium voltage-gated channel subfamily H member 5" Q8NCM2 14 62699454-63102037 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Calmodulin-binding, Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 4.6;brain: 9.2;retina: 5.7" "Group enriched" "Detected in some" 5 "HeLa: 9.9;RT4: 13.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA030487, HPA072351" Uncertain Approved Nucleoplasm,Centrosome,Cytosol Centrosome "Nucleoplasm, Cytosol" "HPA030487: AB_10609995, HPA072351: " "unprognostic (1.16e-1)" "unprognostic (7.23e-2)" "unprognostic (1.25e-1)" "unprognostic (4.23e-2)" "unprognostic (2.70e-1)" "unprognostic (1.12e-1)" "unprognostic (1.50e-1)" "unprognostic (1.76e-2)" "unprognostic (8.45e-2)" "unprognostic (2.66e-1)" "unprognostic (1.70e-3)" "unprognostic (3.11e-1)" 0.9 4.6 1.7 0.5 3.6 0.3 0.4 0.2 9.2 0.3 0.4 0.4 0.0 0.3 0.4 0.5 0.3 0.3 0.3 0.3 1.3 3.0 0.4 0.3 0.3 0.3 1.2 4.2 0.3 0.3 0.3 1.5 1.2 6.5 0.7 0.3 5.7 0.3 0.3 0.3 0.3 0.3 0.3 1.6 0.3 0.3 1.7 0.0 0.0 0.3 0.0 0.3 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.0 0.0 0.0 0.0 0.0 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 13.1 0.1 0.0 1.7 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 3.6 0.2 9.2 1.3 3.0 1.2 4.2 6.5 0.0 KCNH7 "erg3, HERG3, Kv11.3" ENSG00000184611 "Potassium voltage-gated channel subfamily H member 7" Q9NS40 2 162371407-162838730 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 11.0;pituitary gland: 5.4" "Group enriched" "Detected in some" 13 "SCLC-21H: 10.5;SK-BR-3: 9.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "eosinophil: 1.5;neutrophil: 3.0" "Lineage enriched" "Detected in single" 15 "granulocytes: 3.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA018039 Uncertain "HPA018039: AB_1852125" "unprognostic (1.80e-1)" "unprognostic (2.68e-1)" "unprognostic (2.66e-1)" "unprognostic (5.55e-2)" "unprognostic (3.05e-2)" "unprognostic (5.51e-2)" "unprognostic (8.12e-3)" "unprognostic (7.31e-2)" "unprognostic (1.73e-1)" "unprognostic (2.69e-1)" "unprognostic (3.30e-2)" "unprognostic (3.52e-2)" "unprognostic (7.55e-3)" "unprognostic (2.76e-3)" "unprognostic (2.13e-1)" "unprognostic (4.71e-2)" "unprognostic (1.68e-2)" 0.4 1.0 4.4 0.9 6.8 0.8 0.4 6.0 11.0 0.4 0.4 0.0 0.7 0.7 0.4 0.6 0.4 0.5 0.4 1.0 2.6 1.8 0.6 2.7 0.5 0.5 0.7 4.6 0.4 1.0 0.3 5.4 0.6 3.1 0.4 0.3 0.4 0.4 1.5 0.3 0.4 0.5 0.4 0.7 1.1 2.5 1.6 0.3 0.0 0.4 0.0 0.3 0.4 0.4 0.1 0.1 3.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 10.5 0.7 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 3.0 0.0 0.1 0.0 0.0 0.0 4.4 6.8 6.0 11.0 2.6 1.8 0.7 4.6 3.1 0.3 KCNH8 "elk3, Kv12.1" ENSG00000183960 "Potassium voltage-gated channel subfamily H member 8" Q96L42 3 19148454-19535646 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 31.3;pituitary gland: 16.1" "Cell line enriched" "Detected in some" 4 "SH-SY5Y: 9.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 2.1;naive B-cell: 4.5" "Lineage enriched" "Detected in single" 5 "B-cells: 4.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA016586, HPA077537, HPA077773" Approved Supported "Plasma membrane" "Plasma membrane" "HPA016586: AB_1852127, HPA077537: , HPA077773: " "unprognostic (6.68e-3)" "unprognostic (1.68e-1)" "unprognostic (2.99e-2)" "unprognostic (8.56e-6)" "unprognostic (1.04e-1)" "unprognostic (1.10e-1)" "unprognostic (1.88e-1)" "unprognostic (9.13e-3)" "unprognostic (4.86e-2)" "unprognostic (1.69e-1)" "unprognostic (5.04e-3)" "unprognostic (2.90e-2)" "unprognostic (1.63e-1)" "unprognostic (1.17e-1)" "unprognostic (3.89e-2)" "unprognostic (8.71e-5)" "unprognostic (1.72e-1)" 0.6 7.0 8.4 1.6 22.0 1.4 2.4 1.3 11.4 1.3 1.9 31.3 0.0 2.2 1.2 1.2 0.7 1.4 2.2 1.0 11.8 5.7 0.7 0.7 0.8 3.2 16.4 10.2 0.7 2.7 0.8 16.1 0.6 15.0 2.2 2.5 0.1 3.3 1.4 0.6 1.9 1.8 1.1 9.9 2.6 5.9 4.0 18.1 0.0 1.1 0.0 3.2 0.9 0.5 4.5 0.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.1 9.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 4.5 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 8.4 22.0 1.3 11.4 11.8 5.7 16.4 10.2 15.0 18.1 KCNK1 "DPK, K2p1.1, TWIK-1" ENSG00000135750 "Potassium two pore domain channel subfamily K member 1" O00180 1 233614004-233672512 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 75.3" "Cell line enhanced" "Detected in many" "HeLa: 20.6;SCLC-21H: 19.4;U-266/70: 44.7;U-266/84: 40.3" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in all" "cerebellum: 75.3" "Cell type enriched" "Detected in single" 98 "plasmacytoid DC: 9.7" "Lineage enriched" "Detected in single" 98 "dendritic cells: 9.7" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 236.2" "HPA016049, CAB022588" Approved Approved Vesicles Vesicles "CAB022588: , HPA016049: AB_1855571" "unprognostic (7.06e-3)" "unprognostic (1.76e-1)" "unprognostic (4.64e-2)" "unprognostic (7.46e-2)" "unprognostic (9.15e-2)" "unprognostic (1.27e-1)" "prognostic favourable (3.84e-4)" "unprognostic (4.32e-2)" "unprognostic (6.15e-2)" "unprognostic (1.34e-2)" "prognostic unfavourable (7.29e-4)" "unprognostic (1.10e-1)" "prognostic unfavourable (8.69e-8)" "unprognostic (1.62e-1)" "unprognostic (2.76e-1)" "unprognostic (1.77e-1)" "unprognostic (1.97e-1)" 1.9 3.3 15.2 2.2 12.7 0.3 4.5 75.3 22.8 5.5 11.5 7.9 5.1 12.5 4.5 22.9 12.0 8.4 9.3 20.8 10.3 5.2 7.2 10.8 3.4 0.8 8.9 11.1 3.8 4.4 2.5 11.3 5.0 22.3 4.6 10.6 2.6 7.2 9.3 0.5 8.7 9.6 3.2 12.3 0.8 28.0 0.7 7.8 0.0 5.6 1.6 3.2 4.3 6.5 0.0 9.7 0.0 0.0 0.0 0.0 0.0 10.1 5.5 0.0 0.0 0.0 0.0 15.5 2.7 0.0 0.0 0.0 0.0 16.7 0.0 6.5 2.0 14.7 2.8 4.8 0.0 0.0 4.8 0.0 20.6 0.0 0.1 0.0 0.5 1.2 5.2 0.0 3.8 0.0 2.3 4.4 0.0 3.7 3.6 0.0 3.3 12.5 0.0 0.8 1.1 4.9 8.5 19.4 3.8 10.1 4.5 0.0 1.3 0.0 0.0 0.0 8.2 0.0 0.3 44.7 40.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 15.2 12.7 75.3 17.1 10.3 5.2 8.9 11.1 22.3 7.8 KCNK10 "K2p10.1, PPP1R97, TREK-2, TREK2" ENSG00000100433 "Potassium two pore domain channel subfamily K member 10" P57789 14 88180103-88326907 "Predicted membrane proteins" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 12.2;brain: 14.1;intestine: 11.6" "Cell line enhanced" "Detected in some" "AF22: 2.5;NTERA-2: 1.7;REH: 4.2;SCLC-21H: 7.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 67 "plasmacytoid DC: 12.2" "Lineage enriched" "Detected in single" 123 "dendritic cells: 12.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030462 Approved "HPA030462: AB_10601919" "unprognostic (9.52e-3)" "unprognostic (1.17e-1)" "unprognostic (1.94e-2)" "unprognostic (1.08e-1)" "unprognostic (8.20e-2)" "unprognostic (1.45e-1)" "unprognostic (1.18e-1)" "unprognostic (2.25e-1)" "unprognostic (4.58e-1)" "unprognostic (1.23e-2)" "unprognostic (2.70e-1)" "unprognostic (2.45e-1)" "unprognostic (6.97e-2)" "unprognostic (1.92e-1)" "unprognostic (3.21e-2)" "unprognostic (1.29e-1)" "unprognostic (4.26e-3)" 0.4 1.1 7.4 1.2 6.9 0.9 0.5 14.1 11.2 0.4 3.2 5.6 0.0 11.6 0.3 0.3 2.2 0.4 0.5 0.4 7.2 4.5 5.7 0.4 0.6 0.7 5.0 5.7 0.4 3.5 0.4 0.9 0.3 6.4 0.5 2.1 0.0 0.5 0.3 0.4 0.4 5.7 0.5 5.0 0.6 6.7 1.3 2.3 0.0 0.4 0.5 1.3 0.5 0.4 0.0 12.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.5 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.7 0.2 4.2 0.1 0.0 0.1 0.1 7.7 0.3 0.1 0.1 0.0 0.0 1.0 0.1 0.1 1.4 0.2 0.5 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 12.2 0.0 0.1 7.4 6.9 14.1 11.2 7.2 4.5 5.0 5.7 6.4 2.3 KCNK12 "K2p12.1, THIK-2, THIK2" ENSG00000184261 "Potassium two pore domain channel subfamily K member 12" Q9HB15 2 47516581-47570939 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 22.7" "Group enriched" "Detected in some" 6 "REH: 21.6;SCLC-21H: 8.5" "Cancer enriched" "Detected in single" 12 "testis cancer: 2.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "unprognostic (6.10e-2)" "unprognostic (1.24e-1)" "unprognostic (6.02e-3)" "unprognostic (3.29e-2)" "unprognostic (2.50e-1)" "unprognostic (3.77e-2)" "unprognostic (3.76e-2)" "unprognostic (2.16e-2)" "unprognostic (2.54e-2)" "unprognostic (2.14e-1)" "unprognostic (6.55e-3)" "unprognostic (2.12e-1)" "unprognostic (1.12e-6)" "unprognostic (1.36e-1)" "unprognostic (1.34e-1)" "unprognostic (3.06e-2)" "unprognostic (2.25e-1)" 1.1 1.7 9.8 5.1 4.6 1.0 0.9 22.7 16.1 0.8 1.1 2.4 0.0 1.0 1.0 1.0 1.0 0.9 0.9 0.9 5.6 3.4 1.0 0.8 1.0 1.6 7.2 4.0 1.2 0.8 0.9 5.5 1.7 8.1 1.0 0.9 0.6 0.9 0.8 1.2 1.0 0.9 0.9 10.1 1.1 1.2 1.5 2.1 0.0 1.0 0.0 1.5 1.0 0.3 0.7 0.1 0.2 0.0 0.4 1.8 0.2 0.0 0.1 0.7 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 1.2 0.5 21.6 0.0 1.6 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.3 0.7 1.0 1.8 0.1 0.2 1.1 1.0 0.2 0.4 0.0 0.0 1.1 0.2 9.8 4.6 22.7 16.1 5.6 3.4 7.2 4.0 8.1 2.1 KCNK16 "K2p16.1, TALK-1, TALK1" ENSG00000095981 "Potassium two pore domain channel subfamily K member 16" Q96T55 6 39314698-39322968 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pancreas: 22.4;stomach 1: 11.3" "Cell line enriched" "Detected in single" 406 "SCLC-21H: 54.6" "Cancer enriched" "Detected in some" 17 "pancreatic cancer: 13.3" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 7 "basophil: 4.6" "Lineage enriched" "Detected in single" 7 "granulocytes: 4.6" "Low region specificity" "Detected in all" "unprognostic (3.29e-2)" "unprognostic (3.48e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 1.2 0.1 0.1 3.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 22.4 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.8 0.1 0.1 0.1 11.3 0.1 0.1 0.1 0.7 0.1 0.1 0.1 0.1 0.0 0.4 4.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 KCNK17 "K2p17.1, TALK-2, TALK2, TASK-4, TASK4" ENSG00000124780 "Potassium two pore domain channel subfamily K member 17" Q96T54 6 39299001-39314553 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 29.1;retina: 20.0" "Cell line enriched" "Detected in some" 7 "SCLC-21H: 41.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 34 "plasmacytoid DC: 29.1" "Lineage enriched" "Detected in single" 34 "dendritic cells: 29.1" "Not detected" "Not detected" HPA043892 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Nucleoplasm "HPA043892: AB_10962838" "unprognostic (5.33e-3)" "unprognostic (6.42e-2)" "unprognostic (1.33e-1)" "unprognostic (1.04e-1)" "unprognostic (1.54e-1)" "unprognostic (3.70e-2)" "unprognostic (3.85e-2)" "unprognostic (4.09e-2)" "unprognostic (4.95e-1)" "unprognostic (2.35e-1)" "unprognostic (1.71e-2)" "unprognostic (2.54e-1)" "unprognostic (3.77e-11)" "unprognostic (5.89e-2)" "unprognostic (5.36e-1)" "unprognostic (2.82e-1)" "unprognostic (3.86e-3)" 0.7 0.4 0.3 0.6 1.1 1.4 3.3 0.3 0.8 0.7 1.3 0.8 1.9 3.0 1.9 0.5 1.0 1.3 6.5 7.9 0.6 0.6 0.3 4.6 10.4 0.9 2.6 0.8 0.4 6.1 0.4 2.7 6.3 1.9 1.1 0.6 20.0 2.9 1.0 0.2 0.1 1.7 1.5 0.6 1.1 5.4 0.6 0.1 3.4 9.3 2.6 2.4 0.9 0.5 0.0 29.1 0.1 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 41.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 29.1 0.0 0.1 0.3 1.1 0.3 0.8 0.6 0.6 2.6 0.8 1.9 0.1 KCNK18 "K2p18.1, TRESK, TRESK-2, TRESK2, TRIK" ENSG00000186795 "Potassium two pore domain channel subfamily K member 18" Q7Z418 10 117197489-117210299 "Disease related genes, Potential drug targets, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 1.5;testis: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA044739 Uncertain "HPA044739: AB_10795008" 0.0 0.0 0.0 0.0 1.5 0.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KCNK2 "K2p2.1, TREK-1" ENSG00000082482 "Potassium two pore domain channel subfamily K member 2" O95069 1 215005775-215237093 "FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "adrenal gland: 49.1" "Cell line enhanced" "Detected in some" "ASC TERT1: 31.2;fHDF/TERT166: 27.5;T-47d: 41.8;U-2197: 14.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (3.43e-2)" "unprognostic (1.02e-1)" "unprognostic (6.91e-2)" "unprognostic (3.81e-4)" "unprognostic (2.58e-1)" "unprognostic (3.58e-2)" "unprognostic (3.48e-3)" "unprognostic (1.26e-1)" "unprognostic (1.49e-2)" "unprognostic (1.82e-1)" "unprognostic (1.03e-1)" "unprognostic (1.38e-1)" "unprognostic (2.98e-6)" "unprognostic (1.63e-2)" "unprognostic (4.37e-2)" "unprognostic (7.69e-3)" "unprognostic (7.46e-3)" 2.9 49.1 4.8 1.1 7.4 0.5 6.1 1.1 6.2 2.3 1.1 2.5 0.0 0.6 0.8 2.6 1.2 1.0 1.6 0.5 5.1 4.3 1.2 0.5 0.7 0.5 2.3 7.3 3.5 2.0 0.5 0.5 0.5 3.3 1.2 1.6 0.0 0.8 3.7 1.2 3.4 2.3 1.5 4.5 0.4 3.7 1.5 3.3 0.0 8.9 2.7 0.4 2.6 3.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 7.8 31.2 0.0 11.0 7.3 3.5 8.2 0.0 0.4 0.0 0.0 27.5 0.0 4.8 0.0 6.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 8.1 0.0 8.4 0.8 0.0 0.0 0.0 4.0 0.0 0.1 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 2.7 0.0 1.8 0.2 0.1 41.8 0.0 0.0 6.1 0.2 14.9 0.6 0.6 1.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 4.8 7.4 1.1 6.2 5.1 4.3 2.3 7.3 3.3 3.3 KCNK5 "K2p5.1, TASK-2" ENSG00000164626 "Potassium two pore domain channel subfamily K member 5" O95279 6 39188973-39229450 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 48.4;intestine: 74.2;kidney: 46.3" "Cell line enhanced" "Detected in many" "CACO-2: 18.8;HEL: 19.3;HMC-1: 17.8;K-562: 17.9;T-47d: 14.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.4" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA059148 Uncertain Approved Nucleoplasm Nucleoplasm "HPA059148: " "unprognostic (1.46e-1)" "prognostic favourable (3.29e-4)" "unprognostic (1.08e-1)" "unprognostic (2.92e-3)" "unprognostic (8.09e-4)" "unprognostic (3.97e-2)" "unprognostic (2.33e-1)" "unprognostic (9.57e-3)" "unprognostic (7.14e-2)" "unprognostic (3.43e-1)" "prognostic unfavourable (5.85e-4)" "unprognostic (2.98e-1)" "prognostic favourable (4.98e-7)" "unprognostic (2.34e-1)" "unprognostic (7.13e-2)" "unprognostic (1.03e-2)" "prognostic favourable (4.45e-4)" 2.2 1.3 0.3 4.5 0.4 4.5 3.9 0.4 0.5 4.3 25.5 0.8 2.6 16.1 5.6 4.0 4.3 1.4 48.4 1.5 0.3 0.0 46.3 12.6 3.6 1.1 0.8 0.4 4.0 15.3 1.2 1.0 15.2 0.8 2.3 4.7 3.6 16.0 1.6 0.5 15.8 74.2 1.3 0.6 1.2 9.4 0.9 0.3 2.0 9.0 2.2 4.1 2.2 3.8 0.0 0.9 0.2 0.1 0.0 1.4 0.5 3.4 3.2 4.3 1.6 0.0 0.0 3.7 0.0 0.0 0.0 0.0 18.8 7.8 0.0 5.7 0.0 7.2 3.3 0.1 0.0 0.0 2.4 19.3 1.5 0.1 0.0 3.9 17.8 0.0 0.0 0.1 0.0 0.0 17.9 0.0 0.0 6.0 8.7 4.3 7.9 0.0 0.0 0.8 7.2 3.0 2.9 1.0 0.8 3.1 4.0 0.0 14.3 6.5 0.1 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.3 0.0 0.0 0.0 0.9 0.0 0.4 0.0 0.9 1.4 0.0 0.0 0.1 0.4 0.2 0.0 0.1 0.9 0.2 0.5 0.3 0.4 0.4 0.5 0.3 0.0 0.8 0.4 0.8 0.3 KCNMA1 "KCa1.1, mSLO1, SLO" ENSG00000156113 "Potassium calcium-activated channel subfamily M alpha 1" Q12791 10 76869601-77638369 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 27.2;hTERT-HME1: 32.0;PC-3: 43.5;U-138 MG: 31.3;U-87 MG: 30.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "intermediate monocyte: 5.5;memory B-cell: 1.7;non-classical monocyte: 3.7" "Group enriched" "Detected in many" 5 "B-cells: 1.7;monocytes: 5.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054648 Approved "HPA054648: " "unprognostic (1.25e-1)" "unprognostic (2.23e-2)" "unprognostic (1.86e-2)" "unprognostic (5.29e-2)" "unprognostic (9.43e-2)" "unprognostic (2.25e-1)" "unprognostic (1.77e-1)" "unprognostic (2.81e-2)" "unprognostic (1.87e-1)" "unprognostic (1.34e-1)" "unprognostic (4.12e-3)" "unprognostic (1.20e-1)" "unprognostic (2.26e-2)" "unprognostic (1.42e-2)" "unprognostic (5.19e-2)" "unprognostic (1.42e-2)" "unprognostic (3.99e-3)" 6.0 8.1 12.5 8.8 13.6 1.1 7.1 8.2 18.5 36.3 39.0 5.7 27.9 4.8 54.0 19.7 20.7 18.3 15.6 2.7 10.8 8.2 2.0 6.6 4.0 6.2 7.4 16.5 7.0 4.1 0.7 10.1 3.3 10.1 30.1 13.2 6.6 24.0 47.6 37.1 1.8 8.6 55.1 6.8 10.4 14.8 2.6 4.9 0.4 1.4 2.7 2.5 21.7 12.6 1.7 0.6 0.3 5.5 0.0 0.0 0.3 0.0 8.1 0.0 0.1 1.3 7.0 0.1 27.2 24.3 6.6 3.2 1.8 0.1 0.0 0.2 20.3 0.0 0.0 15.9 4.0 16.1 0.1 0.0 0.0 0.0 12.7 0.0 0.1 4.9 2.9 10.5 32.0 2.6 0.0 0.0 11.6 0.3 0.5 0.0 0.5 43.5 0.0 1.0 0.0 4.2 0.0 2.5 0.3 0.0 0.6 0.0 3.3 0.0 17.6 31.3 3.5 5.6 24.0 0.0 0.0 0.0 30.6 0.0 12.2 0.0 0.2 0.0 0.0 5.5 0.0 1.7 0.0 0.0 0.6 0.3 0.0 0.0 0.3 0.0 3.7 0.0 0.0 0.3 12.5 13.6 8.2 18.5 10.8 8.2 7.4 16.5 10.1 4.9 KCNN4 "hIKCa1, hKCa4, hSK4, IK, KCa3.1" ENSG00000104783 "Potassium calcium-activated channel subfamily N member 4" O15554 19 43766533-43781257 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Immunity, Ion transport, Transport" "Calmodulin-binding, Ion channel" "Disease mutation, FDA approved drug targets, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 45.7;salivary gland: 82.3" "Cell line enhanced" "Detected in many" "CAPAN-2: 27.8;SK-BR-3: 27.5;WM-115: 70.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Region enhanced" "Detected in single" "olfactory region: 2.3" "Low region specificity" "Detected in some" "HPA053841, HPA059622" Approved "HPA053841: , HPA059622: " "unprognostic (1.23e-2)" "unprognostic (3.22e-2)" "unprognostic (4.29e-1)" "unprognostic (3.74e-3)" "prognostic unfavourable (2.68e-4)" "unprognostic (1.98e-2)" "unprognostic (7.33e-2)" "unprognostic (1.42e-2)" "unprognostic (2.48e-3)" "unprognostic (4.12e-2)" "prognostic unfavourable (4.56e-4)" "unprognostic (9.96e-3)" "prognostic unfavourable (1.05e-14)" "unprognostic (3.70e-2)" "unprognostic (2.17e-2)" "unprognostic (7.50e-2)" "prognostic favourable (1.75e-4)" 3.0 0.1 0.5 12.2 2.5 6.5 5.6 0.4 0.5 8.0 5.7 0.7 6.4 2.0 0.9 2.9 2.6 2.6 8.8 0.6 1.4 0.5 0.8 0.3 2.6 5.7 1.7 0.6 1.3 0.3 0.0 0.3 45.7 1.5 11.0 3.8 0.8 82.3 6.8 0.7 10.8 10.0 2.0 1.1 8.4 13.6 0.9 1.0 9.1 0.7 3.6 17.3 10.3 2.4 18.7 14.4 1.9 15.8 0.0 6.9 5.2 5.1 9.5 0.0 0.0 0.0 0.8 13.5 0.2 0.7 0.5 0.1 0.1 27.8 1.4 2.2 0.2 4.1 0.0 9.8 1.4 9.3 0.0 6.8 12.5 0.2 0.0 0.0 0.1 0.0 1.2 0.6 4.4 0.0 1.5 0.8 0.1 5.0 1.4 5.2 0.0 10.3 4.6 0.1 5.1 8.5 14.4 0.0 0.0 13.8 27.5 8.1 0.0 5.5 0.3 3.8 19.7 0.1 11.1 0.0 0.3 0.6 13.1 1.2 70.6 1.9 10.2 0.0 0.3 15.8 0.4 18.7 5.1 2.6 14.4 9.4 3.4 3.2 0.5 0.0 8.6 0.4 6.9 5.2 0.5 2.5 0.4 0.5 1.4 0.5 1.7 0.6 1.5 1.0 KCNQ1 "JLNS1, KCNA8, KCNA9, Kv7.1, KVLQT1, LQT, LQT1" ENSG00000053918 "Potassium voltage-gated channel subfamily Q member 1" P51787 11 2444684-2849110 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Calmodulin-binding, Ion channel, Potassium channel, Voltage-gated channel" "Atrial fibrillation, Deafness, Diabetes mellitus, Disease mutation, FDA approved drug targets, Long QT syndrome, Short QT syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 78.2;ductus deferens: 88.1;seminal vesicle: 83.6" "Cell line enhanced" "Detected in some" "HMC-1: 22.3;RPMI-8226: 15.0;U-266/70: 8.9;U-937: 8.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB018656, HPA048553" Enhanced "CAB018656: AB_2131551, HPA048553: " "unprognostic (6.02e-2)" "unprognostic (2.48e-1)" "unprognostic (6.39e-3)" "unprognostic (4.38e-1)" "unprognostic (1.86e-1)" "unprognostic (1.83e-1)" "unprognostic (3.46e-2)" "unprognostic (7.36e-2)" "unprognostic (8.07e-2)" "unprognostic (8.81e-2)" "unprognostic (1.58e-1)" "unprognostic (5.39e-2)" "unprognostic (2.46e-3)" "prognostic favourable (9.85e-4)" "unprognostic (3.99e-2)" "unprognostic (4.19e-2)" "unprognostic (5.27e-2)" 3.0 78.2 1.0 5.1 1.0 3.4 3.1 0.6 1.2 5.0 13.7 4.1 88.1 14.2 1.9 15.9 1.5 2.1 12.2 10.7 1.5 1.0 13.8 1.0 11.4 5.8 1.2 0.8 1.6 25.6 5.6 2.7 1.8 1.8 7.5 4.6 2.5 9.5 83.6 0.8 1.0 18.4 1.5 1.4 5.5 31.2 3.6 1.5 1.6 36.2 0.9 4.8 5.5 3.6 1.2 5.6 5.3 4.7 0.0 1.7 1.4 0.0 0.1 0.0 4.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 1.6 1.0 3.7 0.0 0.1 0.5 0.0 0.0 0.2 1.0 0.0 2.6 0.3 0.2 0.0 22.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.5 0.8 0.2 0.1 0.0 15.0 5.6 1.8 0.5 4.1 0.5 0.0 0.0 0.1 5.7 0.0 0.0 0.2 0.1 0.0 8.9 0.0 0.0 0.0 8.8 0.0 1.6 4.7 4.7 0.0 2.6 0.1 1.2 0.6 0.1 5.6 0.6 1.7 1.7 5.3 0.0 3.7 1.9 0.5 1.4 1.0 1.0 0.6 1.2 1.5 1.0 1.2 0.8 1.8 1.5 KCNQ2 "BFNC, EBN, EBN1, ENB1, HNSPC, KCNA11, Kv7.2" ENSG00000075043 "Potassium voltage-gated channel subfamily Q member 2" O43526 20 63400210-63472677 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 50.8" "Cell line enhanced" "Detected in some" "AF22: 8.3;AN3-CA: 13.7;NTERA-2: 7.6;SCLC-21H: 26.9;SH-SY5Y: 47.2" "Cancer enriched" "Detected in some" 9 "glioma: 8.7" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 2.2;T-reg: 1.5" "Lineage enriched" "Detected in single" 22 "T-cells: 2.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016642, HPA057112" Enhanced Approved "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA016642: AB_1855555, HPA057112: " "unprognostic (2.35e-1)" "unprognostic (1.41e-1)" "unprognostic (2.22e-4)" "unprognostic (8.21e-6)" "unprognostic (6.18e-2)" "unprognostic (7.58e-2)" "unprognostic (6.06e-2)" "unprognostic (3.16e-1)" "unprognostic (1.73e-1)" "unprognostic (1.92e-1)" "unprognostic (9.96e-2)" "unprognostic (9.39e-2)" "unprognostic (1.43e-5)" "unprognostic (4.36e-2)" "unprognostic (1.02e-1)" "unprognostic (1.81e-1)" "unprognostic (2.70e-2)" 1.2 10.0 18.7 1.3 21.4 1.2 1.2 24.1 50.8 1.2 1.3 2.4 0.0 1.3 1.2 1.3 1.2 1.7 1.7 1.2 15.4 10.0 1.2 1.2 1.2 1.2 8.4 14.1 1.2 1.9 1.2 9.2 1.2 8.9 2.8 1.2 0.0 1.2 1.2 1.2 1.2 1.3 1.2 2.6 1.2 1.3 6.9 4.2 0.0 1.2 0.0 1.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 8.3 13.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 26.9 47.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.8 0.9 0.0 0.0 0.0 0.0 1.5 0.0 18.7 21.4 24.1 31.2 15.4 10.0 8.4 14.1 8.9 4.2 KCNQ4 "DFNA2, Kv7.4" ENSG00000117013 "Potassium voltage-gated channel subfamily Q member 4" P56696 1 40783814-40840452 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Hearing, Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 40.1;retina: 23.0" "Cell line enhanced" "Detected in some" "HAP1: 3.9;HEK 293: 5.8;K-562: 5.8;MCF7: 3.4;REH: 3.0;THP-1: 3.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA018305 Uncertain "HPA018305: AB_1855556" "unprognostic (1.42e-2)" "unprognostic (1.56e-1)" "unprognostic (8.43e-3)" "unprognostic (4.59e-3)" "unprognostic (8.51e-2)" "unprognostic (1.64e-1)" "unprognostic (1.29e-2)" "unprognostic (5.86e-2)" "unprognostic (4.34e-2)" "unprognostic (6.64e-2)" "unprognostic (1.20e-1)" "unprognostic (7.40e-2)" "unprognostic (5.18e-4)" "unprognostic (2.68e-1)" "unprognostic (1.22e-1)" "unprognostic (3.17e-2)" "unprognostic (3.44e-2)" 2.5 0.9 1.1 1.5 2.9 0.4 1.3 3.8 3.6 2.5 9.1 0.9 1.5 1.5 5.8 0.9 3.5 4.6 2.8 2.1 1.6 0.7 0.4 0.4 1.4 0.4 1.4 2.1 1.6 40.1 0.5 0.6 2.1 1.3 3.3 1.7 23.0 5.4 5.3 5.9 1.1 2.3 7.5 2.0 0.4 2.9 1.2 1.4 0.5 0.6 0.9 0.4 5.3 2.5 0.0 0.5 0.0 0.0 0.0 0.4 0.4 0.1 0.2 0.3 0.1 0.0 0.0 2.0 0.0 0.0 0.0 0.1 0.3 1.6 0.3 0.6 0.0 0.0 3.9 0.0 0.0 0.1 5.8 1.9 0.3 0.0 0.4 0.4 0.2 0.5 0.0 0.0 0.0 0.0 5.8 0.1 0.0 3.4 0.7 0.0 0.4 0.1 3.0 0.0 0.0 0.6 0.0 2.6 0.5 0.0 1.5 0.6 0.3 3.4 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.4 1.1 2.9 3.8 3.6 1.6 0.7 1.4 2.1 1.3 1.4 KCNS2 Kv9.2 ENSG00000156486 "Potassium voltage-gated channel modifier subfamily S member 2" Q9ULS6 8 98427022-98432848 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 20.9" "Group enriched" "Detected in some" 6 "HSkMC: 3.9;SCLC-21H: 11.6" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebral cortex: 20.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051417 Uncertain "HPA051417: " "unprognostic (7.83e-2)" "unprognostic (9.39e-3)" "unprognostic (5.25e-2)" "unprognostic (2.87e-1)" "unprognostic (1.38e-2)" "unprognostic (2.59e-2)" "unprognostic (1.21e-1)" "unprognostic (1.12e-2)" "unprognostic (4.27e-2)" "unprognostic (4.58e-2)" "unprognostic (1.47e-1)" "unprognostic (5.30e-5)" "unprognostic (2.43e-2)" "unprognostic (1.42e-2)" "unprognostic (2.31e-1)" "unprognostic (1.30e-1)" "unprognostic (1.27e-3)" 1.6 1.4 2.9 0.6 6.6 0.3 0.7 0.7 20.9 2.0 1.0 0.1 0.5 0.4 1.3 1.7 0.9 1.0 1.5 0.4 1.9 2.8 0.7 0.3 0.7 0.4 0.8 6.4 1.9 0.8 0.8 1.2 4.4 3.4 0.9 0.9 0.1 0.3 3.3 0.2 0.3 0.7 0.6 0.9 0.3 1.5 1.0 0.4 0.0 0.5 0.0 0.3 2.5 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.4 1.3 0.0 0.5 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 11.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 6.6 0.7 20.9 1.9 2.8 0.8 6.4 3.4 0.4 KCNS3 Kv9.3 ENSG00000170745 "Potassium voltage-gated channel modifier subfamily S member 3" Q9BQ31 2 17877847-18361616 "Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 54.4" "Cell line enhanced" "Detected in many" "RH-30: 33.1;RPMI-8226: 13.3;RT4: 22.5;U-266/84: 15.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 12 "memory B-cell: 1.6" "Lineage enriched" "Detected in single" 17 "B-cells: 1.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA014864 Approved Supported "Golgi apparatus,Plasma membrane,Cytosol" Cytosol "Golgi apparatus, Plasma membrane" "HPA014864: AB_1852155" "unprognostic (5.62e-2)" "unprognostic (4.27e-3)" "unprognostic (6.87e-2)" "unprognostic (1.68e-1)" "unprognostic (3.19e-1)" "unprognostic (1.64e-2)" "unprognostic (3.30e-1)" "unprognostic (9.47e-3)" "unprognostic (9.06e-2)" "unprognostic (8.45e-2)" "unprognostic (5.82e-2)" "unprognostic (1.36e-1)" "prognostic unfavourable (1.53e-4)" "unprognostic (1.64e-2)" "unprognostic (2.34e-1)" "unprognostic (1.67e-1)" "unprognostic (4.71e-2)" 2.2 1.1 2.7 5.6 3.2 0.4 14.8 0.5 5.1 6.8 7.9 4.8 1.3 3.1 4.5 2.4 7.2 3.3 5.3 4.6 3.9 3.4 4.2 2.6 17.6 1.2 6.8 1.4 1.1 7.7 1.9 0.8 8.3 15.2 4.4 4.1 9.9 7.6 2.8 54.4 3.7 4.3 9.7 4.7 1.1 7.0 3.9 1.4 0.2 2.4 19.0 3.6 5.0 4.7 1.6 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.6 0.3 0.0 0.8 0.4 1.8 1.3 4.0 0.8 1.0 0.0 8.1 0.0 0.4 1.4 1.2 9.8 0.0 0.9 0.0 2.5 0.0 0.1 0.0 4.0 0.1 0.3 0.3 6.2 0.0 0.6 0.2 0.2 0.0 0.5 1.0 0.0 0.0 4.8 0.1 1.1 33.1 13.3 0.8 22.5 9.8 0.3 0.0 2.5 2.7 1.3 0.0 0.0 1.3 0.0 0.1 9.9 0.0 15.4 0.0 7.4 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 3.2 0.5 5.1 3.9 3.4 6.8 1.4 15.2 1.4 KCNT1 "KCa4.1, KIAA1422, SLACK, Slo2.2" ENSG00000107147 "Potassium sodium-activated channel subfamily T member 1" Q5JUK3 9 135702185-135795508 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.7;skeletal muscle: 19.5" "Cell line enhanced" "Detected in some" "RH-30: 2.0;RPMI-8226: 4.5;SCLC-21H: 6.8;SH-SY5Y: 1.4" "Cancer enhanced" "Detected in single" "ovarian cancer: 0.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059880 Uncertain "HPA059880: " "unprognostic (1.50e-3)" "unprognostic (1.72e-2)" "unprognostic (2.07e-3)" "unprognostic (2.98e-13)" "unprognostic (9.26e-2)" "unprognostic (7.73e-2)" "unprognostic (9.60e-2)" "unprognostic (1.67e-1)" "unprognostic (1.15e-1)" "unprognostic (1.30e-3)" "unprognostic (9.89e-2)" "unprognostic (6.20e-2)" "unprognostic (4.89e-7)" "unprognostic (9.15e-2)" "unprognostic (2.70e-1)" "unprognostic (2.26e-1)" "unprognostic (1.66e-2)" 1.4 0.8 7.3 1.0 12.4 1.0 0.7 29.7 29.3 0.7 0.9 0.2 0.0 1.0 0.8 0.9 1.2 0.9 1.1 1.8 5.3 4.2 0.7 0.7 0.9 0.8 1.8 12.0 7.3 0.8 0.7 4.7 1.2 6.1 0.8 0.8 0.0 0.7 0.8 19.5 0.8 0.8 0.8 2.1 9.6 1.4 1.9 3.1 0.0 0.8 0.0 0.7 1.1 0.1 0.0 0.0 0.7 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.0 2.0 4.5 0.0 0.0 6.8 1.4 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.3 0.1 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 7.3 12.4 29.7 29.3 5.3 4.2 1.8 12.0 6.1 3.1 KCNT2 "KCa4.2, SLICK, SLO2.1" ENSG00000162687 "Potassium sodium-activated channel subfamily T member 2" Q6UVM3 1 196225779-196609225 "Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+ RasG12V: 3.0;HHSteC: 4.8;NTERA-2: 3.8;SCLC-21H: 10.5;SH-SY5Y: 9.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA051218 Uncertain Approved Vesicles Vesicles "HPA051218: " "unprognostic (5.06e-2)" "unprognostic (2.94e-2)" "unprognostic (8.01e-2)" "unprognostic (5.10e-6)" "unprognostic (1.22e-3)" "unprognostic (1.30e-2)" "unprognostic (1.07e-1)" "unprognostic (3.03e-2)" "unprognostic (5.90e-2)" "unprognostic (2.18e-1)" "unprognostic (9.56e-3)" "unprognostic (2.61e-1)" "prognostic unfavourable (1.67e-5)" "unprognostic (3.30e-4)" "unprognostic (2.95e-2)" "unprognostic (4.75e-1)" "unprognostic (1.72e-3)" 3.9 2.8 4.8 1.3 5.5 0.6 2.2 1.4 8.3 1.8 2.3 0.6 0.0 2.1 2.2 1.7 4.0 2.7 5.9 6.8 9.4 3.1 1.8 10.5 5.5 1.3 1.8 5.2 14.9 1.1 0.9 14.1 1.8 3.7 4.2 2.5 2.9 2.6 2.5 1.2 1.9 2.1 2.6 5.2 1.4 2.6 3.3 1.0 0.0 4.5 3.4 1.2 3.3 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.8 0.0 0.1 0.3 0.0 0.0 1.5 0.3 3.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.0 1.8 0.0 4.8 0.0 0.0 1.2 0.0 0.5 0.1 0.6 0.1 0.0 0.3 0.0 0.2 0.0 3.8 0.2 0.0 0.3 0.0 0.0 0.8 10.5 9.4 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.2 0.0 0.1 0.3 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 5.5 1.4 8.3 9.4 3.1 1.8 5.2 3.7 1.0 KCNU1 "KCa5.1, Kcnma3, KCNMC1, Slo3" ENSG00000215262 "Potassium calcium-activated channel subfamily U member 1" A8MYU2 8 36784324-36936128 "Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 21 "testis: 15.8" "Cell line enriched" "Detected in some" 5 "HDLM-2: 12.8" "Cancer enhanced" "Detected in single" "liver cancer: 0.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA063317 Uncertain "Plasma membrane" "Plasma membrane" "HPA063317: " "unprognostic (2.42e-3)" "unprognostic (4.26e-2)" "unprognostic (2.07e-1)" "unprognostic (4.76e-3)" "unprognostic (7.57e-2)" "unprognostic (1.12e-1)" "unprognostic (1.11e-1)" "unprognostic (2.71e-1)" "unprognostic (1.98e-1)" "unprognostic (7.73e-2)" "unprognostic (1.24e-2)" 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.1 12.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.2 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MBOAT7 "BB1, hMBOA-7, LENG4, LPIAT" ENSG00000125505 "Membrane bound O-acyltransferase domain containing 7" Q96N66 19 54173412-54189882 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 56.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 9 "basophil: 15.7;eosinophil: 30.6;neutrophil: 30.0" "Lineage enriched" "Detected in many" 10 "granulocytes: 30.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055967 Approved Approved Cytosol Cytosol "HPA055967: " "unprognostic (1.89e-2)" "unprognostic (2.60e-2)" "unprognostic (2.60e-1)" "unprognostic (3.31e-1)" "unprognostic (3.54e-2)" "unprognostic (5.95e-2)" "prognostic unfavourable (5.55e-6)" "prognostic unfavourable (5.13e-4)" "unprognostic (5.36e-2)" "unprognostic (2.31e-2)" "unprognostic (1.08e-2)" "unprognostic (2.81e-1)" "prognostic unfavourable (6.62e-5)" "unprognostic (1.31e-1)" "unprognostic (4.75e-2)" "unprognostic (3.95e-1)" "prognostic favourable (4.31e-4)" 10.7 63.1 16.8 14.8 24.2 15.9 7.9 11.3 37.8 10.3 17.7 9.2 15.6 30.3 10.5 8.0 10.5 11.5 14.3 6.9 18.5 23.4 10.5 11.6 11.5 14.7 10.0 18.8 15.1 24.4 23.8 12.4 11.9 21.6 11.4 6.1 8.1 10.8 28.8 7.9 10.0 28.5 6.5 9.2 14.4 16.4 30.8 6.8 7.6 12.7 5.0 6.3 22.6 17.5 0.3 2.9 30.6 2.1 0.9 0.5 0.8 14.0 8.4 1.3 13.8 4.5 3.6 12.2 24.7 8.8 5.7 11.3 4.8 16.0 3.6 11.1 5.3 28.8 0.0 5.0 1.1 5.0 16.4 3.9 9.0 3.1 4.4 8.9 56.5 6.6 3.4 2.8 1.9 10.2 14.5 11.6 2.0 8.5 2.6 3.1 5.8 17.9 8.3 2.4 7.4 5.7 17.0 0.5 3.7 16.5 10.0 5.0 10.2 0.8 20.4 12.1 4.3 3.6 9.7 5.3 9.2 1.5 17.4 6.3 8.0 15.7 2.1 30.6 0.2 1.5 0.5 0.2 0.2 0.2 2.9 0.3 0.1 0.2 30.0 0.9 0.8 0.8 0.2 0.8 16.8 24.2 11.3 37.8 18.5 23.4 10.0 18.8 21.6 6.8 MCOLN1 "ML4, MLIV, MST080, MSTP080, TRPM-L1, TRPML1" ENSG00000090674 "Mucolipin 1" Q9GZU1 19 7522626-7534009 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Adaptive immunity, Calcium transport, Immunity, Ion transport, Transport" "Ion channel" "Disease mutation, Mucolipidosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 5 "granulocytes: 30.9;monocytes: 28.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031763, CAB032637, HPA069495" Uncertain Supported "Nucleoplasm,Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" Nucleoplasm "CAB032637: AB_2142964, HPA031763: AB_10600822, HPA069495: " "unprognostic (5.51e-2)" "unprognostic (1.31e-2)" "unprognostic (1.35e-2)" "unprognostic (3.30e-2)" "unprognostic (2.66e-1)" "unprognostic (4.07e-2)" "unprognostic (8.38e-3)" "unprognostic (1.57e-1)" "unprognostic (1.79e-2)" "unprognostic (1.47e-1)" "prognostic favourable (5.60e-5)" "unprognostic (1.36e-1)" "prognostic favourable (5.67e-4)" "unprognostic (2.58e-1)" "unprognostic (1.66e-1)" "unprognostic (1.07e-1)" "unprognostic (1.83e-1)" 18.9 27.5 10.1 10.3 11.9 10.0 10.3 8.2 19.7 7.7 9.6 11.2 7.2 9.6 8.8 9.5 11.2 8.4 11.7 11.7 9.0 9.2 11.5 20.6 17.9 20.6 10.6 10.0 7.8 10.5 9.8 26.0 17.9 13.6 8.8 6.9 9.7 9.2 8.0 14.2 13.9 8.0 9.5 10.4 38.3 8.9 6.5 9.4 7.0 6.2 7.6 5.1 12.5 8.7 1.3 6.2 30.9 28.9 2.8 2.7 4.4 6.3 6.5 3.2 10.8 18.7 6.0 9.2 11.9 9.6 14.4 12.5 5.0 5.6 3.5 14.7 8.0 2.9 5.4 4.1 4.3 6.9 11.9 3.1 6.4 4.0 16.4 3.6 14.0 8.5 9.6 13.8 2.4 6.1 5.9 15.9 8.3 2.1 4.9 3.6 7.1 14.1 6.8 5.4 7.6 5.4 5.5 8.3 10.2 5.1 9.0 15.0 5.4 6.3 7.5 6.9 3.9 27.8 8.8 12.3 18.8 2.5 11.1 5.0 10.3 30.9 13.7 29.7 2.3 27.5 2.0 1.1 2.0 1.9 5.6 1.3 1.9 2.0 12.2 2.8 28.9 6.2 2.7 4.4 10.1 11.9 8.2 19.7 9.0 9.2 10.6 10.0 13.6 9.4 MCOLN2 "FLJ36691, TRP-ML2, TRPML2" ENSG00000153898 "Mucolipin 2" Q8IZK6 1 84925583-84997113 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Adaptive immunity, Calcium transport, Immunity, Innate immunity, Ion transport, Protein transport, Transport" "Calcium channel, Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 18.9;epididymis: 18.4;lymphoid tissue: 31.9" "Cell line enhanced" "Detected in many" "Daudi: 13.8;HAP1: 9.9;HDLM-2: 16.4;THP-1: 19.7;U-698: 12.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 18.9" "Group enriched" "Detected in many" 12 "B-cells: 6.6;dendritic cells: 18.9;T-cells: 5.9" "Region enriched" "Detected in single" 5 "amygdala: 0.4" "Low region specificity" "Detected in all" "HPA019114, HPA048999" Uncertain Supported "Intermediate filaments" "Intermediate filaments" "HPA019114: AB_1853645, HPA048999: " "unprognostic (3.02e-2)" "unprognostic (5.67e-2)" "unprognostic (3.07e-1)" "unprognostic (1.44e-1)" "unprognostic (2.47e-1)" "unprognostic (5.66e-3)" "unprognostic (2.38e-1)" "prognostic favourable (2.56e-4)" "unprognostic (8.92e-2)" "unprognostic (1.48e-2)" "unprognostic (6.84e-2)" "unprognostic (2.21e-2)" "unprognostic (3.12e-4)" "unprognostic (3.68e-2)" "unprognostic (4.69e-2)" "unprognostic (1.24e-1)" "unprognostic (4.23e-2)" 1.3 12.5 0.4 31.9 0.4 2.2 1.1 0.2 0.4 1.7 8.5 0.5 1.6 1.2 1.4 18.4 1.3 2.9 3.8 2.0 0.6 0.4 1.4 0.6 7.5 18.4 0.6 0.0 1.0 1.8 0.0 1.2 2.1 1.5 1.5 14.0 1.6 3.2 0.9 0.6 1.8 7.5 0.5 1.7 9.7 1.7 2.7 0.4 4.1 1.0 2.8 27.5 2.3 1.3 6.6 18.9 0.2 0.8 0.4 5.9 1.4 1.0 1.1 0.1 2.9 0.6 0.2 0.4 0.7 3.8 0.9 1.2 0.0 0.1 13.8 0.4 0.0 0.1 9.9 1.2 1.1 16.4 7.3 1.4 0.4 0.0 0.8 0.3 1.3 0.2 0.0 0.9 0.8 0.1 0.0 0.3 0.2 0.4 0.2 0.1 1.1 1.9 0.1 2.3 0.0 0.1 0.3 0.7 0.0 0.1 0.2 6.1 1.7 19.7 0.1 0.9 1.5 0.1 2.6 0.1 0.0 12.3 0.8 0.1 2.4 0.1 0.2 0.0 4.1 0.8 1.3 6.6 3.3 5.9 4.5 1.9 0.5 3.4 0.2 0.4 0.1 18.9 0.2 1.4 0.4 0.4 0.2 0.4 0.6 0.4 0.6 0.0 1.5 0.4 MCOLN3 "FLJ11006, TRP-ML3, TRPML3" ENSG00000055732 "Mucolipin 3" Q8TDD5 1 85018082-85048499 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 29.2;pituitary gland: 38.3" "Cell line enhanced" "Detected in many" "BJ hTERT+: 9.8;HAP1: 9.8;RH-30: 11.9;SK-MEL-30: 21.2" "Cancer enriched" "Detected in many" 6 "melanoma: 8.0" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 2.9" "Lineage enriched" "Detected in single" 29 "T-cells: 2.9" "Not detected" "Not detected" "Region enhanced" "Detected in single" "olfactory region: 1.7" "HPA018106, HPA062137" Enhanced Approved Nucleoli,Cytosol "Nucleoli, Cytosol" "HPA018106: AB_1853647, HPA062137: " "unprognostic (5.91e-2)" "unprognostic (1.24e-1)" "unprognostic (1.49e-2)" "unprognostic (3.21e-5)" "unprognostic (2.25e-1)" "unprognostic (8.80e-3)" "unprognostic (3.97e-3)" "unprognostic (1.13e-1)" "unprognostic (2.04e-1)" "unprognostic (1.10e-1)" "unprognostic (1.45e-3)" "unprognostic (3.09e-2)" "unprognostic (7.32e-5)" "unprognostic (6.36e-3)" "unprognostic (2.61e-1)" "unprognostic (6.11e-2)" "unprognostic (6.43e-2)" 4.7 29.2 1.5 0.8 0.8 0.0 3.0 0.2 0.4 6.1 2.8 0.9 2.1 3.2 5.4 15.6 0.8 1.1 0.6 5.1 3.4 0.3 4.5 0.2 4.1 0.0 0.5 0.0 2.2 6.5 17.9 38.3 1.8 2.7 0.5 0.5 4.5 8.1 0.4 1.9 2.5 1.9 1.1 0.3 0.9 1.6 0.4 0.3 2.6 1.5 0.9 0.4 0.7 2.8 0.0 0.0 0.0 0.0 0.0 2.9 0.7 6.4 1.5 0.0 0.0 5.2 4.7 1.6 0.1 9.8 2.5 6.9 0.5 1.2 0.0 0.7 0.1 0.0 9.8 3.2 1.6 2.6 5.8 0.0 0.5 0.0 0.0 0.0 0.0 0.5 1.2 2.1 1.1 0.0 0.0 0.0 4.8 0.6 0.0 0.0 0.7 0.6 0.0 11.9 0.0 0.3 0.0 0.4 0.0 0.3 0.0 21.2 4.0 4.9 0.0 1.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.8 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.5 0.8 0.2 0.4 3.4 0.3 0.5 0.0 2.7 0.3 MFSD8 "CLN7, MGC33302" ENSG00000164073 "Major facilitator superfamily domain containing 8" Q8NHS3 4 127917732-127966034 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease mutation, Neurodegeneration, Neuronal ceroid lipofuscinosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044802 Approved Supported Nucleoplasm,Vesicles "Nucleoplasm, Vesicles" "HPA044802: AB_10963221" "unprognostic (1.67e-1)" "unprognostic (1.95e-1)" "unprognostic (4.47e-2)" "unprognostic (8.10e-2)" "unprognostic (1.57e-1)" "unprognostic (4.12e-2)" "unprognostic (1.18e-1)" "unprognostic (8.99e-2)" "unprognostic (2.19e-2)" "unprognostic (8.69e-2)" "unprognostic (4.51e-2)" "unprognostic (3.44e-2)" "unprognostic (3.93e-3)" "unprognostic (1.70e-1)" "unprognostic (5.61e-3)" "unprognostic (3.14e-1)" "prognostic favourable (2.21e-4)" 8.9 9.6 9.1 11.7 15.4 5.3 13.0 19.6 15.4 12.2 12.1 14.6 9.4 17.1 19.0 11.9 10.3 9.8 9.2 7.5 8.9 10.1 12.6 19.1 9.1 9.7 9.3 11.8 13.2 14.5 16.7 21.5 18.0 15.8 10.2 15.6 14.8 10.9 9.7 7.2 11.0 15.0 12.4 11.8 13.5 12.0 9.4 10.2 12.9 13.6 7.1 15.0 9.9 10.5 7.0 5.8 7.1 8.2 5.4 8.3 4.1 8.3 6.9 7.2 4.0 6.4 5.7 6.2 6.2 8.0 8.1 8.2 4.3 11.9 3.9 12.2 11.2 6.9 8.4 6.3 11.8 9.0 6.7 4.7 7.8 6.6 7.1 5.0 5.9 6.2 2.1 7.6 5.8 8.6 8.1 5.2 11.5 7.6 4.3 1.7 1.4 4.6 4.6 0.5 4.5 5.8 11.8 7.3 2.6 7.8 7.9 3.3 4.6 3.4 4.5 2.7 2.8 10.1 5.8 11.4 18.9 8.8 8.7 4.3 7.3 4.6 5.6 7.1 7.1 6.2 6.2 7.0 7.9 6.6 4.5 3.6 8.3 8.3 6.3 5.4 8.2 5.8 8.0 4.1 9.1 15.4 19.6 15.4 8.9 10.1 9.3 11.8 15.8 10.2 MIP "AQP0, LIM1, MP26" ENSG00000135517 "Major intrinsic protein of lens fiber" P30301 12 56449502-56469166 "Disease related genes, Predicted membrane proteins" "Sensory transduction, Transport, Vision" "Eye lens protein" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "liver: 2.9;retina: 2.1;testis: 3.3" "Cell line enhanced" "Detected in some" "HEL: 2.7;SK-BR-3: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA014940 Supported "HPA014940: " "unprognostic (6.48e-2)" "unprognostic (6.12e-2)" "unprognostic (2.23e-1)" "unprognostic (1.62e-1)" "unprognostic (7.14e-2)" "unprognostic (3.96e-2)" "unprognostic (2.90e-3)" "unprognostic (1.72e-1)" "unprognostic (3.47e-1)" "unprognostic (1.51e-5)" "unprognostic (4.56e-3)" "unprognostic (6.75e-2)" "unprognostic (1.16e-2)" "unprognostic (2.83e-2)" "unprognostic (3.27e-1)" "unprognostic (2.62e-1)" "unprognostic (8.82e-2)" 0.2 0.4 0.4 0.2 0.5 0.1 0.2 0.3 0.7 0.2 0.2 0.2 0.2 0.5 0.2 0.2 0.2 0.0 0.2 0.4 0.5 0.8 0.2 2.9 0.2 0.2 0.4 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.3 2.1 0.2 0.2 0.2 0.1 0.2 0.2 0.6 0.2 0.0 3.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 1.1 1.3 1.0 1.4 0.3 0.6 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.6 0.1 0.0 0.3 0.8 0.0 0.2 0.9 0.1 0.1 0.2 0.2 0.0 0.0 0.6 0.3 2.7 0.2 0.0 0.1 0.8 1.8 0.1 0.0 0.3 0.1 0.0 0.3 1.7 0.4 0.4 0.0 0.9 0.6 0.6 0.0 0.1 0.7 0.3 0.4 1.5 0.5 0.9 2.5 0.7 0.5 1.8 0.2 0.4 0.3 0.0 0.0 0.1 0.2 0.9 0.0 0.8 0.3 1.0 1.4 0.1 0.6 0.8 0.3 0.7 0.6 0.2 0.0 1.1 0.2 0.4 0.6 0.3 0.3 1.3 0.5 0.0 0.4 0.5 0.3 0.5 0.5 0.8 0.4 0.2 0.2 0.2 MRGPRX3 MRGX3 ENSG00000179826 "MAS related GPR family member X3" Q96LB0 11 18120955-18138480 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "breast: 10.3;salivary gland: 7.9;tongue: 4.4" "Cell line enriched" "Detected in some" 10 "HBEC3-KT: 17.8" "Cancer enhanced" "Detected in some" "melanoma: 2.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.6" "Lineage enriched" "Detected in single" 8 "granulocytes: 1.6" "unprognostic (1.54e-3)" "unprognostic (5.07e-2)" "unprognostic (1.61e-1)" "unprognostic (1.50e-1)" "unprognostic (7.65e-2)" "unprognostic (1.74e-1)" "unprognostic (4.75e-2)" "unprognostic (2.09e-1)" 0.1 0.0 0.1 0.8 0.1 0.4 10.3 0.1 0.3 0.3 0.1 0.1 0.1 0.3 0.1 0.1 3.1 0.0 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.0 0.1 7.9 0.1 0.4 0.4 0.2 0.1 0.1 0.6 0.1 0.9 0.1 0.1 0.1 4.4 1.4 0.1 0.5 0.1 0.2 1.6 0.1 0.0 0.1 0.0 0.7 0.1 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.4 0.0 17.8 0.0 0.1 0.3 0.0 0.1 0.6 0.0 0.1 0.4 0.0 0.0 0.0 1.5 0.0 0.0 0.7 0.4 0.2 0.3 0.3 0.2 0.1 0.2 0.1 0.2 0.0 0.7 0.1 0.0 0.8 0.2 0.2 0.4 0.2 0.1 1.8 1.1 0.4 0.2 0.7 0.2 0.1 0.2 0.3 0.4 0.0 0.1 0.4 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.1 1.6 0.0 0.0 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 MT-ATP6 "ATP6, ATPase-6, MTATP6, RP, Su6m" ENSG00000198899 "Mitochondrially encoded ATP synthase membrane subunit 6" P00846 MT 8527-9207 "Disease related genes, Predicted membrane proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Cardiomyopathy, Disease mutation, Leber hereditary optic neuropathy, Leigh syndrome, Neuropathy, Primary mitochondrial disease, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 419.0;skeletal muscle: 475.3" "Cell line enhanced" "Detected in all" "HeLa: 1161.8" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 419.0" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (2.97e-1)" "unprognostic (4.16e-1)" "unprognostic (1.86e-2)" "unprognostic (4.55e-2)" "unprognostic (8.45e-3)" "unprognostic (1.66e-1)" "prognostic favourable (3.79e-4)" "unprognostic (6.47e-2)" "unprognostic (2.39e-1)" "unprognostic (1.44e-2)" "prognostic favourable (7.64e-4)" "unprognostic (6.01e-2)" "unprognostic (4.64e-2)" "unprognostic (1.46e-1)" "unprognostic (1.37e-1)" "unprognostic (3.56e-1)" "unprognostic (2.52e-3)" 85.2 89.2 126.0 25.1 159.3 20.1 29.6 45.2 81.2 20.1 60.3 75.6 23.5 30.9 42.8 19.8 24.6 309.5 122.3 90.2 154.4 166.8 18.0 19.3 102.8 26.5 54.7 36.2 22.0 34.1 37.6 59.4 66.8 35.6 475.3 62.5 52.6 27.9 61.3 20.7 58.4 27.7 22.4 18.6 23.0 15.7 110.2 58.9 419.0 88.2 72.3 90.5 35.3 98.7 162.9 113.7 178.4 217.2 49.9 74.3 145.5 26.6 19.7 33.3 191.6 108.6 175.9 61.8 78.5 215.2 11.8 113.5 36.6 125.7 103.1 154.0 1161.8 331.5 36.9 91.1 199.6 81.3 100.7 35.3 34.2 34.9 101.3 128.4 76.7 278.0 56.1 242.7 29.9 67.5 70.7 48.5 108.4 204.5 250.6 65.0 83.4 52.1 111.3 105.2 119.0 313.0 184.2 80.3 118.7 132.6 103.9 56.7 74.9 122.0 70.1 194.6 44.9 419.0 88.2 156.1 56.6 66.3 71.6 106.0 64.7 71.1 47.5 110.2 76.5 90.5 100.1 72.3 67.8 58.9 47.6 35.3 MYADM ENSG00000179820 "Myeloid associated differentiation marker" Q96S97 19 53866223-53876437 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 52.2" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056301 Approved "Nuclear speckles" 34000 "Nuclear speckles" "HPA056301: " "unprognostic (5.17e-2)" "unprognostic (1.41e-1)" "unprognostic (1.85e-1)" "unprognostic (2.94e-1)" "unprognostic (6.41e-2)" "unprognostic (1.01e-2)" "unprognostic (8.21e-3)" "prognostic unfavourable (8.15e-4)" "unprognostic (3.97e-2)" "unprognostic (1.29e-1)" "unprognostic (2.52e-1)" "unprognostic (4.11e-1)" "prognostic unfavourable (7.71e-7)" "unprognostic (2.28e-3)" "unprognostic (1.29e-1)" "unprognostic (2.37e-2)" "unprognostic (6.14e-3)" 58.2 9.5 9.2 26.4 13.9 53.5 39.2 7.4 17.1 67.9 58.9 18.8 25.1 15.8 105.6 33.0 44.6 66.1 40.8 39.9 9.3 11.7 13.0 15.6 42.4 22.3 8.2 11.4 51.7 31.8 8.7 8.9 46.5 13.3 41.9 13.4 22.2 21.1 45.4 13.2 19.5 26.8 76.8 9.6 22.6 37.6 28.7 9.4 20.3 20.5 32.6 15.3 81.6 30.5 2.0 14.3 52.2 11.6 4.1 5.4 3.9 6.4 54.2 6.9 5.6 23.7 16.4 11.1 34.5 24.8 13.7 14.0 22.3 20.1 0.6 12.3 43.9 13.3 3.5 13.1 11.9 8.1 8.1 8.8 9.0 17.0 54.3 18.2 32.0 17.8 3.1 17.5 2.5 12.3 9.3 16.7 8.7 7.7 4.8 14.2 6.6 15.5 19.1 7.5 3.2 15.4 0.7 0.1 10.8 0.3 10.8 3.4 10.6 15.6 25.1 30.9 11.1 4.1 15.5 10.8 6.7 0.1 18.9 8.8 0.5 14.1 11.6 38.3 5.4 6.7 5.1 1.4 3.5 3.9 14.3 2.0 3.4 2.8 52.2 4.1 5.4 5.5 1.3 3.9 9.2 13.9 7.4 17.1 9.3 11.7 8.2 11.4 13.3 9.4 MYMK "TMEM226, TMEM8C" ENSG00000187616 "Myomaker, myoblast fusion factor" A6NI61 9 133514586-133528612 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Myogenesis "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.3;epididymis: 3.1;skeletal muscle: 8.0" "Group enriched" "Detected in some" 34 "HSkMC: 18.0;RH-30: 8.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA051846, HPA055785" Uncertain "HPA051846: , HPA055785: " "unprognostic (9.17e-3)" "unprognostic (8.63e-2)" "unprognostic (3.76e-1)" "unprognostic (1.13e-1)" "unprognostic (1.03e-1)" "unprognostic (5.37e-1)" "unprognostic (9.32e-2)" "unprognostic (1.91e-1)" 0.6 0.2 0.5 0.0 3.3 0.2 0.0 0.7 2.6 0.0 0.0 0.8 0.0 0.0 0.0 3.1 0.6 0.1 0.0 0.3 1.0 0.4 1.7 0.2 0.3 0.0 0.9 2.1 0.0 0.0 0.0 0.1 2.0 1.6 0.6 0.0 0.0 0.2 0.0 8.0 0.2 0.0 0.0 0.4 0.1 0.0 1.5 0.4 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 3.3 0.7 2.6 1.0 0.4 0.9 2.1 1.6 0.4 NDC1 "FLJ10407, NET3, TMEM48" ENSG00000058804 "NDC1 transmembrane nucleoporin" Q9BTX1 1 53765460-53838860 "Predicted membrane proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA069751, HPA070882" Approved Supported "Nuclear membrane,Plasma membrane,Actin filaments" "Nuclear membrane" "Plasma membrane, Actin filaments" "HPA069751: , HPA070882: " "unprognostic (2.51e-1)" "unprognostic (1.93e-1)" "prognostic favourable (4.48e-5)" "unprognostic (6.96e-3)" "unprognostic (1.31e-1)" "unprognostic (1.36e-3)" "prognostic unfavourable (7.52e-7)" "unprognostic (3.46e-3)" "unprognostic (1.53e-2)" "unprognostic (2.01e-1)" "prognostic unfavourable (3.58e-4)" "unprognostic (9.27e-2)" "unprognostic (6.22e-3)" "unprognostic (3.00e-3)" "unprognostic (4.38e-2)" "unprognostic (9.24e-2)" "unprognostic (6.07e-2)" 8.8 6.7 3.3 8.6 5.7 4.9 12.9 10.9 7.7 4.8 8.4 5.1 1.9 6.2 6.0 5.4 11.0 5.3 2.9 5.5 4.3 2.8 4.9 11.7 4.4 10.6 8.0 1.5 4.6 6.0 7.6 5.5 5.5 6.6 4.0 10.7 5.5 6.4 3.7 7.1 6.8 6.5 5.0 7.5 7.1 5.8 17.4 7.5 9.1 5.8 6.7 13.0 6.4 5.8 5.5 3.8 2.0 7.2 4.0 8.2 3.4 19.6 10.4 14.2 14.5 5.2 5.3 16.7 13.5 10.1 21.2 17.2 15.3 13.2 38.9 8.9 6.0 23.8 23.9 14.1 30.1 9.7 17.2 18.9 15.3 13.0 4.9 30.4 10.8 3.2 5.6 20.9 12.5 12.8 21.6 5.6 11.6 7.1 14.8 12.1 33.6 16.6 16.8 22.9 21.3 9.9 13.6 8.6 10.9 12.1 23.6 11.6 18.3 16.1 7.4 11.1 11.1 15.2 24.2 6.2 15.3 27.7 9.2 23.1 13.8 0.0 3.2 2.0 4.5 7.2 6.9 5.5 4.3 4.0 3.8 4.1 8.2 6.3 0.2 4.0 4.5 3.3 4.7 3.4 3.3 5.7 10.9 7.7 4.3 2.8 8.0 1.5 6.6 7.5 NIPAL3 "DJ462O23.2, NPAL3" ENSG00000001461 "NIPA like domain containing 3" Q6P499 1 24415794-24472976 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 42.4" "Cell line enhanced" "Detected in many" "BJ: 41.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039978 Approved Approved Nucleoplasm Nucleoplasm "HPA039978: AB_10697712" "unprognostic (9.36e-2)" "unprognostic (7.63e-2)" "unprognostic (2.88e-2)" "unprognostic (1.19e-2)" "unprognostic (5.96e-2)" "unprognostic (5.38e-2)" "unprognostic (3.72e-3)" "unprognostic (3.60e-2)" "unprognostic (2.43e-1)" "unprognostic (6.66e-2)" "unprognostic (2.79e-1)" "unprognostic (3.14e-1)" "prognostic favourable (3.03e-7)" "unprognostic (1.46e-2)" "unprognostic (1.94e-1)" "prognostic favourable (3.95e-4)" "unprognostic (2.85e-1)" 5.3 5.1 21.4 5.2 21.8 4.9 8.3 41.2 29.4 6.9 8.9 42.4 5.6 7.1 4.2 7.4 10.3 10.4 6.3 9.2 25.5 21.3 9.4 2.3 9.2 7.1 32.9 14.7 5.5 11.3 14.0 6.5 2.8 31.5 38.4 9.3 7.1 9.9 5.7 3.5 7.7 8.5 8.1 34.8 4.8 9.6 3.1 22.5 5.8 20.7 2.3 7.9 7.8 5.4 12.9 8.4 8.9 3.6 9.2 26.0 9.7 12.6 5.1 0.5 1.6 7.7 8.7 1.8 41.0 29.4 15.0 11.1 1.7 14.5 5.9 13.2 22.7 12.4 5.0 15.2 14.8 12.0 15.7 6.5 8.5 2.0 7.2 5.7 5.9 8.6 14.2 10.0 30.3 5.1 3.8 3.7 9.0 2.8 4.6 2.4 3.1 14.4 2.2 0.0 6.7 15.9 4.1 19.1 1.8 5.5 7.8 11.0 10.7 4.4 7.3 13.5 2.9 4.5 9.0 11.7 9.5 2.1 9.0 10.4 12.0 8.9 3.6 4.7 10.8 3.4 10.7 12.9 18.2 14.0 6.5 10.9 26.0 16.1 1.6 9.2 2.3 8.4 17.6 9.7 21.4 21.8 41.2 24.6 25.5 21.3 32.9 14.7 31.5 22.5 NOX1 "GP91-2, MOX1, NOH-1, NOH1" ENSG00000007952 "NADPH oxidase 1" Q9Y5S8 X 100843324-100874345 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Electron transport, Ion transport, Transport" "Ion channel, Oxidoreductase, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "ductus deferens: 15.0;intestine: 36.3;seminal vesicle: 18.0" "Cell line enriched" "Detected in some" 21 "CACO-2: 25.9" "Cancer enriched" "Detected in many" 18 "colorectal cancer: 82.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in single" "Region enhanced" "Detected in some" "olfactory region: 1.8" "unprognostic (8.31e-2)" "unprognostic (2.07e-3)" "prognostic favourable (9.71e-4)" "unprognostic (1.67e-2)" "unprognostic (3.37e-1)" "unprognostic (6.55e-3)" "unprognostic (5.48e-3)" "unprognostic (8.68e-3)" "unprognostic (1.32e-1)" "unprognostic (5.23e-2)" "unprognostic (1.18e-1)" "unprognostic (3.86e-3)" "unprognostic (2.56e-3)" "unprognostic (1.64e-1)" "unprognostic (1.78e-2)" "unprognostic (5.28e-2)" "unprognostic (1.81e-3)" 0.1 0.1 0.2 8.8 0.2 0.0 0.1 0.2 0.2 0.2 28.3 0.0 15.0 0.1 0.3 0.0 0.1 0.1 0.2 0.1 0.2 0.2 0.1 0.1 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.3 36.3 0.0 0.1 18.0 0.1 0.8 1.7 0.7 0.1 0.1 0.1 0.4 0.0 0.4 0.1 0.0 0.1 0.6 0.1 0.2 0.7 0.9 0.6 0.8 1.5 0.2 0.4 0.9 0.4 0.3 0.2 0.0 0.3 0.3 0.0 0.0 0.0 25.9 0.3 0.3 0.6 0.0 0.6 0.0 0.0 0.0 0.3 1.2 0.4 0.6 0.7 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.2 1.1 1.0 0.7 0.9 0.6 0.6 0.4 0.0 0.9 0.4 0.5 0.6 0.3 0.6 0.2 0.8 0.2 0.3 0.2 0.5 0.6 0.3 0.6 0.3 0.7 1.1 0.2 0.9 0.3 0.3 0.5 0.3 0.3 0.2 1.1 0.2 0.1 0.1 1.5 0.6 0.1 0.8 0.6 0.7 1.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.0 0.0 0.0 NOX4 "KOX, KOX-1" ENSG00000086991 "NADPH oxidase 4" Q9NPH5 11 89324356-89498187 "Predicted membrane proteins, Transporters" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "kidney: 65.2" "Group enriched" "Detected in some" 7 "HUVEC TERT2: 15.4;TIME: 34.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA015475 Approved Nucleoplasm Nucleoplasm "HPA015475: AB_1854574" "unprognostic (2.91e-2)" "unprognostic (1.08e-1)" "unprognostic (1.74e-3)" "unprognostic (6.58e-3)" "unprognostic (1.92e-1)" "unprognostic (2.33e-1)" "unprognostic (8.83e-3)" "unprognostic (8.95e-3)" "unprognostic (3.80e-1)" "unprognostic (6.88e-2)" "unprognostic (1.56e-2)" "unprognostic (1.73e-1)" "prognostic favourable (6.14e-4)" "unprognostic (1.99e-4)" "unprognostic (9.71e-2)" "unprognostic (5.69e-2)" "unprognostic (3.03e-3)" 7.5 0.6 0.2 0.6 0.6 0.3 6.5 0.3 0.5 1.2 0.9 1.1 0.4 0.3 7.3 2.5 1.5 0.8 1.3 6.9 0.6 0.2 65.2 0.3 1.2 0.3 0.3 0.2 0.7 1.1 3.8 0.8 1.7 1.0 2.6 0.4 0.8 2.6 0.9 5.1 1.1 0.5 3.5 1.2 0.4 0.4 1.0 0.0 0.0 1.7 1.7 0.4 2.1 1.1 0.4 0.3 1.7 0.3 0.8 0.3 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.7 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 15.4 0.0 0.1 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 1.1 0.0 0.0 3.1 0.0 0.0 0.2 0.3 0.0 34.4 0.1 2.7 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.3 0.4 0.3 0.2 0.3 0.2 0.3 0.2 0.0 0.4 0.3 0.3 1.7 0.8 0.2 0.3 0.2 0.0 0.2 0.6 0.3 0.5 0.6 0.2 0.3 0.2 1.0 0.0 NPC1 SLC65A1 ENSG00000141458 "NPC intracellular cholesterol transporter 1" O15118 18 23506184-23586898 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Cholesterol metabolism, Host-virus interaction, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport" "Host cell receptor for virus entry, Receptor" "Disease mutation, Niemann-Pick disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 65.6" "Cell line enhanced" "Detected in all" "hTERT-HME1: 70.3;U-87 MG: 46.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 32.7" "Group enriched" "Detected in all" 4 "dendritic cells: 32.7;T-cells: 14.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026618, CAB070132, HPA077445" Approved Supported Nucleoplasm,Vesicles 27000 "Nucleoplasm, Vesicles" "CAB070132: AB_10001101, HPA026618: AB_1854580, HPA077445: " "unprognostic (1.74e-1)" "unprognostic (1.53e-3)" "unprognostic (2.67e-1)" "unprognostic (1.25e-1)" "unprognostic (3.20e-2)" "unprognostic (1.50e-1)" "prognostic unfavourable (2.26e-6)" "unprognostic (1.31e-1)" "unprognostic (1.01e-2)" "unprognostic (7.36e-3)" "unprognostic (1.07e-2)" "unprognostic (1.09e-3)" "unprognostic (2.78e-2)" "unprognostic (1.89e-1)" "unprognostic (2.73e-2)" "unprognostic (1.38e-1)" "unprognostic (2.08e-3)" 13.4 38.8 17.4 11.2 30.9 26.4 15.8 7.1 25.1 10.1 8.7 65.6 3.4 10.2 11.1 11.7 12.8 8.2 11.2 7.1 23.4 14.3 9.9 10.3 17.8 13.0 46.0 15.4 12.0 7.9 51.8 9.9 18.9 27.7 9.7 8.9 12.0 25.4 10.1 13.7 17.0 12.2 10.9 41.4 11.5 12.0 9.5 38.4 7.0 8.3 5.3 10.7 10.8 10.8 3.6 32.7 3.8 5.8 4.6 14.5 4.1 5.3 10.6 4.5 7.4 14.9 11.6 10.5 9.3 20.2 9.9 21.4 7.1 7.8 4.5 7.2 13.4 15.0 5.8 15.9 8.8 3.5 4.6 1.6 9.6 16.0 21.4 6.1 7.3 11.1 15.8 20.8 70.3 9.7 4.8 12.0 11.0 8.1 2.5 3.6 3.2 9.6 3.6 7.2 11.2 23.0 13.3 1.9 3.7 11.1 16.1 13.7 4.0 4.8 12.5 21.0 4.1 8.3 8.0 7.5 23.1 3.1 46.2 5.4 9.4 1.8 4.1 3.8 14.5 3.8 9.8 2.4 5.9 9.9 1.7 3.6 2.7 7.3 3.7 4.6 5.8 32.7 7.7 4.1 17.4 30.9 7.1 25.1 23.4 14.3 46.0 15.4 27.7 38.4 NPC1L1 SLC65A2 ENSG00000015520 "NPC1 like intracellular cholesterol transporter 1" Q9UHC9 7 44512535-44541315 "FDA approved drug targets, Predicted membrane proteins" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "intestine: 77.0;liver: 29.8" "Group enriched" "Detected in some" 7 "CACO-2: 6.7;Hep G2: 16.8;SCLC-21H: 14.4" "Group enriched" "Detected in many" 5 "liver cancer: 8.5;pancreatic cancer: 7.8;stomach cancer: 4.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebral cortex: 0.7" "Low region specificity" "Detected in all" "CAB070127, CAB070128" Enhanced "CAB070127: AB_10002744, CAB070128: AB_10000815" "unprognostic (2.96e-2)" "unprognostic (2.23e-1)" "unprognostic (7.57e-3)" "unprognostic (8.43e-2)" "unprognostic (1.62e-1)" "unprognostic (2.07e-1)" "unprognostic (9.40e-2)" "unprognostic (6.75e-2)" "unprognostic (1.44e-1)" "unprognostic (1.96e-2)" "unprognostic (4.51e-2)" "unprognostic (7.59e-2)" "unprognostic (8.08e-10)" "unprognostic (1.64e-2)" "unprognostic (2.83e-1)" "unprognostic (3.62e-2)" "unprognostic (5.83e-2)" 0.5 0.1 0.1 0.0 0.2 0.0 0.4 0.5 0.2 0.3 42.0 0.0 0.0 30.5 0.4 0.3 0.3 0.3 11.4 0.1 0.1 0.1 0.7 29.8 0.2 0.0 0.1 0.0 0.5 1.4 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.2 77.0 0.0 0.1 0.1 0.8 0.7 0.0 0.0 0.1 0.0 0.0 0.3 0.5 0.2 0.0 0.6 0.2 0.4 0.5 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.2 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 16.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.0 14.4 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.5 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.1 0.2 0.5 0.2 0.1 0.1 0.1 0.0 0.0 0.0 OCSTAMP "C20orf123, dJ257E24.3" ENSG00000149635 "Osteoclast stimulatory transmembrane protein" Q9BR26 20 46540946-46550574 "Predicted membrane proteins, Transporters" Differentiation "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "adipose tissue: 6.9;blood: 2.6" "Cell line enhanced" "Detected in some" "AF22: 2.6;HMC-1: 5.1;Karpas-707: 2.9;NB-4: 5.5;RPMI-8226: 2.4;U-266/70: 1.8;U-266/84: 5.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 26 "plasmacytoid DC: 2.6" "Lineage enriched" "Detected in single" 26 "dendritic cells: 2.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA031116 Uncertain "HPA031116: AB_10600758" "unprognostic (2.77e-1)" "unprognostic (3.04e-1)" "unprognostic (8.80e-2)" "unprognostic (5.02e-2)" "unprognostic (2.42e-1)" "unprognostic (2.71e-1)" "unprognostic (2.65e-1)" "unprognostic (9.59e-2)" "unprognostic (2.08e-1)" 6.9 0.0 0.1 0.1 0.4 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.6 0.0 0.0 0.1 0.5 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.2 0.1 0.2 0.6 0.0 0.2 1.9 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 5.5 0.4 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 1.8 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.1 0.4 0.0 0.1 0.3 0.2 0.5 0.0 0.0 0.0 OPN4 "melanopsin, MOP" ENSG00000122375 "Opsin 4" Q9UHM6 10 86654557-86666848 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "Biological rhythms, Sensory transduction" "G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 21.2;skeletal muscle: 14.6" "Cell line enhanced" "Detected in single" "PC-3: 1.0" "Not detected" "Not detected" "Region enhanced" "Detected in many" "basal ganglia: 21.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA039147 Approved "HPA039147: AB_10673304" "unprognostic (3.67e-3)" "unprognostic (1.40e-2)" "unprognostic (3.02e-2)" "unprognostic (1.62e-1)" "unprognostic (7.03e-3)" "unprognostic (2.89e-2)" "unprognostic (3.26e-1)" "unprognostic (9.54e-2)" "unprognostic (5.68e-2)" "unprognostic (8.88e-3)" "unprognostic (1.93e-6)" "unprognostic (4.10e-2)" "unprognostic (5.58e-2)" "unprognostic (6.76e-2)" 3.5 0.3 5.4 0.4 21.2 0.2 1.1 0.0 5.1 0.6 0.9 0.0 0.0 0.5 0.4 0.4 0.6 0.4 0.5 3.1 3.0 0.1 0.3 0.2 0.3 0.2 0.2 3.3 0.3 0.4 3.6 0.6 0.5 0.0 0.2 0.7 1.2 1.6 0.2 14.6 1.2 1.1 0.5 0.0 0.3 0.5 0.5 2.0 0.0 1.4 2.7 0.3 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 21.2 0.0 3.5 3.0 0.1 0.2 3.3 0.0 2.0 OPN5 "dJ402H5.1, neuropsin, TMEM13" ENSG00000124818 "Opsin 5" Q6U736 6 47781982-47832780 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction" "G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 12 "testis: 7.3" "Cell line enhanced" "Detected in some" "Karpas-707: 1.0;SK-BR-3: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA026084 Supported "HPA026084: " "unprognostic (1.95e-1)" "unprognostic (6.18e-2)" "unprognostic (4.84e-1)" "unprognostic (1.07e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OPRD1 ENSG00000116329 "Opioid receptor delta 1" P41143 1 28812142-28871267 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 8.7" "Group enriched" "Detected in some" 12 "RH-30: 14.5;SCLC-21H: 5.7;SH-SY5Y: 5.8;WM-115: 19.3" "Cancer enhanced" "Detected in single" "melanoma: 1.0" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA070831 Approved "HPA070831: " "unprognostic (1.44e-1)" "unprognostic (4.07e-1)" "unprognostic (1.25e-1)" "unprognostic (3.89e-2)" "unprognostic (2.68e-1)" "unprognostic (5.84e-3)" "unprognostic (6.28e-3)" "unprognostic (5.92e-2)" "unprognostic (1.82e-2)" "unprognostic (5.95e-3)" "unprognostic (4.28e-3)" "unprognostic (2.98e-1)" "unprognostic (1.52e-7)" "unprognostic (1.44e-2)" "unprognostic (1.28e-1)" "unprognostic (1.26e-1)" "unprognostic (2.18e-3)" 0.4 2.4 5.5 0.6 3.9 1.9 0.4 0.4 8.7 0.4 0.6 0.0 0.0 0.5 0.4 0.4 0.4 0.4 0.6 0.4 3.0 1.3 0.4 0.4 0.5 0.7 0.6 5.9 0.5 1.3 0.2 0.5 0.5 4.7 0.4 0.5 0.1 1.0 0.2 3.2 1.0 0.6 0.4 0.4 0.7 0.8 0.8 0.2 0.0 0.6 0.0 0.2 0.4 0.4 1.2 1.1 3.1 0.5 1.1 0.7 0.1 0.0 0.1 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.5 0.2 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.1 0.0 0.2 0.9 0.0 0.0 14.5 0.1 0.0 0.0 5.7 5.8 0.0 0.1 0.9 0.1 0.1 0.0 0.1 0.3 0.2 0.0 0.2 0.0 0.2 0.1 0.3 19.3 3.1 0.5 0.6 0.6 0.3 0.4 0.6 0.6 0.5 0.1 1.2 0.6 0.7 2.5 1.1 0.3 1.1 0.3 0.1 5.5 3.9 0.4 8.7 3.0 1.3 0.6 5.9 4.7 0.2 OPRK1 "KOR, OPRK" ENSG00000082556 "Opioid receptor kappa 1" P41145 8 53225716-53251697 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" Behavior "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 18.0;prostate: 6.7" "Cell line enriched" "Detected in some" 5 "U-937: 21.6" "Cancer enhanced" "Detected in some" "prostate cancer: 1.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 1.2" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA067549 Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" "Plasma membrane" "Nucleoplasm, Cytosol" "HPA067549: " "unprognostic (1.01e-1)" "unprognostic (1.17e-2)" "unprognostic (8.70e-3)" "unprognostic (3.73e-2)" "unprognostic (6.74e-2)" "unprognostic (2.22e-3)" "unprognostic (8.09e-2)" "unprognostic (9.71e-2)" "unprognostic (4.28e-3)" "unprognostic (3.29e-1)" "unprognostic (3.35e-2)" "unprognostic (9.54e-4)" "unprognostic (1.61e-1)" 0.7 0.7 15.9 0.3 18.0 0.4 0.3 2.2 8.8 0.4 0.4 0.3 0.0 0.4 0.4 0.6 0.5 0.7 0.4 0.8 4.5 6.2 0.3 0.5 0.8 0.4 1.7 5.8 0.4 0.3 0.4 0.8 2.8 3.1 6.7 0.4 0.0 0.3 0.4 3.8 0.4 0.5 0.5 0.5 0.6 0.3 2.8 1.6 0.2 0.9 0.0 0.3 0.3 0.1 0.2 0.8 1.2 0.2 0.1 0.4 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 21.6 0.1 1.2 0.2 0.1 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.4 0.1 0.1 0.8 0.0 0.0 15.9 18.0 2.2 8.8 4.5 6.2 1.7 5.8 3.1 1.6 OPRM1 MOR1 ENSG00000112038 "Opioid receptor mu 1" P35372 6 154010496-154246867 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 37.9" "Cell line enriched" "Detected in single" 24 "SH-SY5Y: 12.8" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebellum: 37.9" "Cell type enhanced" "Detected in single" "neutrophil: 2.1" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA014509, HPA067435" Enhanced Supported "HPA014509: AB_1854801, HPA067435: " "unprognostic (7.34e-2)" "unprognostic (6.91e-2)" 0.5 3.4 7.0 0.6 17.5 1.8 0.9 37.9 7.6 0.5 0.6 0.8 0.0 0.6 0.7 1.4 3.7 0.5 1.0 0.5 2.6 2.3 0.5 0.5 0.5 0.9 0.6 9.3 0.8 0.7 0.4 0.6 0.5 5.2 0.7 0.4 0.0 0.6 0.2 0.9 1.8 0.5 0.3 1.9 0.6 1.0 8.0 0.5 0.0 1.0 0.0 0.3 0.5 0.5 0.5 0.2 2.1 0.1 0.1 0.7 0.0 0.1 0.0 0.2 0.4 0.0 0.2 0.2 0.2 0.0 0.1 0.0 0.2 0.4 0.4 0.1 0.0 0.3 0.3 0.2 0.1 0.2 0.1 0.1 0.4 0.1 0.0 0.3 0.5 0.1 0.5 0.0 0.1 0.1 0.1 0.3 0.3 0.2 0.1 0.0 0.1 0.0 0.2 0.2 0.0 0.1 0.1 0.3 12.8 0.0 0.0 0.3 0.3 0.1 0.3 0.4 0.1 0.3 0.1 0.4 0.2 0.1 0.3 0.1 0.0 0.2 0.1 0.6 0.6 0.0 0.7 0.2 0.3 0.5 0.1 0.5 0.4 0.1 2.1 0.1 0.0 0.2 0.3 0.0 7.0 17.5 37.9 7.6 2.6 2.3 0.6 9.3 5.2 0.5 OR10J3 OR10J3P ENSG00000196266 "Olfactory receptor family 10 subfamily J member 3" Q5JRS4 1 159313670-159314659 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "placenta: 3.3" "Cell line enriched" "Detected in single" 8 "LHCN-M2: 5.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA042963 Uncertain "HPA042963: AB_10961176" 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR56A5 OR56A5P ENSG00000188691 "Olfactory receptor family 56 subfamily A member 5" P0C7T3 11 5967177-5968494 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RPMI-8226: 1.2;U-266/70: 1.6;U-266/84: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "unprognostic (9.82e-2)" 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR9A2 ENSG00000179468 "Olfactory receptor family 9 subfamily A member 2" Q8NGT5 7 143026158-143027195 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 4 "brain: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.6 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PAQR4 FLJ30002 ENSG00000162073 "Progestin and adipoQ receptor family member 4" Q8N4S7 16 2969245-2973489 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 54.4;parathyroid gland: 32.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 7 "non-classical monocyte: 6.7" "Lineage enriched" "Detected in single" 8 "monocytes: 6.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068394 Approved Vesicles Vesicles "HPA068394: " "unprognostic (1.93e-1)" "unprognostic (2.75e-1)" "unprognostic (6.73e-2)" "unprognostic (1.30e-3)" "unprognostic (8.39e-2)" "unprognostic (3.00e-2)" "prognostic unfavourable (6.86e-4)" "unprognostic (2.62e-2)" "unprognostic (7.59e-2)" "unprognostic (9.65e-3)" "unprognostic (5.21e-2)" "unprognostic (8.59e-2)" "prognostic unfavourable (3.01e-6)" "prognostic favourable (1.70e-4)" "unprognostic (1.36e-1)" "unprognostic (3.79e-2)" "unprognostic (6.06e-3)" 3.1 3.2 14.1 5.2 19.2 10.3 2.3 8.0 26.3 2.4 4.8 49.6 1.3 4.9 1.8 1.0 4.2 3.0 5.5 4.2 24.1 11.7 1.7 1.6 3.9 6.3 30.6 11.1 0.4 6.6 32.8 0.9 2.2 19.1 9.6 4.5 16.8 17.0 1.3 12.3 12.3 4.9 2.8 54.4 3.2 7.4 1.6 20.3 3.6 1.5 3.5 7.8 2.1 1.7 0.5 0.9 0.1 6.7 0.0 0.4 0.5 12.7 10.9 12.3 17.8 2.0 3.7 4.1 4.8 5.9 9.0 8.6 6.5 13.7 12.8 6.6 5.6 18.0 12.8 7.6 3.7 13.5 5.6 3.9 21.3 8.9 0.2 8.3 14.2 0.9 4.0 4.9 1.2 5.9 7.6 34.7 7.7 25.6 11.9 8.9 10.4 7.5 23.9 16.2 41.2 6.1 4.4 28.4 13.2 18.0 17.5 13.1 18.7 12.9 3.6 15.8 9.7 7.3 6.8 15.2 10.5 17.0 7.0 11.3 17.3 0.0 1.0 0.1 0.4 0.5 0.0 0.5 0.2 0.1 0.9 0.1 0.0 0.3 0.1 0.0 6.7 0.5 0.1 0.5 14.1 19.2 8.0 21.2 24.1 11.7 30.6 11.1 19.1 20.3 PCNX4 "C14orf135, PCNXL4" ENSG00000126773 "Pecanex homolog 4" Q63HM2 14 60091911-60169133 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002076, HPA003390" Uncertain Approved Cytosol Cytosol "HPA002076: AB_1078322, HPA003390: AB_2066703" "unprognostic (2.00e-1)" "unprognostic (1.45e-1)" "unprognostic (1.89e-1)" "unprognostic (9.87e-2)" "unprognostic (2.18e-1)" "unprognostic (2.94e-1)" "unprognostic (3.83e-3)" "unprognostic (2.01e-1)" "unprognostic (1.54e-1)" "unprognostic (3.28e-1)" "unprognostic (1.40e-1)" "unprognostic (1.81e-1)" "prognostic favourable (6.84e-5)" "unprognostic (2.13e-1)" "unprognostic (2.08e-1)" "unprognostic (4.14e-2)" "unprognostic (8.59e-2)" 12.0 16.5 13.6 14.7 18.2 9.1 14.3 19.4 18.6 18.8 10.2 15.2 14.0 8.2 21.2 13.6 10.4 22.7 14.2 17.8 12.7 13.6 20.6 11.1 12.2 11.0 12.5 12.4 27.4 12.1 26.3 39.8 13.7 16.1 21.3 11.2 17.7 12.7 17.2 15.2 13.0 11.3 16.2 14.5 13.1 10.0 23.0 11.6 24.6 16.5 11.1 11.7 11.6 13.9 7.3 7.7 5.3 8.1 13.4 11.4 5.3 39.4 6.2 11.9 8.1 10.2 12.1 5.3 13.1 21.6 15.9 20.0 6.6 12.0 7.0 5.5 11.0 5.2 7.9 7.8 27.0 8.9 3.6 11.2 4.5 5.1 21.6 11.6 8.2 9.8 5.4 11.0 18.6 7.4 5.7 9.9 24.6 5.2 16.0 4.1 6.1 8.0 9.4 15.2 2.9 8.7 5.4 9.0 10.6 12.2 4.8 9.6 10.7 5.1 14.7 32.6 24.9 7.7 10.1 3.2 3.2 9.5 12.4 4.2 15.8 4.8 6.9 5.3 8.7 7.2 11.4 7.3 6.3 7.5 7.0 5.5 7.2 8.0 3.2 13.4 8.1 7.7 6.2 5.3 13.6 18.2 19.4 18.6 12.7 13.6 12.5 12.4 16.1 11.6 PDE3A CGI-PDE ENSG00000172572 "Phosphodiesterase 3A" Q14432 12 20369245-20684381 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins" Hydrolase "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 62.2" "Cell line enhanced" "Detected in some" "AF22: 7.7;HEL: 14.2;HeLa: 38.7;HUVEC TERT2: 6.9;SH-SY5Y: 14.5;U-138 MG: 11.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Region enhanced" "Detected in many" "cerebellum: 35.4" "HPA014492, HPA074258" Uncertain Approved "Plasma membrane" 23000 "Plasma membrane" "HPA014492: AB_1855120, HPA074258: " "unprognostic (2.59e-2)" "unprognostic (2.94e-2)" "unprognostic (1.25e-1)" "unprognostic (3.23e-1)" "unprognostic (2.27e-1)" "unprognostic (1.21e-1)" "unprognostic (3.50e-2)" "unprognostic (1.67e-2)" "unprognostic (8.14e-2)" "unprognostic (1.49e-1)" "unprognostic (4.25e-1)" "unprognostic (3.37e-1)" "prognostic unfavourable (1.72e-6)" "unprognostic (5.58e-2)" "unprognostic (5.94e-2)" "unprognostic (4.28e-2)" "unprognostic (2.76e-4)" 7.1 1.0 1.7 4.7 2.0 0.0 3.8 3.5 1.4 7.8 15.9 1.0 2.0 2.1 7.8 3.5 9.1 4.9 5.5 62.2 1.6 1.4 3.7 1.8 3.9 3.3 1.9 1.1 7.1 6.5 1.0 2.8 13.8 2.7 6.3 9.0 12.0 7.8 4.2 2.0 1.4 21.4 6.0 1.8 2.1 5.5 2.3 0.7 0.0 2.8 1.9 0.9 4.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 7.7 0.0 1.8 1.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 14.2 38.7 0.2 0.6 0.0 0.0 1.8 0.0 0.4 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.1 0.0 0.0 0.0 2.1 0.0 0.1 14.5 0.0 0.0 0.0 0.0 0.0 0.2 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.7 2.0 3.5 1.4 1.6 1.4 1.9 1.1 2.7 0.7 PDE3B HcGIP1 ENSG00000152270 "Phosphodiesterase 3B" Q13370 11 14643723-14872044 "Enzymes, FDA approved drug targets, Predicted membrane proteins" Angiogenesis Hydrolase "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 42.6" "Cell line enhanced" "Detected in many" "HL-60: 13.3;Karpas-707: 15.4;THP-1: 16.3;U-266/70: 17.4" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 6 "cerebellum: 19.2" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 6 "granulocytes: 5.0;T-cells: 8.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056111 Approved "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA056111: " "unprognostic (1.05e-1)" "unprognostic (2.86e-2)" "unprognostic (4.12e-2)" "unprognostic (2.76e-3)" "unprognostic (4.25e-1)" "unprognostic (1.84e-3)" "unprognostic (3.40e-2)" "unprognostic (3.24e-2)" "unprognostic (5.39e-2)" "unprognostic (1.20e-1)" "prognostic favourable (7.91e-4)" "unprognostic (1.77e-1)" "unprognostic (2.33e-2)" "unprognostic (1.39e-2)" "unprognostic (3.42e-1)" "unprognostic (2.47e-1)" "unprognostic (9.03e-3)" 42.6 1.0 2.3 12.6 2.2 6.7 17.0 19.2 3.0 2.9 21.8 0.9 0.8 2.2 0.9 1.4 2.6 1.0 6.9 4.7 2.2 2.1 2.4 18.2 10.2 14.1 1.6 1.6 0.9 7.3 0.3 5.1 5.5 1.5 10.7 8.1 1.9 16.5 1.3 0.8 0.9 6.3 9.7 2.1 8.7 3.0 12.5 0.8 7.8 1.2 2.3 7.1 10.5 4.5 0.3 0.4 5.0 1.2 0.1 8.7 1.8 0.0 1.5 3.3 5.4 6.6 0.0 1.3 0.4 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.1 11.1 0.1 8.1 10.0 2.3 13.3 0.0 0.5 0.0 0.0 0.3 0.0 11.7 15.4 0.0 0.1 2.6 6.5 4.5 2.4 6.4 1.5 10.0 0.0 1.1 5.1 9.5 1.3 8.6 2.9 0.0 16.3 0.0 0.0 0.8 0.0 0.0 17.4 5.3 0.4 0.1 2.3 1.0 0.0 0.7 2.9 1.4 0.7 2.9 0.3 4.2 3.2 0.4 0.2 8.7 7.5 5.0 0.1 1.2 0.1 4.2 1.8 2.3 2.2 19.2 3.0 2.2 2.1 1.6 1.6 1.5 0.8 PGAP2 "CWH43-N, FRAG1, MRT21" ENSG00000148985 "Post-GPI attachment to proteins 2" Q9UHJ9 11 3797724-3826371 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "GPI-anchor biosynthesis" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 117.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063099 Approved Approved Microtubules Microtubules "HPA063099: " "unprognostic (1.94e-1)" "unprognostic (1.14e-1)" "unprognostic (2.19e-1)" "unprognostic (3.18e-2)" "unprognostic (5.13e-2)" "unprognostic (6.06e-2)" "prognostic unfavourable (7.49e-4)" "unprognostic (1.74e-1)" "unprognostic (2.51e-2)" "unprognostic (3.07e-1)" "unprognostic (1.11e-1)" "unprognostic (6.44e-2)" "unprognostic (3.85e-2)" "unprognostic (4.66e-3)" "unprognostic (4.13e-2)" "unprognostic (2.17e-2)" "unprognostic (2.67e-2)" 4.9 9.5 7.6 7.3 8.2 5.2 6.9 5.0 10.6 7.3 12.3 12.4 18.3 10.2 7.4 117.3 20.0 11.1 8.1 9.3 8.0 6.3 8.6 17.1 9.5 8.6 6.9 8.8 7.1 30.8 12.6 9.1 10.7 5.6 10.1 7.9 12.5 14.5 19.6 6.4 25.0 16.7 4.9 8.9 6.6 7.5 17.7 8.4 15.0 14.1 14.6 15.3 7.7 10.4 11.2 8.7 15.9 8.0 8.7 17.0 7.5 12.7 17.5 8.5 7.8 7.7 14.8 13.5 5.3 4.6 7.9 7.1 14.9 22.7 13.9 6.2 3.8 21.6 13.5 14.8 7.8 16.9 14.8 8.5 7.6 18.2 5.4 10.8 11.1 11.7 20.8 5.7 19.7 8.9 17.9 20.7 8.2 19.2 13.2 9.2 16.1 10.6 20.6 1.0 13.3 14.9 15.5 11.3 11.3 9.6 25.7 5.7 21.4 4.7 8.3 4.9 4.7 11.6 3.2 13.0 14.2 10.3 6.5 7.3 9.3 1.9 5.8 5.0 8.8 8.0 10.8 11.0 12.6 10.7 8.7 11.2 17.0 11.3 15.9 8.7 8.0 5.9 11.5 7.5 7.6 8.2 5.0 10.6 8.0 6.3 6.9 8.8 5.6 8.4 PGAP3 "CAB2, MGC9753, PER1, PERLD1, PP1498" ENSG00000161395 "Post-GPI attachment to proteins 3" Q96FM1 17 39671122-39696797 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enriched" "Detected in many" 6 "SK-BR-3: 54.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA016591 Approved Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA016591: AB_1855203" "unprognostic (1.29e-1)" "unprognostic (8.64e-2)" "unprognostic (1.65e-1)" "unprognostic (6.53e-3)" "unprognostic (9.19e-2)" "unprognostic (1.68e-2)" "prognostic favourable (3.94e-4)" "unprognostic (1.61e-2)" "unprognostic (1.90e-2)" "prognostic unfavourable (6.82e-4)" "unprognostic (1.57e-2)" "unprognostic (7.79e-2)" "prognostic favourable (3.89e-4)" "unprognostic (5.16e-2)" "unprognostic (1.31e-1)" "unprognostic (9.05e-2)" "unprognostic (1.94e-2)" 6.8 8.2 8.9 7.6 14.3 3.4 10.2 6.4 17.3 11.3 19.2 10.0 15.1 12.5 8.3 16.5 16.2 14.0 19.7 9.9 11.3 7.3 13.7 20.7 9.5 6.5 6.3 10.7 9.7 22.7 16.0 10.1 39.2 6.1 11.2 11.7 14.2 16.7 15.6 5.0 16.0 20.7 7.3 5.5 8.1 13.4 9.0 7.3 4.4 20.3 8.7 15.8 8.1 8.9 7.8 5.3 4.0 10.5 9.0 15.1 6.3 1.4 3.8 3.1 2.9 3.3 3.4 3.2 1.7 4.1 2.7 2.5 2.2 9.6 1.6 8.1 3.3 5.0 1.0 1.1 1.3 3.4 3.1 2.0 2.2 3.6 4.5 5.0 5.2 6.3 6.2 1.3 2.8 0.9 1.9 3.8 2.4 3.4 1.0 4.5 3.1 0.8 1.2 1.9 4.6 4.4 4.8 2.9 1.9 4.7 54.7 2.7 4.6 4.9 1.3 2.9 3.1 1.4 1.3 3.4 0.7 0.5 3.3 1.9 3.3 2.4 6.7 4.0 15.1 10.5 8.3 7.8 10.6 12.3 5.3 7.6 10.5 10.1 1.7 9.0 3.8 3.6 5.1 6.3 8.9 14.3 6.4 17.3 11.3 7.3 6.3 10.7 6.1 7.3 PHTF1 PHTF ENSG00000116793 "Putative homeodomain transcription factor 1" Q9UMS5 1 113696831-113759489 "Plasma proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059486 Approved "Nucleoli,Nuclear bodies" "Nuclear bodies" Nucleoli "HPA059486: " "unprognostic (1.52e-1)" "unprognostic (3.33e-1)" "unprognostic (2.58e-2)" "unprognostic (4.54e-2)" "unprognostic (5.92e-2)" "unprognostic (1.62e-2)" "unprognostic (6.55e-2)" "unprognostic (1.30e-1)" "unprognostic (3.30e-3)" "unprognostic (1.70e-3)" "unprognostic (1.93e-1)" "unprognostic (2.16e-1)" "prognostic unfavourable (1.21e-6)" "unprognostic (1.26e-1)" "unprognostic (1.67e-1)" "unprognostic (1.13e-1)" "unprognostic (1.25e-1)" 6.5 10.4 11.5 7.9 8.6 19.5 11.8 31.6 15.1 7.1 5.4 4.0 7.6 4.5 6.6 9.6 3.4 13.1 8.8 8.2 10.1 12.4 8.9 10.1 10.8 11.9 8.2 12.9 4.0 8.2 15.3 20.9 8.5 10.4 5.8 6.5 8.2 5.2 6.9 5.5 2.4 4.9 8.4 6.4 10.5 8.0 33.8 6.6 3.4 6.1 2.4 7.7 8.1 6.3 3.0 4.5 6.0 2.6 4.3 5.7 1.7 12.7 6.7 19.1 10.1 9.5 8.6 5.0 11.8 15.7 10.6 17.4 7.3 10.4 3.7 16.8 8.1 7.1 7.2 4.7 12.2 15.2 7.2 8.9 14.1 8.4 7.9 10.9 12.6 7.2 1.3 14.1 3.1 19.5 5.3 17.0 12.8 19.0 0.1 11.0 15.1 10.9 11.5 28.7 7.3 17.0 5.6 13.4 12.4 13.2 6.5 7.0 2.6 8.8 20.5 8.3 11.5 15.3 11.4 23.8 24.2 6.9 20.5 9.5 22.6 3.0 2.6 4.9 3.0 1.3 2.3 3.0 3.7 3.7 4.5 1.6 0.1 2.6 6.0 4.3 1.7 3.0 5.7 1.7 11.5 8.6 31.6 15.1 10.1 12.4 8.2 12.9 10.4 6.6 PIGB ENSG00000069943 "Phosphatidylinositol glycan anchor biosynthesis class B" Q92521 15 55318960-55355648 "Predicted membrane proteins" "GPI-anchor biosynthesis" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039929 Uncertain Uncertain "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA039929: AB_10673539" "unprognostic (1.91e-2)" "unprognostic (7.45e-2)" "unprognostic (3.00e-1)" "unprognostic (2.03e-2)" "unprognostic (2.96e-2)" "unprognostic (4.65e-2)" "unprognostic (2.04e-1)" "unprognostic (3.37e-3)" "unprognostic (7.52e-2)" "unprognostic (3.52e-2)" "unprognostic (2.56e-2)" "unprognostic (4.27e-2)" "unprognostic (2.13e-1)" "unprognostic (1.30e-1)" "unprognostic (2.86e-1)" "unprognostic (5.93e-2)" "unprognostic (4.24e-2)" 9.5 11.9 5.7 13.0 11.9 11.2 10.4 3.9 9.3 7.1 8.5 8.2 6.6 9.1 10.5 13.2 11.1 9.5 10.0 6.3 5.9 5.9 12.4 10.3 8.8 20.1 6.9 6.8 8.7 8.1 19.2 12.5 8.7 8.6 9.7 9.4 13.0 9.6 8.4 3.2 8.1 11.6 7.0 8.9 14.2 9.3 17.4 6.0 11.5 16.3 6.2 16.2 10.7 9.3 8.4 8.1 20.1 11.5 5.6 8.9 6.4 7.3 8.6 3.9 3.1 4.3 8.8 5.6 6.2 12.5 7.0 11.2 3.8 7.7 7.2 8.3 8.6 12.5 2.5 6.5 5.9 7.2 5.6 7.1 10.7 4.7 7.8 20.1 6.2 9.2 8.0 5.5 7.1 8.7 8.4 6.1 9.2 6.5 2.5 7.9 2.5 4.3 3.2 3.8 16.4 10.9 8.2 2.3 4.4 5.7 9.2 10.8 9.9 14.7 6.6 9.5 3.1 2.4 12.5 6.1 11.0 6.4 8.4 22.7 6.8 10.5 8.9 4.1 8.3 10.4 8.9 8.4 8.3 8.6 8.1 5.4 7.0 7.8 20.1 5.6 11.5 6.3 8.6 6.4 5.7 11.9 3.9 9.3 5.9 5.9 6.9 6.8 8.6 6.0 PIGF ENSG00000151665 "Phosphatidylinositol glycan anchor biosynthesis class F" Q07326 2 46580937-46617119 "Predicted membrane proteins" "GPI-anchor biosynthesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051389 Uncertain "HPA051389: " "unprognostic (3.85e-3)" "unprognostic (5.42e-2)" "unprognostic (1.11e-3)" "unprognostic (8.18e-2)" "unprognostic (2.56e-1)" "unprognostic (4.52e-3)" "prognostic unfavourable (1.39e-5)" "unprognostic (4.97e-2)" "unprognostic (9.29e-3)" "unprognostic (6.08e-2)" "unprognostic (5.89e-2)" "unprognostic (9.40e-2)" "unprognostic (1.02e-1)" "unprognostic (7.30e-3)" "unprognostic (1.84e-1)" "unprognostic (6.04e-2)" "unprognostic (6.71e-2)" 14.4 30.9 18.5 13.9 19.3 6.9 17.7 13.6 17.9 14.0 17.3 19.0 19.6 16.3 20.1 29.4 17.1 15.3 14.8 12.4 16.6 19.4 20.8 15.9 13.6 11.8 20.6 12.8 13.2 21.0 17.7 37.8 15.5 21.5 14.9 19.8 14.9 28.6 13.4 16.4 11.4 16.5 8.3 25.4 15.2 14.9 25.0 23.0 11.0 25.8 15.3 14.7 18.4 13.5 13.6 17.8 9.2 15.9 9.5 13.2 6.0 14.1 8.2 18.0 9.3 23.0 24.8 11.0 15.5 10.8 7.3 7.5 4.1 10.5 7.2 31.5 11.3 11.4 16.8 12.8 14.8 24.0 17.7 16.6 6.4 22.3 13.2 10.1 11.9 17.0 19.3 11.1 16.3 19.8 14.7 19.9 27.0 3.6 7.9 9.6 14.2 13.6 8.0 15.0 17.7 21.2 14.1 12.3 14.1 7.4 10.7 18.7 5.9 11.2 11.9 9.1 10.5 13.7 15.7 9.5 12.6 12.5 9.4 18.9 19.9 3.0 12.3 9.2 9.8 15.9 10.1 11.1 11.3 9.3 12.9 13.6 8.8 11.1 5.3 9.5 15.0 17.8 13.2 6.0 18.5 19.3 13.6 17.9 16.6 19.4 20.6 12.8 21.5 23.0 PKD2L1 "PCL, PKD2L, PKDL, TRPP3" ENSG00000107593 "Polycystin 2 like 1, transient receptor potential cation channel" Q9P0L9 10 100288154-100330486 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.2;lymphoid tissue: 12.0" "Cell line enhanced" "Detected in some" "Karpas-707: 1.6;NB-4: 1.7;PC-3: 1.9;RT4: 1.0;SK-MEL-30: 1.6;U-266/70: 1.0;U-266/84: 2.7;U-937: 1.3" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "classical monocyte: 2.7;intermediate monocyte: 3.0;non-classical monocyte: 2.3" "Lineage enriched" "Detected in single" 5 "monocytes: 3.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" CAB022621 Uncertain "CAB022621: " "unprognostic (2.67e-1)" "unprognostic (3.66e-7)" "unprognostic (8.07e-3)" "unprognostic (4.38e-2)" "unprognostic (4.70e-2)" "unprognostic (5.31e-2)" "unprognostic (2.19e-1)" "unprognostic (2.85e-2)" "unprognostic (2.01e-1)" "unprognostic (9.25e-2)" "unprognostic (1.55e-1)" "unprognostic (9.37e-2)" "unprognostic (1.49e-4)" "unprognostic (3.00e-1)" "unprognostic (2.05e-2)" "unprognostic (7.94e-2)" "unprognostic (2.25e-1)" 0.3 0.3 0.4 0.6 3.7 1.3 1.4 0.1 6.2 0.1 1.5 0.2 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 2.0 0.3 0.5 2.7 4.0 2.3 0.5 4.0 0.2 0.2 0.0 0.2 0.7 1.3 0.4 2.2 1.0 0.3 0.0 0.1 0.1 0.8 0.0 1.5 12.0 0.1 2.3 0.0 0.3 0.1 0.0 2.9 0.4 0.1 0.2 0.3 0.6 3.0 0.0 0.1 0.4 0.0 0.0 0.0 0.6 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 1.7 0.0 1.9 0.0 0.0 0.0 0.0 1.0 0.4 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 2.7 0.0 0.0 1.3 0.0 0.0 2.7 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.1 0.6 0.0 2.3 0.0 0.0 0.4 0.4 3.7 0.1 6.2 2.0 0.3 0.5 4.0 1.3 0.0 PKD2L2 TRPP5 ENSG00000078795 "Polycystin 2 like 2, transient receptor potential cation channel" Q9NZM6 5 137887968-137942747 "Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 7.5;testis: 29.3" "Cell line enhanced" "Detected in many" "Karpas-707: 5.8;U-266/70: 4.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA041903, HPA043634" Approved Approved "Plasma membrane,Cytosol" "Plasma membrane" Cytosol "HPA041903: , HPA043634: " "unprognostic (7.53e-3)" "unprognostic (2.21e-2)" "unprognostic (1.90e-1)" "unprognostic (3.59e-1)" "unprognostic (4.04e-1)" "unprognostic (1.21e-2)" "unprognostic (3.06e-1)" "unprognostic (1.40e-4)" "unprognostic (1.64e-2)" "unprognostic (2.13e-2)" "unprognostic (3.00e-2)" "unprognostic (5.85e-2)" "unprognostic (1.05e-3)" "unprognostic (2.21e-2)" "unprognostic (1.12e-1)" "unprognostic (1.28e-2)" "unprognostic (1.22e-1)" 0.5 1.5 2.0 0.6 2.5 2.2 1.2 1.7 1.9 0.5 0.3 0.7 0.7 0.3 0.5 1.0 0.5 0.4 0.6 1.7 1.0 0.8 0.4 0.3 0.4 1.3 1.2 1.3 0.6 1.1 0.0 1.5 0.2 1.8 0.5 0.1 0.2 0.7 0.0 3.3 0.8 0.3 0.0 0.7 1.0 0.6 29.3 0.4 0.0 1.0 0.0 0.2 0.4 0.6 3.9 3.5 7.5 1.7 1.9 1.9 0.8 1.6 1.2 0.2 0.1 0.4 0.5 1.7 0.6 0.0 0.0 0.0 0.1 3.2 2.3 3.4 0.0 0.7 0.1 0.0 0.1 1.5 1.0 1.3 4.2 0.1 0.0 0.4 1.8 0.1 0.2 0.0 0.0 0.6 1.5 5.8 0.8 0.5 1.1 2.3 0.6 1.0 0.0 0.1 0.0 0.0 2.3 0.8 0.9 1.4 0.2 0.9 0.4 0.5 0.5 1.0 1.8 0.6 1.0 4.6 3.3 0.4 2.2 0.7 1.7 7.1 1.7 3.0 1.8 1.2 1.0 2.5 1.6 1.4 0.9 3.9 1.9 1.7 7.5 1.9 1.0 3.5 1.1 0.8 2.0 2.5 1.7 1.9 1.0 0.8 1.2 1.3 1.8 0.4 PLPP1 "LPP1, PAP-2a, PPAP2A" ENSG00000067113 "Phospholipid phosphatase 1" O14494 5 55424854-55535050 "Enzymes, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 91.2;fHDF/TERT166: 27.7;HMC-1: 47.8;HSkMC: 35.0" "Cancer enhanced" "Detected in all" "prostate cancer: 200.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033331, HPA047815" Enhanced Supported "Plasma membrane" "Plasma membrane" "CAB033331: AB_2168044, HPA047815: " "unprognostic (1.22e-1)" "unprognostic (1.54e-1)" "unprognostic (1.74e-1)" "unprognostic (1.55e-2)" "unprognostic (2.52e-1)" "unprognostic (1.36e-1)" "prognostic favourable (6.06e-4)" "unprognostic (2.81e-1)" "unprognostic (2.20e-1)" "unprognostic (4.05e-3)" "unprognostic (2.43e-2)" "unprognostic (1.05e-1)" "unprognostic (4.37e-3)" "prognostic unfavourable (5.77e-4)" "unprognostic (3.94e-2)" "unprognostic (1.66e-1)" "unprognostic (3.11e-2)" 56.3 26.7 12.5 14.8 14.6 0.6 57.9 10.6 18.5 34.5 30.9 26.1 18.0 17.3 36.8 26.0 18.4 20.4 61.0 33.7 13.4 10.8 34.5 42.0 15.9 17.3 20.8 10.1 16.5 17.6 16.9 10.1 22.4 21.4 82.0 24.7 29.8 9.8 24.0 18.4 16.6 25.4 39.6 28.2 10.2 21.7 18.1 14.5 4.4 32.7 9.6 10.0 43.1 18.1 5.4 13.6 3.3 0.7 2.7 9.5 1.6 1.9 4.8 1.4 2.8 91.2 10.6 2.0 4.3 12.1 2.4 5.6 3.3 3.6 2.0 4.1 27.7 1.2 4.9 2.4 2.7 1.3 3.9 0.2 2.1 4.1 14.4 0.5 47.8 35.0 5.1 3.5 2.2 3.9 0.0 5.5 4.7 1.2 1.3 1.0 3.2 3.9 0.4 2.4 0.1 9.1 15.5 1.7 1.2 4.3 0.8 2.6 3.1 0.3 4.8 0.8 1.4 3.6 3.1 3.4 1.4 2.3 3.2 0.2 3.9 0.0 0.4 3.3 1.5 0.4 1.6 5.4 5.2 3.2 1.9 3.4 9.5 7.5 0.3 2.7 0.7 13.6 2.2 1.6 12.5 14.6 10.6 18.5 13.4 10.8 20.8 10.1 21.4 14.5 PLPP2 "LPP2, PAP-2c, PPAP2C" ENSG00000141934 "Phospholipid phosphatase 2" O43688 19 281040-291504 "Enzymes, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 38.3;CAPAN-2: 41.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 4.4;MAIT T-cell: 9.4" "Lineage enriched" "Detected in single" 52 "T-cells: 9.4" "Low region specificity" "Detected in many" HPA055540 Uncertain Approved Mitochondria Mitochondria "HPA055540: " "prognostic unfavourable (4.55e-4)" "unprognostic (8.91e-3)" "unprognostic (1.06e-1)" "prognostic favourable (3.21e-8)" "unprognostic (2.95e-1)" "unprognostic (1.36e-1)" "unprognostic (3.83e-3)" "unprognostic (5.48e-2)" "unprognostic (1.59e-1)" "unprognostic (5.67e-2)" "unprognostic (1.18e-3)" "unprognostic (3.85e-1)" "unprognostic (3.53e-3)" "unprognostic (1.06e-2)" "unprognostic (1.71e-1)" "unprognostic (1.30e-3)" "unprognostic (1.36e-3)" 1.4 4.7 8.3 5.3 20.9 0.2 17.5 2.0 11.1 30.4 18.2 28.1 13.4 27.5 7.7 4.1 9.1 38.1 31.2 1.5 13.6 7.1 4.7 1.1 3.7 0.8 37.1 6.5 2.4 19.8 0.6 4.1 1.8 16.6 10.7 15.3 6.7 45.8 19.0 0.3 19.0 21.9 3.3 26.0 1.4 22.2 2.2 25.8 0.7 2.2 5.9 5.0 12.1 5.7 0.0 0.1 0.1 0.0 0.0 9.4 0.3 22.5 38.3 0.5 0.0 0.0 0.1 0.0 2.2 0.0 7.1 5.5 11.0 41.6 0.0 24.5 3.3 12.5 0.0 4.9 3.2 0.2 0.7 0.0 15.4 0.0 8.5 0.0 1.5 1.5 2.1 3.6 4.9 1.2 0.1 0.0 0.0 25.6 0.1 0.0 17.0 0.0 0.0 0.0 0.6 17.9 3.6 4.8 11.5 6.3 10.5 16.5 13.8 0.7 1.2 15.6 10.3 0.1 16.6 0.2 26.2 18.5 4.4 0.0 12.8 0.0 0.0 0.0 4.4 0.0 9.4 0.0 2.0 2.2 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.3 8.3 20.9 2.0 11.1 13.6 7.1 37.1 6.5 16.6 25.8 PLPP3 "LPP3, PAP-2b, PPAP2B" ENSG00000162407 "Phospholipid phosphatase 3" O14495 1 56494747-56645301 "Enzymes, Plasma proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 102.8;ASC TERT1: 51.4;HSkMC: 63.5;U-2197: 93.3" "Cancer enhanced" "Detected in all" "thyroid cancer: 168.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "memory B-cell: 5.4;naive B-cell: 4.5" "Lineage enriched" "Detected in single" 7 "B-cells: 5.4" "HPA028892, HPA072751" Uncertain Supported "Golgi apparatus" "Golgi apparatus" "HPA028892: AB_10602149, HPA072751: " "unprognostic (2.50e-2)" "unprognostic (3.94e-1)" "unprognostic (1.81e-1)" "unprognostic (1.65e-1)" "unprognostic (2.71e-1)" "unprognostic (2.22e-3)" "unprognostic (5.86e-3)" "unprognostic (7.25e-2)" "unprognostic (1.59e-1)" "unprognostic (3.75e-2)" "unprognostic (3.91e-2)" "unprognostic (3.08e-1)" "prognostic favourable (4.59e-4)" "unprognostic (3.16e-2)" "unprognostic (1.74e-1)" "unprognostic (3.54e-2)" "unprognostic (2.09e-1)" 46.4 17.2 29.0 10.8 30.7 4.2 39.1 13.5 27.5 102.7 15.5 33.8 22.1 8.1 32.7 36.9 20.8 36.7 24.0 23.3 39.9 13.5 30.2 57.7 24.3 6.7 19.2 30.1 27.9 12.2 30.7 7.2 70.9 20.0 37.7 14.4 34.7 22.4 58.7 16.6 24.4 12.5 32.9 16.5 7.9 18.7 23.4 29.7 5.2 107.1 19.4 6.7 35.8 44.0 5.4 0.0 0.8 0.3 0.0 0.0 0.2 0.4 1.5 2.0 0.2 102.8 51.4 4.9 5.4 5.5 5.0 2.5 4.3 0.8 0.7 0.6 8.1 0.8 0.2 0.1 1.0 0.0 1.3 0.1 0.6 6.0 2.5 0.0 0.0 63.5 0.4 4.8 4.0 4.7 0.3 0.0 5.4 0.4 0.0 0.0 6.1 5.9 0.0 0.0 0.2 0.8 4.5 0.0 4.0 1.7 2.2 0.5 0.7 0.0 2.9 25.2 2.1 93.3 0.2 0.0 0.0 0.0 4.4 0.2 1.7 0.0 0.3 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 4.5 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.2 29.0 30.7 13.5 27.5 39.9 13.5 19.2 30.1 20.0 29.7 PLPP4 "DPPL2, PPAPDC1, PPAPDC1A" ENSG00000203805 "Phospholipid phosphatase 4" Q5VZY2 10 120456954-120589855 "Enzymes, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.5;kidney: 12.6" "Cell line enhanced" "Detected in some" "BJ: 15.1;fHDF/TERT166: 10.7;TIME: 12.0;U-138 MG: 9.6;U-251 MG: 46.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 22 "eosinophil: 2.2" "Lineage enriched" "Detected in single" 22 "granulocytes: 2.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045188 Approved Approved Nucleoplasm,Nucleoli Nucleoli Nucleoplasm "HPA045188: " "unprognostic (8.19e-2)" "unprognostic (2.94e-2)" "unprognostic (8.86e-2)" "unprognostic (1.90e-3)" "unprognostic (3.45e-1)" "unprognostic (2.92e-2)" "unprognostic (2.69e-1)" "unprognostic (2.26e-3)" "unprognostic (1.55e-1)" "unprognostic (8.62e-3)" "unprognostic (2.70e-3)" "unprognostic (1.89e-1)" "unprognostic (2.40e-3)" "unprognostic (3.49e-2)" "unprognostic (3.75e-2)" "unprognostic (1.11e-1)" "unprognostic (1.21e-3)" 0.6 1.7 11.4 1.2 13.6 4.9 3.1 11.6 18.2 3.4 1.2 12.1 1.0 0.7 1.7 2.7 0.9 1.2 11.3 0.7 15.9 17.4 12.6 2.8 0.5 0.6 15.5 6.0 0.6 0.6 0.4 0.5 0.6 26.5 3.0 0.8 0.0 2.0 6.1 0.4 1.7 0.8 1.5 19.1 0.5 1.2 11.1 12.5 0.0 1.5 0.0 0.5 0.8 0.7 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.1 1.1 2.3 1.4 0.1 1.3 0.0 0.0 10.7 0.1 0.9 0.2 1.2 1.4 1.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 1.1 0.0 8.7 0.9 2.1 0.9 0.0 0.0 0.0 0.9 2.7 0.0 0.0 0.0 4.4 0.0 0.8 0.2 0.7 0.0 0.7 1.9 0.0 12.0 9.6 5.3 0.5 46.4 0.0 0.0 0.0 8.9 0.0 2.5 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 13.6 11.6 10.0 15.9 17.4 15.5 6.0 26.5 12.5 PLPP5 "DPPL1, HTPAP, PPAPDC1B" ENSG00000147535 "Phospholipid phosphatase 5" Q8NEB5 8 38263130-38269243 "Enzymes, Predicted membrane proteins" Hydrolase "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 77.8" "Cell line enhanced" "Detected in many" "RPMI-8226: 50.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "memory B-cell: 37.2;naive B-cell: 65.4" "Lineage enriched" "Detected in all" 5 "B-cells: 65.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055777 Approved Vesicles Vesicles "HPA055777: " "unprognostic (4.54e-2)" "unprognostic (2.51e-3)" "unprognostic (3.66e-2)" "prognostic favourable (1.48e-5)" "unprognostic (1.80e-2)" "unprognostic (1.27e-2)" "unprognostic (5.58e-2)" "prognostic favourable (8.72e-5)" "unprognostic (9.79e-2)" "prognostic favourable (2.42e-5)" "unprognostic (1.50e-1)" "unprognostic (5.08e-2)" "prognostic unfavourable (8.33e-10)" "unprognostic (3.82e-2)" "unprognostic (1.58e-1)" "unprognostic (1.59e-3)" "unprognostic (1.57e-2)" 5.5 9.3 6.9 11.9 7.9 4.8 8.8 7.5 6.7 11.2 11.5 3.9 33.9 14.4 5.7 30.9 6.6 10.2 21.0 4.6 6.1 6.1 9.6 20.3 7.5 12.0 4.5 5.1 8.4 77.8 4.2 29.9 8.3 6.7 27.9 12.8 16.2 52.0 36.5 2.3 4.7 18.4 5.2 3.5 12.8 16.1 4.6 4.4 3.8 11.9 5.0 14.8 8.0 6.7 65.4 5.3 13.3 3.6 4.3 5.0 3.7 5.4 10.9 6.5 13.3 12.8 12.5 9.0 15.6 19.7 8.0 10.5 5.0 8.4 0.4 13.3 16.1 6.1 5.4 11.4 6.9 3.4 3.5 9.6 4.6 14.6 21.8 2.8 11.7 9.8 11.9 11.1 14.6 12.9 0.4 25.2 9.7 11.3 6.3 4.7 9.9 3.7 6.9 4.8 50.8 20.0 7.1 5.2 7.9 6.4 9.9 9.1 21.3 5.4 7.7 5.7 5.0 9.5 4.1 15.7 10.2 1.6 15.6 7.4 9.7 13.3 2.7 4.5 3.0 2.7 5.0 37.2 3.9 3.8 2.5 65.4 2.0 1.9 1.6 4.3 3.6 5.3 3.4 3.7 6.9 7.9 7.5 6.7 6.1 6.1 4.5 5.1 6.7 4.4 PLPPR1 "FLJ20300, LPPR1, MGC26189, PRG-3" ENSG00000148123 "Phospholipid phosphatase related 1" Q8TBJ4 9 101028709-101325135 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 38.5;kidney: 24.4" "Group enriched" "Detected in some" 4 "Hep G2: 5.6;SCLC-21H: 10.3" "Group enriched" "Detected in some" 5 "glioma: 11.1;liver cancer: 5.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA014760, HPA014968, HPA014979" Supported Supported Nucleoplasm Nucleoplasm "HPA014760: , HPA014968: AB_1855702, HPA014979: " "unprognostic (1.08e-2)" "unprognostic (2.79e-1)" "unprognostic (2.98e-2)" "unprognostic (2.54e-1)" "unprognostic (1.14e-1)" "unprognostic (7.33e-2)" "unprognostic (3.41e-1)" "prognostic favourable (1.37e-4)" "unprognostic (2.09e-1)" "unprognostic (1.14e-1)" "unprognostic (9.86e-4)" "unprognostic (1.44e-1)" "unprognostic (1.65e-6)" "unprognostic (3.68e-2)" "unprognostic (1.46e-1)" "unprognostic (2.85e-1)" "unprognostic (4.83e-2)" 0.8 0.9 12.6 0.7 38.5 0.7 1.4 1.7 24.4 1.0 0.9 7.6 0.0 0.8 0.8 5.2 0.8 1.0 0.9 0.8 12.7 7.0 24.4 5.0 2.8 0.7 7.5 5.5 0.7 1.1 0.7 0.1 0.8 5.3 1.0 1.0 0.1 1.1 0.8 0.8 0.8 0.8 0.8 10.2 0.7 0.9 1.5 9.3 0.0 0.7 0.0 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.9 10.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 38.5 1.7 6.4 12.7 7.0 7.5 5.5 5.3 9.3 PLPPR2 "LPPR2, PRG-4" ENSG00000105520 "Phospholipid phosphatase related 2" Q96GM1 19 11355386-11365698 "Enzymes, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-2197: 37.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 32.3" "Lineage enriched" "Detected in many" 4 "granulocytes: 32.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048973 Uncertain Approved Nucleoplasm Nucleoplasm "HPA048973: " "unprognostic (1.29e-2)" "unprognostic (1.69e-1)" "prognostic unfavourable (6.45e-4)" "unprognostic (2.90e-1)" "unprognostic (1.43e-1)" "unprognostic (1.70e-2)" "unprognostic (7.10e-2)" "unprognostic (1.37e-1)" "unprognostic (9.60e-2)" "unprognostic (1.72e-1)" "prognostic favourable (6.82e-4)" "unprognostic (2.23e-1)" "prognostic unfavourable (7.46e-11)" "unprognostic (1.99e-2)" "unprognostic (1.46e-1)" "unprognostic (4.37e-2)" "unprognostic (1.17e-1)" 12.0 17.1 32.5 10.5 39.9 14.1 6.6 17.7 51.2 14.0 11.1 10.8 5.1 6.0 12.7 8.4 8.4 9.7 13.7 10.4 37.0 22.3 5.5 18.0 10.0 5.4 11.8 17.9 15.2 12.4 11.7 22.7 11.5 12.3 18.5 5.1 11.8 13.1 15.1 23.1 16.2 5.7 16.8 10.5 10.6 9.3 7.6 9.4 0.5 7.7 4.4 3.3 9.8 8.1 0.0 2.9 32.3 7.2 0.0 0.3 2.3 8.7 5.4 3.0 12.5 12.7 12.2 0.8 15.6 14.6 9.7 9.9 1.0 1.6 1.7 9.3 19.9 1.6 1.7 4.7 5.2 4.6 3.2 0.5 3.8 1.0 6.6 0.5 17.8 10.9 8.5 8.3 1.6 6.5 8.4 14.0 8.1 12.9 0.2 2.4 3.3 30.4 0.2 0.4 4.8 4.5 4.1 3.2 10.8 6.5 5.6 3.3 8.1 11.2 7.5 22.0 4.7 37.1 8.2 8.7 5.3 0.6 21.3 8.0 8.6 0.8 7.2 3.7 0.3 6.7 0.0 0.0 0.1 0.0 2.9 0.0 0.1 0.0 32.3 0.0 4.4 0.1 0.3 2.3 32.5 39.9 17.7 51.2 37.0 22.3 11.8 17.9 12.3 9.4 PLPPR3 "FLJ11535, LPPR3, PRG-2, PRG2" ENSG00000129951 "Phospholipid phosphatase related 3" Q6T4P5 19 812488-821977 "Enzymes, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "bone marrow: 18.2;brain: 30.0;fallopian tube: 12.6" "Group enriched" "Detected in some" 6 "NB-4: 23.5;THP-1: 49.8" "Cancer enhanced" "Detected in many" "testis cancer: 4.4" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 8 "eosinophil: 1.6" "Lineage enriched" "Detected in single" 8 "granulocytes: 1.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052293, HPA057034" Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA052293: , HPA057034: " "unprognostic (7.65e-2)" "unprognostic (1.39e-2)" "unprognostic (1.33e-2)" "unprognostic (3.66e-3)" "unprognostic (1.00e-1)" "unprognostic (1.59e-2)" "unprognostic (2.62e-2)" "unprognostic (1.47e-1)" "unprognostic (4.32e-1)" "unprognostic (4.51e-4)" "unprognostic (8.06e-3)" "unprognostic (1.07e-1)" "unprognostic (1.72e-12)" "unprognostic (1.21e-2)" "unprognostic (6.82e-2)" "unprognostic (8.50e-2)" "unprognostic (2.91e-1)" 0.7 0.7 20.5 1.2 30.0 18.2 2.1 0.1 21.3 0.9 0.7 0.7 0.0 0.7 1.3 0.7 0.7 12.6 1.1 0.7 14.4 13.1 0.7 0.7 2.6 0.9 3.9 14.9 1.0 0.7 0.7 0.1 0.8 4.7 0.9 0.7 0.1 0.7 0.8 0.9 0.8 1.0 0.7 1.1 0.9 0.9 3.0 3.1 0.0 0.7 0.0 0.7 0.8 0.0 0.1 0.0 1.6 0.0 0.0 0.1 0.0 0.1 0.6 4.8 0.0 0.0 0.0 2.7 0.1 0.0 0.0 0.0 0.3 0.0 0.0 3.4 0.0 0.1 0.9 0.0 0.0 0.0 2.0 0.0 0.6 0.0 0.2 1.6 0.1 0.6 0.0 0.0 0.0 0.0 4.5 0.1 0.0 0.4 0.0 23.5 3.8 0.1 0.0 0.0 0.0 0.0 0.0 0.1 6.2 0.1 0.0 0.0 2.1 49.8 0.0 0.0 0.1 0.1 0.0 0.1 0.2 0.0 0.0 3.8 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.5 30.0 0.1 21.3 14.4 13.1 3.9 14.9 4.7 3.1 PLPPR4 "KIAA0455, LPPR4, PHP1, PRG-1" ENSG00000117600 "Phospholipid phosphatase related 4" Q7Z2D5 1 99263953-99309590 "Enzymes, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 55.3" "Cell line enhanced" "Detected in some" "BJ hTERT+: 19.8;BJ hTERT+ SV40 Large T+ RasG12V: 7.7;fHDF/TERT166: 6.7;SH-SY5Y: 14.9;U-138 MG: 7.5;U-87 MG: 12.6" "Cancer enhanced" "Detected in many" "glioma: 7.2" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 22 "non-classical monocyte: 2.1" "Lineage enriched" "Detected in single" 22 "monocytes: 2.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (4.32e-2)" "unprognostic (4.92e-2)" "unprognostic (2.74e-1)" "unprognostic (1.67e-2)" "unprognostic (1.67e-2)" "unprognostic (2.95e-2)" "unprognostic (1.00e-2)" "unprognostic (1.17e-2)" "unprognostic (9.09e-2)" "unprognostic (9.70e-3)" "unprognostic (3.36e-2)" "unprognostic (2.21e-1)" "unprognostic (7.25e-12)" "unprognostic (1.67e-5)" "unprognostic (3.47e-1)" "unprognostic (1.34e-2)" "unprognostic (1.16e-3)" 3.0 1.7 25.1 1.2 25.8 0.8 1.8 2.0 55.3 4.6 1.5 2.6 0.0 1.2 1.7 1.7 3.2 1.3 6.0 1.4 39.2 10.8 1.4 0.8 3.5 1.5 5.2 16.7 0.8 1.5 1.7 9.0 1.9 6.1 1.1 1.9 0.6 1.4 1.3 1.2 4.6 1.5 2.1 2.2 1.3 1.1 5.2 2.7 0.0 1.5 0.4 1.7 7.0 1.4 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.3 0.0 0.0 3.8 19.8 4.4 7.7 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.2 14.9 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.1 0.0 0.1 0.0 0.0 0.0 12.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 25.1 25.8 2.0 33.8 39.2 10.8 5.2 16.7 6.1 2.7 PLPPR5 "LPPR5, PAP2, PAP2D, PRG5" ENSG00000117598 "Phospholipid phosphatase related 5" Q32ZL2 1 98890245-99005032 "Predicted membrane proteins" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "brain: 18.6;testis: 5.5" "Group enriched" "Detected in some" 7 "PC-3: 12.0;SH-SY5Y: 21.5" "Group enriched" "Detected in some" 13 "glioma: 2.7;renal cancer: 1.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018072, HPA059085" Uncertain Approved "Plasma membrane,Cytosol" "Plasma membrane" Cytosol "HPA018072: AB_1854958, HPA059085: " "unprognostic (2.57e-1)" "unprognostic (1.63e-2)" "unprognostic (1.68e-1)" "unprognostic (1.68e-2)" "unprognostic (2.01e-1)" "unprognostic (2.26e-1)" "unprognostic (1.11e-1)" "unprognostic (3.18e-1)" "unprognostic (1.43e-1)" "unprognostic (2.07e-1)" "prognostic unfavourable (6.22e-4)" "unprognostic (1.81e-2)" "unprognostic (1.28e-1)" "unprognostic (2.33e-1)" 0.5 1.8 7.8 0.7 8.7 0.5 0.5 0.8 18.6 1.4 0.6 2.1 0.0 0.7 0.7 0.5 0.6 0.5 0.6 0.5 8.0 6.6 0.7 0.5 0.7 0.5 2.5 4.5 0.6 1.6 0.5 0.3 0.5 3.6 0.6 0.8 1.8 0.5 1.0 0.9 0.6 0.7 0.6 1.0 0.5 0.7 5.5 1.8 0.0 0.5 0.0 0.5 0.6 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 12.0 0.0 0.0 0.0 0.5 0.1 0.4 21.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.8 8.7 0.8 11.6 8.0 6.6 2.5 4.5 3.6 1.8 PQLC1 FLJ22378 ENSG00000122490 "PQ loop repeat containing 1" Q8N2U9 18 79902420-79951664 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051666 Uncertain Approved Nucleoplasm Nucleoplasm "HPA051666: " "unprognostic (6.03e-2)" "unprognostic (1.51e-1)" "unprognostic (2.36e-1)" "unprognostic (6.45e-2)" "unprognostic (3.94e-2)" "unprognostic (2.07e-2)" "unprognostic (1.39e-1)" "unprognostic (2.47e-1)" "unprognostic (2.50e-1)" "unprognostic (4.58e-2)" "unprognostic (1.02e-2)" "unprognostic (4.34e-1)" "unprognostic (1.40e-3)" "unprognostic (2.00e-1)" "unprognostic (1.20e-1)" "unprognostic (1.79e-1)" "unprognostic (1.70e-2)" 31.3 12.5 17.4 12.4 16.6 28.3 23.0 12.5 27.0 9.4 16.9 12.3 9.6 8.9 13.4 12.0 20.0 10.8 13.2 13.8 21.3 12.6 16.5 56.7 14.3 14.2 13.0 13.8 9.9 23.8 8.0 8.5 9.5 14.2 10.8 7.1 19.9 21.4 10.1 29.6 19.2 10.0 12.4 7.5 14.0 10.1 22.9 9.7 8.7 25.8 14.4 13.6 11.7 15.8 1.7 7.2 3.8 3.8 2.0 2.5 1.9 16.5 5.7 5.9 11.3 13.1 8.5 8.0 10.9 7.5 8.8 8.4 7.5 9.1 6.9 4.3 9.8 17.1 8.0 11.6 2.3 21.5 11.7 8.8 8.0 20.2 15.8 20.9 22.4 9.5 11.6 8.1 3.1 7.5 3.3 5.7 4.5 12.7 10.3 22.5 1.9 15.5 18.5 6.2 11.7 5.9 11.9 17.4 7.8 8.2 10.5 12.0 6.2 23.1 9.4 13.4 13.8 7.1 8.2 3.0 4.6 9.0 10.3 25.5 5.9 0.7 3.8 3.8 1.7 3.8 1.0 1.7 1.7 0.8 4.0 1.5 2.1 2.5 2.5 2.0 3.1 7.2 1.5 1.9 17.4 16.6 12.5 27.0 21.3 12.6 13.0 13.8 14.2 9.7 PQLC2 FLJ20320 ENSG00000040487 "PQ loop repeat containing 2" Q6ZP29 1 19312326-19329300 "Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057810 Approved Supported Vesicles Vesicles "HPA057810: " "unprognostic (7.84e-3)" "unprognostic (6.56e-2)" "unprognostic (6.54e-2)" "prognostic favourable (3.50e-4)" "unprognostic (3.77e-3)" "unprognostic (2.19e-1)" "prognostic unfavourable (2.64e-5)" "unprognostic (2.61e-1)" "unprognostic (4.47e-2)" "unprognostic (1.04e-1)" "unprognostic (1.42e-3)" "unprognostic (3.82e-2)" "unprognostic (4.70e-3)" "unprognostic (8.64e-2)" "unprognostic (2.07e-1)" "unprognostic (6.56e-2)" "unprognostic (4.46e-2)" 10.9 19.9 11.7 8.5 12.3 18.4 9.4 28.8 16.2 12.2 13.1 16.8 8.6 16.9 11.5 15.5 9.2 8.8 11.1 9.3 10.6 11.2 11.9 20.3 12.1 11.1 14.3 9.1 10.9 19.4 10.0 19.4 24.8 14.4 11.7 7.7 18.9 12.1 11.0 10.9 15.3 16.2 9.3 12.2 12.2 13.3 13.8 10.9 6.2 14.0 9.2 10.5 8.0 9.0 5.1 16.7 7.8 10.1 2.9 3.4 3.5 8.2 8.7 8.2 13.0 8.0 7.5 10.4 10.4 14.3 14.5 12.4 12.6 10.4 2.6 13.6 7.6 6.2 7.9 9.3 6.6 5.5 9.7 2.0 7.4 13.5 22.9 1.7 3.6 12.4 9.8 20.5 6.5 5.6 14.8 6.1 13.9 7.4 1.1 5.7 7.8 7.8 4.5 10.3 4.6 10.9 5.4 10.1 8.4 7.8 5.3 19.8 8.8 20.4 7.4 12.2 7.1 20.5 9.1 10.8 7.5 1.4 14.9 10.3 9.9 0.9 8.7 7.8 3.2 7.1 2.4 5.1 3.4 2.7 11.1 5.0 1.0 2.1 5.4 2.9 10.1 16.7 3.1 3.5 11.7 12.3 28.8 16.2 10.6 11.2 14.3 9.1 14.4 10.9 PRRT4 ENSG00000224940 "Proline rich transmembrane protein 4" C9JH25 7 128350325-128361685 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "bone marrow: 49.0" "Cell line enriched" "Detected in some" 5 "SH-SY5Y: 70.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.5" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA046373, HPA052681" Uncertain Approved "Nucleoplasm,Peroxisomes,Plasma membrane" "Intracellular and membrane" Nucleoplasm "Peroxisomes, Plasma membrane" "HPA046373: , HPA052681: " "unprognostic (1.72e-1)" "unprognostic (4.55e-2)" "unprognostic (5.36e-3)" "unprognostic (1.20e-4)" "unprognostic (2.60e-1)" "unprognostic (7.81e-2)" "unprognostic (1.88e-1)" "unprognostic (1.56e-1)" "unprognostic (5.62e-3)" "unprognostic (1.61e-1)" "unprognostic (2.48e-4)" "unprognostic (9.11e-2)" "unprognostic (3.73e-4)" "unprognostic (5.28e-3)" "unprognostic (9.09e-2)" "unprognostic (1.22e-2)" "unprognostic (1.27e-2)" 12.1 1.9 2.0 5.9 11.3 49.0 6.8 6.5 3.1 1.6 2.7 0.6 0.0 0.6 0.7 0.5 1.9 1.0 1.1 2.4 1.7 6.2 0.5 0.7 0.8 0.6 1.6 2.4 1.0 0.6 0.8 0.0 0.6 2.9 0.8 0.7 3.4 1.9 1.3 4.2 1.5 0.8 1.0 2.8 1.3 1.6 0.7 1.5 0.7 0.7 1.7 1.0 2.0 3.2 0.0 0.4 0.4 0.4 0.0 1.5 0.4 0.0 0.0 0.1 0.1 0.4 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 2.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 13.8 0.3 0.0 3.8 0.2 0.3 0.0 0.0 0.1 70.3 0.1 0.0 0.1 0.0 1.8 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.2 0.5 0.0 0.0 1.5 0.7 0.4 0.0 0.0 0.4 0.0 0.4 2.0 11.3 6.5 3.1 1.7 6.2 1.6 2.4 2.9 1.5 PTGDR "DP, DP1, PTGDR1" ENSG00000168229 "Prostaglandin D2 receptor" Q13258 14 52267713-52276724 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" Asthma "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 30.1" "Group enriched" "Detected in some" 4 "ASC diff: 1.4;HSkMC: 1.5;REH: 2.4;U-138 MG: 1.8" "Low cancer specificity" "Detected in single" "Region enhanced" "Detected in many" "pons and medulla: 13.9" "Group enriched" "Detected in many" 5 "gdT-cell: 25.4;MAIT T-cell: 12.7;memory CD8 T-cell: 15.2;naive CD8 T-cell: 8.9;NK-cell: 30.1" "Group enriched" "Detected in many" 30 "NK-cells: 30.1;T-cells: 25.4" "Low region specificity" "Detected in many" HPA049668 Enhanced "HPA049668: " "unprognostic (9.32e-3)" "unprognostic (3.31e-2)" "unprognostic (1.00e-2)" "unprognostic (2.04e-3)" "unprognostic (4.80e-2)" "unprognostic (2.70e-2)" "unprognostic (3.11e-3)" "unprognostic (5.00e-2)" "unprognostic (9.38e-3)" "unprognostic (4.94e-2)" "unprognostic (1.81e-2)" "unprognostic (1.54e-1)" "unprognostic (5.60e-8)" "unprognostic (1.14e-2)" "unprognostic (2.32e-1)" "unprognostic (4.02e-2)" "unprognostic (5.89e-2)" 3.9 0.9 0.7 9.6 2.5 1.8 9.3 1.4 1.4 5.5 10.0 0.7 0.9 1.1 4.1 2.2 2.1 2.5 4.9 2.3 0.8 0.8 1.5 1.8 3.4 8.9 1.0 3.5 2.3 0.8 0.8 4.5 0.4 13.9 2.1 12.8 11.2 2.6 3.5 0.9 1.3 2.4 2.0 3.6 10.9 2.0 0.9 0.8 1.8 2.5 0.1 3.1 3.3 3.2 0.0 0.0 0.9 0.1 30.1 25.4 4.1 0.0 0.0 0.0 0.0 1.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.5 0.0 0.3 0.1 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.1 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 25.4 0.0 12.7 0.0 3.5 15.2 0.0 0.0 0.6 8.9 0.9 30.1 0.1 0.0 0.0 4.1 0.7 2.5 1.4 1.4 0.8 0.8 1.0 3.5 13.9 0.8 PTGFR FP ENSG00000122420 "Prostaglandin F receptor" P43088 1 78303884-78539749 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 7 "ASC TERT1: 77.9;HSkMC: 24.3" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "hippocampal formation: 10.1" "Cell type enriched" "Detected in single" 13 "classical monocyte: 1.3" "Lineage enriched" "Detected in single" 13 "monocytes: 1.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "unprognostic (4.14e-2)" "unprognostic (1.35e-2)" "unprognostic (5.89e-3)" "unprognostic (6.03e-2)" "unprognostic (5.63e-2)" "unprognostic (1.45e-3)" "unprognostic (7.61e-2)" "unprognostic (2.25e-1)" "unprognostic (9.90e-2)" "unprognostic (8.46e-4)" "unprognostic (2.21e-1)" "unprognostic (5.34e-2)" "unprognostic (2.16e-4)" "unprognostic (3.21e-4)" "unprognostic (8.48e-2)" "unprognostic (2.16e-2)" "unprognostic (1.21e-3)" 13.0 4.1 1.1 5.2 1.8 0.0 8.7 0.3 1.0 8.3 3.8 0.3 2.1 0.9 27.2 7.0 6.1 5.3 8.8 7.7 10.1 3.3 5.6 3.6 2.3 1.1 0.5 0.3 14.5 1.5 0.0 0.5 7.7 0.6 12.9 2.7 1.8 6.5 2.1 6.9 7.3 3.0 21.3 0.7 0.8 2.7 4.0 0.0 0.0 2.1 13.4 4.3 20.3 15.9 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.2 0.0 7.5 77.9 0.0 5.6 5.4 1.9 0.7 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 24.3 0.0 0.4 4.9 0.0 0.0 0.2 3.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.6 2.4 1.3 0.5 0.4 0.3 0.0 0.0 0.1 0.0 0.6 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 1.8 0.3 1.0 10.1 3.3 0.5 0.3 0.6 0.0 PTGIR IP ENSG00000160013 "Prostaglandin I2 receptor" P43119 19 46620468-46625118 "FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 27.7;lung: 35.1" "Cell line enhanced" "Detected in some" "BJ: 8.3;BJ hTERT+: 9.5;fHDF/TERT166: 11.7;HDLM-2: 5.8;HEL: 21.5;HHSteC: 5.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 10 "classical monocyte: 12.6;intermediate monocyte: 27.7;myeloid DC: 9.1;non-classical monocyte: 15.5" "Group enriched" "Detected in many" 12 "dendritic cells: 9.1;monocytes: 27.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "unprognostic (3.79e-1)" "unprognostic (1.95e-1)" "unprognostic (2.94e-2)" "unprognostic (2.39e-1)" "unprognostic (1.03e-1)" "unprognostic (3.49e-3)" "unprognostic (4.22e-2)" "unprognostic (6.09e-2)" "unprognostic (2.12e-1)" "unprognostic (7.45e-2)" "unprognostic (4.47e-1)" "unprognostic (1.14e-1)" "prognostic unfavourable (2.09e-8)" "unprognostic (1.66e-2)" "prognostic unfavourable (1.74e-4)" "unprognostic (1.16e-1)" "unprognostic (5.66e-2)" 7.8 6.3 0.4 8.0 0.6 3.8 3.0 0.1 0.6 6.5 6.0 1.2 1.4 2.7 5.0 2.7 4.5 2.7 6.4 16.0 0.6 0.3 9.0 9.6 35.1 6.5 0.8 0.7 6.9 3.5 0.1 1.2 6.3 1.1 3.2 1.4 3.3 2.5 1.3 12.2 3.0 3.7 4.1 0.5 11.3 4.5 1.6 0.8 3.5 14.5 3.4 4.3 10.2 6.5 0.5 9.1 0.5 27.7 0.0 1.5 7.2 0.0 0.0 0.0 0.0 0.1 4.5 0.0 8.3 9.5 1.2 3.4 0.0 0.0 0.0 0.7 11.7 0.0 0.0 0.0 0.7 5.8 0.0 21.5 0.0 0.0 5.8 0.0 0.0 1.4 0.0 3.0 0.2 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.4 1.0 1.4 0.2 0.2 0.0 0.0 0.0 0.0 0.3 0.6 0.5 0.0 12.6 0.0 0.0 27.7 0.2 0.5 0.1 0.0 9.1 0.3 1.5 0.0 0.5 0.0 15.5 0.8 1.4 7.2 0.4 0.6 0.1 0.6 0.6 0.3 0.8 0.7 1.1 0.8 RCE1 "FACE-2, FACE2, hRCE1, RCE1A, RCE1B" ENSG00000173653 "Ras converting CAAX endopeptidase 1" Q9Y256 11 66842835-66846546 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074124 Approved "HPA074124: " "unprognostic (1.11e-1)" "unprognostic (7.23e-2)" "unprognostic (1.15e-1)" "unprognostic (8.16e-3)" "unprognostic (3.11e-1)" "unprognostic (6.40e-3)" "unprognostic (1.98e-3)" "unprognostic (7.69e-3)" "unprognostic (1.39e-1)" "unprognostic (9.14e-3)" "unprognostic (2.35e-3)" "unprognostic (5.31e-3)" "unprognostic (1.06e-1)" "unprognostic (4.48e-3)" "unprognostic (2.17e-2)" "unprognostic (1.04e-1)" "unprognostic (4.28e-2)" 12.3 9.0 7.6 11.9 9.4 19.5 15.9 27.5 9.4 10.8 13.0 9.2 9.3 11.3 10.9 11.8 15.9 9.6 9.7 5.9 6.6 9.4 13.7 7.4 9.7 17.6 8.9 5.1 13.2 23.9 10.2 12.6 20.8 5.6 13.7 9.5 11.2 14.9 13.9 5.6 22.1 13.0 6.7 5.0 12.0 10.2 17.1 5.4 14.8 14.3 10.5 13.6 9.9 9.9 11.4 22.0 12.2 17.9 10.0 17.1 12.4 10.6 12.0 7.4 6.9 4.6 4.0 16.1 5.7 5.6 8.9 8.1 22.5 23.2 8.1 10.8 5.4 19.3 8.6 8.6 5.2 9.7 9.5 7.2 8.5 8.6 16.4 9.1 10.9 6.5 16.5 10.1 9.0 7.3 9.9 12.8 4.5 20.6 13.2 18.2 21.5 12.3 10.6 5.2 15.8 9.8 5.8 9.1 8.2 8.0 11.2 35.1 13.0 7.9 4.3 12.3 9.2 13.2 8.7 6.9 6.9 8.9 8.3 9.7 8.8 12.2 15.6 10.7 13.7 17.9 12.5 11.4 11.5 17.1 14.4 9.0 9.4 14.3 5.1 10.0 15.3 22.0 4.8 12.4 7.6 9.4 27.5 9.4 6.6 9.4 8.9 5.1 5.6 5.4 RNF121 FLJ11099 ENSG00000137522 "Ring finger protein 121" Q9H920 11 71928701-71997597 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046041 Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" "Golgi apparatus" "Nucleoplasm, Vesicles" "HPA046041: AB_10965850" "unprognostic (1.36e-2)" "unprognostic (8.84e-2)" "unprognostic (9.72e-2)" "unprognostic (1.16e-1)" "unprognostic (2.64e-1)" "unprognostic (1.38e-2)" "unprognostic (1.41e-2)" "unprognostic (3.73e-2)" "unprognostic (1.22e-1)" "unprognostic (6.54e-2)" "unprognostic (1.85e-2)" "unprognostic (1.90e-1)" "prognostic favourable (2.72e-6)" "unprognostic (1.54e-1)" "unprognostic (1.81e-1)" "unprognostic (2.57e-2)" "unprognostic (1.70e-1)" 9.8 14.1 18.5 14.0 14.9 6.5 14.1 18.5 16.6 12.6 13.0 12.4 22.4 18.5 17.9 26.3 10.6 14.3 10.8 13.1 11.7 11.7 20.2 16.9 9.4 8.9 12.4 13.4 15.0 15.6 24.1 19.4 18.9 12.1 13.5 13.1 15.7 18.0 19.5 19.2 11.8 18.7 14.1 10.1 10.1 12.8 16.3 13.6 8.9 15.6 8.1 15.3 11.9 10.4 5.9 6.9 8.8 5.5 5.6 7.0 5.1 5.0 10.9 11.3 8.3 11.0 8.6 7.9 9.3 10.1 14.8 15.6 21.3 11.2 4.7 8.2 10.5 11.9 12.4 11.2 16.0 6.7 7.2 7.9 10.7 10.5 8.2 6.8 6.7 8.1 10.1 16.0 9.7 26.4 11.8 5.0 13.0 11.4 4.6 7.8 7.8 11.1 5.9 23.9 4.3 16.8 9.9 8.0 8.6 12.1 10.4 17.0 12.0 5.0 16.4 10.5 10.0 7.0 7.8 6.1 5.5 5.3 9.2 4.4 9.3 8.8 4.1 4.0 5.6 5.5 7.0 5.9 4.7 4.5 3.9 2.2 5.3 5.9 2.1 5.6 3.9 6.9 3.9 5.1 18.5 14.9 18.5 16.6 11.7 11.7 12.4 13.4 12.1 13.6 RNF175 FLJ34190 ENSG00000145428 "Ring finger protein 175" Q8N4F7 4 153710125-153760235 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.3" "Cell line enhanced" "Detected in some" "AF22: 7.7;HSkMC: 5.1;REH: 6.5;SH-SY5Y: 6.5;THP-1: 15.8;U-87 MG: 3.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 26 "classical monocyte: 2.4;intermediate monocyte: 1.7;myeloid DC: 1.7;naive CD4 T-cell: 4.0;neutrophil: 4.5;non-classical monocyte: 3.6;T-reg: 1.1" "Low lineage specificity" "Detected in many" HPA035837 Uncertain "HPA035837: AB_10601609" "unprognostic (3.23e-2)" "unprognostic (4.12e-2)" "unprognostic (3.34e-1)" "unprognostic (1.48e-2)" "prognostic unfavourable (3.11e-4)" "unprognostic (9.00e-2)" "unprognostic (2.65e-1)" "unprognostic (7.15e-4)" "unprognostic (1.17e-1)" "unprognostic (2.96e-3)" "unprognostic (6.30e-3)" "unprognostic (1.42e-1)" "unprognostic (3.63e-4)" "unprognostic (7.25e-3)" "unprognostic (3.27e-1)" "unprognostic (1.28e-1)" "unprognostic (7.66e-2)" 2.7 4.8 8.6 5.4 14.3 9.5 1.3 9.3 17.3 5.4 0.8 1.4 0.8 0.8 0.8 2.0 1.5 0.6 2.2 4.4 9.0 12.1 0.6 0.5 2.2 2.2 6.4 9.8 0.5 1.1 0.4 3.0 0.6 13.0 4.7 0.6 0.6 3.4 6.7 0.5 1.6 0.9 0.6 2.5 3.4 0.8 2.8 1.8 0.0 0.6 0.3 1.3 1.8 1.5 0.0 1.7 4.5 3.6 0.0 4.0 1.2 0.1 0.0 7.7 0.0 0.0 0.6 0.0 0.0 2.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 5.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 2.6 0.0 6.5 0.0 0.3 0.0 0.1 0.0 6.5 0.0 0.0 0.2 0.0 15.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.9 0.0 0.0 2.4 0.0 0.0 1.7 0.0 0.0 0.1 0.0 1.7 0.0 4.0 0.1 4.5 0.0 3.6 0.0 1.1 1.2 8.6 14.3 9.3 17.3 9.0 12.1 6.4 9.8 13.0 1.8 RYR2 "ARVC2, ARVD2, VTSIP" ENSG00000198626 "Ryanodine receptor 2" Q92736 1 237042205-237833988 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Calmodulin-binding, Developmental protein, Ion channel, Ligand-gated ion channel, Receptor" "Cardiomyopathy, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "heart muscle: 106.6" "Cell line enhanced" "Detected in some" "HDLM-2: 7.7;HEK 293: 10.4;K-562: 3.2;NB-4: 2.7;NTERA-2: 3.9;U-937: 4.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020028 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" "Nucleoplasm, Plasma membrane, Cytosol" "HPA020028: AB_1856528" "unprognostic (5.23e-3)" "unprognostic (2.15e-2)" "unprognostic (5.02e-4)" "unprognostic (6.26e-2)" "unprognostic (8.74e-2)" "unprognostic (2.99e-3)" "unprognostic (5.28e-2)" "unprognostic (1.45e-3)" "unprognostic (2.69e-2)" "unprognostic (1.04e-1)" "unprognostic (1.10e-1)" "unprognostic (4.04e-2)" "unprognostic (0.00e+0)" "unprognostic (2.36e-2)" "unprognostic (1.42e-1)" "unprognostic (3.13e-2)" "unprognostic (1.06e-2)" 1.1 0.9 6.2 0.9 18.7 0.5 1.1 14.8 10.5 1.3 1.2 0.0 1.2 0.7 1.1 0.7 1.8 1.0 1.8 106.6 5.7 1.1 0.9 0.9 1.4 0.6 1.0 7.3 2.2 4.2 0.5 2.0 1.1 1.6 2.0 0.8 0.2 0.9 1.4 0.9 1.0 1.0 4.6 1.0 1.0 1.2 1.1 3.0 0.0 2.7 0.0 0.6 1.2 1.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.3 0.0 0.3 0.5 0.0 0.0 7.7 10.4 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 3.2 0.2 0.0 0.0 0.0 2.7 3.9 0.4 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 4.8 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.2 18.7 14.8 10.5 5.7 1.1 1.0 7.3 1.6 3.0 RYR3 ENSG00000198838 "Ryanodine receptor 3" Q15413 15 33310945-33866121 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Calcium channel, Calmodulin-binding, Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 28.8;skeletal muscle: 26.8" "Cell line enhanced" "Detected in some" "A549: 7.0;RH-30: 10.6;RPTEC TERT1: 5.0" "Cancer enhanced" "Detected in single" "glioma: 1.3" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 31 "basophil: 4.0" "Lineage enriched" "Detected in single" 31 "granulocytes: 4.0" "Low region specificity" "Detected in many" HPA062004 Approved Vesicles Vesicles "HPA062004: " "unprognostic (5.85e-2)" "unprognostic (1.57e-1)" "unprognostic (5.30e-2)" "unprognostic (1.35e-1)" "unprognostic (1.26e-2)" "unprognostic (8.03e-4)" "unprognostic (1.10e-1)" "unprognostic (1.10e-1)" "unprognostic (7.85e-2)" "unprognostic (7.10e-2)" "unprognostic (8.25e-3)" "unprognostic (2.36e-1)" "unprognostic (2.48e-2)" "unprognostic (1.86e-2)" "unprognostic (1.15e-1)" "unprognostic (3.16e-2)" "unprognostic (1.91e-1)" 1.8 2.0 9.9 1.1 15.4 2.5 2.9 4.9 12.4 2.8 4.5 6.0 0.2 1.5 10.2 1.0 2.7 3.9 1.6 1.0 13.3 3.5 1.2 0.9 1.2 0.9 5.6 6.9 1.7 0.8 28.8 1.2 1.0 10.7 1.8 2.9 0.6 1.4 3.9 26.8 1.2 1.3 7.4 5.9 1.4 1.6 1.6 7.9 0.0 1.1 1.5 1.4 2.1 2.6 0.1 0.0 4.0 0.0 0.0 0.1 0.0 0.3 7.0 1.5 0.1 0.0 0.0 0.2 0.6 0.0 0.0 0.0 1.6 0.1 0.4 0.6 0.0 0.2 0.0 0.0 0.0 0.4 0.2 1.4 0.2 0.0 0.0 1.0 0.7 0.0 0.0 0.1 0.0 0.0 0.4 2.6 0.0 0.4 0.2 0.3 1.1 0.1 0.5 10.6 0.2 5.0 0.5 0.1 0.5 0.8 0.0 0.2 0.1 0.3 0.9 0.2 0.1 0.0 0.7 0.3 1.2 0.7 0.5 2.3 0.0 4.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 15.4 4.9 12.4 13.3 3.5 5.6 6.9 10.7 7.9 SAMD8 "FLJ25082, SMSr" ENSG00000156671 "Sterile alpha motif domain containing 8" Q96LT4 10 75099586-75182123 "Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 18.3" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044402 Supported "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA044402: " "unprognostic (4.32e-1)" "unprognostic (3.14e-1)" "unprognostic (3.24e-2)" "unprognostic (7.87e-2)" "unprognostic (3.37e-2)" "unprognostic (2.77e-2)" "unprognostic (1.61e-2)" "unprognostic (1.39e-1)" "unprognostic (5.29e-1)" "unprognostic (3.12e-2)" "unprognostic (2.70e-1)" "unprognostic (4.69e-2)" "unprognostic (4.16e-3)" "unprognostic (3.89e-2)" "unprognostic (3.76e-1)" "unprognostic (2.53e-1)" "unprognostic (9.26e-3)" 17.6 14.6 18.8 9.3 18.9 20.7 11.9 12.4 34.8 15.6 7.9 20.1 10.2 8.2 15.0 10.1 17.9 9.4 12.5 14.3 18.6 15.9 10.1 10.1 10.7 8.7 22.7 13.8 18.7 7.6 13.0 17.1 14.8 17.4 11.5 7.0 10.9 8.9 11.5 28.3 7.6 9.3 13.7 37.8 10.0 7.7 19.9 15.5 5.5 10.7 7.3 8.6 10.9 18.1 5.7 3.6 18.3 5.9 3.8 3.3 1.5 5.5 5.3 8.1 6.4 17.8 16.4 10.3 10.0 19.1 6.6 9.0 7.8 7.9 4.5 6.6 9.3 10.0 4.5 6.8 11.9 4.9 6.7 1.8 5.3 5.3 9.8 2.0 4.6 15.8 6.9 12.3 17.8 9.1 3.7 7.8 12.7 4.3 3.2 2.5 3.5 20.7 3.0 7.4 1.6 6.3 4.8 1.2 5.8 9.1 10.9 8.8 4.6 1.9 15.6 6.6 12.3 7.9 6.5 5.5 4.1 4.2 10.2 4.4 4.1 2.4 3.7 2.2 2.9 4.5 1.9 4.8 3.1 3.3 3.2 5.7 2.7 3.1 18.3 3.8 5.9 3.6 2.8 1.5 18.8 18.9 12.4 21.3 18.6 15.9 22.7 13.8 17.4 15.5 SCN2A "HBSCI, HBSCII, Nav1.2, SCN2A1, SCN2A2" ENSG00000136531 "Sodium voltage-gated channel alpha subunit 2" Q99250 2 165194993-165392310 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 68.0" "Cell line enhanced" "Detected in some" "HSkMC: 3.3;SH-SY5Y: 3.1;U-138 MG: 5.7;U-266/84: 11.8;U-87 MG: 3.5" "Cancer enhanced" "Detected in single" "glioma: 1.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive B-cell: 1.4" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB022567 Enhanced "CAB022567: " "unprognostic (1.16e-1)" "unprognostic (3.56e-4)" "unprognostic (5.28e-2)" "unprognostic (6.12e-3)" "unprognostic (2.97e-1)" "unprognostic (8.62e-3)" "unprognostic (1.18e-1)" "unprognostic (7.25e-3)" "unprognostic (1.40e-1)" "unprognostic (2.78e-1)" "unprognostic (1.32e-2)" "unprognostic (5.21e-2)" "unprognostic (3.44e-2)" "unprognostic (1.76e-1)" "unprognostic (1.05e-1)" "unprognostic (4.88e-2)" "unprognostic (2.14e-1)" 1.3 3.0 19.1 1.3 36.4 1.1 2.2 68.0 50.3 1.5 1.3 1.1 0.0 1.5 1.9 2.6 1.2 1.3 2.3 1.3 30.3 8.2 4.0 1.4 1.5 1.2 3.8 23.5 1.5 1.3 1.1 8.2 1.3 9.9 1.3 1.3 0.0 1.5 1.8 1.1 1.2 1.5 2.0 3.7 1.3 1.5 1.5 4.1 0.0 1.1 0.0 1.2 1.3 0.5 1.4 0.6 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.2 0.7 0.0 0.0 2.7 0.0 2.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.1 1.0 0.7 0.0 0.4 0.0 0.4 0.0 0.2 3.3 0.1 0.3 0.0 0.0 0.0 0.3 1.5 0.0 0.2 0.0 2.0 0.2 0.0 0.0 0.0 0.1 0.1 2.8 3.1 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.4 0.3 0.0 0.5 11.8 0.0 3.5 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 19.1 36.4 68.0 43.7 30.3 8.2 3.8 23.5 9.9 4.1 SEC61A1 ENSG00000058262 "Sec61 translocon alpha 1 subunit" P61619 3 128051641-128071683 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Protein transport, Translocation, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 178.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB022076 Supported "Endoplasmic reticulum" "Endoplasmic reticulum" "CAB022076: " "unprognostic (1.84e-1)" "unprognostic (8.00e-2)" "unprognostic (8.21e-2)" "prognostic favourable (7.82e-4)" "unprognostic (2.13e-1)" "unprognostic (1.24e-1)" "prognostic unfavourable (1.07e-6)" "unprognostic (2.84e-2)" "unprognostic (4.67e-1)" "unprognostic (1.23e-1)" "unprognostic (3.85e-2)" "unprognostic (1.43e-1)" "prognostic unfavourable (6.84e-9)" "unprognostic (2.73e-2)" "unprognostic (3.18e-2)" "unprognostic (8.33e-2)" "unprognostic (2.51e-2)" 28.6 38.2 15.2 23.2 16.2 18.5 38.4 12.8 16.2 45.0 24.2 15.9 77.9 22.1 32.6 52.8 31.1 28.3 34.4 27.6 14.3 13.5 37.6 132.2 33.2 44.9 17.4 10.3 28.5 178.4 31.5 36.5 51.6 15.2 26.2 26.0 19.0 87.1 81.7 22.7 22.7 32.5 31.3 15.4 28.8 33.8 21.2 15.4 22.9 35.5 28.8 36.6 24.2 26.4 13.8 35.6 40.0 25.1 18.7 39.3 29.0 39.5 20.8 20.9 37.2 59.4 51.3 38.5 63.9 74.1 55.7 60.1 39.5 28.8 26.4 38.6 82.4 35.2 32.7 45.1 54.0 23.8 17.9 30.1 23.2 41.5 87.6 38.1 34.3 56.3 54.6 52.5 67.8 48.9 19.7 64.7 64.5 36.1 19.6 12.6 28.2 29.2 20.7 18.8 51.8 29.0 34.7 23.8 23.4 31.5 30.1 40.2 28.0 32.6 48.0 43.9 24.9 51.0 29.8 59.3 28.2 38.0 71.9 24.8 56.7 40.0 25.1 19.1 28.3 23.0 39.3 13.8 20.5 24.8 24.7 8.5 13.0 15.0 6.6 18.7 22.4 35.6 13.1 29.0 15.2 16.2 12.8 16.2 14.3 13.5 17.4 10.3 15.2 15.4 SERINC4 FLJ40363 ENSG00000184716 "Serine incorporator 4" A6NH21 15 43794162-43800221 "Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "retina: 24.5" "Cell line enhanced" "Detected in some" "CACO-2: 1.2;RT4: 1.4;SCLC-21H: 3.1;U-138 MG: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" 0.0 0.0 0.5 0.0 0.6 0.2 0.1 0.6 0.4 0.0 0.4 0.3 0.0 0.7 0.7 0.0 0.2 0.2 0.0 0.1 0.3 0.3 0.4 0.0 0.4 0.2 0.8 0.0 0.3 0.0 0.0 0.1 0.2 1.8 0.3 0.3 24.5 0.1 0.1 0.2 0.0 0.3 0.0 0.8 0.0 0.1 5.8 0.0 0.0 0.2 0.0 0.2 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.1 0.0 0.0 1.4 3.1 0.0 0.0 0.8 0.0 0.7 0.0 0.0 1.3 0.0 0.0 0.3 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.6 0.3 0.3 0.3 0.8 0.0 1.8 0.0 SGMS1 "MGC17342, MOB, SMS1, TMEM23" ENSG00000198964 "Sphingomyelin synthase 1" 10 50305586-50625163 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045191 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus,Cytosol" Nucleoplasm "Nucleoli fibrillar center, Golgi apparatus, Cytosol" "HPA045191: AB_10959605" "unprognostic (1.13e-1)" "unprognostic (5.75e-2)" "unprognostic (1.87e-1)" "unprognostic (9.08e-2)" "unprognostic (8.69e-3)" "unprognostic (8.34e-2)" "unprognostic (7.98e-2)" "unprognostic (2.29e-1)" "unprognostic (1.30e-2)" "unprognostic (5.75e-2)" "unprognostic (9.20e-2)" "unprognostic (2.05e-1)" "prognostic favourable (1.95e-7)" "unprognostic (8.38e-2)" "unprognostic (1.95e-1)" "unprognostic (3.31e-1)" "unprognostic (3.05e-1)" 14.7 19.6 16.9 12.3 19.4 17.6 13.2 17.5 20.1 15.8 12.8 24.0 11.9 11.7 12.5 18.1 13.7 14.8 13.6 16.6 18.2 14.6 17.9 23.5 18.6 11.6 22.9 14.0 16.9 19.1 64.6 22.9 20.7 18.6 17.6 10.7 15.5 19.8 15.8 13.2 25.6 13.7 15.2 31.7 13.6 12.8 9.6 24.9 11.4 21.5 8.7 14.9 15.2 21.3 5.3 3.7 20.1 6.7 7.6 11.0 4.2 15.8 7.5 2.2 4.9 8.0 10.6 10.4 10.6 10.7 7.5 7.0 6.2 16.5 11.7 6.2 13.9 10.1 5.2 11.1 7.8 10.2 5.5 16.9 10.1 4.8 9.3 3.8 4.2 6.8 13.1 9.9 12.1 10.5 32.5 17.7 8.0 6.7 1.7 2.2 5.0 7.2 2.8 10.2 4.5 10.9 16.8 3.4 2.7 7.7 7.8 4.0 11.7 1.4 14.6 8.1 9.9 7.7 7.7 6.0 4.7 3.3 10.1 6.4 6.6 2.4 6.7 20.1 3.7 3.4 8.2 5.3 4.9 5.4 3.7 5.0 6.8 4.3 12.5 7.6 2.7 2.3 11.0 4.2 16.9 19.4 17.5 20.1 18.2 14.6 22.9 14.0 18.6 24.9 SGMS2 "MGC26963, SMS2" ENSG00000164023 "Sphingomyelin synthase 2" Q8NHU3 4 107824563-107915047 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" "Kinase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 6 "pons and medulla: 17.0" "Group enriched" "Detected in some" 8 "classical monocyte: 5.7;eosinophil: 3.9;intermediate monocyte: 2.4;myeloid DC: 6.6;non-classical monocyte: 2.0" "Group enriched" "Detected in many" 32 "dendritic cells: 6.6;granulocytes: 3.9;monocytes: 5.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA015076 Supported "HPA015076: AB_1857298" "unprognostic (7.44e-2)" "unprognostic (2.32e-2)" "unprognostic (2.36e-2)" "unprognostic (1.87e-2)" "unprognostic (7.88e-3)" "unprognostic (9.53e-2)" "unprognostic (5.01e-2)" "unprognostic (1.32e-1)" "unprognostic (4.15e-1)" "unprognostic (1.10e-1)" "unprognostic (1.82e-3)" "unprognostic (3.26e-1)" "prognostic favourable (1.37e-4)" "unprognostic (6.18e-2)" "unprognostic (5.63e-2)" "unprognostic (8.71e-2)" "unprognostic (5.22e-3)" 7.5 3.3 1.9 8.6 2.9 2.1 8.0 1.7 1.9 8.3 22.2 3.4 5.6 11.4 12.5 9.7 14.9 7.5 24.9 7.8 2.5 2.6 13.2 12.6 20.7 6.4 2.7 1.4 5.4 8.4 4.6 48.5 30.7 17.0 8.0 6.4 11.8 14.2 3.2 5.0 4.5 38.1 18.5 4.6 1.5 9.8 8.6 1.0 0.2 22.0 12.2 5.3 10.7 11.2 0.1 6.6 3.9 5.7 0.0 0.1 1.4 9.9 3.8 0.5 2.9 6.6 15.4 0.2 12.3 9.3 5.8 6.1 1.7 20.7 0.7 4.9 19.4 3.7 7.1 10.8 10.4 2.8 2.8 0.4 8.4 0.5 7.6 6.7 0.0 5.3 7.6 11.3 13.8 12.8 0.1 0.2 9.2 3.3 0.2 0.0 0.3 4.2 0.2 5.0 1.4 15.5 4.9 1.0 0.0 9.3 13.4 1.6 7.2 0.1 21.8 7.0 11.1 10.0 5.6 0.7 0.2 0.4 9.4 1.6 2.9 0.0 5.7 3.9 0.0 2.4 0.0 0.1 0.0 0.0 6.6 0.1 0.1 0.0 0.5 0.0 2.0 0.0 0.0 1.4 1.9 2.9 1.7 1.9 2.5 2.6 2.7 1.4 17.0 1.0 SLC10A7 "C4orf13, DKFZp313H0531, DKFZp566M114, DKFZp779O2438, MGC25043" ENSG00000120519 "Solute carrier family 10 member 7" Q0GE19 4 146253975-146521964 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Amelogenesis imperfecta, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039996 Uncertain "HPA039996: AB_10673266" "unprognostic (9.44e-2)" "unprognostic (4.03e-1)" "unprognostic (3.39e-3)" "unprognostic (5.07e-2)" "unprognostic (1.01e-1)" "unprognostic (9.02e-2)" "unprognostic (7.96e-2)" "unprognostic (2.54e-1)" "unprognostic (3.55e-1)" "unprognostic (8.53e-2)" "unprognostic (2.68e-3)" "unprognostic (1.24e-1)" "unprognostic (1.43e-2)" "unprognostic (8.99e-2)" "unprognostic (2.79e-1)" "unprognostic (6.69e-2)" "unprognostic (9.57e-2)" 12.0 10.7 8.0 8.1 14.3 8.8 11.3 17.0 10.5 13.5 11.8 10.0 17.4 7.8 13.2 21.4 14.9 9.2 9.7 8.3 8.6 6.4 8.6 17.2 16.0 13.9 10.9 6.9 12.0 14.5 7.9 22.2 15.0 11.2 11.1 16.2 7.8 15.5 16.0 8.8 9.4 10.3 10.3 19.3 11.0 16.3 6.6 11.7 16.8 12.3 9.2 12.8 10.2 12.7 6.7 6.4 11.5 7.7 7.5 7.8 3.7 3.7 1.3 9.3 3.9 7.0 8.4 4.6 4.8 6.3 4.4 4.5 3.6 16.4 7.3 3.4 5.2 4.0 5.4 6.6 5.3 8.2 2.6 8.8 3.1 6.3 4.4 15.3 14.0 4.1 5.5 5.2 6.7 7.9 9.7 19.2 3.2 2.7 11.4 3.7 1.8 6.3 6.3 6.8 10.0 3.1 2.9 2.8 2.5 3.2 9.8 3.9 5.8 6.1 4.4 3.9 4.2 6.0 3.3 16.2 17.6 10.0 5.4 6.4 5.6 11.5 5.1 6.8 6.4 7.7 6.6 6.7 6.5 5.8 6.4 4.5 6.0 5.9 0.5 7.5 5.9 4.4 7.8 3.7 8.0 14.3 17.0 10.5 8.6 6.4 10.9 6.9 11.2 11.7 SLC12A1 NKCC2 ENSG00000074803 "Solute carrier family 12 member 1" Q13621 15 48178438-48304078 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Sodium transport, Symport, Transport" "Bartter syndrome, Disease mutation, FDA approved drug targets, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 75 "kidney: 143.2" "Cell line enriched" "Detected in single" 26 "RPTEC TERT1: 23.7" "Cancer enhanced" "Detected in single" "renal cancer: 1.0" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 9 "basophil: 1.9;neutrophil: 1.5" "Lineage enriched" "Detected in single" 10 "granulocytes: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA014967, HPA018107" Enhanced Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA014967: AB_1854503, HPA018107: AB_1854504" "unprognostic (3.52e-2)" "unprognostic (1.30e-2)" "unprognostic (9.65e-2)" "unprognostic (1.74e-2)" "unprognostic (7.77e-2)" "unprognostic (1.04e-1)" "unprognostic (8.72e-2)" "unprognostic (2.06e-1)" "unprognostic (9.85e-3)" "unprognostic (2.81e-4)" "unprognostic (9.75e-2)" "unprognostic (2.61e-1)" "unprognostic (5.47e-2)" "unprognostic (2.03e-1)" "unprognostic (5.20e-4)" "unprognostic (8.52e-2)" 0.0 0.0 0.3 0.0 1.0 0.0 0.0 1.4 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 143.2 0.1 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.1 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.9 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.7 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 1.5 0.1 0.0 0.1 0.0 0.0 0.3 1.0 1.4 1.5 0.1 0.3 0.3 0.4 1.4 0.1 SLC12A4 KCC1 ENSG00000124067 "Solute carrier family 12 member 4" Q9UP95 16 67943474-67969601 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Symport, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041138 Approved Approved Endosomes Endosomes "HPA041138: AB_10794544" "unprognostic (5.07e-2)" "unprognostic (6.18e-2)" "unprognostic (1.25e-1)" "unprognostic (2.68e-2)" "unprognostic (9.28e-2)" "unprognostic (1.48e-2)" "unprognostic (4.28e-2)" "unprognostic (3.26e-3)" "unprognostic (9.58e-2)" "unprognostic (1.55e-1)" "unprognostic (2.01e-2)" "unprognostic (1.81e-2)" "prognostic favourable (2.25e-6)" "unprognostic (6.42e-2)" "unprognostic (1.42e-1)" "unprognostic (7.64e-2)" "unprognostic (2.26e-1)" 16.6 18.3 9.2 8.0 8.8 3.1 26.5 7.0 12.7 19.4 16.5 20.1 12.0 5.1 20.7 9.7 11.8 13.8 15.5 24.4 12.2 5.2 10.7 17.1 19.5 6.6 11.4 8.2 14.2 11.9 30.1 8.1 32.6 18.1 17.8 4.3 23.0 10.5 20.7 14.6 16.9 8.6 27.4 10.0 10.2 10.9 17.6 9.8 8.8 21.0 9.1 8.4 16.5 16.6 1.0 2.4 8.3 5.4 2.7 1.6 1.6 5.0 6.8 5.2 9.9 17.4 15.3 28.3 15.4 16.0 13.3 11.6 13.5 8.1 1.7 7.6 21.3 9.2 2.4 19.1 10.1 1.8 2.0 1.3 8.8 14.7 19.8 0.1 6.3 16.9 12.5 17.9 6.5 8.2 4.0 1.5 18.2 0.7 1.9 5.0 3.9 3.6 2.0 9.9 1.6 7.3 4.4 0.0 3.2 29.4 1.8 2.6 14.0 2.0 11.1 19.0 13.5 8.4 6.6 9.2 2.3 3.0 11.1 1.4 16.4 8.3 3.9 2.0 1.5 5.4 1.0 0.4 0.9 0.9 2.4 1.0 0.8 0.7 1.4 2.7 3.8 1.1 1.6 1.6 9.2 8.8 7.0 8.6 12.2 5.2 11.4 8.2 18.1 9.8 SLC12A5 "KCC2, KIAA1176" ENSG00000124140 "Solute carrier family 12 member 5" Q9H2X9 20 46021690-46060152 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Symport, Transport" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 64.6" "Cell line enhanced" "Detected in many" "Hep G2: 13.4;NB-4: 27.6;SK-BR-3: 14.0;U-2 OS: 16.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 5.7" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072058 Enhanced "HPA072058: " "unprognostic (2.01e-1)" "unprognostic (3.58e-1)" "unprognostic (7.55e-2)" "unprognostic (9.44e-4)" "prognostic unfavourable (5.60e-4)" "unprognostic (2.48e-1)" "unprognostic (5.16e-3)" "unprognostic (3.61e-1)" "unprognostic (2.49e-1)" "unprognostic (6.63e-2)" "unprognostic (3.72e-3)" "unprognostic (5.61e-4)" "unprognostic (8.78e-4)" "unprognostic (3.25e-2)" "unprognostic (9.22e-2)" "unprognostic (1.99e-1)" "unprognostic (2.34e-2)" 1.4 11.2 21.1 2.0 28.8 1.5 1.7 52.1 64.6 2.3 2.1 2.7 0.0 2.2 1.6 2.2 1.3 1.7 1.9 2.1 20.5 19.2 1.4 2.2 2.7 3.1 9.5 32.1 2.0 3.6 1.5 4.8 3.3 15.3 1.5 2.1 4.9 1.9 1.8 1.5 1.5 2.1 1.6 6.3 2.8 3.1 3.4 5.8 0.0 1.3 0.0 2.6 1.2 0.5 1.3 0.2 0.1 1.5 0.7 5.7 1.3 0.0 8.4 3.7 2.7 0.3 0.0 0.8 0.3 0.0 0.0 0.3 1.1 0.0 3.1 12.8 0.2 0.7 2.4 1.2 0.2 2.0 3.2 2.7 1.6 13.4 1.4 0.0 3.7 0.5 0.0 0.0 0.2 0.7 5.0 0.0 0.0 12.7 1.8 27.6 1.3 4.3 3.1 2.4 0.7 1.3 0.0 4.6 6.6 1.6 14.0 4.0 5.1 7.9 1.3 1.5 16.0 0.1 0.6 0.0 2.1 4.4 3.4 3.2 0.1 0.0 1.5 0.0 2.6 0.8 1.0 1.0 0.3 0.4 0.2 1.3 5.7 3.2 0.1 0.7 0.2 0.0 3.5 1.3 21.1 28.8 52.1 36.4 20.5 19.2 9.5 32.1 15.3 5.8 SLC12A9 CIP1 ENSG00000146828 "Solute carrier family 12 member 9" Q9BXP2 7 100826820-100867009 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 32.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067536 Approved "HPA067536: " "unprognostic (6.53e-2)" "unprognostic (3.65e-1)" "unprognostic (8.75e-3)" "unprognostic (3.11e-3)" "unprognostic (3.47e-2)" "unprognostic (2.37e-2)" "unprognostic (8.38e-3)" "prognostic favourable (5.97e-4)" "unprognostic (1.17e-1)" "prognostic unfavourable (4.00e-4)" "unprognostic (2.47e-2)" "unprognostic (1.03e-2)" "prognostic unfavourable (4.92e-4)" "unprognostic (1.52e-2)" "unprognostic (6.00e-2)" "unprognostic (6.74e-3)" "unprognostic (6.38e-2)" 11.3 12.1 10.6 13.4 12.7 10.5 9.0 7.3 14.2 11.0 12.8 26.8 12.7 12.4 11.9 7.5 11.8 10.2 18.2 6.3 11.7 9.8 12.0 9.2 12.7 16.3 18.3 9.6 10.2 16.7 12.5 6.2 21.8 13.8 11.1 9.2 7.6 11.8 11.5 3.7 11.9 13.2 10.3 19.8 19.5 10.8 4.8 13.9 8.8 9.5 6.5 14.5 13.6 8.5 1.3 5.1 2.9 4.0 0.3 0.8 1.6 8.0 6.4 2.1 17.4 6.5 3.9 22.3 4.2 7.8 6.1 8.7 9.0 13.7 5.7 13.3 7.5 8.6 3.7 8.8 1.6 6.1 6.2 2.0 5.8 6.3 8.0 2.6 9.1 9.5 5.2 4.8 4.9 11.8 5.0 3.1 8.6 25.3 2.8 12.5 4.2 12.7 6.5 2.1 9.0 6.0 7.2 3.6 8.4 4.5 32.0 8.4 3.9 9.7 7.1 7.5 7.5 12.4 7.3 1.6 6.6 1.9 5.3 8.9 9.1 0.0 2.9 0.0 0.5 3.8 0.8 1.3 0.2 0.3 5.1 1.3 0.5 0.3 2.9 0.3 4.0 2.5 0.6 1.6 10.6 12.7 7.3 14.2 11.7 9.8 18.3 9.6 13.8 13.9 SLC14A1 "HsT1341, JK, RACH1, RACH2" ENSG00000141469 "Solute carrier family 14 member 1 (Kidd blood group)" Q13336 18 45687025-45752520 "Blood group antigen proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Blood group antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 44.5;prostate: 64.7;urinary bladder: 29.6" "Cell line enriched" "Detected in some" 14 "RT4: 49.9" "Group enriched" "Detected in many" 5 "glioma: 5.3;prostate cancer: 8.6;urothelial cancer: 16.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "eosinophil: 2.4;gdT-cell: 2.0;memory CD4 T-cell: 2.0;memory CD8 T-cell: 2.4;naive CD8 T-cell: 3.4;NK-cell: 1.8;T-reg: 7.2" "Group enriched" "Detected in many" 5 "granulocytes: 2.4;NK-cells: 1.8;T-cells: 7.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059570, HPA077233" Supported Supported "Plasma membrane" "Plasma membrane" "HPA059570: , HPA077233: " "unprognostic (2.04e-1)" "unprognostic (2.56e-3)" "unprognostic (5.20e-2)" "unprognostic (1.27e-1)" "unprognostic (6.86e-2)" "unprognostic (1.84e-2)" "unprognostic (1.70e-2)" "unprognostic (7.97e-2)" "unprognostic (8.17e-2)" "unprognostic (9.99e-2)" "unprognostic (2.69e-1)" "unprognostic (1.42e-1)" "unprognostic (3.02e-2)" "unprognostic (2.31e-1)" "unprognostic (1.52e-1)" "unprognostic (9.09e-2)" "unprognostic (6.93e-2)" 2.2 2.1 15.6 1.5 21.5 10.3 2.4 4.6 24.2 2.9 1.6 33.7 0.0 1.9 1.1 1.4 1.1 1.0 8.7 8.2 33.7 11.7 10.1 1.5 4.1 2.4 28.0 23.4 1.0 1.5 1.2 0.4 2.0 44.5 64.7 1.8 0.0 2.6 3.2 3.4 1.7 2.1 3.9 34.9 2.6 2.0 1.0 44.0 0.0 3.6 0.0 2.6 29.6 3.0 0.7 0.3 2.4 0.1 1.8 7.2 1.1 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.1 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.0 0.0 0.0 1.3 49.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.2 0.4 0.0 1.9 0.0 0.0 1.1 0.5 0.5 0.1 0.1 2.4 2.0 0.0 0.1 0.6 2.0 2.4 0.0 0.7 0.5 3.4 0.4 1.8 0.0 0.3 7.2 1.1 15.6 21.5 4.6 24.2 33.7 11.7 28.0 23.4 44.5 44.0 SLC15A3 "hPTR3, PHT2" ENSG00000110446 "Solute carrier family 15 member 3" Q8IY34 11 60937084-60952530 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Peptide transport, Protein transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 35.8;BJ hTERT+ SV40 Large T+ RasG12V: 43.3;HHSteC: 21.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA047880, HPA057642" Approved Supported Vesicles Vesicles "HPA047880: AB_10959455, HPA057642: " "unprognostic (5.61e-2)" "prognostic favourable (4.07e-5)" "unprognostic (8.79e-2)" "unprognostic (1.67e-2)" "unprognostic (8.48e-2)" "unprognostic (9.33e-3)" "unprognostic (1.49e-1)" "unprognostic (2.10e-1)" "unprognostic (1.10e-1)" "unprognostic (1.39e-1)" "unprognostic (1.60e-1)" "unprognostic (1.46e-1)" "unprognostic (9.78e-3)" "unprognostic (6.47e-2)" "unprognostic (4.42e-2)" "unprognostic (1.34e-1)" "unprognostic (1.02e-1)" 27.2 7.5 7.7 23.5 8.3 36.8 9.3 2.0 7.0 11.0 16.3 10.6 8.1 9.0 10.3 7.4 12.0 8.6 15.4 11.1 8.2 5.4 8.9 9.1 30.1 24.2 12.2 5.9 16.1 6.6 1.9 5.0 26.6 9.8 10.2 6.7 13.2 5.8 5.5 4.0 4.2 14.0 9.7 12.6 40.0 9.8 5.0 8.3 8.6 5.6 6.5 19.3 11.4 9.3 5.0 10.8 15.0 12.5 0.1 1.4 2.2 3.4 0.1 1.3 0.0 7.6 5.4 13.1 0.8 13.3 35.8 43.3 0.0 1.7 5.5 0.1 5.8 1.1 0.0 0.4 1.3 5.5 0.0 0.0 0.0 0.2 21.0 0.2 0.5 3.8 0.1 9.6 0.0 2.1 0.0 1.0 2.2 0.2 0.0 0.8 6.3 0.2 2.4 0.1 1.7 0.0 0.8 0.0 0.0 1.6 6.7 0.5 2.8 4.3 0.0 0.2 1.1 0.7 0.1 0.0 0.0 3.4 2.3 0.1 9.5 0.0 9.5 0.9 0.1 12.5 0.1 5.0 0.0 0.0 6.0 2.4 1.3 1.4 15.0 0.1 6.4 10.8 0.0 2.2 7.7 8.3 2.0 7.0 8.2 5.4 12.2 5.9 9.8 8.3 SLC16A1 "MCT, MCT1" ENSG00000155380 "Solute carrier family 16 member 1" P53985 1 112911847-112957013 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003324, CAB017489, HPA071055, CAB079035" Enhanced Supported Enhanced "Plasma membrane,Cell Junctions" "Plasma membrane, Cell Junctions" "CAB017489: AB_2189197, CAB079035: , HPA003324: AB_1856982, HPA071055: " "unprognostic (1.19e-1)" "unprognostic (1.61e-2)" "unprognostic (2.97e-1)" "prognostic unfavourable (8.37e-6)" "unprognostic (1.53e-1)" "unprognostic (2.89e-2)" "unprognostic (2.15e-3)" "prognostic unfavourable (4.05e-4)" "unprognostic (6.92e-2)" "unprognostic (6.31e-3)" "prognostic unfavourable (2.10e-4)" "unprognostic (1.18e-1)" "prognostic unfavourable (6.78e-8)" "unprognostic (1.30e-1)" "unprognostic (2.31e-1)" "unprognostic (1.04e-2)" "unprognostic (1.53e-3)" 11.6 7.2 17.4 8.7 19.5 3.1 4.4 10.0 24.0 4.6 23.4 12.7 3.3 18.4 19.3 15.1 10.4 8.7 8.3 39.0 19.5 12.3 6.5 26.9 3.2 5.8 19.2 6.5 6.0 1.9 5.6 3.7 18.8 16.6 8.3 18.1 22.8 2.5 6.5 31.4 7.5 9.5 20.0 16.1 4.8 14.5 17.9 22.5 4.9 5.4 17.7 6.2 9.6 6.2 3.0 5.9 0.6 3.2 2.0 11.4 2.4 19.9 4.7 14.4 12.3 10.0 8.5 47.4 10.8 8.2 8.5 13.7 15.8 11.6 21.9 15.1 9.7 19.1 20.1 20.1 16.1 13.7 20.4 18.0 12.8 18.3 17.7 22.9 1.9 11.9 24.6 12.6 24.7 20.5 22.7 14.6 9.5 3.9 13.5 11.5 46.6 15.0 12.0 22.8 15.1 10.5 0.3 16.0 8.4 20.9 0.6 16.0 0.9 8.7 13.8 8.2 14.5 16.1 15.9 7.7 6.7 22.1 23.8 14.5 10.1 0.6 3.2 0.0 4.1 2.6 6.3 3.0 4.1 4.4 5.9 2.1 4.4 3.8 0.3 2.0 0.7 1.0 11.4 2.4 17.4 19.5 10.0 24.0 19.5 12.3 19.2 6.5 16.6 22.5 SLC16A10 "MCT10, TAT1" ENSG00000112394 "Solute carrier family 16 member 10" Q8TF71 6 111087503-111231194 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 25.1;skeletal muscle: 33.4" "Cell line enhanced" "Detected in many" "HAP1: 28.8;HEK 293: 12.4;RPMI-8226: 23.8" "Cancer enriched" "Detected in many" 6 "testis cancer: 4.5" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 4.7" "Lineage enriched" "Detected in single" 5 "T-cells: 4.7" "Low region specificity" "Detected in many" HPA016860 Approved Supported "Vesicles,Cell Junctions" "Vesicles, Cell Junctions" "HPA016860: AB_2189211" "unprognostic (2.03e-1)" "unprognostic (2.08e-1)" "unprognostic (6.11e-2)" "unprognostic (3.56e-4)" "unprognostic (2.24e-1)" "unprognostic (2.15e-1)" "unprognostic (1.64e-1)" "unprognostic (1.89e-1)" "unprognostic (1.86e-3)" "unprognostic (5.22e-1)" "unprognostic (1.74e-2)" "unprognostic (1.06e-1)" "unprognostic (1.10e-3)" "unprognostic (2.73e-1)" "unprognostic (1.60e-1)" "unprognostic (1.33e-1)" "unprognostic (1.91e-1)" 7.6 4.9 1.8 2.4 5.4 0.4 1.1 9.5 2.0 0.8 4.8 1.7 1.7 7.6 0.7 1.6 0.7 1.1 1.0 2.8 1.8 1.0 8.1 9.8 6.1 1.8 0.8 0.5 1.2 25.1 8.9 1.5 17.4 5.6 1.2 1.3 3.6 3.5 6.0 33.4 12.1 6.0 0.8 1.0 2.7 3.9 3.5 0.8 19.6 2.2 1.5 0.9 4.4 1.4 0.5 0.3 0.8 0.2 0.3 4.7 0.3 0.6 0.6 0.2 1.3 0.0 0.0 2.3 0.0 0.1 0.5 0.7 5.0 0.2 4.0 0.9 0.1 0.0 28.8 0.0 0.5 0.0 12.4 4.7 0.3 4.7 0.0 4.9 4.8 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 2.0 6.1 0.6 8.9 1.8 3.5 4.3 23.8 0.0 0.4 6.7 2.1 0.1 0.6 1.1 1.1 0.7 0.0 0.1 1.1 0.3 1.6 1.9 0.0 1.0 0.2 3.7 0.5 0.8 0.2 0.1 0.2 0.2 0.2 0.2 1.1 0.3 0.0 0.5 4.7 4.0 0.8 0.3 0.1 0.3 4.0 0.3 1.8 5.4 9.5 2.0 1.8 1.0 0.8 0.5 5.6 0.8 SLC16A2 "AHDS, DXS128, MCT7, MCT8, MRX22, XPCT" ENSG00000147100 "Solute carrier family 16 member 2" P36021 X 74421461-74533917 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 43.6" "Cell line enhanced" "Detected in many" "BJ: 35.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "gdT-cell: 1.0" "Lineage enriched" "Detected in single" 11 "T-cells: 1.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072719 Approved "Plasma membrane" "Plasma membrane" "HPA072719: " "prognostic unfavourable (8.88e-5)" "unprognostic (2.48e-1)" "unprognostic (1.99e-1)" "unprognostic (2.90e-3)" "unprognostic (1.49e-1)" "unprognostic (1.58e-2)" "unprognostic (1.58e-3)" "unprognostic (2.47e-2)" "unprognostic (1.48e-1)" "unprognostic (2.54e-1)" "unprognostic (5.67e-2)" "unprognostic (3.51e-1)" "prognostic unfavourable (1.83e-4)" "unprognostic (2.15e-2)" "unprognostic (1.89e-1)" "unprognostic (6.89e-3)" "prognostic unfavourable (3.16e-4)" 13.5 24.4 10.9 5.4 12.2 0.7 4.9 5.9 14.3 9.9 5.5 8.4 1.8 4.1 9.4 2.7 5.2 6.7 10.5 10.7 8.0 5.9 9.4 43.6 6.0 1.6 4.2 8.0 14.7 6.6 12.7 12.6 10.0 8.2 9.2 2.6 11.1 5.8 7.0 3.5 2.2 3.0 7.6 4.1 1.9 4.2 1.8 5.1 6.4 13.6 4.3 3.0 5.0 5.8 0.0 0.0 0.0 0.0 0.0 1.0 0.0 3.3 4.1 3.0 16.9 8.1 4.2 0.0 35.2 10.9 14.3 8.2 0.0 0.3 0.0 0.5 13.6 0.6 0.4 14.9 8.4 2.3 1.3 0.0 0.0 0.0 0.6 0.0 0.0 6.3 3.6 7.4 8.7 0.0 0.0 0.0 3.3 0.0 0.2 1.0 11.2 3.1 6.7 8.1 0.0 7.0 0.0 0.7 5.3 3.9 19.7 0.1 0.2 0.4 0.0 13.9 3.7 15.2 17.4 0.0 0.0 0.0 15.3 0.0 0.3 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 10.9 12.2 5.9 14.3 8.0 5.9 4.2 8.0 8.2 5.1 SLC16A3 "MCT3, MCT4" ENSG00000141526 "Solute carrier family 16 member 3" O15427 17 82228397-82261129 "Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 81.2" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in single" "CAB017490, HPA021451" Approved Supported "Nuclear membrane,Plasma membrane" "Plasma membrane" "Nuclear membrane" "CAB017490: AB_2189333, HPA021451: AB_1853663" "unprognostic (2.49e-1)" "prognostic unfavourable (6.07e-4)" "unprognostic (4.31e-1)" "unprognostic (1.74e-1)" "unprognostic (3.47e-3)" "unprognostic (4.26e-3)" "prognostic unfavourable (1.19e-7)" "prognostic unfavourable (2.02e-5)" "unprognostic (2.52e-1)" "unprognostic (2.09e-2)" "unprognostic (4.35e-3)" "unprognostic (1.53e-1)" "prognostic unfavourable (3.71e-7)" "unprognostic (2.27e-1)" "unprognostic (4.00e-2)" "unprognostic (8.00e-2)" "unprognostic (1.36e-2)" 10.4 4.8 3.9 16.9 5.2 11.2 8.8 1.0 5.2 8.0 10.5 3.8 1.7 8.0 4.8 4.7 12.4 5.0 10.4 7.4 4.1 3.8 10.9 3.7 19.0 14.2 9.6 0.6 8.3 3.9 1.4 3.6 36.7 8.4 6.9 4.3 42.9 8.1 4.8 81.2 2.1 8.0 4.5 8.0 17.3 13.9 12.7 6.9 3.9 8.7 7.3 11.0 13.0 7.4 3.7 10.3 40.4 12.4 9.9 6.2 5.4 11.4 5.7 0.1 0.1 2.5 8.3 11.4 47.9 29.5 34.0 38.7 2.7 30.0 0.1 37.7 33.7 4.1 4.1 69.4 14.3 20.6 0.2 21.8 42.6 50.0 43.9 32.0 27.0 17.0 10.2 22.9 10.5 18.5 0.1 6.8 29.5 3.1 0.3 31.6 0.4 46.6 0.1 0.5 7.5 18.0 0.5 0.7 0.3 46.0 41.0 0.5 5.9 27.0 31.9 67.9 1.1 1.0 49.9 22.0 0.3 1.0 33.3 20.3 0.5 17.5 12.4 34.6 4.1 11.7 6.2 3.7 3.5 4.6 10.3 2.8 1.8 2.2 40.4 9.9 11.8 6.1 3.0 5.4 3.9 5.2 1.0 5.2 4.1 3.8 9.6 0.6 8.4 6.9 SLC16A5 "MCT5, MCT6" ENSG00000170190 "Solute carrier family 16 member 5" O15375 17 75087727-75106162 "Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A549: 23.2;RPTEC TERT1: 24.9;RT4: 49.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "classical monocyte: 8.4;neutrophil: 22.1" "Group enriched" "Detected in many" 6 "granulocytes: 22.1;monocytes: 8.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "unprognostic (1.86e-2)" "unprognostic (1.18e-1)" "unprognostic (1.98e-1)" "unprognostic (2.51e-2)" "unprognostic (2.90e-2)" "unprognostic (2.72e-1)" "unprognostic (6.30e-2)" "unprognostic (2.55e-1)" "unprognostic (1.61e-1)" "unprognostic (5.26e-2)" "unprognostic (8.43e-3)" "unprognostic (8.07e-2)" "unprognostic (9.63e-2)" "unprognostic (3.53e-3)" "unprognostic (5.44e-2)" "unprognostic (1.07e-2)" "unprognostic (1.80e-1)" 6.0 1.0 0.9 6.3 1.0 4.1 4.9 2.0 1.1 8.9 18.7 1.5 7.5 19.4 6.6 14.6 6.9 9.4 15.3 8.6 1.2 0.9 35.0 2.3 16.9 7.5 1.7 1.2 8.3 4.1 3.6 2.0 30.8 2.3 13.0 5.7 9.5 5.2 15.2 7.9 8.8 30.5 4.7 1.5 6.8 14.6 4.9 1.0 1.8 13.3 9.5 8.8 15.3 11.0 0.7 2.5 22.1 8.4 0.6 1.0 2.4 4.9 23.2 0.4 0.0 1.2 1.5 7.9 2.7 7.1 2.7 2.0 6.0 14.1 0.0 3.3 8.4 14.1 1.1 3.8 1.0 0.0 0.0 1.7 10.8 3.0 5.5 0.0 0.0 3.7 4.6 2.8 0.0 5.6 0.3 0.0 0.2 0.8 0.1 2.4 1.8 0.0 0.5 0.0 0.1 24.9 49.3 0.0 0.1 6.8 1.6 3.4 11.4 2.5 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.5 1.5 2.4 8.4 2.1 0.3 3.1 0.2 0.7 0.4 0.1 2.5 0.2 1.0 0.3 22.1 0.6 1.6 0.0 0.4 2.4 0.9 1.0 2.0 1.1 1.2 0.9 1.7 1.2 2.3 1.0 SLC19A1 "FOLT, RFC1" ENSG00000173638 "Solute carrier family 19 member 1" P41440 21 45493572-45544411 "Cancer-related genes, Predicted membrane proteins, Transporters" "Antiport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 37.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 37.6" "Lineage enriched" "Detected in many" 6 "granulocytes: 37.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024802 Approved Approved "Plasma membrane" "Plasma membrane" "HPA024802: AB_10602892" "unprognostic (4.31e-3)" "prognostic unfavourable (4.15e-4)" "unprognostic (5.23e-2)" "unprognostic (2.02e-1)" "unprognostic (3.11e-1)" "unprognostic (3.04e-2)" "unprognostic (7.34e-2)" "unprognostic (2.87e-3)" "unprognostic (4.04e-2)" "unprognostic (4.09e-2)" "unprognostic (2.85e-1)" "unprognostic (2.39e-1)" "prognostic unfavourable (1.07e-10)" "unprognostic (1.44e-1)" "unprognostic (2.31e-1)" "unprognostic (7.97e-5)" "unprognostic (3.10e-1)" 9.0 7.8 7.1 8.2 13.5 10.5 12.5 9.6 8.9 5.0 9.7 6.0 9.4 31.2 4.3 4.6 2.3 4.6 3.5 3.2 7.1 6.1 4.7 14.1 13.9 14.1 8.7 4.4 8.1 5.4 1.8 3.5 32.9 11.5 4.7 2.0 17.8 6.0 3.5 3.5 6.1 16.5 2.3 5.9 11.7 5.7 3.4 3.4 11.8 9.6 2.8 4.1 3.1 3.1 0.9 4.9 37.6 6.4 0.4 1.1 2.4 10.4 9.5 1.9 7.8 0.6 0.8 15.6 4.9 0.8 4.5 2.9 22.0 9.7 9.7 9.8 1.2 5.4 3.9 3.6 1.1 8.9 19.0 20.5 5.2 15.3 2.7 13.3 3.2 1.0 2.7 4.9 1.6 3.7 24.4 4.3 1.6 11.7 18.1 12.4 11.2 11.2 24.6 2.2 28.3 2.0 6.3 11.7 10.3 5.5 9.1 4.2 6.9 15.8 4.5 5.9 7.4 1.6 8.0 1.8 6.5 8.8 2.6 21.8 4.7 0.6 6.4 8.5 0.3 6.0 1.1 0.9 0.5 0.7 4.9 0.3 0.8 0.5 37.6 0.4 3.7 1.5 1.0 2.4 7.1 13.5 9.6 8.9 7.1 6.1 8.7 4.4 11.5 3.4 SLC19A2 "THTR1, TRMA" ENSG00000117479 "Solute carrier family 19 member 2" O60779 1 169463909-169486003 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Deafness, Diabetes mellitus, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 75.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006119, HPA016599" Uncertain Approved Cytosol Cytosol "HPA006119: AB_1079996, HPA016599: AB_1857005" "prognostic favourable (8.41e-4)" "unprognostic (8.82e-2)" "unprognostic (1.90e-1)" "unprognostic (3.29e-3)" "prognostic favourable (2.90e-4)" "unprognostic (4.45e-2)" "unprognostic (9.69e-2)" "unprognostic (1.45e-1)" "unprognostic (2.86e-2)" "unprognostic (1.60e-1)" "unprognostic (1.76e-1)" "unprognostic (1.65e-1)" "prognostic favourable (2.70e-5)" "unprognostic (1.08e-1)" "unprognostic (2.09e-1)" "unprognostic (3.60e-2)" "unprognostic (2.14e-2)" 23.1 11.1 1.9 5.3 4.4 4.8 14.2 7.4 6.1 5.9 5.4 2.8 2.7 2.1 5.0 9.0 7.5 10.0 17.5 14.8 2.7 2.1 8.6 23.4 9.2 3.1 2.8 1.7 10.3 14.4 6.8 16.3 22.1 4.7 9.4 2.8 16.4 10.4 4.6 75.7 7.5 6.6 11.3 3.7 1.8 9.4 7.3 1.8 3.6 7.9 21.6 3.9 10.4 9.8 1.4 1.9 3.0 4.6 2.6 3.3 0.7 4.4 3.1 7.2 5.6 22.3 8.2 15.8 3.6 2.6 2.9 4.2 12.8 4.7 4.0 4.1 2.4 4.8 8.6 5.2 3.3 11.3 8.1 3.8 10.2 11.7 12.2 9.4 3.7 9.7 7.7 4.7 12.0 4.3 15.0 2.5 4.9 3.0 4.8 4.2 16.2 4.8 0.0 15.5 4.5 7.7 9.5 6.2 8.4 4.9 8.5 17.4 5.3 6.1 3.6 3.5 4.9 4.3 6.9 3.5 3.3 1.3 5.2 3.7 4.6 0.0 1.7 3.0 0.9 0.7 3.3 1.4 1.1 2.1 1.9 1.2 3.1 3.0 1.1 2.6 4.6 0.7 1.0 0.7 1.9 4.4 7.4 6.1 2.7 2.1 2.8 1.7 4.7 1.8 SLC19A3 THTR2 ENSG00000135917 "Solute carrier family 19 member 3" Q9BZV2 2 227683763-227718031 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 48.2;breast: 78.2;placenta: 27.5" "Cell line enhanced" "Detected in some" "ASC diff: 14.1;BEWO: 7.2;CACO-2: 18.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 8.6" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038898 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" Nucleoplasm "Plasma membrane, Cytosol" "HPA038898: AB_10673481" "unprognostic (3.37e-2)" "unprognostic (3.59e-5)" "unprognostic (1.95e-3)" "unprognostic (1.24e-2)" "unprognostic (1.22e-1)" "unprognostic (6.82e-2)" "unprognostic (1.93e-2)" "unprognostic (1.67e-1)" "unprognostic (1.19e-1)" "unprognostic (2.04e-1)" "unprognostic (4.67e-2)" "unprognostic (3.12e-3)" "unprognostic (7.28e-2)" "unprognostic (8.20e-2)" "unprognostic (1.68e-1)" "unprognostic (1.71e-2)" "unprognostic (7.01e-3)" 48.2 0.6 2.2 1.8 2.4 1.2 78.2 1.5 1.9 0.5 6.1 1.0 0.5 7.7 0.6 0.4 0.6 0.6 8.9 1.9 2.3 2.4 2.1 16.0 5.6 1.3 3.0 0.7 0.9 1.3 0.2 0.3 27.5 2.6 0.5 1.6 0.7 0.9 0.2 0.7 1.6 4.5 0.5 2.6 0.5 0.5 0.6 1.5 0.0 0.5 0.4 0.4 1.0 2.3 2.6 1.8 8.6 1.8 4.3 1.1 0.4 0.3 1.6 0.3 1.0 14.1 0.4 7.2 0.1 0.2 0.3 0.6 18.4 0.5 0.4 0.2 0.1 0.5 0.5 0.5 0.8 0.1 1.2 0.1 0.9 0.7 1.7 0.2 0.2 3.2 0.4 0.1 0.9 0.0 0.2 0.8 0.0 1.8 0.1 0.6 3.2 0.3 0.3 0.2 0.2 0.2 0.3 1.0 0.1 0.5 2.0 0.5 0.3 0.2 0.5 0.5 0.5 4.1 0.3 0.2 0.1 0.6 1.4 0.3 0.4 8.6 1.8 1.7 1.0 1.2 0.6 1.6 0.8 0.9 0.4 2.6 1.0 1.1 6.1 4.3 1.1 1.8 0.4 0.4 2.2 2.4 1.5 1.9 2.3 2.4 3.0 0.7 2.6 1.5 SLC1A5 "AAAT, ASCT2, M7V1, RDRC" ENSG00000105281 "Solute carrier family 1 member 5" Q15758 19 46774883-46788594 "FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Host-virus interaction, Symport, Transport" "Host cell receptor for virus entry, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 34.6" "Group enriched" "Detected in many" 4 "dendritic cells: 34.6;monocytes: 22.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA035239, HPA035240" Enhanced Enhanced "Plasma membrane" "Plasma membrane" "HPA035239: AB_10670587, HPA035240: AB_10604092" "unprognostic (8.26e-3)" "unprognostic (6.38e-2)" "unprognostic (7.24e-2)" "unprognostic (7.94e-2)" "unprognostic (2.32e-1)" "unprognostic (1.24e-1)" "prognostic unfavourable (1.66e-8)" "unprognostic (2.08e-1)" "unprognostic (1.06e-2)" "unprognostic (9.82e-2)" "unprognostic (9.40e-3)" "unprognostic (9.57e-3)" "prognostic unfavourable (1.18e-7)" "unprognostic (1.28e-2)" "unprognostic (6.30e-2)" "unprognostic (1.06e-2)" "unprognostic (9.83e-2)" 39.3 5.7 3.4 16.0 5.4 16.2 45.0 0.9 3.0 20.7 15.8 5.0 50.4 4.9 14.3 33.7 33.9 18.1 31.2 10.0 4.5 2.2 23.7 4.1 23.4 17.7 8.2 0.9 33.3 24.6 0.2 9.1 25.8 4.9 35.2 13.8 5.2 99.0 55.7 6.9 18.6 12.1 23.1 5.3 19.8 17.9 21.7 6.1 14.9 6.5 28.4 25.9 48.3 44.9 7.0 34.6 0.9 22.4 6.9 5.6 7.4 24.2 44.9 10.8 16.3 28.2 24.0 25.6 34.7 39.7 26.1 37.9 40.7 27.5 26.6 17.0 86.1 39.2 31.5 41.2 19.5 17.6 28.5 44.2 17.2 38.1 73.0 30.7 26.1 39.0 103.2 30.6 77.6 13.8 46.6 70.6 13.9 41.3 14.0 82.7 18.9 19.8 16.0 12.2 37.9 14.6 53.1 16.7 12.2 17.1 46.8 37.2 26.9 40.6 10.3 15.7 25.1 12.2 28.2 43.8 42.3 22.2 29.5 38.4 38.4 0.0 11.5 0.9 5.3 19.9 4.4 7.0 3.1 3.7 17.8 2.5 0.7 2.3 0.3 6.9 22.4 34.6 5.6 7.4 3.4 5.4 0.9 3.0 4.5 2.2 8.2 0.9 4.9 6.1 SLC22A15 FLIPT1 ENSG00000163393 "Solute carrier family 22 member 15" Q8IZD6 1 115976498-116070054 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 34.6;brain: 27.8" "Cell line enhanced" "Detected in many" "hTCEpi: 20.6;hTERT-HME1: 27.4;NB-4: 14.9;THP-1: 16.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 3.9" "Group enriched" "Detected in many" 7 "granulocytes: 3.9;monocytes: 2.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019785 Approved "HPA019785: AB_1857011" "unprognostic (3.81e-1)" "unprognostic (1.11e-2)" "unprognostic (7.65e-3)" "unprognostic (1.01e-3)" "unprognostic (5.62e-2)" "unprognostic (5.22e-2)" "unprognostic (5.85e-5)" "unprognostic (8.91e-3)" "unprognostic (1.81e-1)" "unprognostic (4.97e-2)" "unprognostic (5.15e-2)" "unprognostic (9.06e-2)" "unprognostic (7.29e-3)" "unprognostic (8.78e-3)" "unprognostic (3.44e-1)" "unprognostic (9.97e-4)" "unprognostic (1.30e-1)" 2.9 4.5 7.0 3.2 14.1 34.6 2.3 8.6 11.1 2.6 2.1 27.8 0.7 1.7 1.9 2.2 5.5 2.4 2.9 6.1 9.9 8.0 4.9 1.3 6.3 1.7 20.0 8.1 2.0 4.2 7.5 4.5 2.9 15.1 2.8 2.7 2.5 4.6 2.7 0.8 11.8 1.7 1.7 14.1 3.5 4.8 1.8 17.6 0.0 4.0 0.8 1.9 2.5 4.6 0.5 0.3 3.9 2.9 0.2 0.0 0.3 1.6 0.1 1.2 0.0 2.1 2.6 0.8 2.6 3.9 1.6 2.9 0.0 0.3 1.8 2.9 1.3 2.5 2.0 5.4 1.6 0.0 1.3 1.7 1.8 0.2 7.2 2.7 2.4 2.6 20.6 0.0 27.4 0.0 0.1 0.0 2.6 1.4 0.0 14.9 1.7 1.3 0.0 0.0 0.0 2.2 0.9 1.2 1.1 4.5 0.9 7.6 0.2 16.2 0.0 2.9 1.6 0.5 0.6 2.7 2.5 0.2 3.0 4.4 4.5 1.0 2.5 0.9 0.0 0.7 0.0 0.5 0.0 0.0 0.3 0.1 0.0 0.0 3.9 0.2 2.9 0.0 0.0 0.3 7.0 14.1 8.6 11.1 9.9 8.0 20.0 8.1 15.1 17.6 SLC22A23 "C6orf85, FLJ22174" ENSG00000137266 "Solute carrier family 22 member 23" A1A5C7 6 3268962-3457022 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "T-47d: 18.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014697 Approved Approved Nucleoplasm,Vesicles,Cytosol "Nucleoplasm, Vesicles" Cytosol "HPA014697: AB_1844371" "unprognostic (4.58e-2)" "unprognostic (2.48e-1)" "unprognostic (1.05e-1)" "prognostic favourable (6.57e-4)" "unprognostic (5.16e-3)" "unprognostic (3.25e-3)" "unprognostic (1.40e-1)" "unprognostic (4.53e-3)" "unprognostic (9.74e-2)" "unprognostic (2.87e-2)" "unprognostic (1.07e-2)" "unprognostic (2.62e-2)" "prognostic unfavourable (2.39e-4)" "unprognostic (8.91e-2)" "unprognostic (4.30e-1)" "unprognostic (4.06e-2)" "unprognostic (1.74e-1)" 7.4 2.2 9.0 4.6 16.2 8.1 9.3 8.4 14.8 5.6 17.4 30.8 3.4 19.6 3.6 11.8 16.8 11.3 7.5 2.2 11.0 8.1 6.9 12.6 8.0 3.9 28.6 8.7 3.0 14.9 14.8 6.5 8.3 17.8 14.2 14.4 5.7 10.0 2.8 5.9 14.9 20.3 3.0 17.5 4.6 26.0 7.2 21.0 5.2 4.1 9.8 9.9 3.8 9.9 0.1 0.7 0.8 0.3 0.3 1.4 1.9 2.4 5.7 12.6 14.0 4.5 5.0 16.1 0.4 0.1 0.7 0.3 12.6 0.4 0.6 1.5 2.7 3.6 2.5 6.7 0.2 2.0 7.8 5.9 2.2 11.1 0.6 0.3 0.4 1.2 13.2 12.2 0.6 0.4 5.3 3.4 0.4 2.9 0.5 1.4 4.3 2.3 1.3 0.8 10.0 0.0 15.4 1.4 0.2 3.3 4.8 4.1 18.7 0.1 3.1 7.4 2.3 9.5 1.5 7.6 0.1 0.2 12.9 0.4 4.5 0.0 0.3 0.0 0.4 0.0 0.2 0.0 1.0 0.4 0.2 0.1 1.4 0.9 0.8 0.3 0.2 0.7 0.0 1.9 9.0 16.2 8.4 14.8 11.0 8.1 28.6 8.7 17.8 21.0 SLC22A7 "NLT, OAT2" ENSG00000137204 "Solute carrier family 22 member 7" Q9Y694 6 43295694-43305538 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "liver: 88.9" "Cell line enriched" "Detected in single" 19 "Hep G2: 14.5" "Cancer enriched" "Detected in some" 37 "liver cancer: 81.5" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 4 "naive B-cell: 1.2" "Lineage enriched" "Detected in single" 4 "B-cells: 1.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in single" HPA030220 Approved "HPA030220: AB_10603027" "unprognostic (9.17e-2)" "unprognostic (9.73e-4)" "unprognostic (2.13e-1)" "prognostic favourable (5.48e-6)" "unprognostic (1.45e-1)" "unprognostic (1.54e-3)" "unprognostic (1.74e-2)" "prognostic favourable (8.98e-4)" "unprognostic (1.29e-1)" "unprognostic (1.07e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 13.8 88.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 14.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.7 0.2 0.0 0.0 0.5 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 SLC23A2 "KIAA0238, SLC23A1, SVCT2, YSPL2" ENSG00000089057 "Solute carrier family 23 member 2" Q9UGH3 20 4852356-5010293 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 55.6" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052825, HPA059314" Approved Uncertain "Golgi apparatus,Vesicles" Vesicles "Golgi apparatus" "HPA052825: , HPA059314: " "unprognostic (3.83e-1)" "unprognostic (1.08e-2)" "unprognostic (1.95e-3)" "unprognostic (1.64e-3)" "unprognostic (8.05e-2)" "unprognostic (2.09e-1)" "prognostic favourable (3.35e-4)" "unprognostic (6.22e-3)" "unprognostic (2.08e-1)" "unprognostic (6.36e-3)" "prognostic favourable (7.14e-5)" "unprognostic (1.57e-1)" "unprognostic (1.60e-2)" "unprognostic (2.63e-1)" "unprognostic (1.11e-1)" "unprognostic (1.33e-1)" "prognostic favourable (6.08e-5)" 6.6 55.6 14.7 6.1 17.5 5.4 6.3 15.9 27.2 8.6 4.6 19.3 4.0 5.0 9.5 7.1 4.6 12.4 7.8 5.4 14.4 14.5 6.0 27.7 7.4 7.2 14.9 16.6 29.4 7.5 15.1 12.5 25.1 16.4 9.0 5.0 22.1 4.2 8.4 2.6 8.5 6.3 7.8 17.5 11.7 7.1 8.5 11.4 5.3 18.6 2.2 7.4 18.7 6.4 4.2 6.0 3.1 2.5 0.8 2.8 2.0 10.5 12.4 16.8 6.3 11.8 6.7 21.3 4.5 6.2 5.4 5.0 6.4 12.1 4.8 4.9 6.2 10.3 4.6 12.3 10.2 3.0 8.3 6.7 2.1 24.0 6.7 9.3 4.0 5.6 7.2 13.4 8.1 7.8 4.5 4.1 7.1 3.9 10.2 5.2 5.9 7.7 9.4 11.1 7.2 2.9 17.3 5.6 6.3 8.7 9.2 32.2 5.1 5.5 6.7 12.1 5.6 14.4 8.7 5.8 10.8 13.0 4.3 5.6 18.9 0.0 2.5 0.2 2.8 1.8 2.6 4.2 2.2 2.0 3.6 2.9 2.1 2.1 3.1 0.8 2.1 6.0 1.3 2.0 14.7 17.5 15.9 25.3 14.4 14.5 14.9 16.6 16.4 11.4 SLC25A17 PMP34 ENSG00000100372 "Solute carrier family 25 member 17" O43808 22 40769630-40819399 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052708, HPA060972" Approved Supported Peroxisomes Peroxisomes "HPA052708: , HPA060972: " "unprognostic (2.75e-1)" "unprognostic (1.11e-3)" "unprognostic (1.91e-3)" "unprognostic (2.44e-2)" "unprognostic (2.61e-1)" "unprognostic (1.96e-2)" "unprognostic (2.85e-3)" "unprognostic (2.16e-1)" "unprognostic (1.72e-1)" "unprognostic (1.63e-3)" "unprognostic (8.44e-2)" "unprognostic (2.72e-1)" "unprognostic (5.59e-2)" "unprognostic (8.54e-2)" "unprognostic (1.55e-1)" "unprognostic (1.76e-1)" "unprognostic (1.18e-1)" 9.7 15.0 10.2 10.2 10.9 3.3 16.8 12.9 14.1 11.8 7.2 12.2 7.5 6.4 22.4 22.6 8.7 13.7 7.4 5.5 10.4 13.4 18.6 19.7 9.0 11.8 10.3 7.7 26.5 12.4 14.3 13.0 14.9 11.9 12.6 8.7 9.5 11.4 10.3 4.6 10.9 7.1 12.1 11.4 8.8 8.9 12.1 9.5 12.6 14.7 10.4 11.2 7.1 8.7 10.2 6.8 5.9 4.9 10.3 11.7 6.4 13.2 7.3 12.4 10.8 7.9 9.5 10.1 12.1 13.2 19.2 21.2 10.6 5.0 15.7 7.4 11.8 10.6 18.0 9.9 19.7 16.1 24.2 17.6 11.4 11.0 11.1 20.2 9.4 9.5 13.3 17.0 10.9 11.7 25.3 7.5 15.6 11.4 12.2 13.1 10.5 12.1 13.3 19.3 22.8 15.8 11.3 8.6 7.8 24.8 15.3 14.7 12.7 6.0 6.8 10.8 14.8 9.6 10.9 8.3 16.1 14.9 11.8 10.2 11.8 5.9 4.4 5.1 7.0 4.9 9.2 10.2 8.1 7.5 5.7 9.5 11.7 9.3 1.8 10.3 3.9 6.8 10.8 6.4 10.2 10.9 12.9 14.1 10.4 13.4 10.3 7.7 11.9 9.5 SLC26A7 SUT2 ENSG00000147606 "Solute carrier family 26 member 7" Q8TE54 8 91209494-91398152 "Predicted membrane proteins" "Anion exchange, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "thyroid gland: 194.5" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.7;EFO-21: 1.3;HAP1: 2.9;HEK 293: 1.6;U-266/70: 3.1" "Group enriched" "Detected in some" 11 "renal cancer: 8.7;thyroid cancer: 32.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "unprognostic (1.63e-1)" "unprognostic (1.17e-1)" "unprognostic (5.84e-2)" "unprognostic (8.04e-3)" "unprognostic (4.15e-3)" "unprognostic (1.51e-1)" "unprognostic (2.39e-3)" "unprognostic (2.94e-3)" "unprognostic (1.24e-1)" "unprognostic (1.43e-1)" "unprognostic (1.41e-2)" "unprognostic (8.26e-2)" "unprognostic (4.82e-2)" "unprognostic (3.31e-2)" "unprognostic (2.07e-1)" "unprognostic (5.19e-3)" "unprognostic (6.83e-3)" 0.3 0.1 0.1 0.4 0.1 0.0 0.2 0.1 0.2 1.6 0.2 0.0 0.2 0.0 1.4 0.2 0.3 0.1 0.1 0.3 0.1 0.1 13.0 0.1 0.1 1.7 0.1 0.0 0.1 0.3 0.1 0.3 4.4 0.7 0.1 0.0 8.6 0.8 0.1 0.2 0.2 0.1 0.0 0.3 0.1 1.5 0.2 0.0 0.0 194.5 0.0 0.0 0.1 0.1 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.2 1.3 0.0 0.0 2.9 0.1 0.2 0.0 1.6 0.3 0.1 0.0 0.0 0.0 1.1 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.6 3.1 0.7 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.7 0.0 SLC29A1 ENT1 ENSG00000112759 "Solute carrier family 29 member 1 (Augustine blood group)" Q99808 6 44219505-44234151 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 117.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 25 "eosinophil: 117.2" "Lineage enriched" "Detected in many" 25 "granulocytes: 117.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012384 Approved "HPA012384: AB_1857073" "unprognostic (1.82e-2)" "unprognostic (1.41e-2)" "unprognostic (1.81e-1)" "unprognostic (2.49e-3)" "unprognostic (2.76e-1)" "unprognostic (5.13e-2)" "unprognostic (1.05e-1)" "unprognostic (1.07e-2)" "unprognostic (1.30e-1)" "unprognostic (1.17e-1)" "unprognostic (2.36e-1)" "unprognostic (1.76e-1)" "prognostic unfavourable (2.96e-4)" "unprognostic (1.38e-2)" "unprognostic (4.60e-2)" "unprognostic (9.02e-2)" "unprognostic (1.34e-1)" 42.9 40.9 5.8 9.4 9.6 17.9 57.2 10.4 15.2 21.2 35.8 5.9 6.9 5.2 19.8 11.7 22.8 14.9 24.4 46.8 5.4 6.4 14.7 23.2 15.3 14.4 5.5 8.4 12.5 35.8 8.7 15.2 23.2 9.8 21.4 7.4 18.0 15.7 8.4 53.0 23.8 12.4 39.0 5.3 11.4 33.0 8.8 4.8 53.9 18.8 17.2 11.1 28.7 20.7 0.5 4.7 117.2 4.5 0.3 0.9 0.7 16.5 16.5 11.8 18.9 18.1 1.7 70.4 12.2 4.8 17.1 11.7 17.9 6.8 33.6 12.3 3.6 20.6 21.0 14.7 10.3 19.1 19.3 29.0 11.4 23.3 2.9 32.6 28.1 2.2 3.7 25.1 8.8 42.8 39.2 19.9 9.3 18.2 26.9 21.9 17.9 11.0 18.0 23.8 40.7 9.9 9.7 15.2 19.6 3.5 11.9 8.6 16.1 20.7 64.8 9.4 15.4 12.7 23.1 13.6 17.6 42.9 5.7 26.7 11.3 1.8 1.4 117.2 0.6 4.5 0.4 0.5 0.3 0.4 0.8 0.3 0.1 0.3 0.2 0.3 3.6 4.7 0.9 0.7 5.8 9.6 10.4 15.2 5.4 6.4 5.5 8.4 9.8 4.8 SLC29A2 "DER12, ENT2, HNP36" ENSG00000174669 "Solute carrier family 29 member 2" Q14542 11 66362521-66372214 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 68.9" "Cell line enhanced" "Detected in many" "BEWO: 16.4;CAPAN-2: 21.0;T-47d: 25.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 10 "B-cells: 1.6;dendritic cells: 1.6;T-cells: 4.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018168 Approved Uncertain Nucleoplasm Nucleoplasm "HPA018168: AB_1857077" "unprognostic (3.20e-2)" "unprognostic (4.50e-2)" "unprognostic (1.05e-1)" "prognostic unfavourable (2.04e-4)" "unprognostic (3.37e-1)" "unprognostic (5.08e-2)" "unprognostic (5.64e-2)" "unprognostic (1.60e-1)" "unprognostic (1.96e-1)" "unprognostic (2.09e-1)" "unprognostic (1.76e-1)" "unprognostic (5.28e-2)" "prognostic favourable (2.78e-4)" "unprognostic (2.55e-2)" "unprognostic (1.59e-1)" "unprognostic (1.13e-1)" "unprognostic (6.38e-3)" 5.4 1.3 2.5 2.8 3.2 1.2 13.2 10.3 5.1 1.9 4.0 3.1 4.8 5.6 1.2 5.2 2.7 3.0 3.2 9.0 2.9 3.3 6.4 1.5 3.4 2.5 3.3 3.5 1.0 7.8 11.3 5.9 3.3 7.0 4.2 2.3 2.2 6.0 6.3 68.9 1.9 4.3 0.9 1.7 2.0 6.6 0.9 2.0 1.6 4.2 18.0 2.5 1.5 2.2 1.6 1.6 0.2 0.1 0.1 4.1 1.2 5.7 4.3 3.4 0.6 0.3 0.0 16.4 0.2 0.0 0.1 0.2 6.9 21.0 2.6 5.4 0.0 5.8 3.2 4.1 0.0 0.1 9.4 5.6 5.3 0.5 0.7 9.4 0.1 0.3 1.6 0.6 1.9 0.3 15.8 0.0 0.0 11.9 0.7 13.1 9.9 4.5 0.7 0.0 11.9 8.8 4.4 7.0 3.1 0.3 9.0 0.6 25.5 2.0 0.0 0.1 5.7 0.1 0.0 0.1 0.3 0.2 0.4 0.2 0.2 0.0 0.1 0.0 3.5 0.0 1.1 0.6 2.2 4.1 0.8 1.6 4.1 4.1 0.2 0.1 0.1 1.6 0.4 1.2 2.5 3.2 10.3 5.1 2.9 3.3 3.3 3.5 7.0 2.0 SLC2A8 "GLUT8, GLUTX1" ENSG00000136856 "Solute carrier family 2 member 8" Q9NY64 9 127397138-127408424 "Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CACO-2: 45.7;Hep G2: 26.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "plasmacytoid DC: 33.8" "Lineage enriched" "Detected in all" 5 "dendritic cells: 33.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011935 Uncertain Approved Vesicles Vesicles "HPA011935: AB_1849760" "unprognostic (6.49e-2)" "prognostic favourable (2.57e-6)" "unprognostic (9.13e-2)" "unprognostic (1.85e-3)" "unprognostic (4.23e-2)" "unprognostic (9.43e-3)" "unprognostic (2.62e-1)" "unprognostic (1.30e-1)" "unprognostic (6.33e-2)" "unprognostic (1.36e-1)" "prognostic favourable (9.86e-6)" "unprognostic (1.70e-1)" "prognostic favourable (6.55e-6)" "unprognostic (4.25e-2)" "unprognostic (3.55e-1)" "unprognostic (1.59e-3)" "unprognostic (2.04e-3)" 10.9 24.5 11.4 13.3 11.3 3.5 10.4 15.0 15.2 9.0 19.8 11.7 37.0 17.7 9.5 17.4 8.7 6.0 9.4 9.8 10.4 9.3 8.7 25.7 8.1 7.3 12.5 10.2 6.7 12.1 5.7 5.5 13.2 8.7 18.5 6.5 12.5 9.4 28.3 22.6 11.6 17.0 44.1 10.3 11.3 13.1 30.6 9.3 1.2 9.1 6.9 4.3 42.4 9.1 2.4 33.8 6.9 5.6 1.2 6.3 2.0 1.7 7.0 3.2 7.0 0.0 0.0 10.0 2.7 1.8 4.4 2.6 45.7 1.7 2.7 6.2 1.4 9.5 3.8 4.4 1.1 2.6 6.1 0.4 5.5 26.9 4.1 0.0 3.0 0.1 4.1 0.4 1.8 3.4 2.9 6.2 1.7 12.9 0.0 0.0 5.1 11.1 1.0 4.4 7.6 4.1 18.9 5.3 3.6 6.6 11.3 2.4 7.3 1.6 2.9 0.0 4.6 0.3 6.1 19.1 17.8 4.1 3.0 0.0 3.3 0.0 3.0 6.9 4.9 5.6 3.5 2.3 1.6 3.3 4.6 2.4 0.3 1.2 0.2 1.2 5.1 33.8 6.3 2.0 11.4 11.3 15.0 15.2 10.4 9.3 12.5 10.2 8.7 9.3 SLC30A1 "ZNT1, ZRC1" ENSG00000170385 "Solute carrier family 30 member 1" Q9Y6M5 1 211571568-211578742 "Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 53.3" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015275, HPA049000" Uncertain Supported "Vesicles,Plasma membrane" "Plasma membrane" Vesicles "HPA015275: AB_1857083, HPA049000: " "unprognostic (1.13e-1)" "unprognostic (2.67e-3)" "unprognostic (6.94e-2)" "unprognostic (1.81e-3)" "unprognostic (3.47e-1)" "unprognostic (1.80e-1)" "unprognostic (2.27e-2)" "unprognostic (1.82e-3)" "unprognostic (4.72e-1)" "unprognostic (1.01e-1)" "unprognostic (1.42e-3)" "unprognostic (4.78e-2)" "unprognostic (2.23e-2)" "unprognostic (3.03e-1)" "unprognostic (2.55e-1)" "unprognostic (1.02e-1)" "unprognostic (4.53e-2)" 11.4 16.6 9.3 7.5 11.4 15.5 17.3 5.2 13.6 13.0 15.3 6.9 4.9 17.2 7.1 7.6 9.0 9.2 12.9 6.1 9.7 7.9 13.4 53.3 12.0 3.5 9.5 8.0 9.5 8.9 8.8 4.8 9.3 8.7 7.3 8.9 7.7 5.9 9.2 3.6 13.9 28.1 7.5 8.3 10.7 6.4 12.5 5.5 3.1 11.0 5.2 4.4 7.7 8.4 0.5 2.5 3.9 4.2 1.3 1.7 1.0 4.6 6.8 3.7 4.8 16.3 7.6 33.1 12.8 9.4 6.8 6.7 2.9 22.2 2.6 11.2 11.7 8.0 5.6 7.4 8.2 6.6 4.2 2.1 13.8 6.8 9.2 7.3 4.7 11.3 18.7 8.7 14.2 4.2 8.2 12.3 8.4 4.2 1.4 4.6 11.5 5.4 4.4 1.8 9.5 21.2 12.5 3.8 6.6 12.5 6.5 28.6 3.3 9.5 6.7 5.1 11.9 17.0 10.1 5.4 8.2 2.1 4.8 7.4 4.4 3.9 3.9 1.3 1.2 4.2 1.7 0.5 0.9 0.8 2.5 0.3 0.9 1.2 0.4 1.3 3.2 1.7 0.8 1.0 9.3 11.4 5.2 13.6 9.7 7.9 9.5 8.0 8.7 5.5 SLC30A10 "DKFZp547M236, ZnT-10, ZNT8, ZRC1" ENSG00000196660 "Solute carrier family 30 member 10" Q6XR72 1 219685427-219958647 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Disease mutation, Dystonia, Neurodegeneration, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "liver: 33.4" "Cell line enhanced" "Detected in some" "HEK 293: 4.3;HEL: 2.2;Hep G2: 4.2;K-562: 2.7" "Cancer enriched" "Detected in some" 14 "liver cancer: 7.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064547 Enhanced "HPA064547: " "unprognostic (7.88e-2)" "unprognostic (1.07e-2)" "unprognostic (1.02e-1)" "unprognostic (7.25e-2)" "unprognostic (1.75e-2)" "unprognostic (3.74e-3)" "unprognostic (6.96e-2)" "unprognostic (3.72e-2)" "unprognostic (1.41e-1)" "unprognostic (1.95e-2)" "unprognostic (5.10e-2)" "unprognostic (3.10e-3)" "unprognostic (4.47e-7)" "unprognostic (3.16e-1)" "unprognostic (6.11e-2)" "unprognostic (6.19e-3)" "unprognostic (5.72e-2)" 0.3 0.3 2.9 0.7 3.5 0.4 0.3 1.8 3.9 0.3 7.1 1.9 0.0 5.9 0.3 0.3 0.3 0.3 0.5 0.3 3.5 1.6 0.3 33.4 0.3 0.3 1.7 1.7 0.6 0.3 0.3 0.4 0.4 2.5 0.3 1.7 0.6 0.3 0.3 0.3 0.3 6.8 0.3 0.8 0.3 0.3 1.9 1.9 0.0 0.3 0.0 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 4.3 2.2 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 3.5 1.8 3.9 3.5 1.6 1.7 1.7 2.5 1.9 SLC30A2 ZNT2 ENSG00000158014 "Solute carrier family 30 member 2" Q9BRI3 1 26037252-26046133 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 78.0;placenta: 20.0" "Group enriched" "Detected in some" 5 "BEWO: 4.6;RPTEC TERT1: 10.4;WM-115: 6.3" "Cancer enhanced" "Detected in many" "thyroid cancer: 19.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Region enriched" "Detected in single" 5 "olfactory region: 1.5" "Low region specificity" "Detected in some" HPA017979 Approved Vesicles Vesicles "HPA017979: AB_1857085" "unprognostic (4.87e-2)" "unprognostic (6.70e-2)" "unprognostic (3.79e-2)" "unprognostic (1.79e-3)" "unprognostic (1.11e-1)" "unprognostic (2.37e-2)" "unprognostic (2.25e-2)" "unprognostic (2.59e-1)" "unprognostic (3.67e-2)" "unprognostic (1.02e-1)" "unprognostic (6.99e-2)" "unprognostic (1.10e-1)" "prognostic favourable (2.86e-6)" "unprognostic (9.38e-2)" "unprognostic (3.50e-2)" "unprognostic (1.17e-1)" "unprognostic (3.01e-2)" 0.1 0.7 0.1 0.1 0.1 0.2 0.4 0.1 0.1 0.1 0.1 0.1 0.6 0.0 1.3 1.1 0.1 0.1 4.0 2.2 0.1 0.1 10.4 0.1 0.2 0.1 0.1 0.1 0.1 78.0 0.1 0.1 20.0 0.1 0.3 0.0 2.0 1.0 1.4 1.7 0.4 0.6 0.1 0.1 0.1 0.1 0.4 0.1 0.1 12.8 0.2 0.1 0.5 0.1 1.5 1.1 3.1 1.0 1.5 0.9 0.4 0.2 0.2 0.2 0.9 0.3 0.1 4.6 0.4 0.1 0.1 0.1 0.9 1.0 0.2 0.9 0.1 0.8 0.2 0.3 0.1 0.6 0.3 0.6 0.7 0.1 0.1 0.6 0.7 0.0 0.2 0.1 0.1 0.0 0.6 1.4 0.0 0.7 0.5 0.9 0.7 0.2 0.3 0.7 0.6 10.4 0.4 0.9 0.5 0.6 1.1 0.4 0.7 0.5 0.5 0.7 1.1 0.6 0.3 1.0 0.5 0.7 0.5 0.6 6.3 3.1 1.0 0.4 0.9 0.4 0.5 0.7 0.6 0.8 0.2 1.5 0.6 0.8 3.1 1.5 0.5 1.1 0.5 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 SLC30A3 ZNT3 ENSG00000115194 "Solute carrier family 30 member 3" Q99726 2 27253684-27275817 "Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 28.7;epididymis: 41.0;testis: 19.5" "Cell line enhanced" "Detected in some" "HAP1: 8.8;Hep G2: 11.7;REH: 18.9;RH-30: 9.8" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in many" 9 "amygdala: 15.8;basal ganglia: 11.4;cerebral cortex: 28.7;hippocampal formation: 10.2;olfactory region: 12.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "amygdala: 135.1;basal ganglia: 48.1;cerebral cortex: 108.9;hippocampal formation: 75.6" "Group enriched" "Detected in many" 7 "amygdala: 43.9;cerebral cortex: 117.8;hippocampal formation: 91.9" "HPA060505, HPA067637, CAB079044" Enhanced Approved Approved Nucleoplasm,Nucleoli,Vesicles,Cytosol Vesicles "Nucleoplasm, Nucleoli, Cytosol" "CAB079044: , HPA060505: , HPA067637: " "unprognostic (2.05e-4)" "unprognostic (1.17e-1)" "unprognostic (6.84e-4)" "unprognostic (5.26e-2)" "unprognostic (2.34e-1)" "unprognostic (1.13e-1)" "unprognostic (1.43e-2)" "unprognostic (2.93e-2)" "unprognostic (2.64e-2)" "unprognostic (3.05e-1)" "unprognostic (2.20e-1)" "unprognostic (1.89e-1)" "unprognostic (4.65e-12)" "unprognostic (3.23e-2)" "unprognostic (1.76e-1)" "unprognostic (2.74e-2)" "unprognostic (2.63e-4)" 0.5 1.9 15.8 0.5 11.4 0.5 0.4 0.4 28.7 0.5 0.5 0.0 1.9 0.4 0.5 41.0 0.4 0.7 0.4 5.0 10.2 0.8 0.4 0.5 0.5 0.8 1.1 12.1 0.5 0.4 0.6 0.4 0.4 1.6 0.6 0.5 0.7 0.4 0.9 0.4 0.4 0.5 0.5 0.7 0.5 0.4 19.5 0.0 0.0 0.4 0.0 0.4 0.5 0.4 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.3 1.1 0.0 1.5 0.0 0.2 0.1 0.0 0.0 1.0 1.0 0.3 0.4 0.0 0.0 0.0 0.2 8.8 0.0 0.2 0.0 1.0 5.0 0.2 11.7 0.2 0.1 2.0 0.0 0.0 0.5 0.0 0.7 1.4 0.0 0.1 3.8 0.0 0.3 1.4 0.0 18.9 9.8 1.0 0.0 0.0 0.0 0.6 2.3 0.0 0.0 0.0 0.7 0.0 0.2 4.7 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 15.8 11.4 0.4 28.7 10.2 0.8 1.1 12.1 1.6 0.0 SLC30A4 ZNT4 ENSG00000104154 "Solute carrier family 30 member 4" O14863 15 45479611-45522807 "Plasma proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "prostate: 47.7" "Low cell line specificity" "Detected in many" "Cancer enriched" "Detected in all" 20 "prostate cancer: 34.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018178 Uncertain "HPA018178: AB_1857087" "unprognostic (1.64e-2)" "unprognostic (1.40e-1)" "unprognostic (3.71e-1)" "unprognostic (9.49e-2)" "unprognostic (1.98e-1)" "unprognostic (3.29e-2)" "unprognostic (6.15e-2)" "unprognostic (9.74e-2)" "unprognostic (7.38e-3)" "unprognostic (1.51e-1)" "prognostic favourable (6.02e-4)" "unprognostic (2.66e-2)" "unprognostic (4.72e-3)" "unprognostic (1.29e-2)" "unprognostic (9.83e-2)" "unprognostic (8.28e-3)" "unprognostic (2.01e-3)" 3.7 2.9 6.2 4.5 11.3 1.6 4.1 6.7 8.1 3.7 8.8 7.0 2.3 8.5 4.3 4.1 5.6 3.4 3.1 3.0 5.2 3.8 5.5 3.6 2.9 3.6 6.9 4.9 3.9 2.8 6.8 3.0 4.6 5.1 47.7 4.4 3.1 2.7 3.5 2.4 3.6 19.9 4.7 4.5 4.0 3.0 15.8 9.0 1.0 6.2 1.8 4.5 3.1 4.4 7.1 0.5 2.6 0.3 2.4 4.3 1.0 2.0 2.5 0.7 5.5 10.1 7.1 0.5 5.3 4.8 3.3 4.6 0.3 1.8 7.9 1.8 5.4 1.5 2.3 2.5 3.0 1.9 2.2 0.2 2.5 0.2 6.5 0.2 4.2 6.0 4.0 4.3 1.1 3.7 1.1 4.5 6.0 0.9 2.7 0.4 0.2 0.5 4.1 4.7 1.2 2.6 0.5 1.8 2.7 3.5 4.0 0.9 3.5 0.3 7.0 4.9 2.8 5.8 1.8 8.5 6.1 2.0 2.1 0.3 3.6 2.6 0.3 0.3 4.3 0.2 3.9 3.8 2.9 2.4 0.3 7.1 2.9 4.2 1.1 2.4 0.3 0.5 0.4 1.0 6.2 11.3 6.7 8.1 5.2 3.8 6.9 4.9 5.1 9.0 SLC30A6 "FLJ31101, ZNT6" ENSG00000152683 "Solute carrier family 30 member 6" Q6NXT4 2 32165841-32224379 "Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055032, HPA057328" Uncertain Enhanced "Golgi apparatus" "Golgi apparatus" "HPA055032: , HPA057328: " "unprognostic (5.61e-2)" "unprognostic (9.11e-3)" "unprognostic (1.05e-3)" "prognostic unfavourable (6.55e-4)" "unprognostic (1.36e-1)" "unprognostic (1.48e-1)" "prognostic unfavourable (9.58e-6)" "unprognostic (2.98e-1)" "unprognostic (9.47e-2)" "unprognostic (1.88e-1)" "unprognostic (3.30e-3)" "unprognostic (7.05e-2)" "unprognostic (3.06e-2)" "unprognostic (3.51e-1)" "unprognostic (3.00e-1)" "unprognostic (1.13e-1)" "unprognostic (1.90e-1)" 15.9 17.9 10.3 11.9 13.1 5.4 15.3 21.1 13.7 16.6 14.4 14.2 10.6 12.6 22.5 12.1 16.8 13.8 13.5 13.5 10.6 8.7 17.9 18.4 14.3 17.9 17.3 8.1 17.8 23.7 15.7 19.8 18.1 13.2 13.7 15.3 14.8 17.2 12.4 18.8 15.2 14.3 14.1 20.1 16.2 14.9 12.8 15.9 21.3 17.8 9.9 18.8 15.0 14.2 4.3 3.9 12.5 3.1 9.2 6.1 2.6 18.4 13.8 14.2 12.4 18.1 16.3 15.8 17.3 17.2 14.2 13.0 10.7 17.5 8.8 11.5 13.8 11.6 16.9 11.9 18.2 17.7 9.4 19.2 7.9 13.7 11.7 20.0 11.9 12.1 18.7 19.1 15.4 11.4 16.1 11.8 16.2 6.8 10.5 9.2 21.5 7.3 9.5 17.2 12.9 15.7 16.2 10.7 16.3 13.6 14.7 13.6 8.1 9.2 9.7 18.3 10.1 12.0 20.3 16.1 28.0 13.1 16.2 15.7 18.3 12.5 3.1 2.6 3.6 2.7 4.9 4.3 3.3 4.0 3.9 3.8 5.0 4.6 3.5 9.2 3.0 3.2 6.1 2.6 10.3 13.1 21.1 13.7 10.6 8.7 17.3 8.1 13.2 15.9 SLC30A8 "ZnT-8, ZNT8" ENSG00000164756 "Solute carrier family 30 member 8" Q8IWU4 8 116950273-117176714 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "pancreas: 37.1" "Group enriched" "Detected in some" 34 "U-266/70: 29.8;U-266/84: 20.8" "Group enriched" "Detected in some" 28 "breast cancer: 10.6;pancreatic cancer: 15.6" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "gdT-cell: 1.5" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA076165 Enhanced "HPA076165: " "unprognostic (2.14e-2)" "unprognostic (1.48e-2)" "unprognostic (1.61e-1)" "unprognostic (1.41e-1)" "unprognostic (5.38e-2)" "unprognostic (5.57e-2)" "unprognostic (4.38e-1)" "unprognostic (3.36e-1)" "unprognostic (1.19e-1)" "unprognostic (6.66e-2)" "unprognostic (6.51e-3)" "unprognostic (2.15e-2)" "unprognostic (1.25e-1)" "unprognostic (1.99e-1)" "unprognostic (9.16e-3)" 0.1 0.0 0.1 0.1 0.4 0.0 0.2 0.1 0.1 0.1 0.3 0.1 0.1 0.2 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 2.4 0.1 0.1 0.1 0.1 0.1 0.1 37.1 0.0 0.3 0.1 0.1 0.1 0.0 5.0 6.4 0.1 0.1 0.3 0.4 0.1 0.1 0.1 0.6 2.1 0.1 0.1 0.1 0.1 0.1 0.5 0.1 0.1 0.5 0.0 0.0 0.0 1.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 29.8 20.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.1 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 SLC33A1 "ACATN, AT-1, AT1, SPG42" ENSG00000169359 "Solute carrier family 33 member 1" O00400 3 155821024-155854456 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Cataract, Deafness, Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042430, HPA060345" Uncertain Approved Nucleoplasm Nucleoplasm "HPA042430: AB_10806238, HPA060345: " "unprognostic (5.12e-3)" "unprognostic (7.78e-2)" "unprognostic (1.13e-2)" "unprognostic (7.21e-2)" "unprognostic (1.88e-2)" "unprognostic (1.34e-1)" "unprognostic (2.73e-2)" "unprognostic (9.57e-2)" "unprognostic (5.65e-2)" "unprognostic (6.61e-2)" "unprognostic (4.36e-2)" "unprognostic (1.19e-1)" "unprognostic (1.93e-1)" "unprognostic (2.08e-2)" "unprognostic (2.92e-1)" "unprognostic (4.73e-2)" "unprognostic (5.74e-2)" 11.3 17.3 6.5 9.9 8.6 3.1 12.1 9.4 9.4 18.8 13.1 10.5 29.9 11.3 14.0 22.9 11.8 12.3 11.5 12.9 7.8 6.7 19.4 38.3 12.8 13.6 9.4 5.6 13.6 42.4 18.8 24.6 13.9 8.9 15.0 10.5 9.2 26.6 33.9 7.0 9.4 15.2 10.4 8.2 11.9 12.4 8.9 8.8 14.9 26.1 5.8 10.7 10.2 11.6 6.0 16.7 12.1 8.3 6.9 10.8 6.0 14.6 10.2 5.3 6.5 19.7 17.0 10.0 11.0 14.8 13.4 13.1 5.8 15.7 7.6 17.8 9.0 12.5 9.1 10.8 15.1 10.7 9.4 7.8 4.9 11.4 28.4 8.6 6.9 13.5 21.7 7.1 27.6 14.6 6.2 18.2 11.9 9.3 3.5 5.1 5.1 9.9 3.9 5.9 22.7 13.7 9.3 6.2 5.1 9.2 21.5 19.5 6.8 11.0 15.2 7.9 3.9 14.4 11.5 21.5 7.5 8.0 11.3 7.0 11.2 12.1 8.3 6.0 9.4 6.5 10.8 6.0 6.8 7.4 10.7 4.1 6.5 6.3 1.8 6.9 6.3 16.7 6.1 6.0 6.5 8.6 9.4 9.4 7.8 6.7 9.4 5.6 8.9 8.8 SLC35A1 "CMPST, hCST" ENSG00000164414 "Solute carrier family 35 member A1" P78382 6 87470623-87512336 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Congenital disorder of glycosylation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (3.04e-2)" "unprognostic (1.93e-1)" "unprognostic (6.33e-2)" "unprognostic (2.55e-2)" "unprognostic (2.82e-1)" "unprognostic (4.07e-2)" "unprognostic (1.38e-1)" "unprognostic (1.18e-1)" "unprognostic (1.58e-2)" "unprognostic (3.01e-3)" "unprognostic (7.26e-2)" "unprognostic (3.85e-1)" "prognostic unfavourable (2.70e-6)" "unprognostic (2.85e-1)" "unprognostic (8.51e-2)" "unprognostic (5.48e-2)" "unprognostic (1.04e-1)" 11.0 18.0 14.0 9.2 19.8 6.3 20.5 24.1 22.9 19.2 25.3 10.0 8.0 12.0 20.1 15.1 10.0 13.6 12.7 10.6 15.2 13.8 15.7 20.8 24.2 10.3 16.3 11.6 15.8 11.6 13.0 24.4 12.6 21.4 24.9 31.6 13.1 19.4 11.4 9.1 15.9 14.5 18.9 12.2 14.0 18.8 8.1 14.5 18.6 14.2 8.2 11.8 17.4 12.0 9.4 24.6 21.6 28.4 8.7 15.1 17.2 2.0 5.0 9.1 10.7 24.9 22.8 7.4 6.1 5.4 5.1 7.1 4.3 37.9 7.6 7.6 7.5 8.1 10.9 4.9 6.6 10.8 8.1 8.6 6.8 7.6 16.4 11.2 6.0 11.6 12.0 6.0 11.8 12.2 11.0 12.6 7.5 19.0 3.0 16.9 4.9 8.2 9.6 8.9 8.1 15.8 8.8 6.0 6.6 11.3 21.1 9.8 18.7 22.9 11.4 7.4 5.0 8.1 4.9 9.5 13.7 2.8 6.2 20.0 10.5 21.6 28.4 11.6 9.8 22.1 15.1 9.4 10.6 11.9 24.6 8.7 13.6 12.6 7.0 8.7 21.5 9.1 13.6 17.2 14.0 19.8 24.1 22.9 15.2 13.8 16.3 11.6 21.4 14.5 SLC35A3 ENSG00000117620 "Solute carrier family 35 member A3" Q9Y2D2 1 99969351-100035637 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Autism spectrum disorder, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015253 Uncertain "HPA015253: AB_1857106" "unprognostic (1.05e-1)" "unprognostic (2.69e-1)" "unprognostic (1.57e-3)" "unprognostic (5.89e-2)" "unprognostic (9.64e-2)" "unprognostic (1.61e-1)" "unprognostic (1.72e-1)" "unprognostic (4.02e-2)" "unprognostic (2.59e-2)" "unprognostic (1.47e-1)" "unprognostic (1.76e-3)" "unprognostic (1.69e-1)" "unprognostic (1.02e-1)" "unprognostic (1.49e-3)" "unprognostic (2.32e-1)" "unprognostic (2.73e-2)" "unprognostic (9.34e-2)" 10.7 9.4 6.5 16.7 6.8 5.9 16.2 7.4 8.9 12.4 31.4 5.5 16.2 29.1 10.5 10.8 14.9 9.5 12.5 7.1 5.4 4.8 13.2 21.9 18.0 10.9 7.0 6.3 7.9 13.8 12.8 8.6 12.2 9.6 14.4 32.7 6.0 22.3 21.9 7.5 10.0 41.0 15.3 7.6 6.3 19.9 5.1 5.6 24.7 15.3 7.9 8.1 13.9 13.0 4.3 9.0 6.4 3.7 7.7 5.2 3.2 17.1 4.7 4.2 4.5 9.6 8.5 17.0 15.3 9.3 6.1 8.8 3.0 9.3 9.2 19.3 8.9 10.0 8.0 6.9 14.0 11.4 5.8 8.3 6.6 7.2 6.1 13.3 1.0 4.5 7.8 7.3 14.3 7.0 13.8 13.8 12.2 4.2 8.7 7.0 5.2 15.6 2.7 13.0 5.8 11.1 10.0 5.5 3.1 10.6 20.6 8.1 12.5 10.2 8.1 9.3 8.3 20.4 8.2 8.2 9.6 6.9 14.8 8.3 3.8 6.4 3.6 2.0 4.2 3.7 4.7 4.3 4.2 4.9 3.1 3.4 5.2 4.4 1.2 7.7 2.9 9.0 4.8 3.2 6.5 6.8 7.4 8.9 5.4 4.8 7.0 6.3 9.6 5.6 SLC35B4 "FLJ14697, YEA4" ENSG00000205060 "Solute carrier family 35 member B4" Q969S0 7 134289332-134317051 "Predicted membrane proteins" "Sugar transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049779 Approved "HPA049779: " "unprognostic (1.84e-1)" "unprognostic (1.94e-2)" "unprognostic (7.19e-2)" "unprognostic (2.49e-2)" "unprognostic (1.77e-3)" "unprognostic (3.47e-2)" "unprognostic (3.23e-2)" "unprognostic (1.25e-2)" "unprognostic (1.57e-1)" "unprognostic (3.32e-2)" "unprognostic (6.88e-3)" "unprognostic (1.86e-1)" "unprognostic (2.24e-3)" "unprognostic (3.18e-2)" "unprognostic (2.86e-1)" "unprognostic (9.81e-2)" "unprognostic (1.00e-1)" 7.8 10.1 9.6 7.4 16.8 2.7 5.3 22.4 21.6 6.8 5.4 10.8 4.8 4.5 9.4 10.1 5.0 6.8 6.1 4.0 10.1 12.4 15.9 11.6 5.1 6.3 9.4 9.6 10.3 4.0 6.4 6.7 17.5 12.7 8.4 5.7 9.9 3.8 10.0 3.5 4.9 5.9 10.8 8.6 6.5 5.2 6.9 8.6 6.8 5.4 2.0 7.2 6.4 4.3 3.2 6.5 1.3 4.6 4.0 5.7 2.9 3.7 12.6 11.1 16.6 10.9 9.1 5.7 9.5 8.0 8.4 7.2 4.9 3.6 12.6 3.2 10.3 4.1 16.4 8.4 14.2 8.0 12.2 8.5 7.4 6.4 8.0 12.0 7.8 8.0 3.6 10.1 8.7 8.2 8.2 4.7 12.6 3.3 10.6 8.8 22.9 11.4 7.7 9.7 6.2 4.8 4.6 3.9 22.8 8.5 2.8 10.4 1.5 6.9 9.1 11.1 3.7 6.6 9.4 15.6 21.4 14.7 19.8 11.4 12.7 1.3 3.4 0.7 3.8 4.6 5.7 3.1 3.5 4.7 6.5 3.2 3.4 5.0 0.4 4.0 3.5 4.5 3.7 2.9 9.6 16.8 22.4 21.6 10.1 12.4 9.4 9.6 12.7 8.6 SLC36A4 "FLJ38932, PAT4" ENSG00000180773 "Solute carrier family 36 member 4" Q6YBV0 11 93144171-93197964 "Predicted membrane proteins, Transporters" "Amino-acid transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017887 Enhanced Approved "Golgi apparatus,Plasma membrane,Cytosol" "Golgi apparatus, Plasma membrane, Cytosol" "HPA017887: AB_2190238" "unprognostic (1.23e-2)" "unprognostic (1.08e-1)" "unprognostic (2.17e-3)" "unprognostic (1.32e-3)" "unprognostic (3.66e-2)" "unprognostic (8.77e-2)" "unprognostic (1.08e-3)" "unprognostic (7.83e-3)" "unprognostic (3.06e-2)" "unprognostic (7.97e-2)" "unprognostic (2.09e-2)" "unprognostic (8.04e-3)" "unprognostic (7.07e-2)" "unprognostic (4.40e-2)" "unprognostic (1.74e-1)" "unprognostic (9.45e-3)" "unprognostic (4.20e-2)" 8.0 11.0 16.0 12.6 19.3 24.1 6.5 20.7 20.2 8.0 7.3 8.7 2.1 3.0 10.4 3.6 7.8 6.2 8.4 9.2 14.2 14.8 13.7 11.0 8.2 7.0 16.8 10.3 8.6 8.0 8.0 17.2 8.7 17.6 7.5 9.4 5.4 5.4 9.1 3.4 5.9 4.2 11.5 20.0 5.7 6.4 6.0 13.4 5.6 12.7 2.3 9.2 8.6 7.7 1.6 2.9 8.1 7.7 0.8 2.6 1.8 5.1 9.1 18.7 3.7 6.6 13.6 10.5 8.8 14.8 13.2 16.1 7.3 16.8 6.2 5.1 8.2 6.3 5.7 3.2 12.2 10.3 6.7 7.1 19.2 4.8 5.2 17.9 10.6 6.5 10.3 7.6 4.8 7.1 0.6 0.1 13.5 1.3 7.8 13.5 7.5 9.3 3.5 11.1 2.5 4.4 7.6 17.4 22.6 12.9 5.0 3.2 9.2 5.2 7.8 25.0 7.7 14.7 12.9 2.6 5.2 0.0 5.6 7.5 12.9 0.2 7.7 8.1 1.3 3.9 1.8 1.3 1.0 1.6 2.9 1.6 2.6 1.7 2.5 0.8 2.5 1.1 0.8 1.8 16.0 19.3 20.7 20.2 14.2 14.8 16.8 10.3 17.6 13.4 SLC37A3 DKFZp761N0624 ENSG00000157800 "Solute carrier family 37 member 3" Q8NCC5 7 140293693-140404433 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "unprognostic (2.39e-1)" "prognostic unfavourable (9.54e-4)" "unprognostic (1.44e-1)" "unprognostic (5.59e-2)" "unprognostic (2.69e-2)" "unprognostic (2.35e-1)" "prognostic unfavourable (4.78e-5)" "unprognostic (1.97e-1)" "unprognostic (2.94e-1)" "unprognostic (3.78e-2)" "unprognostic (2.84e-2)" "unprognostic (1.54e-1)" "unprognostic (2.16e-2)" "unprognostic (3.31e-1)" "unprognostic (3.82e-1)" "unprognostic (1.49e-1)" "unprognostic (5.50e-2)" 11.7 6.9 8.4 6.2 13.6 6.6 14.1 14.0 15.0 18.7 16.3 9.1 5.1 8.7 31.5 16.1 7.7 15.6 12.3 8.5 10.1 7.9 10.2 8.2 10.5 5.0 8.4 12.3 14.6 20.4 20.0 17.4 13.9 10.6 9.8 16.1 10.4 26.6 8.6 5.0 8.7 10.4 21.6 9.6 10.6 11.6 6.8 8.6 10.0 13.8 6.8 9.2 13.5 12.0 2.5 3.2 12.8 3.9 5.6 8.6 4.0 7.8 13.2 13.8 24.1 19.9 21.9 16.5 11.8 13.8 8.2 12.3 10.5 17.0 1.1 15.0 10.6 6.5 8.4 14.3 12.6 17.7 12.2 1.3 3.4 10.6 16.8 0.0 4.4 16.9 14.8 8.6 10.2 12.5 7.8 3.3 12.5 15.1 7.5 0.7 20.4 8.3 4.0 3.7 3.6 15.7 16.1 13.5 16.9 3.2 13.3 12.8 7.2 0.7 14.3 9.4 6.8 23.6 11.9 6.4 11.7 3.0 9.9 0.1 21.4 6.3 3.9 3.7 7.4 2.2 4.1 2.5 8.0 5.6 3.2 2.0 8.6 6.4 12.8 5.6 1.3 1.0 8.6 4.0 8.4 13.6 14.0 15.0 10.1 7.9 8.4 12.3 10.6 8.6 SLC38A6 NAT-1 ENSG00000139974 "Solute carrier family 38 member 6" Q8IZM9 14 60981114-61083733 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 34.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018508 Approved Approved "Plasma membrane,Cell Junctions,Microtubules" "Cell Junctions" "Plasma membrane, Microtubules" "HPA018508: AB_2190518" "unprognostic (7.08e-2)" "unprognostic (4.14e-2)" "unprognostic (1.75e-1)" "unprognostic (3.49e-1)" "unprognostic (1.00e-1)" "unprognostic (1.74e-2)" "prognostic unfavourable (9.47e-6)" "unprognostic (9.89e-3)" "unprognostic (2.38e-1)" "unprognostic (2.18e-2)" "unprognostic (2.20e-1)" "unprognostic (5.13e-2)" "prognostic unfavourable (1.37e-5)" "unprognostic (1.73e-1)" "unprognostic (4.63e-2)" "unprognostic (1.47e-1)" "unprognostic (2.90e-1)" 26.1 16.9 8.3 6.7 16.6 4.0 11.4 9.7 14.0 8.1 7.1 5.2 5.5 4.5 10.0 20.5 5.0 8.4 14.4 5.4 8.8 8.6 16.9 9.2 12.2 9.6 8.6 10.9 9.9 6.1 23.8 21.5 13.7 14.3 8.1 10.1 10.9 11.7 6.4 4.1 4.6 5.6 8.0 7.6 10.8 6.4 10.9 6.5 8.8 9.7 7.1 7.2 11.6 8.1 2.4 5.2 0.2 8.6 0.7 5.2 3.4 7.1 10.0 3.3 5.9 34.2 12.4 2.3 5.5 16.4 5.2 4.9 2.5 19.7 1.7 9.4 4.9 6.3 3.1 5.6 4.8 2.5 1.5 3.0 4.1 6.6 11.2 1.5 5.9 9.8 2.4 5.0 5.9 6.8 4.1 3.7 18.0 4.1 2.8 3.9 2.0 6.6 0.5 9.5 5.5 15.1 4.0 1.5 1.3 4.6 3.3 8.8 4.8 2.6 7.3 8.1 3.5 9.4 3.0 0.7 2.1 0.6 16.5 1.4 6.3 0.0 8.4 0.1 2.2 8.6 2.6 2.4 4.0 2.9 4.4 2.2 3.3 4.3 0.2 0.7 5.4 5.2 5.2 3.4 8.3 16.6 9.7 14.0 8.8 8.6 8.6 10.9 14.3 6.5 SLC38A8 ENSG00000166558 "Solute carrier family 38 member 8" A6NNN8 16 84009667-84042636 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Ion transport, Sodium transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.1;liver: 4.5" "Cell line enhanced" "Detected in some" "CACO-2: 1.4;HMC-1: 2.1;SCLC-21H: 8.5;SK-MEL-30: 1.3" "Cancer enriched" "Detected in single" 14 "melanoma: 6.5" "Group enriched" "Detected in some" 5 "amygdala: 6.1;cerebral cortex: 2.6;hypothalamus: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "unprognostic (9.69e-2)" "unprognostic (6.16e-2)" "unprognostic (8.00e-3)" "unprognostic (6.40e-2)" "unprognostic (1.03e-1)" "unprognostic (8.20e-3)" "unprognostic (1.89e-1)" "unprognostic (7.70e-2)" "unprognostic (2.59e-1)" "unprognostic (2.16e-2)" "unprognostic (3.54e-2)" "unprognostic (1.37e-1)" "unprognostic (1.45e-1)" 0.2 0.1 6.1 0.2 0.6 0.0 0.2 0.2 2.9 0.2 0.2 0.2 0.2 0.3 0.2 2.2 0.2 0.0 0.2 1.4 0.6 2.5 0.2 4.5 0.2 0.2 0.7 0.2 0.2 1.3 0.5 1.6 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 2.3 2.4 0.2 2.1 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.1 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.6 0.2 2.6 0.6 2.5 0.7 0.2 0.2 0.2 SLC39A10 "DKFZp564L2123, FLJ90515, KIAA1265" ENSG00000196950 "Solute carrier family 39 member 10" Q9ULF5 2 195575977-195737702 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 41.0;thyroid gland: 39.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036512, HPA036513, HPA066087" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" 49000 "Nucleoplasm, Cytosol" "Plasma membrane" "HPA036512: , HPA036513: AB_10670801, HPA066087: " "unprognostic (1.06e-1)" "unprognostic (3.87e-3)" "unprognostic (5.33e-2)" "unprognostic (1.33e-3)" "prognostic favourable (1.46e-5)" "unprognostic (7.40e-2)" "prognostic unfavourable (4.39e-5)" "unprognostic (2.10e-2)" "unprognostic (8.73e-2)" "unprognostic (2.84e-2)" "prognostic unfavourable (3.23e-4)" "unprognostic (8.46e-2)" "unprognostic (9.71e-2)" "unprognostic (1.34e-2)" "unprognostic (3.68e-1)" "unprognostic (2.47e-2)" "unprognostic (6.89e-2)" 6.6 10.9 16.0 6.0 24.8 3.7 6.2 10.8 41.0 9.8 3.8 4.2 4.9 3.6 9.4 3.3 3.5 8.5 7.6 4.7 15.0 11.2 7.8 2.1 6.3 6.5 8.5 24.4 7.4 5.7 5.8 5.7 10.7 15.7 16.7 4.0 1.4 4.8 6.5 3.3 5.7 5.7 6.7 10.2 14.4 4.3 7.9 6.2 10.6 39.9 1.7 6.4 6.1 4.9 9.4 18.4 19.3 2.7 11.0 4.6 1.5 3.1 10.5 20.2 5.5 3.9 9.4 10.4 14.6 7.1 7.1 3.5 15.7 11.3 4.3 22.3 8.3 4.5 12.3 13.5 8.9 2.3 9.1 4.9 16.4 12.9 4.4 17.9 2.1 5.5 2.0 7.8 9.0 15.8 14.1 6.1 11.3 3.0 5.1 5.6 23.5 8.3 12.0 7.1 10.8 30.7 5.2 7.8 10.7 14.6 29.9 7.6 4.8 11.1 15.4 12.9 14.9 8.4 7.6 2.1 1.3 2.6 10.4 8.4 13.0 19.3 2.7 1.9 4.5 2.5 3.5 6.8 4.0 3.7 3.3 9.4 3.5 4.6 0.5 11.0 1.8 18.4 3.9 1.5 16.0 24.8 10.8 39.7 15.0 11.2 8.5 24.4 15.7 6.2 SLC39A13 FLJ25785 ENSG00000165915 "Solute carrier family 39 member 13" Q96H72 11 47407132-47416501 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Ehlers-Danlos syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043971 Approved "HPA043971: AB_10959744" "unprognostic (7.84e-2)" "unprognostic (1.02e-2)" "prognostic unfavourable (2.60e-4)" "unprognostic (1.18e-1)" "unprognostic (8.56e-3)" "unprognostic (3.81e-2)" "unprognostic (7.44e-3)" "unprognostic (1.36e-1)" "unprognostic (5.40e-2)" "prognostic unfavourable (2.73e-5)" "unprognostic (1.39e-2)" "unprognostic (2.04e-2)" "prognostic favourable (1.96e-4)" "unprognostic (3.16e-1)" "unprognostic (1.73e-1)" "unprognostic (8.61e-2)" "unprognostic (4.12e-1)" 17.0 19.2 14.1 19.7 17.0 6.3 15.1 25.6 21.8 17.8 18.6 18.8 12.4 12.1 32.1 20.2 17.1 18.5 19.0 35.5 16.1 10.3 39.9 17.6 23.2 14.8 18.5 15.0 21.3 20.7 19.0 21.0 34.5 15.5 20.5 6.3 23.8 20.0 24.9 19.8 27.1 12.0 22.8 10.6 15.3 16.1 25.9 16.4 9.8 18.7 9.3 10.4 19.5 15.7 5.8 5.0 6.5 14.4 6.7 13.2 5.2 7.4 6.5 7.7 8.6 18.9 26.5 2.2 29.6 22.0 16.6 18.9 2.5 5.1 2.9 8.1 22.2 12.5 2.3 19.9 4.6 8.3 8.7 1.5 15.6 5.2 28.4 2.5 3.7 22.0 14.3 10.5 8.6 17.7 1.4 6.4 17.8 6.5 5.4 3.6 3.6 9.8 6.6 11.3 2.9 28.1 3.5 6.8 12.4 8.9 15.9 8.3 10.6 3.7 24.7 25.4 11.7 28.9 13.5 5.0 1.6 1.2 28.1 3.5 18.4 2.0 3.6 3.0 13.2 13.7 8.8 4.5 8.7 9.3 4.6 5.8 8.3 6.8 6.5 6.7 14.4 5.0 4.5 5.2 14.1 17.0 25.6 21.8 16.1 10.3 18.5 15.0 15.5 16.4 SLC39A14 "KIAA0062, NET34, ZIP14" ENSG00000104635 "Solute carrier family 39 member 14" Q15043 8 22367249-22434129 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport, Zinc transport" "Disease mutation, Dystonia, Neurodegeneration, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 135.5;pancreas: 77.2" "Cell line enhanced" "Detected in all" "BJ hTERT+: 68.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA016508 Approved Approved "Endoplasmic reticulum,Golgi apparatus,Plasma membrane" 950000 "Endoplasmic reticulum, Golgi apparatus, Plasma membrane" "HPA016508: AB_1857148" "unprognostic (1.67e-1)" "unprognostic (6.67e-3)" "prognostic favourable (5.00e-5)" "unprognostic (9.83e-3)" "unprognostic (9.21e-3)" "unprognostic (8.99e-3)" "unprognostic (1.99e-1)" "unprognostic (2.91e-2)" "unprognostic (4.95e-2)" "unprognostic (5.66e-2)" "unprognostic (6.64e-2)" "unprognostic (1.53e-1)" "prognostic unfavourable (3.79e-7)" "unprognostic (4.88e-2)" "unprognostic (8.73e-2)" "unprognostic (1.63e-2)" "unprognostic (1.11e-3)" 15.0 16.1 2.6 7.7 5.4 0.1 45.5 2.4 6.1 3.6 13.7 1.9 2.8 31.6 6.7 2.8 3.9 5.6 9.8 41.1 2.8 2.4 10.4 135.5 4.8 5.3 3.7 1.9 10.6 77.2 3.0 6.4 4.0 9.2 5.1 11.4 4.1 20.2 4.4 46.1 4.4 18.2 14.1 4.7 2.3 16.2 5.9 2.8 0.7 25.1 2.1 1.4 11.3 19.0 5.0 1.8 2.5 0.5 2.9 8.7 3.9 10.6 14.3 4.0 8.0 14.3 12.1 8.7 15.4 68.2 24.1 38.0 47.3 10.1 10.7 8.7 18.0 11.8 19.7 19.2 39.7 11.1 11.2 8.5 11.4 47.7 34.1 5.8 9.4 12.9 15.6 42.7 29.8 10.7 7.4 10.9 12.2 4.9 8.8 3.7 24.3 11.0 12.6 7.5 22.8 8.8 4.6 6.8 10.6 15.7 6.7 31.8 5.4 8.5 5.9 30.0 15.2 18.8 15.7 6.3 5.7 14.0 42.4 7.8 17.4 0.0 0.5 2.5 8.3 0.1 8.7 5.0 4.8 6.3 1.8 2.6 5.7 7.6 0.2 2.9 0.1 0.8 3.8 3.9 2.6 5.4 2.4 6.1 2.8 2.4 3.7 1.9 9.2 2.8 SLC39A4 "AEZ, AWMS2, ZIP4" ENSG00000147804 "Solute carrier family 39 member 4" Q6P5W5 8 144409742-144416895 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport, Zinc transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "intestine: 77.7" "Group enriched" "Detected in some" 11 "CAPAN-2: 17.3;Hep G2: 44.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "unprognostic (2.59e-1)" "unprognostic (2.35e-3)" "unprognostic (9.16e-2)" "unprognostic (3.84e-2)" "unprognostic (5.63e-3)" "unprognostic (1.46e-1)" "unprognostic (5.40e-2)" "unprognostic (1.54e-1)" "unprognostic (1.61e-1)" "unprognostic (3.28e-2)" "unprognostic (1.41e-2)" "unprognostic (1.24e-1)" "prognostic favourable (9.04e-4)" "unprognostic (2.78e-2)" "unprognostic (3.97e-1)" "unprognostic (9.04e-3)" "unprognostic (1.87e-1)" 0.2 0.0 0.5 1.1 0.2 0.1 0.2 0.2 1.1 0.2 73.9 0.2 0.2 42.1 0.2 0.4 0.2 0.3 0.7 0.2 0.2 0.0 8.3 0.4 1.3 0.2 0.2 0.2 1.5 0.6 0.0 0.3 0.4 0.2 0.4 0.1 0.2 0.5 0.2 0.2 0.0 77.7 0.2 0.2 0.2 1.2 0.4 0.2 0.2 2.3 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 1.1 17.3 0.0 0.5 0.0 0.1 0.0 0.0 0.0 2.9 0.4 0.7 0.1 44.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.7 1.0 0.0 0.7 0.0 0.1 0.0 0.0 0.2 0.0 0.5 0.0 0.2 0.4 0.9 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.2 0.2 1.1 0.2 0.0 0.2 0.2 0.2 0.2 SLC39A5 ENSG00000139540 "Solute carrier family 39 member 5" Q6ZMH5 12 56230049-56237846 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 77.8;liver: 38.2;pancreas: 101.1" "Group enriched" "Detected in some" 60 "CACO-2: 22.2;Hep G2: 32.1" "Cancer enhanced" "Detected in many" "liver cancer: 36.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "basal ganglia: 0.9" "Low region specificity" "Detected in many" HPA018423 Approved Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA018423: AB_1857154" "unprognostic (5.94e-3)" "unprognostic (8.29e-2)" "unprognostic (1.82e-2)" "unprognostic (2.19e-7)" "unprognostic (1.73e-1)" "unprognostic (7.79e-2)" "unprognostic (1.56e-1)" "unprognostic (1.36e-1)" "unprognostic (1.08e-1)" "unprognostic (1.32e-1)" "unprognostic (7.33e-2)" "unprognostic (2.93e-3)" "prognostic favourable (5.05e-4)" "unprognostic (2.75e-1)" "unprognostic (1.15e-1)" "unprognostic (1.23e-1)" "unprognostic (1.96e-4)" 0.2 0.1 0.2 4.1 0.2 0.0 0.2 0.2 0.2 0.2 40.5 0.2 0.2 48.6 0.2 2.3 0.2 0.1 5.9 0.2 0.2 0.1 22.5 38.2 0.2 0.2 0.2 0.2 0.2 101.1 0.0 0.2 0.2 0.2 0.2 9.1 0.2 0.2 0.2 0.2 0.1 77.8 0.2 0.2 0.2 0.1 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.1 0.1 0.1 0.1 0.2 0.2 0.0 0.0 0.0 0.0 22.2 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.3 0.1 0.1 0.0 32.1 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.1 0.2 0.3 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 SLC39A6 LIV-1 ENSG00000141424 "Solute carrier family 39 member 6" Q13433 18 36108532-36129385 "Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Cancer enhanced" "Detected in all" "breast cancer: 361.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042377 Approved Uncertain "Nucleoplasm,Plasma membrane,Cytosol" Cytosol "Nucleoplasm, Plasma membrane" "HPA042377: " "unprognostic (7.60e-2)" "unprognostic (2.27e-2)" "unprognostic (5.50e-3)" "unprognostic (2.58e-3)" "unprognostic (1.02e-1)" "unprognostic (4.87e-3)" "prognostic unfavourable (5.33e-4)" "unprognostic (1.79e-1)" "unprognostic (2.00e-1)" "unprognostic (1.18e-1)" "unprognostic (3.19e-1)" "unprognostic (4.50e-2)" "unprognostic (7.63e-3)" "unprognostic (2.16e-1)" "unprognostic (4.74e-2)" "unprognostic (1.45e-1)" "unprognostic (1.30e-1)" 11.1 12.6 14.3 8.6 13.4 4.3 63.5 19.4 14.7 15.7 8.7 16.0 68.7 4.1 24.7 24.5 9.8 27.7 10.3 8.2 14.2 17.5 12.3 7.7 7.9 8.2 18.3 8.7 30.5 15.5 32.1 23.9 52.5 16.0 55.2 5.9 25.1 15.5 51.5 7.7 22.6 5.7 12.7 21.7 11.2 8.1 9.9 13.5 8.0 15.7 10.7 11.3 23.8 20.2 12.6 25.2 22.2 14.6 12.9 15.6 9.7 10.2 13.0 31.2 18.3 33.1 24.5 8.2 28.1 33.4 18.9 22.2 7.2 11.5 11.2 14.2 27.0 25.1 27.3 26.3 28.7 24.8 9.9 4.8 18.3 10.5 21.0 16.3 12.2 22.3 58.3 28.6 25.0 2.8 2.5 22.5 26.5 15.8 15.9 3.6 7.5 7.4 16.6 17.9 14.6 21.0 34.8 32.9 29.0 34.6 10.2 47.5 13.8 7.7 4.5 46.0 7.7 8.7 14.1 21.2 20.6 8.5 15.9 11.5 24.2 19.5 9.8 22.2 13.0 14.6 15.6 12.6 11.1 11.5 12.2 12.3 9.8 14.2 7.5 12.9 13.7 25.2 12.2 9.7 14.3 13.4 19.4 12.4 14.2 17.5 18.3 8.7 16.0 13.5 SLC39A7 "D6S2244E, H2-KE4, HKE4, KE4, RING5, ZIP7" ENSG00000112473 "Solute carrier family 39 member 7" Q92504 6 33200445-33204439 "Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053999 Approved Supported "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA053999: " "unprognostic (3.63e-2)" "unprognostic (1.23e-1)" "unprognostic (1.21e-1)" "unprognostic (3.24e-2)" "unprognostic (8.95e-2)" "unprognostic (2.51e-1)" "prognostic unfavourable (3.62e-4)" "unprognostic (4.87e-2)" "unprognostic (9.92e-2)" "unprognostic (7.20e-3)" "unprognostic (3.29e-1)" "unprognostic (2.40e-1)" "unprognostic (1.99e-2)" "unprognostic (4.80e-1)" "unprognostic (1.50e-1)" "unprognostic (8.22e-3)" "unprognostic (1.12e-2)" 14.7 25.1 9.0 12.1 9.5 6.1 15.8 11.9 11.9 24.7 19.8 12.2 43.3 17.3 20.1 24.6 14.4 13.6 25.6 20.7 8.7 8.9 24.6 55.1 20.2 11.6 12.6 9.6 14.4 49.2 37.1 24.2 43.8 18.8 22.8 22.9 16.8 48.0 41.7 10.4 11.3 18.8 20.1 10.6 15.2 21.1 9.5 10.7 9.9 28.2 14.4 17.0 16.6 13.9 2.6 3.4 6.2 2.8 4.2 5.1 2.1 8.4 9.8 15.0 13.9 22.6 15.5 13.1 22.6 29.7 17.6 20.7 16.0 8.2 6.3 11.1 25.1 9.5 11.3 13.3 15.7 8.0 10.0 10.8 11.4 20.5 16.3 10.7 13.1 14.6 11.3 15.5 16.8 14.0 11.7 10.4 12.1 9.6 5.9 6.2 6.4 9.0 6.3 8.8 10.5 11.8 10.6 9.8 7.9 9.2 21.7 12.3 21.0 9.9 13.8 16.2 9.9 12.1 15.0 16.3 14.3 5.6 9.8 10.2 17.9 6.2 2.4 2.3 5.1 2.8 4.8 1.8 3.2 3.9 2.3 2.6 2.9 3.3 2.4 4.2 1.6 3.4 3.0 2.1 9.0 9.5 11.9 11.9 8.7 8.9 12.6 9.6 18.8 10.7 SLC39A8 BIGM103 ENSG00000138821 "Solute carrier family 39 member 8" Q9C0K1 4 102251041-102431258 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Congenital disorder of glycosylation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lung: 67.3;salivary gland: 54.6" "Cell line enhanced" "Detected in many" "BJ hTERT+: 44.6;HL-60: 32.5;Karpas-707: 48.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038832, HPA038833" Approved "HPA038832: , HPA038833: AB_10670910" "prognostic favourable (6.69e-4)" "unprognostic (1.29e-2)" "prognostic favourable (1.34e-4)" "unprognostic (1.91e-2)" "unprognostic (6.50e-2)" "unprognostic (9.59e-2)" "unprognostic (6.07e-2)" "unprognostic (2.74e-1)" "unprognostic (1.20e-3)" "unprognostic (6.32e-2)" "unprognostic (5.46e-3)" "unprognostic (2.78e-2)" "prognostic favourable (6.34e-6)" "unprognostic (3.25e-1)" "unprognostic (6.54e-2)" "unprognostic (6.40e-2)" "unprognostic (7.13e-3)" 22.0 2.0 3.7 11.4 5.5 10.3 6.1 2.8 4.3 31.4 18.1 2.2 1.1 2.1 3.9 7.3 1.7 7.2 2.6 17.8 4.3 3.5 6.2 18.4 67.3 8.6 5.1 1.6 5.4 42.1 25.7 6.7 44.8 5.9 5.7 14.9 4.3 54.6 2.3 1.8 5.1 3.4 3.0 8.8 6.5 2.5 2.3 3.2 7.5 4.9 2.3 5.6 5.8 6.0 3.1 2.7 1.0 1.5 11.5 10.5 3.4 5.4 5.4 1.2 0.0 4.5 10.4 2.8 0.6 44.6 1.6 2.7 0.2 20.2 5.3 5.9 0.1 0.3 3.8 1.2 0.9 9.1 11.0 13.8 11.4 0.1 1.8 32.5 4.7 5.5 1.4 0.8 2.6 0.6 13.8 48.4 8.6 3.6 11.7 15.2 3.6 5.3 3.0 0.0 17.3 9.4 2.0 1.6 4.0 15.2 0.2 1.4 3.7 12.1 3.1 5.4 2.0 11.0 8.6 21.7 9.0 25.1 8.9 21.2 4.9 0.0 1.5 1.0 5.6 1.0 9.8 1.3 10.5 9.0 2.7 3.1 7.9 5.4 0.1 11.5 0.3 1.0 3.9 3.4 3.7 5.5 2.8 4.3 4.3 3.5 5.1 1.6 5.9 3.2 SLC39A9 FLJ11274 ENSG00000029364 "Solute carrier family 39 member 9" Q9NUM3 14 69398015-69462388 "Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007921, HPA075390" Approved Approved "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA007921: AB_1080007, HPA075390: " "unprognostic (2.37e-1)" "unprognostic (9.29e-2)" "unprognostic (1.57e-1)" "unprognostic (2.53e-1)" "unprognostic (4.35e-2)" "unprognostic (1.10e-1)" "unprognostic (5.50e-2)" "unprognostic (1.71e-1)" "unprognostic (2.49e-1)" "unprognostic (2.75e-1)" "unprognostic (1.57e-1)" "unprognostic (1.92e-1)" "prognostic favourable (1.05e-6)" "unprognostic (1.20e-1)" "unprognostic (1.83e-1)" "unprognostic (1.09e-2)" "unprognostic (2.16e-2)" 15.8 22.2 19.5 11.3 19.2 8.8 24.8 15.0 26.3 19.5 25.5 22.4 20.6 20.8 19.1 25.6 22.3 16.5 16.7 14.5 18.9 19.1 31.2 52.9 15.7 13.0 17.8 13.7 16.3 28.0 24.5 24.6 29.7 17.1 19.4 22.7 17.0 65.2 24.2 7.7 16.7 27.8 16.3 19.3 16.3 19.8 17.4 14.1 18.3 22.4 13.7 19.2 14.5 14.6 9.9 17.2 12.5 14.8 9.2 12.5 9.2 29.3 23.1 14.9 14.9 25.5 19.8 13.4 18.1 20.9 15.5 17.8 17.4 27.8 23.9 13.2 20.9 24.3 16.2 16.9 19.5 16.2 8.7 15.1 13.2 13.2 19.1 11.1 21.5 16.0 27.1 14.1 21.4 16.1 11.6 23.9 17.9 16.3 16.6 12.1 11.9 16.5 16.9 20.9 15.5 20.8 32.1 15.3 25.0 17.5 30.5 10.5 42.8 18.2 17.1 28.3 20.2 11.7 12.3 26.3 14.7 18.5 26.7 12.8 23.0 11.9 14.8 12.5 11.7 14.1 12.5 9.9 10.2 11.5 17.2 7.7 10.3 11.2 12.0 9.2 13.0 8.3 7.4 9.2 19.5 19.2 15.0 26.3 18.9 19.1 17.8 13.7 17.1 14.1 SLC43A1 "PB39, POV1, R00504" ENSG00000149150 "Solute carrier family 43 member 1" O75387 11 57484534-57515786 "Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "gallbladder: 27.0;liver: 91.8;pancreas: 100.5" "Cell line enhanced" "Detected in many" "Hep G2: 23.5;NB-4: 27.9;U-937: 26.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA018813, HPA018826" Enhanced Approved "Golgi apparatus,Vesicles,Plasma membrane" "Golgi apparatus, Vesicles, Plasma membrane" "HPA018813: AB_1857164, HPA018826: AB_1857165" "unprognostic (3.04e-1)" "unprognostic (1.15e-1)" "unprognostic (9.19e-2)" "prognostic favourable (3.19e-4)" "unprognostic (2.51e-2)" "unprognostic (5.48e-2)" "unprognostic (2.32e-1)" "unprognostic (6.71e-3)" "unprognostic (1.63e-1)" "unprognostic (3.12e-2)" "unprognostic (6.06e-2)" "unprognostic (2.72e-1)" "prognostic unfavourable (2.97e-5)" "unprognostic (1.39e-2)" "unprognostic (1.48e-1)" "prognostic unfavourable (5.27e-4)" "unprognostic (7.30e-2)" 4.7 3.3 0.8 2.2 0.8 9.3 7.4 0.7 1.3 6.0 4.8 0.9 3.9 2.5 5.0 6.8 4.1 3.3 27.0 3.2 0.7 0.6 3.4 91.8 2.9 3.3 0.8 1.1 6.5 100.5 0.1 1.3 1.8 0.7 6.2 2.8 11.4 14.9 2.1 7.5 5.6 2.6 7.0 0.9 2.5 7.6 3.1 0.7 0.8 7.4 2.9 3.1 7.6 3.5 3.1 8.2 8.1 6.0 6.9 11.1 5.2 0.4 0.6 0.7 7.9 10.3 7.6 0.1 4.1 5.3 1.2 3.0 2.5 1.1 22.7 1.0 3.0 0.3 7.0 0.4 1.5 1.1 1.8 11.7 0.2 23.5 13.6 20.4 2.9 9.6 1.7 2.0 9.2 5.2 16.3 4.2 1.5 0.8 0.1 27.9 2.6 5.3 19.4 3.9 10.1 0.2 0.0 9.3 1.4 0.7 0.1 9.1 0.6 10.4 2.1 1.2 2.9 10.4 0.6 4.8 1.5 13.3 0.6 26.9 1.6 8.1 6.0 0.7 11.1 2.4 9.5 3.1 5.2 8.0 8.2 1.7 5.1 7.2 0.5 6.9 0.1 1.9 9.1 5.2 0.8 0.8 0.7 1.3 0.7 0.6 0.8 1.1 0.7 0.7 SLC46A1 "HCP1, MGC9564, PCFT" ENSG00000076351 "Solute carrier family 46 member 1" Q96NT5 17 28394756-28407197 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 52.7" "Cell line enriched" "Detected in many" 5 "CACO-2: 66.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB011614 Approved Supported "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "CAB011614: AB_2270597" "unprognostic (1.10e-1)" "unprognostic (8.62e-2)" "unprognostic (1.40e-1)" "unprognostic (7.59e-2)" "prognostic unfavourable (5.62e-4)" "unprognostic (9.11e-2)" "unprognostic (4.05e-2)" "unprognostic (1.36e-2)" "unprognostic (1.94e-1)" "unprognostic (3.80e-2)" "unprognostic (1.04e-3)" "unprognostic (6.15e-2)" "unprognostic (2.10e-3)" "unprognostic (2.16e-1)" "unprognostic (2.94e-1)" "unprognostic (2.15e-1)" "unprognostic (1.04e-1)" 3.1 17.8 4.6 2.5 7.0 1.3 5.1 13.2 5.2 2.9 43.8 5.2 9.4 45.4 2.2 4.5 1.8 6.7 3.0 2.2 4.4 6.0 3.8 17.9 3.2 4.9 4.0 4.0 4.4 5.0 8.1 7.8 5.0 5.0 3.7 2.7 6.1 5.7 5.8 2.0 2.0 52.7 2.6 4.6 4.9 2.3 2.2 4.2 2.2 4.0 0.4 1.2 2.4 2.4 2.7 2.6 7.1 5.9 2.9 1.7 0.8 1.7 7.3 2.4 4.0 2.0 0.4 7.6 2.0 1.5 1.7 1.9 66.1 2.1 0.2 1.2 1.1 5.6 2.7 4.6 1.4 4.2 6.4 0.0 4.5 5.6 0.7 0.0 3.3 0.9 8.5 1.8 5.3 0.1 2.8 0.4 0.3 2.3 0.0 0.2 1.4 0.9 0.1 2.0 0.8 1.3 3.8 6.5 3.4 14.2 6.6 0.9 5.1 1.1 0.2 0.2 2.9 0.4 2.1 3.0 3.4 0.1 0.4 0.4 1.5 7.1 1.6 1.1 0.8 5.9 1.4 2.7 0.9 0.7 2.6 1.7 1.0 1.7 2.3 2.9 4.3 1.1 1.6 0.8 4.6 7.0 13.2 5.2 4.4 6.0 4.0 4.0 5.0 4.2 SLC47A1 "FLJ10847, MATE1" ENSG00000142494 "Solute carrier family 47 member 1" Q96FL8 17 19495385-19579034 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 45.6;kidney: 51.1;liver: 44.9" "Cell line enhanced" "Detected in many" "A549: 13.0;AN3-CA: 10.3;Hep G2: 24.9;U-266/70: 19.4" "Cancer enhanced" "Detected in many" "renal cancer: 37.4" "Region enhanced" "Detected in many" "pons and medulla: 11.4" "Group enriched" "Detected in some" 7 "eosinophil: 12.2;plasmacytoid DC: 6.9" "Group enriched" "Detected in many" 7 "dendritic cells: 6.9;granulocytes: 12.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA021987 Enhanced "HPA021987: AB_1857185" "unprognostic (1.17e-2)" "unprognostic (1.94e-2)" "unprognostic (1.46e-1)" "prognostic favourable (5.54e-8)" "unprognostic (7.87e-2)" "unprognostic (8.34e-2)" "unprognostic (2.92e-2)" "prognostic favourable (1.88e-5)" "unprognostic (4.84e-2)" "unprognostic (6.89e-2)" "unprognostic (6.75e-2)" "unprognostic (1.60e-1)" "prognostic favourable (1.06e-5)" "unprognostic (1.77e-1)" "unprognostic (1.48e-1)" "unprognostic (2.91e-2)" "unprognostic (9.40e-2)" 2.2 45.6 0.8 0.4 2.2 1.1 0.6 1.0 3.1 13.2 1.2 3.7 1.3 0.7 7.6 12.2 0.9 2.4 1.7 3.5 4.7 0.5 51.1 44.9 3.0 3.5 0.9 2.5 5.0 0.2 0.2 7.2 0.3 11.4 2.6 0.5 4.3 1.1 5.5 12.1 10.4 0.6 3.5 2.3 1.9 0.5 15.5 0.6 0.9 4.7 5.7 1.2 0.6 4.5 0.1 6.9 12.2 1.3 0.0 0.7 0.4 0.0 13.0 0.3 10.3 0.3 0.0 0.0 0.3 0.3 1.6 1.4 0.0 0.4 0.1 2.5 1.8 0.0 4.6 0.3 0.4 0.0 6.1 0.1 6.9 24.9 0.1 0.1 0.3 0.2 2.3 1.2 0.2 3.6 0.0 0.0 0.0 1.8 0.0 0.2 1.4 0.5 0.1 0.1 0.1 0.0 0.8 2.5 2.1 4.3 0.0 1.1 4.4 1.1 0.0 0.1 0.5 0.2 1.2 19.4 7.6 0.0 0.5 0.1 2.2 0.2 1.3 12.2 0.3 1.0 0.1 0.1 0.1 0.2 0.2 0.1 0.3 0.7 0.3 0.0 0.2 6.9 0.0 0.4 0.8 2.2 1.0 3.1 4.7 0.5 0.9 2.5 11.4 0.6 SLC49A3 "FLJ22269, LP2561, MFSD7" ENSG00000169026 "Solute carrier family 49 member 3" Q6UXD7 4 681829-689441 "Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "BEWO: 7.3;SK-BR-3: 7.2;T-47d: 22.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 4.2" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA043593 Uncertain "HPA043593: AB_10959611" "unprognostic (1.10e-2)" "unprognostic (1.91e-1)" "unprognostic (8.77e-2)" "unprognostic (4.70e-2)" "unprognostic (9.40e-2)" "unprognostic (1.84e-3)" "unprognostic (2.22e-1)" "unprognostic (1.56e-2)" "unprognostic (1.83e-1)" "unprognostic (2.56e-1)" "unprognostic (9.22e-2)" "unprognostic (2.08e-1)" "prognostic favourable (2.66e-5)" "unprognostic (8.35e-2)" "unprognostic (4.92e-2)" "unprognostic (7.48e-2)" "unprognostic (1.11e-1)" 13.8 3.3 4.8 5.4 3.1 3.8 13.9 4.6 4.5 4.7 6.5 1.7 4.1 7.4 4.2 10.0 7.5 3.5 5.0 8.9 1.8 1.5 7.7 8.8 17.6 9.2 2.4 2.4 2.8 8.7 11.1 2.4 4.1 3.6 5.3 2.8 7.4 10.6 2.8 2.9 9.6 7.2 4.2 3.0 9.7 9.8 23.6 2.2 2.2 9.2 4.6 2.8 4.9 5.2 0.0 0.6 4.2 1.8 1.2 0.3 0.9 0.1 0.1 2.4 1.7 1.6 3.8 7.3 0.8 0.0 0.8 0.5 0.4 4.9 0.1 0.1 3.8 0.2 0.0 0.0 0.2 0.5 0.4 1.4 0.6 0.2 0.6 0.0 1.0 2.3 0.0 3.1 0.0 1.1 0.3 0.5 0.0 0.1 0.1 0.5 0.2 0.3 0.0 0.3 0.5 0.0 0.3 0.8 0.6 0.0 7.2 0.4 22.6 1.4 0.3 0.7 0.2 0.3 0.2 2.5 1.3 0.1 0.2 0.6 0.0 0.0 1.8 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 4.2 1.2 0.7 0.0 0.3 0.9 4.8 3.1 4.6 4.5 1.8 1.5 2.4 2.4 3.6 2.2 SLC4A8 NBC3 ENSG00000050438 "Solute carrier family 4 member 8" Q2Y0W8 12 51391317-51515763 "Predicted membrane proteins" "Anion exchange, Antiport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.6;pituitary gland: 20.0;testis: 15.3" "Cell line enhanced" "Detected in many" "BEWO: 17.2;HMC-1: 12.1;SCLC-21H: 12.9" "Group enriched" "Detected in some" 6 "breast cancer: 1.7;glioma: 2.7;testis cancer: 4.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077895 Approved "Plasma membrane" "Plasma membrane" "HPA077895: " "unprognostic (4.01e-1)" "unprognostic (8.15e-2)" "unprognostic (2.49e-2)" "unprognostic (6.39e-2)" "unprognostic (1.29e-1)" "unprognostic (1.96e-2)" "unprognostic (3.46e-2)" "unprognostic (7.72e-4)" "unprognostic (3.13e-2)" "unprognostic (7.03e-3)" "unprognostic (1.07e-4)" "unprognostic (1.70e-1)" "unprognostic (9.60e-6)" "unprognostic (1.35e-1)" "unprognostic (2.57e-1)" "unprognostic (3.21e-2)" "unprognostic (2.47e-1)" 1.0 6.5 5.8 2.2 13.3 1.7 3.1 9.2 22.9 2.7 1.1 9.8 0.0 1.4 1.2 5.4 0.7 3.7 1.1 1.0 10.9 5.6 3.2 0.8 2.8 3.0 6.0 9.3 7.3 2.4 1.0 20.0 1.0 28.6 1.4 1.4 2.2 1.5 1.7 0.8 1.0 2.0 1.1 4.7 2.2 3.0 15.3 5.1 0.0 0.8 0.0 2.7 1.0 0.7 1.1 2.6 3.4 3.1 1.7 1.7 0.7 0.2 0.8 9.7 0.1 0.4 0.5 17.2 2.6 4.4 4.3 2.7 5.7 0.2 3.5 0.4 3.5 0.1 3.8 0.2 4.0 0.7 0.5 1.7 0.3 0.0 0.0 0.6 12.1 0.1 0.2 2.1 0.4 4.9 0.1 6.3 2.1 2.0 5.1 1.1 4.2 2.9 0.1 0.0 0.0 0.5 0.1 12.9 8.7 1.0 1.3 0.0 1.6 0.4 4.6 2.7 1.5 0.2 3.3 3.2 1.0 0.2 3.8 0.5 0.4 1.3 2.1 3.4 1.7 1.4 0.4 0.6 0.6 1.6 2.6 1.1 0.6 1.0 2.3 1.7 3.1 1.0 0.3 0.7 5.8 13.3 9.2 22.9 10.9 5.6 6.0 9.3 28.6 5.1 SLC6A15 "FLJ10316, hv7-3, NTT73, SBAT1, V7-3" ENSG00000072041 "Solute carrier family 6 member 15" Q9H2J7 12 84859488-84913615 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Ion transport, Neurotransmitter transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.0" "Cell line enhanced" "Detected in many" "ASC diff: 30.4;ASC TERT1: 18.8;hTERT-HME1: 43.0;SCLC-21H: 29.3;SK-MEL-30: 21.6" "Cancer enhanced" "Detected in some" "melanoma: 7.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008609 Uncertain Approved Nucleoli,Vesicles Nucleoli Vesicles "HPA008609: AB_1857190" "unprognostic (1.01e-4)" "unprognostic (9.02e-2)" "unprognostic (1.27e-1)" "unprognostic (6.65e-6)" "unprognostic (1.25e-2)" "unprognostic (2.92e-1)" "unprognostic (7.65e-3)" "unprognostic (1.13e-1)" "unprognostic (1.97e-1)" "unprognostic (1.51e-1)" "unprognostic (4.05e-2)" "unprognostic (7.69e-4)" "unprognostic (2.57e-2)" "unprognostic (3.80e-1)" "unprognostic (1.23e-2)" "unprognostic (2.63e-3)" 1.4 4.5 18.0 2.2 16.2 1.0 2.3 17.8 31.0 1.7 2.2 5.4 0.0 1.4 2.8 1.1 6.7 1.2 1.3 1.0 10.9 18.2 1.5 1.0 1.3 1.1 10.3 16.9 2.1 1.0 1.0 5.6 8.9 14.7 1.8 1.8 9.2 1.4 1.5 1.0 4.9 2.1 1.6 4.9 1.1 1.3 3.6 12.8 0.0 2.0 1.8 1.8 1.1 1.5 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 3.6 0.0 30.4 18.8 0.0 0.0 6.4 0.5 0.3 0.0 0.0 0.0 0.0 0.2 0.4 0.0 8.1 0.0 0.0 9.3 0.0 1.5 0.0 11.2 0.0 0.2 10.5 15.7 4.1 43.0 0.1 0.0 0.0 7.7 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.0 0.0 0.0 29.3 7.6 0.0 9.7 21.6 0.0 0.0 0.0 4.6 2.5 0.0 0.0 0.0 0.0 0.0 8.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 18.0 16.2 17.8 18.6 10.9 18.2 10.3 16.9 14.7 12.8 SLC6A20 "XT3, Xtrp3" ENSG00000163817 "Solute carrier family 6 member 20" Q9NP91 3 45755450-45796535 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Amino-acid transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "gallbladder: 14.3;intestine: 25.5;retina: 51.3" "Cell line enhanced" "Detected in some" "HaCaT: 5.2" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "pons and medulla: 6.1" "Cell type enhanced" "Detected in some" "neutrophil: 2.6" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA029873 Uncertain "HPA029873: AB_10602403" "unprognostic (1.57e-1)" "unprognostic (5.26e-2)" "unprognostic (1.10e-1)" "unprognostic (2.70e-2)" "unprognostic (1.48e-1)" "unprognostic (9.43e-3)" "unprognostic (3.26e-2)" "unprognostic (4.33e-3)" "unprognostic (2.76e-1)" "unprognostic (1.34e-1)" "unprognostic (1.68e-3)" "unprognostic (1.46e-1)" "prognostic favourable (1.55e-5)" "unprognostic (2.87e-1)" "unprognostic (1.23e-1)" "unprognostic (7.55e-2)" "unprognostic (2.09e-2)" 0.3 0.1 0.3 0.6 0.8 0.5 0.7 1.5 2.2 2.4 11.2 3.0 0.4 22.3 1.3 1.7 0.1 0.4 14.3 0.1 0.5 0.4 3.3 0.2 1.9 0.2 1.0 1.7 0.1 5.1 0.0 2.0 0.1 6.1 1.0 0.2 51.3 1.3 0.1 0.9 0.6 25.5 0.3 1.5 0.1 4.7 0.4 0.3 0.0 0.1 0.4 0.1 0.2 0.3 0.8 0.7 2.6 0.2 0.5 0.4 0.1 0.4 0.7 0.7 0.7 0.2 0.1 0.8 0.3 0.0 0.1 0.1 2.7 2.4 0.4 1.9 0.0 5.2 0.2 0.0 0.3 0.2 0.3 2.2 2.0 0.4 0.0 0.1 0.4 0.1 1.1 0.0 0.1 0.0 0.3 0.8 0.0 0.6 0.8 0.5 2.4 0.5 0.8 0.2 0.6 0.4 0.6 0.6 0.8 2.6 0.4 0.1 0.5 0.3 0.1 0.9 0.7 0.7 0.5 1.4 0.5 0.2 0.4 0.5 0.2 1.0 0.2 0.2 0.3 0.1 0.3 0.2 0.2 0.2 0.1 0.8 0.4 0.3 2.6 0.5 0.1 0.7 0.1 0.1 0.3 0.8 1.5 2.2 0.5 0.4 1.0 1.7 6.1 0.3 SLC7A5 "CD98, D16S469E, E16, LAT1, MPE16" ENSG00000103257 "Solute carrier family 7 member 5" Q01650 16 87830023-87869488 "Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 71.2" "Cell line enhanced" "Detected in many" "HBEC3-KT: 106.7;hTCEpi: 183.4;MCF7: 99.4;SiHa: 150.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 11 "plasmacytoid DC: 15.9" "Lineage enriched" "Detected in many" 11 "dendritic cells: 15.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052673, HPA056077" Approved Supported "Vesicles,Plasma membrane,Cytosol" "Plasma membrane, Cytosol" Vesicles "HPA052673: , HPA056077: " "unprognostic (2.71e-3)" "unprognostic (1.10e-2)" "unprognostic (1.02e-1)" "unprognostic (2.64e-1)" "unprognostic (3.22e-2)" "unprognostic (2.99e-3)" "unprognostic (1.64e-1)" "prognostic unfavourable (2.43e-4)" "unprognostic (6.86e-2)" "unprognostic (4.46e-2)" "unprognostic (1.27e-1)" "unprognostic (3.17e-1)" "prognostic unfavourable (0.00e+0)" "unprognostic (5.93e-2)" "unprognostic (5.52e-3)" "unprognostic (1.64e-2)" "unprognostic (7.19e-3)" 8.2 3.2 18.3 14.7 24.5 71.2 4.3 15.9 45.8 7.9 4.6 16.7 8.9 6.2 5.3 30.4 38.7 3.3 6.4 8.2 19.8 22.1 3.6 9.7 3.8 11.1 23.9 9.6 5.1 12.1 1.5 9.0 28.4 23.4 4.3 3.4 34.9 11.5 15.4 11.2 10.7 5.7 4.8 17.7 6.4 12.7 34.9 19.8 3.7 4.2 16.7 15.0 11.5 7.7 0.5 15.9 0.6 0.0 0.2 1.4 0.4 14.6 55.6 1.0 15.6 0.4 0.9 40.1 11.8 4.3 7.2 4.6 36.2 21.0 13.4 10.5 15.0 66.2 11.5 106.7 5.0 14.1 5.8 11.0 52.2 25.9 16.8 10.2 20.3 3.0 183.4 8.8 65.7 1.4 16.4 15.1 5.7 99.4 12.3 15.1 5.1 13.5 11.9 4.3 20.6 8.0 1.2 9.0 3.5 150.7 30.1 32.3 13.8 13.6 1.1 2.5 16.8 10.4 9.1 19.6 16.0 58.1 9.9 25.5 24.0 0.6 0.0 0.0 1.0 0.0 1.2 0.5 0.5 0.8 0.3 0.0 0.1 0.4 0.1 0.2 0.0 15.9 1.4 0.4 18.3 24.5 15.9 28.1 19.8 22.1 23.9 9.6 23.4 19.8 SLC7A7 "LPI, y+LAT-1" ENSG00000155465 "Solute carrier family 7 member 7" Q9UM01 14 22773222-22829820 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 63.8;intestine: 93.5;kidney: 67.3" "Cell line enhanced" "Detected in some" "BEWO: 48.1;CACO-2: 78.0;EFO-21: 16.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "intermediate monocyte: 59.5;non-classical monocyte: 63.8" "Lineage enriched" "Detected in many" 4 "monocytes: 63.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA036227 Enhanced "HPA036227: AB_10696653" "unprognostic (1.34e-1)" "unprognostic (7.65e-2)" "unprognostic (4.25e-2)" "unprognostic (2.52e-1)" "unprognostic (6.12e-2)" "unprognostic (3.69e-2)" "unprognostic (7.84e-3)" "unprognostic (1.47e-1)" "unprognostic (2.88e-2)" "unprognostic (1.73e-2)" "unprognostic (2.60e-3)" "unprognostic (7.15e-2)" "prognostic unfavourable (6.28e-6)" "unprognostic (2.68e-3)" "unprognostic (1.86e-2)" "unprognostic (2.61e-1)" "unprognostic (1.12e-1)" 10.4 2.8 1.9 8.3 3.1 3.6 3.2 0.7 2.7 2.6 48.0 4.1 0.2 24.1 2.7 2.3 2.1 4.6 7.6 3.0 2.2 1.6 67.3 6.5 15.3 20.5 3.7 1.0 2.6 2.7 26.3 1.0 6.5 3.2 2.7 3.4 2.1 3.3 0.9 1.6 1.8 93.5 3.5 4.5 32.4 3.0 13.4 2.7 2.1 2.8 0.8 5.7 4.1 3.6 3.0 14.6 5.4 63.8 0.0 0.1 17.8 0.0 2.6 0.2 0.1 0.4 0.9 48.1 0.5 3.9 0.1 0.3 78.0 7.9 3.8 16.9 0.3 2.9 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.8 2.3 0.4 0.4 1.7 0.2 0.2 0.1 6.0 0.0 3.0 0.6 0.1 0.0 0.3 0.8 0.0 0.6 8.4 2.2 0.2 0.2 0.0 0.2 0.1 0.1 0.5 0.1 1.8 0.3 0.2 0.4 0.1 0.1 0.6 0.2 2.0 0.2 0.2 0.0 0.0 41.2 0.1 0.0 59.5 0.0 3.0 0.0 0.0 14.6 2.3 0.1 0.0 5.4 0.0 63.8 0.5 0.1 17.8 1.9 3.1 0.7 2.7 2.2 1.6 3.7 1.0 3.2 2.7 SLC7A8 "LAT2, LPI-PC1" ENSG00000092068 "Solute carrier family 7 member 8" Q9UHI5 14 23125295-23183674 "Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "parathyroid gland: 204.0" "Cell line enhanced" "Detected in many" "AF22: 21.1;ASC diff: 22.2;BEWO: 38.7;CACO-2: 21.4;K-562: 40.5;NTERA-2: 21.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "basophil: 7.6;eosinophil: 13.2;naive CD8 T-cell: 3.5" "Group enriched" "Detected in many" 46 "granulocytes: 13.2;T-cells: 3.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB046015, HPA051950, HPA060672" Enhanced "CAB046015: AB_2239464, HPA051950: , HPA060672: " "unprognostic (1.50e-1)" "unprognostic (1.52e-1)" "unprognostic (2.88e-1)" "unprognostic (1.03e-2)" "unprognostic (1.12e-2)" "unprognostic (3.03e-2)" "prognostic unfavourable (1.97e-4)" "prognostic favourable (3.15e-4)" "unprognostic (1.24e-1)" "unprognostic (2.37e-1)" "unprognostic (1.39e-3)" "unprognostic (9.44e-2)" "unprognostic (7.00e-2)" "unprognostic (2.96e-2)" "unprognostic (8.56e-3)" "unprognostic (1.64e-1)" "prognostic unfavourable (1.52e-4)" 10.5 5.9 4.6 3.0 6.6 1.3 11.0 10.9 10.7 12.7 5.9 2.5 28.2 11.7 23.0 7.2 13.2 21.7 6.2 3.1 7.8 3.0 37.6 3.0 6.2 5.8 2.4 5.6 33.7 9.1 204.0 16.7 19.8 6.9 13.0 5.1 31.2 9.5 50.9 23.6 11.2 8.8 7.5 1.9 10.0 19.3 10.5 4.7 0.3 12.8 5.2 4.9 15.2 14.5 0.1 0.0 13.2 0.1 0.0 3.5 1.7 0.4 0.0 21.1 0.0 22.2 2.7 38.7 2.1 8.5 0.0 0.6 21.4 1.1 0.1 0.3 4.6 3.6 2.8 1.1 0.1 0.0 2.0 0.1 0.0 0.0 8.7 0.0 12.0 19.1 10.6 0.3 0.2 1.7 40.5 0.0 0.4 0.3 0.0 0.2 21.1 15.8 0.0 0.2 4.0 0.2 7.9 2.6 0.1 0.0 3.7 10.0 13.4 0.1 0.1 0.7 0.5 0.2 0.0 0.1 4.6 0.0 2.4 0.0 0.1 7.6 0.1 13.2 0.0 0.1 1.1 0.1 0.9 0.1 0.0 0.0 0.9 3.5 0.4 0.0 0.0 0.0 0.5 1.7 4.6 6.6 10.9 10.7 7.8 3.0 2.4 5.6 6.9 4.7 SLC9B1 "NHA1, NHEDC1" ENSG00000164037 "Solute carrier family 9 member B1" Q4ZJI4 4 102885048-103019739 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Antiport, Fertilization, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "testis: 43.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 2.0;dendritic cells: 1.9;T-cells: 4.9" "Not detected" "Not detected" "HPA058971, HPA065520" Supported "Centriolar satellite,Mitochondria" Mitochondria "Centriolar satellite" "HPA058971: , HPA065520: " "unprognostic (4.87e-3)" "unprognostic (2.38e-1)" "unprognostic (1.18e-1)" "unprognostic (8.26e-4)" "unprognostic (2.53e-1)" "unprognostic (3.39e-1)" "unprognostic (5.06e-4)" "unprognostic (5.85e-2)" "unprognostic (1.35e-1)" "unprognostic (1.54e-1)" "unprognostic (1.07e-3)" "unprognostic (7.68e-2)" "unprognostic (3.03e-2)" "unprognostic (3.33e-1)" "unprognostic (1.85e-1)" "unprognostic (5.66e-5)" "unprognostic (5.78e-2)" 1.1 1.1 1.1 1.1 3.1 0.9 0.9 1.4 2.0 0.9 0.8 3.7 0.0 0.8 2.6 2.3 0.7 0.9 1.6 0.9 1.6 1.0 0.8 0.7 1.1 2.4 2.4 1.1 1.5 1.3 1.2 2.4 0.9 3.1 1.1 0.8 2.8 0.7 0.9 0.7 1.9 0.8 0.7 4.4 1.0 0.8 43.1 2.3 4.2 1.1 0.0 1.7 1.2 0.9 2.0 1.9 0.6 0.6 0.4 4.9 0.6 0.4 0.0 2.2 3.3 4.5 3.3 0.7 0.8 1.1 0.0 0.2 0.0 0.2 1.7 0.6 1.7 0.0 1.7 0.9 1.5 3.2 2.3 2.5 2.0 0.0 0.0 0.7 0.5 0.5 1.0 0.0 1.8 1.3 1.2 1.7 1.7 1.3 1.0 2.2 0.8 0.0 2.7 1.8 0.5 0.9 0.5 2.1 5.0 0.6 0.8 2.5 0.4 1.7 0.7 0.9 0.3 1.0 1.1 5.5 4.0 1.4 1.2 1.0 2.4 0.6 0.6 0.1 1.5 0.4 1.7 1.8 1.2 1.8 0.7 2.0 4.9 2.8 0.3 0.4 0.3 1.9 1.7 0.6 1.1 3.1 1.4 2.0 1.6 1.0 2.4 1.1 3.1 2.3 SLC9B2 "FLJ23984, NHA2, NHEDC2" ENSG00000164038 "Solute carrier family 9 member B2" Q86UD5 4 103019868-103085829 "Predicted membrane proteins, Transporters" "Antiport, Hydrogen ion transport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 45.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 5.6;NK-cells: 12.2;T-cells: 6.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA047008 Uncertain Approved "Nucleoplasm,Cell Junctions" "Nucleoplasm, Cell Junctions" "HPA047008: " "unprognostic (1.85e-1)" "unprognostic (5.43e-2)" "unprognostic (2.68e-1)" "unprognostic (1.11e-1)" "unprognostic (8.83e-2)" "unprognostic (1.23e-1)" "unprognostic (1.43e-2)" "unprognostic (3.78e-2)" "unprognostic (3.26e-1)" "unprognostic (2.53e-2)" "unprognostic (3.53e-2)" "unprognostic (1.67e-1)" "unprognostic (2.51e-5)" "unprognostic (2.23e-1)" "unprognostic (1.28e-1)" "unprognostic (1.90e-2)" "unprognostic (2.35e-5)" 7.3 7.9 8.8 6.3 13.3 5.3 5.5 16.5 24.5 5.6 5.0 5.2 0.4 2.0 8.5 4.2 4.7 5.9 9.8 5.5 8.9 12.5 1.9 45.6 3.3 7.2 10.3 13.4 8.0 2.4 1.2 8.8 5.2 20.8 5.6 3.9 8.3 2.1 6.7 4.5 3.7 3.0 9.8 9.8 4.6 5.7 4.8 4.7 2.5 2.6 1.8 6.9 5.5 8.5 5.6 1.7 0.0 0.1 12.2 6.3 1.8 2.6 1.3 3.1 6.4 15.5 13.0 0.0 11.9 4.7 2.0 1.8 1.3 1.7 16.8 2.1 13.8 0.8 7.0 5.0 2.8 14.7 4.9 16.8 4.2 12.1 8.3 11.7 5.3 11.4 6.7 4.2 14.5 8.5 5.6 12.3 6.2 1.0 9.4 7.2 2.3 3.8 0.0 3.4 7.3 5.7 1.0 10.7 9.7 5.4 1.4 3.5 1.4 7.8 10.5 4.4 2.7 6.9 4.1 10.5 7.6 12.2 5.3 10.3 1.7 0.0 0.1 0.0 5.1 0.0 6.3 5.6 5.6 4.5 0.9 3.6 3.4 4.2 0.0 12.2 0.1 1.7 2.4 1.8 8.8 13.3 16.5 21.2 8.9 12.5 10.3 13.4 20.8 4.7 SPNS1 "HSpin1, LAT, nrs, PP2030, SPIN1, SPINL" ENSG00000169682 "Sphingolipid transporter 1 (putative)" Q9H2V7 16 28974221-28984548 "Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041995, HPA042988" Enhanced Approved "Nucleoli fibrillar center,Golgi apparatus,Vesicles,Cytosol" Vesicles "Nucleoli fibrillar center, Golgi apparatus, Cytosol" "HPA041995: AB_10959609, HPA042988: AB_10964587" "unprognostic (3.54e-2)" "unprognostic (4.57e-4)" "unprognostic (2.15e-1)" "unprognostic (2.49e-1)" "unprognostic (2.08e-1)" "unprognostic (3.66e-1)" "unprognostic (7.86e-5)" "unprognostic (1.01e-1)" "unprognostic (2.00e-1)" "unprognostic (1.27e-1)" "unprognostic (4.12e-2)" "unprognostic (3.02e-3)" "unprognostic (8.85e-7)" "unprognostic (1.48e-1)" "unprognostic (6.15e-2)" "unprognostic (1.26e-3)" "unprognostic (1.12e-2)" 23.4 23.9 14.5 22.0 15.9 38.3 24.2 21.0 22.8 18.2 22.1 24.1 20.1 26.9 25.1 21.3 20.9 17.1 26.8 16.1 14.9 12.1 24.1 28.3 33.4 22.6 15.4 17.0 18.3 20.8 29.5 17.2 40.7 15.4 20.1 12.6 19.8 20.8 22.8 21.3 30.9 22.3 26.3 14.5 27.3 20.7 22.3 17.2 31.0 22.0 24.5 17.2 21.2 19.5 3.1 15.6 7.2 23.5 4.2 7.9 10.1 10.2 24.3 9.2 21.4 17.7 9.8 26.3 11.5 11.9 19.2 17.2 22.2 24.7 6.6 28.4 10.3 21.8 14.9 12.7 6.9 7.5 25.3 9.5 23.7 27.5 30.1 10.5 20.6 16.4 17.1 20.7 8.8 17.7 21.3 11.9 9.6 27.4 11.5 30.1 21.8 16.1 14.6 11.1 29.3 10.4 10.0 16.5 21.4 8.2 24.5 17.9 24.4 12.8 14.9 15.7 11.9 21.8 8.8 18.0 14.1 6.1 20.1 16.1 12.6 6.4 18.2 7.2 6.0 23.5 5.0 3.1 6.0 7.9 15.6 2.8 6.2 4.1 3.3 4.2 15.7 6.5 6.8 10.1 14.5 15.9 21.0 22.8 14.9 12.1 15.4 17.0 15.4 17.2 SPPL3 "DKFZP586C1324, IMP2, MGC126674, MGC126676, MGC90402, PSL4" ENSG00000157837 "Signal peptide peptidase like 3" Q8TCT6 12 120762510-120904371 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004194, HPA059958" Uncertain Supported "Vesicles,Plasma membrane" "Vesicles, Plasma membrane" "HPA004194: , HPA059958: " "unprognostic (3.29e-1)" "unprognostic (2.29e-2)" "unprognostic (3.39e-2)" "unprognostic (1.63e-1)" "unprognostic (2.06e-1)" "unprognostic (7.96e-3)" "prognostic unfavourable (1.29e-5)" "unprognostic (3.17e-2)" "unprognostic (1.10e-1)" "unprognostic (1.28e-1)" "unprognostic (2.48e-1)" "unprognostic (2.44e-1)" "unprognostic (2.66e-1)" "unprognostic (9.34e-2)" "unprognostic (9.92e-2)" "unprognostic (7.54e-2)" "unprognostic (9.40e-2)" 17.8 15.3 18.9 12.8 23.1 13.9 19.4 21.8 31.4 25.2 20.4 25.6 18.4 14.0 23.1 13.3 39.5 23.3 18.2 13.9 17.4 18.3 18.3 14.9 20.8 21.5 19.2 20.6 25.9 19.6 42.4 14.3 21.9 16.5 16.9 21.7 19.1 19.2 22.7 13.8 48.3 18.5 23.5 17.1 19.0 14.2 34.7 20.8 25.2 24.7 22.2 20.6 19.8 29.3 4.1 6.3 7.3 2.9 2.8 4.4 1.5 12.3 12.3 18.7 11.7 24.8 16.8 13.2 9.5 28.4 20.5 16.5 12.8 12.7 11.4 0.1 16.5 15.2 19.1 20.5 21.3 9.0 11.7 9.8 7.4 9.7 26.2 11.2 12.7 16.8 32.9 17.6 16.5 20.1 10.7 5.7 17.6 10.9 14.9 9.0 12.5 8.8 8.9 15.8 8.1 16.1 35.2 12.8 13.8 18.1 8.4 14.3 25.2 7.8 14.9 9.5 13.0 5.8 7.1 13.4 24.0 11.1 14.2 9.4 15.7 7.3 2.9 2.6 3.2 2.8 4.4 3.2 4.0 4.0 4.9 4.1 3.9 4.3 5.5 2.8 2.4 6.3 3.1 1.5 18.9 23.1 21.8 31.4 17.4 18.3 19.2 20.6 16.5 20.8 STEAP1 "PRSS24, STEAP" ENSG00000164647 "STEAP family member 1" Q9UHE8 7 90154375-90164829 "Cancer-related genes, Predicted membrane proteins, Transporters" "Electron transport, Ion transport, Iron transport, Transport" Oxidoreductase "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 44.7" "Cell line enhanced" "Detected in many" "ASC diff: 29.1;CAPAN-2: 34.8;U-138 MG: 44.3" "Cancer enriched" "Detected in all" 6 "prostate cancer: 94.0" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "myeloid DC: 1.7" "Low lineage specificity" "Detected in single" HPA030985 Uncertain "HPA030985: " "unprognostic (2.88e-3)" "unprognostic (2.29e-1)" "unprognostic (1.19e-1)" "unprognostic (3.21e-3)" "unprognostic (9.20e-3)" "unprognostic (2.03e-1)" "unprognostic (1.33e-2)" "unprognostic (6.74e-3)" "unprognostic (6.36e-2)" "unprognostic (6.45e-3)" "unprognostic (8.31e-3)" "unprognostic (3.79e-1)" "unprognostic (2.60e-2)" "unprognostic (4.39e-2)" "unprognostic (2.42e-1)" "unprognostic (6.09e-2)" "unprognostic (1.38e-1)" 19.8 1.5 2.9 16.5 1.4 0.0 26.0 0.9 6.3 5.5 10.0 0.1 0.7 2.7 3.0 4.4 10.0 7.3 8.4 7.1 1.4 0.5 5.3 21.2 9.3 2.9 0.5 2.7 12.4 6.5 0.2 5.8 0.5 1.4 44.7 7.3 1.2 9.8 5.3 3.9 3.3 7.4 13.7 1.4 2.8 7.4 2.1 0.7 0.0 4.6 6.5 3.7 12.5 16.1 0.8 1.7 0.0 0.0 0.0 0.0 0.2 6.7 13.6 0.8 2.5 29.1 24.2 0.2 4.6 5.7 0.6 0.8 10.2 34.8 0.0 0.2 7.5 1.4 5.9 6.4 1.2 0.0 2.2 0.0 0.1 3.4 1.1 0.0 0.0 17.0 0.9 19.2 10.2 25.0 0.3 19.4 7.9 0.1 0.0 0.1 4.1 6.5 0.0 0.0 0.0 5.5 1.4 0.0 0.3 1.7 0.0 3.1 7.7 0.1 12.8 44.3 2.2 22.2 5.6 3.6 0.1 0.0 21.7 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.9 1.4 0.9 6.3 1.4 0.5 0.5 2.7 1.4 0.7 STEAP2 "IPCA-1, PCANAP1, STAMP1, STMP" ENSG00000157214 "STEAP2 metalloreductase" Q8NFT2 7 90167590-90238137 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Electron transport, Ion transport, Iron transport, Transport" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "prostate: 100.2" "Cell line enhanced" "Detected in many" "A549: 13.2;CAPAN-2: 28.4;U-138 MG: 16.5" "Cancer enriched" "Detected in many" 12 "prostate cancer: 88.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029115, HPA055603" Uncertain Supported Vesicles Vesicles "HPA029115: AB_10603894, HPA055603: " "unprognostic (6.26e-3)" "unprognostic (2.48e-1)" "unprognostic (2.55e-1)" "unprognostic (1.65e-1)" "unprognostic (8.20e-4)" "unprognostic (2.34e-1)" "unprognostic (1.13e-1)" "unprognostic (3.67e-3)" "unprognostic (7.91e-2)" "unprognostic (1.70e-1)" "unprognostic (9.92e-2)" "unprognostic (1.34e-1)" "unprognostic (2.71e-2)" "unprognostic (9.73e-2)" "unprognostic (6.11e-2)" "unprognostic (9.86e-5)" "unprognostic (3.69e-2)" 10.7 4.1 6.2 9.7 14.5 1.3 13.6 8.7 18.2 7.0 8.3 2.3 2.2 5.7 5.4 3.6 9.1 7.5 8.8 9.4 5.1 5.2 6.5 3.6 10.8 1.6 3.2 11.1 19.5 6.4 10.3 17.6 1.4 6.0 100.2 7.0 3.8 6.8 6.7 2.3 3.5 5.9 9.0 2.9 3.0 9.2 2.3 1.6 1.6 5.8 1.2 2.5 10.4 19.9 1.1 0.4 1.3 0.4 0.3 0.2 0.0 1.8 13.2 0.3 3.7 7.1 6.9 0.2 1.6 3.4 0.2 0.5 2.4 28.4 0.0 0.2 4.4 1.1 2.9 2.0 0.5 0.0 2.8 0.0 0.0 0.6 0.6 0.0 0.0 5.0 0.4 6.9 1.4 3.6 0.0 0.2 3.9 0.0 0.0 0.4 5.4 1.4 0.0 0.0 0.1 6.2 3.9 0.3 1.3 2.0 0.0 0.0 10.0 0.0 3.0 16.5 3.7 2.3 1.4 0.0 0.0 0.0 7.1 0.0 0.6 1.3 0.4 0.5 0.2 0.2 0.1 1.1 0.1 0.1 0.0 0.4 0.2 0.2 1.2 0.3 0.2 0.4 0.0 0.0 6.2 14.5 8.7 18.2 5.1 5.2 3.2 11.1 6.0 1.6 STEAP3 "dudlin-2, STMP3, TSAP6" ENSG00000115107 "STEAP3 metalloreductase" Q658P3 2 119223831-119265652 "Disease related genes, Predicted membrane proteins" "Apoptosis, Cell cycle, Ion transport, Iron transport, Transport" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "liver: 82.3;parathyroid gland: 47.4" "Cell line enhanced" "Detected in many" "ASC TERT1: 36.9;U-87 MG: 47.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "classical monocyte: 4.0;intermediate monocyte: 4.3;myeloid DC: 7.0;NK-cell: 2.1" "Group enriched" "Detected in many" 5 "dendritic cells: 7.0;monocytes: 4.3;NK-cells: 2.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA050510 Approved Approved Nucleoli,Cytosol 28000 Cytosol Nucleoli "HPA050510: " "unprognostic (6.51e-2)" "unprognostic (6.48e-2)" "unprognostic (4.89e-2)" "unprognostic (3.45e-2)" "unprognostic (1.94e-3)" "unprognostic (9.07e-2)" "unprognostic (1.99e-2)" "unprognostic (3.04e-1)" "unprognostic (9.75e-2)" "unprognostic (1.58e-3)" "unprognostic (5.08e-3)" "unprognostic (6.95e-2)" "prognostic unfavourable (0.00e+0)" "unprognostic (2.82e-1)" "unprognostic (4.45e-1)" "unprognostic (9.37e-2)" "unprognostic (6.82e-2)" 8.1 2.8 2.5 1.2 4.2 5.1 9.2 3.0 2.2 6.4 6.1 3.0 3.7 7.9 1.3 3.1 5.1 4.0 2.8 6.6 2.9 1.4 3.4 82.3 3.9 4.9 3.9 0.4 5.2 9.0 47.4 5.1 4.3 6.1 4.8 2.4 2.1 12.6 9.1 10.9 3.0 9.8 0.9 6.4 1.0 6.7 1.5 3.2 0.2 3.3 6.9 4.0 4.2 3.7 0.8 7.0 0.7 4.3 2.1 0.2 1.5 6.5 7.9 0.0 2.7 3.9 36.9 7.0 2.1 2.3 4.2 3.8 6.0 9.0 0.0 15.9 11.9 11.2 3.4 6.9 4.7 0.0 11.2 12.8 7.1 11.7 9.7 3.1 2.4 21.8 12.2 24.7 8.9 3.6 6.2 1.3 11.7 6.2 0.0 1.8 10.8 16.5 0.0 4.6 5.6 5.1 16.7 13.3 2.4 5.8 20.2 1.5 4.0 4.2 15.3 26.0 15.3 5.5 11.4 0.0 0.0 0.0 47.8 8.1 5.4 0.0 4.0 0.7 0.2 4.3 0.0 0.8 0.0 0.0 7.0 0.2 0.0 0.0 0.1 2.1 0.6 0.3 0.0 1.5 2.5 4.2 3.0 2.2 2.9 1.4 3.9 0.4 6.1 3.2 STEAP4 "FLJ23153, SchLAH, STAMP2, TIARP, TNFAIP9" ENSG00000127954 "STEAP4 metalloreductase" Q687X5 7 88270892-88306891 "Predicted membrane proteins, Transporters" "Electron transport, Ion transport, Iron transport, Transport" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 122.8" "Group enriched" "Detected in some" 6 "HSkMC: 38.4;SiHa: 36.0;U-2197: 51.1" "Cancer enhanced" "Detected in many" "prostate cancer: 45.9" "Group enriched" "Detected in some" 5 "midbrain: 1.7;pons and medulla: 6.4" "Cell type enriched" "Detected in some" 13 "neutrophil: 48.9" "Lineage enriched" "Detected in many" 13 "granulocytes: 48.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA065201 Approved "Nucleoplasm,Plasma membrane" "Nucleoplasm, Plasma membrane" "HPA065201: " "unprognostic (3.76e-2)" "unprognostic (2.16e-2)" "unprognostic (8.82e-2)" "unprognostic (1.43e-1)" "unprognostic (1.62e-1)" "unprognostic (9.96e-2)" "prognostic favourable (2.97e-4)" "unprognostic (7.40e-2)" "unprognostic (3.12e-1)" "unprognostic (4.66e-2)" "unprognostic (4.21e-1)" "unprognostic (2.98e-1)" "unprognostic (7.51e-3)" "prognostic unfavourable (5.77e-4)" "unprognostic (1.72e-1)" "unprognostic (2.00e-1)" "unprognostic (4.53e-2)" 122.8 29.3 0.3 12.7 0.8 2.4 55.6 0.6 0.7 15.9 14.0 1.1 5.3 1.4 10.7 22.3 23.7 17.1 9.3 18.7 0.5 0.3 10.8 71.7 27.5 49.4 1.7 0.2 17.8 13.3 12.0 35.1 45.0 6.4 25.8 3.9 4.9 14.6 4.6 22.1 10.5 5.2 13.9 1.8 5.3 5.7 27.3 0.4 0.4 40.9 8.4 5.2 28.4 26.3 0.0 0.3 48.9 3.8 0.0 0.0 0.7 1.4 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 38.4 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 36.0 3.0 0.0 0.2 0.0 0.0 0.1 0.1 51.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.8 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 48.9 0.0 0.0 0.0 0.0 0.7 0.3 0.8 0.6 0.7 0.5 0.3 1.7 0.2 6.4 0.4 SVOPL MGC46715 ENSG00000157703 "SVOP like" Q8N434 7 138594285-138701352 "Predicted membrane proteins" Transport "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "parathyroid gland: 13.9;salivary gland: 6.5" "Cell line enhanced" "Detected in some" "HMC-1: 8.1;NTERA-2: 2.3;RT4: 1.9;T-47d: 8.2" "Low cancer specificity" "Detected in some" "Cell type enriched" "Detected in single" 41 "eosinophil: 4.1" "Lineage enriched" "Detected in single" 41 "granulocytes: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA018035 Uncertain "HPA018035: AB_2197028" "unprognostic (6.70e-5)" "unprognostic (1.96e-1)" "unprognostic (1.67e-1)" "unprognostic (2.49e-1)" "unprognostic (5.24e-2)" "unprognostic (2.38e-1)" "unprognostic (7.69e-3)" "unprognostic (2.59e-3)" "unprognostic (7.16e-2)" "unprognostic (1.64e-1)" "unprognostic (4.46e-3)" "unprognostic (5.03e-3)" "unprognostic (2.22e-4)" "unprognostic (1.18e-1)" "unprognostic (1.17e-1)" "unprognostic (1.51e-1)" "unprognostic (8.51e-2)" 0.0 2.1 0.5 0.0 1.1 0.0 1.2 0.0 0.1 0.3 0.9 0.0 0.0 0.7 0.0 2.3 0.0 0.0 1.0 0.8 2.7 0.0 0.2 0.0 0.2 0.7 0.3 13.9 1.8 0.5 0.1 0.1 6.5 0.7 0.0 0.4 0.0 0.0 0.8 0.0 0.0 1.5 1.0 0.0 0.4 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 8.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 2.3 0.0 0.9 0.0 0.3 0.0 1.9 0.1 0.9 0.0 0.7 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TACR2 "NK2R, NKNAR, SKR, TAC2R" ENSG00000075073 "Tachykinin receptor 2" P21452 10 69403903-69416867 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 56.3;smooth muscle: 35.5" "Cell line enhanced" "Detected in some" "SK-MEL-30: 8.5;U-87 MG: 4.9" "Cancer enhanced" "Detected in many" "stomach cancer: 6.7" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "intermediate monocyte: 4.2" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA076573 Approved "Plasma membrane" "Plasma membrane" "HPA076573: " "unprognostic (2.83e-1)" "unprognostic (1.58e-3)" "unprognostic (2.48e-2)" "unprognostic (1.67e-1)" "unprognostic (4.22e-1)" "unprognostic (2.30e-1)" "unprognostic (1.30e-2)" "unprognostic (1.96e-2)" "unprognostic (3.72e-1)" "unprognostic (6.14e-2)" "unprognostic (2.45e-2)" "unprognostic (3.16e-2)" "unprognostic (9.88e-4)" "unprognostic (5.59e-3)" "unprognostic (4.31e-3)" "unprognostic (1.25e-3)" "unprognostic (1.32e-1)" 1.6 0.1 0.5 3.1 0.5 0.1 1.2 0.5 1.1 11.1 56.3 0.2 0.4 4.1 12.3 0.9 19.6 7.2 1.2 1.9 0.5 0.3 0.2 0.5 0.8 0.5 0.2 0.4 2.0 0.8 0.0 0.1 0.1 0.4 14.9 8.2 0.2 0.4 0.9 1.1 0.4 14.2 35.5 0.8 0.5 16.5 0.9 0.5 0.1 0.4 0.8 0.4 19.4 3.1 1.2 2.0 0.5 4.2 0.1 0.8 0.3 1.9 1.2 0.4 0.6 3.0 0.2 0.2 0.5 0.3 0.5 0.7 0.7 0.3 0.2 0.5 0.5 0.7 0.1 0.1 0.0 0.4 0.5 1.6 0.6 1.9 0.3 0.0 3.0 0.5 0.7 0.0 0.0 0.2 0.4 2.5 0.0 0.8 0.1 0.5 0.4 1.9 0.1 0.0 0.0 0.0 1.0 0.8 0.6 1.3 2.6 8.5 1.1 0.2 0.8 3.0 0.4 1.2 1.0 1.2 1.3 0.2 4.9 0.3 1.7 0.5 1.5 0.1 0.3 4.2 0.4 1.2 0.8 0.3 2.0 0.6 0.4 0.2 0.2 0.1 1.7 0.3 0.1 0.3 0.5 0.5 0.5 1.1 0.5 0.3 0.2 0.4 0.4 0.5 TAPT1 FLJ90013 ENSG00000169762 "Transmembrane anterior posterior transformation 1" Q6NXT6 4 16160505-16227410 "Disease related genes, Predicted membrane proteins" "Chondrogenesis, Cilium biogenesis/degradation, Differentiation, Host-virus interaction, Osteogenesis" "Developmental protein, Receptor" "Ciliopathy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "REH: 27.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive B-cell: 6.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042567, HPA048658" Approved Approved Vesicles Vesicles "HPA042567: , HPA048658: " "unprognostic (2.34e-1)" "unprognostic (5.84e-2)" "unprognostic (1.41e-2)" "prognostic favourable (9.75e-4)" "unprognostic (2.43e-1)" "unprognostic (2.56e-2)" "unprognostic (2.32e-3)" "unprognostic (3.15e-3)" "unprognostic (1.54e-1)" "unprognostic (6.30e-2)" "prognostic favourable (5.34e-4)" "unprognostic (7.07e-2)" "prognostic favourable (8.52e-4)" "unprognostic (9.00e-2)" "unprognostic (8.52e-2)" "unprognostic (7.25e-3)" "prognostic favourable (4.18e-4)" 10.2 19.2 18.6 7.4 18.0 26.2 13.1 15.0 17.3 10.2 10.1 20.2 8.2 8.3 15.1 12.2 8.2 10.7 10.8 14.4 17.5 13.5 15.8 35.9 14.7 11.0 20.1 10.8 10.8 9.8 14.4 14.5 17.2 13.5 10.2 10.7 11.3 9.4 11.0 38.0 9.8 12.8 12.0 18.5 11.2 9.2 13.1 19.1 15.3 17.8 7.8 9.9 10.1 16.8 6.5 1.8 2.6 0.7 0.9 2.4 0.7 2.9 2.2 3.7 4.3 5.7 4.3 1.6 4.9 3.7 4.6 5.1 2.9 5.2 19.2 5.3 3.0 2.4 3.2 2.4 5.9 1.7 3.9 3.7 3.2 3.1 5.4 7.4 3.9 2.7 4.8 4.5 3.3 2.3 5.7 9.0 4.4 2.1 11.0 6.1 2.4 5.2 27.0 5.3 3.4 7.5 3.1 6.3 5.0 4.5 3.9 5.6 7.1 7.4 4.3 3.9 2.6 2.6 6.2 8.8 7.2 14.6 7.9 18.8 4.5 2.6 0.7 0.2 0.6 0.6 0.2 2.1 1.8 1.0 1.1 6.5 2.4 1.7 1.6 0.9 0.7 1.8 1.3 0.7 18.6 18.0 15.0 16.2 17.5 13.5 20.1 10.8 13.5 19.1 TEDDM1 "EDDM9, Epdd1, HE9, TMEM45C" ENSG00000203730 "Transmembrane epididymal protein 1" Q5T9Z0 1 182398117-182400616 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 33 "epididymis: 128.3" "Cell line enhanced" "Detected in some" "BEWO: 1.2;NB-4: 4.2" "Not detected" "Not detected" "Region enriched" "Detected in single" 6 "cerebellum: 1.3" "Cell type enhanced" "Detected in some" "neutrophil: 3.8" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "unprognostic (4.21e-2)" "unprognostic (8.89e-2)" "unprognostic (2.18e-1)" "unprognostic (4.22e-2)" "unprognostic (6.71e-4)" "unprognostic (4.43e-3)" "unprognostic (2.86e-2)" "unprognostic (4.57e-2)" "unprognostic (4.20e-1)" "unprognostic (7.22e-3)" "unprognostic (1.23e-1)" "unprognostic (3.39e-2)" "unprognostic (2.47e-2)" "unprognostic (6.99e-3)" 0.1 0.0 0.1 0.1 0.2 0.0 0.4 1.3 0.1 0.5 0.1 0.1 1.8 0.0 0.4 128.3 0.1 0.7 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.1 1.0 0.3 0.0 0.3 0.1 0.1 0.4 0.0 0.2 0.2 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.0 2.3 0.1 0.1 0.3 0.1 0.1 0.1 0.6 0.9 0.4 3.8 0.5 0.4 0.6 0.1 0.0 0.2 0.1 0.2 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.1 0.1 0.0 0.2 0.7 0.2 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.3 0.1 0.4 0.1 4.2 0.2 0.0 0.0 0.1 0.9 0.0 0.0 0.4 0.3 0.4 0.2 0.1 0.4 0.4 0.3 0.1 0.2 0.1 0.1 0.2 0.1 0.0 0.3 0.0 0.0 1.3 0.5 1.0 0.6 0.1 0.4 0.1 0.2 0.1 0.1 0.9 0.5 0.3 3.8 0.4 0.5 0.4 0.1 0.1 0.1 0.2 1.3 0.1 0.1 0.0 0.1 0.1 0.1 0.1 TM9SF1 "HMP70, MP70" ENSG00000100926 "Transmembrane 9 superfamily member 1" O15321 14 24189143-24195687 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA059249 Supported Approved "Golgi apparatus" "Golgi apparatus" "HPA059249: " "unprognostic (3.27e-1)" "prognostic unfavourable (8.94e-4)" "unprognostic (9.31e-2)" "unprognostic (1.48e-1)" "unprognostic (3.84e-2)" "unprognostic (1.19e-2)" "unprognostic (4.84e-3)" "prognostic unfavourable (2.04e-4)" "unprognostic (2.54e-1)" "unprognostic (1.37e-1)" "unprognostic (2.24e-1)" "unprognostic (1.23e-1)" "unprognostic (2.62e-3)" "unprognostic (2.44e-1)" "unprognostic (4.24e-1)" "unprognostic (2.20e-1)" "unprognostic (4.18e-3)" 13.3 20.4 6.3 10.9 6.6 3.4 14.0 5.4 8.1 18.5 15.6 10.4 33.1 10.7 17.7 21.8 14.1 23.4 18.4 14.6 6.2 6.0 24.5 46.4 17.0 14.6 6.2 7.1 17.6 39.9 27.4 12.3 25.1 6.5 16.9 9.4 15.6 31.8 36.0 10.1 12.0 16.8 13.6 5.9 12.7 14.7 10.3 5.6 9.6 32.3 12.9 12.1 12.8 12.4 10.6 25.8 18.0 13.6 14.5 10.8 8.6 9.4 15.8 7.0 5.4 14.0 10.9 11.0 18.6 21.1 22.2 25.1 7.9 18.4 5.6 12.4 15.7 21.3 4.4 11.2 12.2 9.4 7.4 4.3 8.3 16.3 9.8 8.1 10.2 12.7 15.7 14.0 8.1 12.6 5.2 10.9 13.3 14.9 4.7 5.5 3.2 18.7 7.1 10.4 9.4 7.8 12.8 7.1 8.2 22.4 10.1 9.0 9.6 3.6 12.7 19.5 8.9 10.2 11.6 15.3 11.7 4.1 6.5 4.5 13.2 17.2 13.6 15.2 10.0 10.9 10.8 10.2 9.9 8.7 15.0 10.6 9.2 8.7 18.0 14.5 10.4 25.8 9.9 8.6 6.3 6.6 5.4 8.1 6.2 6.0 6.2 7.1 6.5 5.6 TMBIM6 "BAXI1, BI-1, TEGT" ENSG00000139644 "Transmembrane BAX inhibitor motif containing 6" P55061 12 49707725-49764934 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Autophagy, Unfolded protein response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017378 Approved "HPA017378: " "prognostic unfavourable (3.54e-4)" "unprognostic (6.25e-2)" "unprognostic (1.90e-2)" "unprognostic (6.52e-2)" "unprognostic (8.46e-3)" "prognostic unfavourable (1.91e-4)" "unprognostic (1.37e-1)" "unprognostic (2.19e-2)" "unprognostic (1.22e-2)" "unprognostic (6.25e-2)" "unprognostic (5.91e-2)" "unprognostic (3.80e-1)" "prognostic favourable (1.00e-5)" "unprognostic (1.95e-1)" "unprognostic (9.27e-2)" "unprognostic (1.28e-1)" "unprognostic (1.54e-2)" 73.3 78.3 57.3 33.4 60.1 34.9 54.9 31.5 56.7 57.1 68.5 84.0 73.0 60.2 46.0 86.7 70.5 57.1 57.5 36.7 47.0 46.1 146.2 245.5 62.2 36.1 56.9 38.2 52.8 88.9 54.6 29.3 69.2 55.1 51.6 65.0 55.1 131.6 59.5 41.3 37.0 123.7 38.4 65.4 53.5 68.0 45.2 50.8 52.5 117.0 42.6 55.8 54.7 42.1 47.1 65.7 139.2 80.5 49.1 69.8 158.0 56.3 49.1 40.1 36.6 116.3 64.6 49.9 42.7 81.9 55.7 51.1 78.9 163.0 35.6 73.0 83.4 62.0 34.8 62.7 60.8 51.1 37.4 56.5 37.6 38.5 70.6 64.6 93.7 65.3 147.0 62.2 91.0 46.1 50.9 147.4 63.6 54.9 33.0 39.2 41.6 37.7 28.1 40.1 60.1 84.6 86.1 31.0 20.4 57.3 75.9 48.1 95.3 68.7 43.3 51.4 39.1 34.4 37.1 63.6 64.2 30.4 71.7 30.4 24.9 79.0 80.5 85.6 66.5 80.1 69.8 47.1 60.6 65.9 65.4 41.4 54.0 61.2 139.2 49.1 79.7 65.7 59.1 158.0 57.3 60.1 31.5 56.7 47.0 46.1 56.9 38.2 55.1 50.8 TMEM101 "FLJ23987, MGC4251" ENSG00000091947 "Transmembrane protein 101" Q96IK0 17 44011188-44023946 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039739 Approved "Nucleoplasm,Plasma membrane,Cytosol" Nucleoplasm "Plasma membrane, Cytosol" "HPA039739: " "unprognostic (1.40e-3)" "unprognostic (1.75e-1)" "unprognostic (1.67e-1)" "prognostic favourable (4.29e-4)" "unprognostic (5.91e-2)" "unprognostic (3.91e-3)" "prognostic unfavourable (7.10e-4)" "unprognostic (1.80e-2)" "unprognostic (2.43e-1)" "unprognostic (2.03e-1)" "unprognostic (1.53e-1)" "unprognostic (1.61e-1)" "prognostic favourable (4.10e-5)" "unprognostic (1.59e-2)" "unprognostic (2.02e-1)" "unprognostic (1.48e-1)" "unprognostic (2.32e-2)" 11.0 10.9 8.4 7.3 14.2 5.1 58.9 6.3 16.5 22.7 11.4 13.7 7.7 8.4 33.3 14.5 15.1 19.2 15.4 12.4 8.7 8.6 37.2 12.0 11.4 16.1 9.5 9.4 13.0 27.8 10.7 8.5 17.8 11.6 13.9 8.6 11.5 20.9 59.7 15.5 13.8 9.5 11.6 10.1 11.0 13.6 16.9 8.9 10.0 25.4 12.9 13.2 12.5 11.6 23.8 25.9 11.7 25.0 23.8 27.2 17.8 9.6 23.7 8.5 7.0 20.3 19.6 8.5 10.1 15.4 20.1 19.2 17.6 25.3 10.9 2.8 10.4 14.9 9.8 17.6 15.4 11.8 19.8 8.2 19.0 35.6 17.5 13.1 14.3 17.5 20.1 14.2 20.2 17.5 16.8 21.5 12.5 12.9 14.1 15.1 4.0 26.8 12.3 18.4 19.8 16.7 7.9 11.1 8.8 6.5 0.2 24.1 11.7 25.3 10.5 18.5 12.4 8.0 19.8 22.4 15.4 5.0 19.4 12.5 16.4 11.7 24.9 8.6 19.4 25.0 21.8 22.7 24.5 22.3 25.9 23.8 27.2 22.1 9.1 23.8 17.8 25.2 25.1 17.8 8.4 14.2 6.3 16.5 8.7 8.6 9.5 9.4 11.6 8.9 TMEM117 DKFZp434K2435 ENSG00000139173 "Transmembrane protein 117" Q9H0C3 12 43835967-44389762 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 8 "B-cells: 2.6;NK-cells: 1.1;T-cells: 4.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046223 Uncertain "HPA046223: AB_10960636" "unprognostic (1.37e-2)" "unprognostic (2.99e-1)" "unprognostic (4.32e-1)" "unprognostic (2.39e-2)" "unprognostic (3.57e-2)" "unprognostic (7.08e-2)" "unprognostic (3.07e-1)" "unprognostic (7.33e-2)" "prognostic unfavourable (3.94e-4)" "unprognostic (2.89e-1)" "unprognostic (6.26e-2)" "unprognostic (1.99e-3)" "unprognostic (1.74e-2)" "unprognostic (2.30e-2)" "unprognostic (2.65e-1)" "unprognostic (9.20e-3)" "unprognostic (3.80e-1)" 4.5 4.5 4.9 5.0 6.6 0.3 5.5 2.6 6.6 8.6 10.8 3.9 23.5 11.4 8.0 6.8 12.5 4.7 6.9 8.4 5.0 5.1 4.4 4.1 2.8 6.0 6.1 5.3 5.2 6.9 7.3 14.5 5.7 10.0 7.3 7.0 8.2 7.4 16.9 6.6 10.4 21.9 7.9 10.3 2.8 5.2 4.3 4.4 1.9 4.6 9.2 7.0 8.0 10.5 2.6 0.3 0.0 0.0 1.1 4.5 1.0 1.1 0.4 4.0 6.7 4.6 9.9 0.1 12.4 6.2 2.4 2.8 9.7 4.3 4.3 0.9 8.9 6.3 2.6 2.8 1.7 1.8 7.0 1.2 2.8 3.9 1.4 1.8 4.7 5.1 10.0 1.3 0.7 0.4 2.1 1.9 4.4 1.0 0.0 1.1 0.8 2.4 2.8 4.5 1.7 4.7 2.6 0.6 6.1 4.7 1.5 9.8 0.3 4.6 1.4 3.5 1.2 1.8 3.2 3.4 3.7 2.6 1.7 2.0 1.2 0.0 0.0 0.0 3.0 0.0 4.5 2.6 0.8 3.2 0.0 1.9 1.3 1.5 0.0 1.1 0.0 0.3 0.4 1.0 4.9 6.6 2.6 6.6 5.0 5.1 6.1 5.3 10.0 4.4 TMEM121 "hole, MGC4659, TMEM121A" ENSG00000184986 "Transmembrane protein 121" Q9BTD3 14 105526603-105530202 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 12.6" "Cell line enhanced" "Detected in some" "EFO-21: 9.4;MCF7: 8.7;PC-3: 11.4;REH: 7.3;SCLC-21H: 6.0;WM-115: 6.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 1.8;MAIT T-cell: 2.6;memory B-cell: 4.7;memory CD4 T-cell: 3.1;memory CD8 T-cell: 1.6;naive B-cell: 1.7;naive CD4 T-cell: 1.9;naive CD8 T-cell: 1.2;NK-cell: 1.8" "Group enriched" "Detected in many" 6 "B-cells: 4.7;NK-cells: 1.8;T-cells: 3.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049857 Uncertain Approved Cytosol Cytosol "HPA049857: " "unprognostic (4.25e-2)" "unprognostic (3.34e-1)" "unprognostic (2.05e-3)" "unprognostic (2.20e-2)" "unprognostic (1.31e-1)" "unprognostic (9.50e-2)" "unprognostic (1.88e-3)" "unprognostic (9.54e-2)" "unprognostic (3.47e-2)" "unprognostic (1.20e-1)" "unprognostic (1.03e-3)" "unprognostic (5.31e-2)" "unprognostic (5.48e-4)" "unprognostic (2.83e-2)" "unprognostic (1.71e-1)" "prognostic unfavourable (5.87e-4)" "unprognostic (5.90e-2)" 3.2 2.6 7.2 2.5 8.8 1.5 1.7 3.3 12.6 2.5 1.6 7.9 1.9 1.5 3.0 2.9 1.6 3.1 1.3 2.3 7.4 6.0 2.5 3.0 1.9 2.5 5.0 3.9 2.7 2.9 2.5 3.5 1.6 3.0 3.8 0.8 2.7 2.8 2.7 1.1 2.1 1.9 1.6 4.3 7.1 3.4 1.6 1.6 0.0 2.9 0.4 1.0 1.1 4.7 4.7 0.5 0.0 0.0 1.8 3.1 0.6 0.0 4.4 0.4 4.1 0.0 0.2 0.8 2.8 0.6 0.4 0.0 0.0 1.5 1.3 9.4 0.0 0.4 0.4 0.1 0.0 0.6 2.2 0.1 0.4 1.5 0.7 0.0 1.6 0.3 0.0 0.1 0.0 0.4 0.1 0.0 0.2 8.7 0.2 0.0 1.4 11.4 7.3 0.0 0.1 0.1 0.0 6.0 2.2 0.5 0.0 2.1 2.7 0.3 1.6 1.3 2.4 0.2 0.4 0.6 0.0 0.0 0.1 0.5 6.1 0.0 0.0 0.0 1.8 0.0 2.6 4.7 3.1 1.6 0.5 1.7 1.9 1.2 0.0 1.8 0.0 0.0 0.2 0.6 7.2 8.8 3.3 8.2 7.4 6.0 5.0 3.9 3.0 1.6 TMEM121B CECR6 ENSG00000183307 "Transmembrane protein 121B" Q9BXQ6 22 17116299-17121367 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.1;prostate: 14.1" "Cell line enhanced" "Detected in some" "AF22: 6.2;SCLC-21H: 14.7;THP-1: 11.8;U-937: 9.8" "Cancer enhanced" "Detected in some" "prostate cancer: 6.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 3.2;intermediate monocyte: 1.4;neutrophil: 4.3" "Group enriched" "Detected in many" 7 "granulocytes: 4.3;monocytes: 3.2" "Group enriched" "Detected in many" 8 "amygdala: 22.5;basal ganglia: 24.0;cerebral cortex: 29.3;hippocampal formation: 26.2;olfactory region: 20.0" "Low region specificity" "Detected in many" HPA068790 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" Vesicles "Nucleoplasm, Plasma membrane" "HPA068790: " "unprognostic (2.30e-1)" "unprognostic (1.05e-1)" "unprognostic (7.11e-3)" "unprognostic (4.49e-3)" "unprognostic (3.36e-1)" "unprognostic (7.14e-3)" "unprognostic (1.12e-3)" "unprognostic (5.32e-2)" "unprognostic (1.97e-1)" "unprognostic (2.01e-2)" "unprognostic (6.88e-4)" "unprognostic (6.08e-2)" "unprognostic (3.10e-4)" "unprognostic (1.02e-2)" "unprognostic (4.37e-2)" "unprognostic (3.49e-3)" "unprognostic (1.71e-1)" 1.3 1.8 7.4 2.2 12.0 2.2 2.0 8.1 19.1 1.0 0.8 2.4 0.0 1.1 1.1 2.3 0.8 1.2 1.0 2.3 7.1 4.0 0.8 0.8 0.9 0.8 2.9 6.9 0.9 2.7 0.8 2.0 1.9 2.3 14.1 1.0 0.2 1.2 1.0 2.8 1.5 0.9 1.3 2.5 1.1 1.0 2.4 4.2 0.0 0.6 0.0 0.8 1.0 0.3 0.0 0.5 4.3 3.2 0.0 0.0 0.6 0.0 0.0 6.2 0.8 0.0 0.0 0.0 0.1 0.1 0.3 0.4 0.2 0.0 0.2 0.1 0.0 0.0 0.7 0.0 0.2 0.1 1.0 0.0 0.0 0.0 0.0 0.7 0.5 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.8 3.1 2.2 0.1 0.2 3.0 0.0 0.3 0.1 14.7 2.2 0.0 0.0 0.3 0.0 11.8 0.6 0.7 0.3 0.2 0.0 0.2 0.3 0.9 0.0 9.8 0.3 0.0 3.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.6 7.4 12.0 8.1 18.0 7.1 4.0 2.9 6.9 2.3 4.2 TMEM135 FLJ22104 ENSG00000166575 "Transmembrane protein 135" Q86UB9 11 87037844-87323758 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 42.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056685, HPA069473" Uncertain Supported Vesicles Vesicles "HPA056685: , HPA069473: " "unprognostic (1.55e-2)" "unprognostic (1.11e-1)" "unprognostic (2.70e-2)" "unprognostic (6.51e-2)" "unprognostic (3.10e-2)" "unprognostic (4.42e-1)" "unprognostic (1.45e-2)" "unprognostic (2.63e-1)" "unprognostic (2.19e-1)" "unprognostic (1.13e-1)" "unprognostic (2.26e-1)" "unprognostic (1.65e-1)" "prognostic favourable (9.02e-4)" "unprognostic (3.48e-2)" "unprognostic (7.34e-2)" "unprognostic (1.35e-2)" "unprognostic (1.80e-1)" 31.6 28.9 10.5 9.5 12.0 5.9 23.3 11.4 14.8 8.3 14.3 12.8 18.9 21.8 15.1 7.8 7.4 8.4 12.6 12.6 9.9 11.3 16.5 31.2 11.7 9.8 13.8 10.2 14.1 9.2 14.7 24.4 13.5 12.9 15.4 12.1 12.8 16.9 17.8 14.9 7.5 20.1 11.1 11.2 8.3 10.1 15.7 11.4 14.1 15.0 6.4 7.0 10.7 9.9 5.9 7.0 2.2 6.0 8.4 10.4 4.5 4.2 6.9 4.8 6.6 15.7 15.1 6.2 3.2 8.5 3.9 8.4 12.1 19.2 12.0 8.4 4.2 4.1 6.6 7.9 4.2 10.5 4.1 9.6 7.3 42.2 8.8 5.2 4.9 17.3 4.8 5.2 3.6 9.8 8.8 16.4 4.2 3.4 12.7 6.1 5.8 5.9 6.7 3.9 9.5 8.8 13.1 2.5 6.3 5.1 14.6 7.0 20.8 5.8 5.2 4.3 5.3 14.7 2.5 6.9 12.4 13.0 3.0 5.9 7.8 0.9 5.8 1.7 9.7 6.0 8.5 5.9 6.3 10.4 6.6 5.2 7.1 6.8 2.2 8.4 2.7 7.0 6.5 4.5 10.5 12.0 11.4 14.8 9.9 11.3 13.8 10.2 12.9 11.4 TMEM136 MGC17839 ENSG00000181264 "Transmembrane protein 136" Q6ZRR5 11 120325129-120333682 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "plasmacytoid DC: 5.7" "Lineage enriched" "Detected in single" 6 "dendritic cells: 5.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA074432 Approved Vesicles,Cytosol Vesicles Cytosol "HPA074432: " "unprognostic (1.02e-1)" "unprognostic (6.56e-2)" "unprognostic (1.49e-2)" "prognostic unfavourable (6.65e-4)" "unprognostic (1.65e-2)" "unprognostic (3.31e-2)" "unprognostic (6.81e-3)" "unprognostic (1.22e-1)" "unprognostic (1.39e-2)" "unprognostic (2.58e-1)" "unprognostic (2.86e-3)" "unprognostic (2.39e-1)" "unprognostic (2.71e-2)" "unprognostic (2.78e-2)" "unprognostic (1.34e-1)" "unprognostic (1.73e-1)" "unprognostic (7.28e-2)" 4.4 18.9 9.1 2.7 13.8 1.0 5.7 5.8 15.1 4.6 2.9 13.8 3.2 2.1 7.6 14.0 2.6 7.4 5.6 19.1 8.2 5.7 4.8 1.9 4.9 4.0 13.0 7.7 9.0 9.7 9.4 7.9 10.4 12.0 8.4 2.3 9.0 2.4 5.9 1.8 2.0 3.1 6.9 13.7 4.2 2.8 5.4 8.8 0.0 7.8 0.7 2.9 3.2 4.1 0.0 5.7 0.0 0.0 0.0 0.9 0.0 1.7 4.5 8.4 8.0 8.4 13.2 2.1 3.7 9.2 6.0 9.7 2.2 7.5 0.0 11.6 2.3 1.2 7.4 2.8 6.7 0.0 4.6 5.5 4.0 3.9 9.4 0.0 0.0 11.4 2.1 8.4 13.1 6.9 1.5 11.1 8.0 2.1 0.0 0.0 3.6 2.8 4.2 3.4 0.6 7.9 1.6 5.4 5.3 5.2 0.6 1.0 6.9 0.2 4.9 6.6 6.7 1.4 2.2 0.1 0.0 0.0 1.9 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.9 0.0 9.1 13.8 5.8 11.5 8.2 5.7 13.0 7.7 12.0 8.8 TMEM150B "TMEM224, TTN2" ENSG00000180061 "Transmembrane protein 150B" A6NC51 19 55312801-55334048 "Predicted membrane proteins" Autophagy "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 37.0" "Cell line enhanced" "Detected in some" "CACO-2: 8.8;HMC-1: 4.6;U-937: 20.0" "Cancer enhanced" "Detected in many" "colorectal cancer: 11.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "classical monocyte: 9.3" "Group enriched" "Detected in many" 8 "granulocytes: 3.7;monocytes: 9.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "unprognostic (3.19e-2)" "unprognostic (1.00e-1)" "unprognostic (5.76e-2)" "unprognostic (4.94e-2)" "unprognostic (5.33e-2)" "unprognostic (6.70e-2)" "unprognostic (5.51e-2)" "unprognostic (1.35e-1)" "unprognostic (5.35e-2)" "unprognostic (4.00e-2)" "unprognostic (4.74e-2)" "unprognostic (3.06e-1)" "prognostic unfavourable (6.14e-6)" "unprognostic (1.48e-1)" "unprognostic (1.63e-3)" "unprognostic (2.45e-1)" "unprognostic (1.18e-2)" 10.5 2.2 0.5 3.1 1.5 0.3 8.3 0.4 1.1 0.8 6.1 0.4 1.2 37.0 0.7 3.0 1.0 1.4 1.7 3.5 1.8 0.6 2.4 5.4 12.7 7.3 0.6 0.3 2.3 0.8 0.0 0.8 5.4 2.1 2.7 4.2 1.2 1.1 0.2 1.5 0.6 31.5 2.3 1.2 14.1 1.2 1.7 0.4 0.3 1.2 0.2 2.0 1.8 3.0 0.0 0.8 3.7 9.3 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 8.8 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.6 0.0 1.2 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.1 2.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 2.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.0 20.0 0.1 3.7 9.3 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.3 0.0 0.5 0.1 0.0 1.2 0.5 1.5 0.4 1.1 1.8 0.6 0.6 0.3 2.1 0.4 TMEM150C "FLJ12993, TTN3" ENSG00000249242 "Transmembrane protein 150C" B9EJG8 4 82483170-82562357 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "epididymis: 74.9" "Cell line enhanced" "Detected in some" "AN3-CA: 8.9;MCF7: 24.6;SCLC-21H: 17.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052921 Enhanced "HPA052921: " "unprognostic (2.99e-1)" "unprognostic (4.31e-2)" "unprognostic (2.27e-1)" "unprognostic (1.89e-3)" "unprognostic (1.71e-3)" "prognostic favourable (7.87e-4)" "unprognostic (2.94e-2)" "unprognostic (5.55e-2)" "unprognostic (1.06e-1)" "unprognostic (3.94e-2)" "prognostic favourable (5.68e-4)" "unprognostic (4.57e-2)" "prognostic favourable (4.59e-6)" "unprognostic (4.18e-1)" "unprognostic (2.64e-2)" "unprognostic (1.19e-1)" "unprognostic (3.51e-3)" 7.0 30.0 10.8 3.2 12.8 1.5 12.4 0.6 16.0 8.4 4.4 8.3 12.9 4.4 3.2 74.9 2.5 4.6 3.9 7.4 12.7 7.9 9.7 7.7 3.6 8.1 7.5 10.3 18.0 2.2 1.7 10.5 5.5 7.3 7.1 2.6 12.4 10.3 4.7 3.5 3.1 4.4 4.0 5.4 7.6 3.0 4.2 6.8 2.7 7.0 1.6 6.9 3.2 3.3 5.5 1.4 5.0 0.9 1.3 0.7 0.3 0.3 0.9 6.8 8.9 0.0 0.1 0.7 1.5 3.7 0.9 1.1 0.0 0.4 0.2 0.7 0.2 0.1 4.2 0.0 1.1 0.4 2.1 0.5 0.8 0.0 0.0 0.0 1.0 4.1 0.4 0.0 0.0 2.2 0.0 0.1 0.1 24.6 0.4 0.6 3.1 0.4 0.9 0.1 0.8 0.3 3.4 17.3 2.7 0.5 0.2 2.4 0.4 0.1 0.5 0.4 0.2 0.1 0.8 0.1 0.3 0.3 0.5 0.3 1.9 5.0 0.9 1.0 0.7 0.4 0.4 3.5 0.7 0.6 0.2 5.5 0.5 0.6 3.7 1.3 0.6 1.4 0.2 0.3 10.8 12.8 0.6 16.0 12.7 7.9 7.5 10.3 7.3 6.8 TMEM161A "FLJ20422, FLJ39645" ENSG00000064545 "Transmembrane protein 161A" Q9NX61 19 19119169-19138513 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043365 Approved Approved Cytosol Cytosol "HPA043365: AB_10796793" "unprognostic (4.31e-2)" "unprognostic (9.13e-2)" "unprognostic (2.34e-2)" "unprognostic (7.42e-3)" "unprognostic (6.60e-2)" "unprognostic (1.57e-1)" "unprognostic (1.12e-2)" "unprognostic (3.51e-2)" "unprognostic (2.04e-1)" "unprognostic (2.74e-1)" "unprognostic (9.42e-2)" "unprognostic (2.46e-1)" "unprognostic (9.15e-2)" "prognostic favourable (2.99e-4)" "unprognostic (4.18e-1)" "unprognostic (2.79e-1)" "unprognostic (4.89e-3)" 10.4 18.3 10.6 9.2 13.5 8.1 10.3 12.8 11.7 12.2 10.5 9.8 15.8 10.0 17.2 8.6 11.7 12.4 15.5 12.7 8.6 6.9 12.7 21.1 9.1 12.1 13.4 8.4 14.2 18.6 17.3 6.6 6.4 9.9 12.8 5.3 12.7 17.1 13.6 34.5 13.5 9.1 9.9 7.8 8.8 10.6 5.3 11.6 15.0 20.8 13.8 9.1 10.8 12.6 6.8 23.5 1.5 7.2 6.7 13.5 5.4 16.0 11.2 6.4 13.7 13.8 9.2 10.1 6.8 8.3 8.4 11.1 9.4 20.0 14.0 33.4 5.1 13.0 10.2 15.7 5.5 6.3 37.3 5.4 6.2 12.7 18.4 7.1 9.0 14.4 13.2 8.4 12.4 9.4 17.9 17.0 5.9 19.4 10.2 14.9 6.1 18.4 16.4 5.4 27.8 6.5 6.6 8.7 8.7 10.2 13.0 8.2 10.4 12.6 5.5 7.8 3.8 17.6 12.6 15.8 9.8 8.4 8.6 14.6 11.3 1.5 7.2 1.4 10.0 6.3 8.8 5.7 9.1 8.1 10.1 6.8 10.8 9.1 0.8 6.7 6.3 23.5 13.5 5.4 10.6 13.5 12.8 11.7 8.6 6.9 13.4 8.4 9.9 11.6 TMEM163 "DKFZP566N034, SV31" ENSG00000152128 "Transmembrane protein 163" Q8TC26 2 134455759-134719000 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.8;pancreas: 19.7" "Cell line enhanced" "Detected in some" "HEL: 10.5;RPTEC TERT1: 36.1;SCLC-21H: 16.4;U-937: 6.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 7 "B-cells: 1.6;NK-cells: 2.0;T-cells: 2.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007224 Uncertain "HPA007224: " "unprognostic (1.05e-2)" "unprognostic (1.33e-1)" "unprognostic (7.25e-3)" "unprognostic (3.18e-1)" "unprognostic (1.47e-1)" "unprognostic (2.25e-1)" "unprognostic (6.08e-3)" "prognostic favourable (7.94e-4)" "unprognostic (9.05e-2)" "unprognostic (9.62e-2)" "unprognostic (6.02e-2)" "unprognostic (2.04e-1)" "unprognostic (2.60e-2)" "unprognostic (2.64e-1)" "unprognostic (3.62e-1)" "unprognostic (6.75e-3)" "prognostic favourable (3.15e-4)" 3.8 6.4 8.1 5.4 5.7 0.5 1.5 31.8 13.4 0.5 0.8 5.8 0.0 0.9 0.8 0.7 0.4 3.4 10.4 7.2 9.1 13.7 1.8 1.7 16.4 10.9 6.9 3.8 1.2 19.7 0.4 11.2 4.2 14.8 0.5 0.9 2.6 3.5 0.5 0.6 0.4 0.8 0.7 13.9 1.9 8.3 6.9 5.0 0.0 1.3 0.0 17.4 9.9 0.3 1.6 0.3 0.1 0.0 2.0 2.5 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.1 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 3.5 0.0 0.1 0.0 0.3 0.0 0.0 2.8 1.2 0.0 0.0 0.0 36.1 5.3 16.4 0.5 0.0 0.0 0.8 0.0 0.0 3.7 0.0 0.2 0.0 0.8 0.8 0.0 0.0 0.0 6.5 0.7 0.0 0.0 0.0 1.3 0.0 1.7 1.6 0.5 2.4 0.3 0.6 0.1 0.5 0.1 2.0 0.0 0.0 2.5 0.8 8.1 5.7 31.8 9.7 9.1 13.7 6.9 3.8 14.8 5.0 TMEM165 "GDT1, TMPT27, TPARL" ENSG00000134851 "Transmembrane protein 165" Q9HC07 4 55395957-55453397 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038299, HPA062424" Supported Enhanced "Golgi apparatus" "Golgi apparatus" "HPA038299: AB_10675793, HPA062424: " "unprognostic (2.53e-2)" "unprognostic (1.08e-3)" "unprognostic (3.46e-3)" "unprognostic (7.07e-3)" "unprognostic (5.97e-2)" "unprognostic (9.84e-2)" "prognostic unfavourable (2.08e-5)" "unprognostic (1.41e-1)" "unprognostic (1.18e-2)" "unprognostic (8.00e-3)" "unprognostic (1.55e-2)" "unprognostic (2.61e-1)" "prognostic unfavourable (1.18e-8)" "unprognostic (9.05e-2)" "unprognostic (8.96e-2)" "unprognostic (2.72e-1)" "unprognostic (2.18e-2)" 28.5 37.6 19.4 25.6 49.0 6.0 27.3 11.3 26.1 31.1 20.0 54.4 17.6 19.8 22.4 20.7 33.0 19.1 29.4 23.9 29.1 20.0 26.7 11.9 30.4 22.3 65.8 16.2 14.0 23.6 22.9 14.9 37.6 33.1 24.9 21.6 15.7 25.5 20.8 9.9 16.2 16.0 25.0 50.5 22.6 23.8 8.4 49.4 14.4 24.3 16.5 25.5 34.0 23.2 11.3 22.8 17.6 24.8 11.3 11.8 17.8 18.5 7.8 12.4 13.0 38.5 28.4 13.1 35.6 55.0 25.8 28.3 8.7 27.9 19.4 25.9 21.9 13.8 12.9 14.6 26.2 10.9 12.0 16.5 13.9 16.7 23.9 22.8 19.7 29.2 19.1 14.6 9.9 29.2 27.8 12.4 30.2 13.6 17.9 19.1 13.4 18.3 13.0 9.2 10.5 38.7 17.9 12.7 17.0 17.9 67.9 21.2 10.7 16.5 25.1 22.0 13.1 9.6 25.8 11.6 9.4 11.9 26.1 19.5 17.5 12.7 24.8 15.5 9.9 20.9 11.3 11.3 9.6 11.8 22.8 7.8 8.2 9.8 17.6 11.3 20.5 17.5 10.8 17.8 19.4 49.0 11.3 26.1 29.1 20.0 65.8 16.2 33.1 49.4 TMEM175 MGC4618 ENSG00000127419 "Transmembrane protein 175" Q9BSA9 4 932387-958656 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel" "Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057160 Approved Approved "Nucleoplasm,Nuclear membrane" "Nucleoplasm, Nuclear membrane" "HPA057160: " "unprognostic (3.84e-1)" "unprognostic (4.27e-2)" "unprognostic (1.28e-2)" "unprognostic (9.61e-3)" "unprognostic (2.43e-1)" "unprognostic (2.33e-3)" "unprognostic (1.12e-2)" "unprognostic (3.25e-3)" "unprognostic (1.22e-2)" "unprognostic (1.50e-2)" "prognostic favourable (9.85e-5)" "unprognostic (4.71e-2)" "unprognostic (5.08e-2)" "unprognostic (1.07e-1)" "unprognostic (3.74e-1)" "unprognostic (1.96e-1)" "unprognostic (7.51e-3)" 17.2 22.9 20.5 13.5 24.0 17.8 12.2 29.0 27.6 17.4 10.8 23.5 16.8 13.6 13.4 14.9 13.4 12.9 16.0 13.3 18.4 19.8 11.7 24.2 14.1 21.9 16.9 25.4 9.3 26.3 18.7 26.4 11.8 20.4 15.0 6.2 17.1 26.8 16.8 14.5 25.8 12.4 10.4 17.2 18.7 14.8 11.8 17.9 13.0 19.7 9.2 12.0 16.2 9.6 13.8 29.3 16.9 23.4 9.5 13.6 11.8 3.3 6.0 3.5 4.8 16.7 8.8 8.1 8.1 5.9 5.0 7.4 2.8 13.2 2.5 5.1 8.5 5.5 3.2 6.4 2.2 6.2 7.4 5.1 8.8 2.8 9.7 2.7 9.6 12.4 7.8 4.4 3.0 3.1 5.2 20.7 4.3 10.8 6.8 11.1 2.2 17.0 4.8 2.1 7.1 4.7 3.1 9.5 8.4 5.7 3.6 5.4 15.8 7.4 4.0 9.2 2.1 10.6 6.2 14.1 3.7 4.8 8.9 5.9 7.4 16.9 19.8 15.5 13.6 23.4 9.1 12.5 11.7 10.1 17.2 13.8 8.4 11.9 16.4 9.5 21.6 29.3 11.0 11.8 20.5 24.0 29.0 27.6 18.4 19.8 16.9 25.4 20.4 17.9 TMEM184B "C22orf5, DKFZP586A1024, FM08, HS5O6A" ENSG00000198792 "Transmembrane protein 184B" Q9Y519 22 38219291-38273034 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/84: 58.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024076 Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Golgi apparatus, Cytosol" Nucleoplasm "HPA024076: AB_1858106" "unprognostic (1.52e-1)" "unprognostic (9.17e-2)" "unprognostic (1.86e-1)" "unprognostic (8.96e-2)" "unprognostic (3.82e-1)" "unprognostic (2.77e-2)" "prognostic unfavourable (5.94e-6)" "unprognostic (1.14e-2)" "unprognostic (5.18e-2)" "unprognostic (4.52e-2)" "unprognostic (9.20e-2)" "unprognostic (1.77e-2)" "unprognostic (1.52e-1)" "unprognostic (5.67e-2)" "unprognostic (1.65e-1)" "unprognostic (1.06e-1)" "unprognostic (2.96e-1)" 21.8 16.5 23.9 14.7 24.1 6.0 27.5 26.4 40.0 22.4 14.4 31.2 12.2 18.5 12.1 9.5 11.0 14.2 16.1 17.8 25.8 21.5 13.0 7.4 20.5 8.6 26.1 22.2 10.8 18.0 27.3 21.9 41.2 23.8 12.3 12.5 20.1 16.8 17.3 19.0 10.9 16.5 15.7 41.2 14.1 19.3 5.8 20.9 3.9 16.7 10.6 9.2 20.0 15.4 1.6 7.3 12.4 3.1 6.2 5.8 2.6 17.0 14.9 8.8 6.9 17.6 14.2 20.4 18.5 26.3 15.2 13.5 10.9 7.9 3.2 14.5 27.5 21.1 7.9 18.2 10.3 11.6 14.2 6.4 10.9 9.0 18.5 5.0 9.0 11.8 16.1 17.8 20.0 18.9 4.1 11.4 13.2 9.7 3.2 4.3 7.1 13.7 5.5 7.9 3.2 11.2 18.9 19.2 3.4 13.9 20.3 9.8 11.1 3.7 27.9 15.5 15.9 13.6 11.2 23.9 58.9 2.6 22.5 3.7 13.3 12.4 3.1 4.6 5.8 2.4 5.3 1.6 3.3 4.3 4.7 1.2 2.3 2.7 11.2 6.2 1.6 7.3 1.0 2.6 23.9 24.1 26.4 35.4 25.8 21.5 26.1 22.2 23.8 20.9 TMEM185A "CXorf13, FAM11A, FRAXF" ENSG00000269556 "Transmembrane protein 185A" Q8NFB2 X 149596556-149631912 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048295, HPA071744" Uncertain Approved "Endoplasmic reticulum" "Endoplasmic reticulum" "HPA048295: , HPA071744: " "unprognostic (9.76e-2)" "unprognostic (2.83e-2)" "unprognostic (7.73e-2)" "unprognostic (2.71e-3)" "unprognostic (4.08e-1)" "unprognostic (1.97e-1)" "unprognostic (4.34e-3)" "unprognostic (1.71e-1)" "unprognostic (1.83e-1)" "unprognostic (1.92e-1)" "unprognostic (2.78e-2)" "unprognostic (2.69e-1)" "unprognostic (3.17e-1)" "unprognostic (1.37e-2)" "unprognostic (1.90e-1)" "unprognostic (1.07e-1)" "unprognostic (1.40e-1)" 4.3 5.0 6.8 4.8 6.2 1.7 4.1 7.2 8.2 5.1 3.8 3.1 7.3 2.3 6.2 7.4 5.8 5.8 5.3 12.0 4.4 4.4 3.1 3.4 3.3 3.0 3.3 13.8 5.4 7.3 4.8 10.8 6.0 5.5 3.5 6.3 4.8 7.2 4.5 6.2 3.3 6.6 3.7 7.8 2.7 12.3 4.0 3.8 3.8 4.5 4.3 4.6 5.8 5.3 7.7 12.2 5.0 13.5 10.4 6.3 11.0 11.2 12.9 7.6 17.6 11.9 5.1 10.9 13.3 11.0 16.7 6.8 19.1 13.5 24.3 12.0 14.0 14.9 10.3 12.0 8.7 11.1 7.8 13.0 7.3 12.7 11.3 8.0 11.3 17.5 11.4 7.1 9.5 3.2 8.8 7.9 18.0 7.8 7.8 9.6 12.5 7.6 19.6 7.7 12.7 14.5 4.5 6.4 8.3 14.3 14.2 7.6 6.5 11.4 8.4 7.7 15.4 13.3 8.3 7.3 19.8 14.9 13.4 11.5 2.2 5.0 12.2 10.1 3.0 9.0 5.3 7.3 10.4 7.7 5.0 10.3 9.2 7.1 13.5 2.5 5.7 9.0 6.3 TMEM187 "CXorf12, DXS9878E, ITBA1" ENSG00000177854 "Transmembrane protein 187" Q14656 X 153972327-153983195 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA038134 Uncertain Approved Nucleoli,Cytosol "Nucleoli, Cytosol" "HPA038134: AB_10669517" "unprognostic (1.51e-1)" "unprognostic (4.35e-2)" "unprognostic (1.41e-1)" "unprognostic (1.28e-1)" "unprognostic (3.08e-1)" "unprognostic (7.88e-2)" "unprognostic (8.94e-2)" "unprognostic (2.41e-1)" "unprognostic (3.09e-1)" "unprognostic (4.22e-2)" "unprognostic (5.33e-2)" "unprognostic (7.41e-2)" "prognostic favourable (9.14e-8)" "unprognostic (6.73e-2)" "unprognostic (1.57e-1)" "unprognostic (1.05e-1)" "unprognostic (7.04e-2)" 8.8 13.0 9.2 6.8 10.2 3.4 10.5 13.2 9.0 7.6 9.0 10.5 13.9 6.8 8.8 9.3 9.5 12.0 6.8 8.1 9.6 6.0 7.6 10.2 7.7 10.2 10.4 9.0 10.9 24.4 7.5 13.0 7.3 11.0 10.3 4.5 6.7 14.1 10.1 8.5 10.7 10.9 6.8 8.0 10.0 8.0 5.9 8.7 8.4 10.8 2.9 9.9 7.9 7.4 13.4 19.6 17.8 9.8 10.1 22.5 10.9 8.3 9.5 2.1 7.6 8.2 7.4 1.1 3.4 1.7 1.0 3.4 1.9 14.4 1.3 19.7 2.7 7.6 2.9 5.0 0.8 10.7 3.9 2.3 5.0 3.1 7.0 1.1 2.6 8.3 7.6 2.9 4.3 2.6 2.0 10.8 4.3 9.0 4.4 1.5 1.5 10.6 4.1 1.1 13.9 5.3 2.7 2.8 2.8 5.0 4.2 3.6 8.0 2.7 4.8 1.7 1.8 6.9 1.9 7.6 5.1 1.7 5.1 5.0 0.9 17.8 9.8 11.9 14.7 7.3 14.7 9.7 18.1 15.9 7.4 13.4 22.5 13.9 9.5 10.1 6.9 19.6 17.6 10.9 9.2 10.2 13.2 9.0 9.6 6.0 10.4 9.0 11.0 8.7 TMEM19 FLJ10936 ENSG00000139291 "Transmembrane protein 19" Q96HH6 12 71686087-71705046 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016830 Approved "HPA016830: AB_1858107" "unprognostic (8.22e-2)" "unprognostic (3.47e-2)" "unprognostic (6.76e-2)" "unprognostic (1.44e-1)" "unprognostic (4.45e-1)" "unprognostic (3.43e-2)" "unprognostic (7.60e-2)" "unprognostic (5.60e-2)" "unprognostic (6.45e-2)" "unprognostic (1.25e-1)" "unprognostic (1.21e-1)" "unprognostic (1.11e-2)" "unprognostic (4.27e-2)" "unprognostic (1.49e-2)" "unprognostic (4.42e-1)" "unprognostic (5.32e-3)" "unprognostic (1.00e-1)" 11.0 10.4 8.6 11.0 14.4 4.7 15.2 9.9 14.6 11.5 20.5 14.3 7.6 24.0 8.2 7.3 35.7 8.8 9.2 16.9 9.3 10.1 27.6 17.1 11.5 14.5 9.8 9.4 6.5 11.3 11.6 13.1 8.2 13.2 8.4 14.7 12.1 12.9 9.8 15.8 18.8 24.5 10.6 13.8 19.9 10.3 7.0 10.9 14.6 11.0 14.4 20.9 15.3 17.8 37.1 40.2 7.0 10.1 8.2 10.5 9.4 14.2 18.6 12.8 7.5 20.3 9.4 7.8 11.6 13.9 13.7 12.0 8.8 13.2 26.6 16.0 22.0 18.8 11.1 12.3 18.4 19.3 13.4 15.4 12.1 10.0 5.6 16.2 15.5 8.5 14.1 17.4 5.7 14.6 9.0 15.7 20.6 7.0 15.5 4.7 7.1 12.4 11.9 18.9 15.1 12.7 33.2 14.0 11.2 20.2 10.2 5.0 15.8 4.9 14.2 19.3 9.4 8.3 10.4 30.9 38.9 19.1 8.1 4.7 20.5 7.0 8.2 2.9 10.5 10.1 8.1 30.6 8.4 8.9 14.2 37.1 8.3 9.8 0.7 8.2 8.8 40.2 8.5 9.4 8.6 14.4 9.9 14.6 9.3 10.1 9.8 9.4 13.2 10.9 TMEM198 "MGC99813, TMEM198A" ENSG00000188760 "Transmembrane protein 198" Q66K66 2 219543663-219550595 "Predicted membrane proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.0" "Cell line enhanced" "Detected in many" "SCLC-21H: 16.9;SH-SY5Y: 14.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 2.6" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042385, HPA062897" Enhanced Approved Vesicles Vesicles "HPA042385: , HPA062897: " "unprognostic (2.59e-2)" "unprognostic (8.51e-2)" "unprognostic (5.97e-3)" "unprognostic (2.77e-1)" "unprognostic (4.43e-2)" "unprognostic (8.09e-2)" "unprognostic (1.83e-1)" "unprognostic (1.03e-1)" "unprognostic (4.28e-1)" "unprognostic (2.06e-1)" "prognostic favourable (6.89e-4)" "unprognostic (6.39e-2)" "unprognostic (7.91e-3)" "unprognostic (3.41e-3)" "unprognostic (2.11e-1)" "unprognostic (1.72e-1)" "unprognostic (1.58e-1)" 3.0 9.4 14.4 3.1 10.3 0.9 2.3 14.2 22.0 3.3 2.6 4.1 1.4 16.1 4.0 2.5 2.7 2.5 3.9 3.4 16.5 5.2 3.0 2.6 2.4 1.8 4.1 11.9 10.9 20.0 5.2 13.0 2.6 6.2 4.0 1.8 3.0 7.0 4.3 3.5 2.2 6.4 3.5 7.5 1.8 4.7 5.0 4.9 0.0 4.0 0.5 1.9 3.8 1.2 0.2 2.6 0.1 0.0 0.8 0.4 0.4 0.5 0.1 4.7 8.0 1.0 0.9 4.2 2.4 1.3 2.0 1.7 10.3 1.3 2.1 2.4 1.5 2.8 1.7 1.1 0.4 7.0 2.0 1.7 2.1 8.4 1.4 0.6 4.0 2.1 0.6 0.9 2.3 0.0 6.1 6.8 1.2 1.0 0.1 0.5 6.1 0.7 0.2 2.9 2.4 1.2 1.1 16.9 14.7 0.6 1.7 4.0 0.2 3.3 0.1 2.2 0.9 2.0 1.0 6.6 1.9 2.2 2.0 0.1 2.9 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.8 0.0 2.6 0.0 0.4 14.4 10.3 14.2 22.0 16.5 5.2 4.1 11.9 6.2 4.9 TMEM201 "Ima1, NET5, RP13-15M17.2, SAMP1" ENSG00000188807 "Transmembrane protein 201" Q5SNT2 1 9588922-9614873 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 37.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 4.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB039039 Approved Supported "Nucleoplasm,Nuclear membrane" "Nuclear membrane" Nucleoplasm "CAB039039: " "unprognostic (1.75e-2)" "prognostic favourable (5.36e-4)" "unprognostic (1.89e-1)" "unprognostic (1.80e-1)" "unprognostic (4.88e-1)" "unprognostic (1.27e-2)" "prognostic unfavourable (9.61e-8)" "unprognostic (2.22e-1)" "unprognostic (3.60e-1)" "unprognostic (3.87e-2)" "unprognostic (5.59e-3)" "unprognostic (1.63e-1)" "unprognostic (9.38e-2)" "unprognostic (3.87e-2)" "unprognostic (6.25e-2)" "unprognostic (7.99e-2)" "unprognostic (1.45e-1)" 6.2 7.3 9.6 5.7 9.4 10.3 4.0 8.7 11.9 4.4 3.9 10.5 4.4 5.4 6.9 5.1 5.9 5.8 4.0 13.2 9.3 7.9 5.7 2.7 4.5 5.0 9.4 8.3 9.0 9.2 5.5 12.6 4.5 7.9 4.9 2.8 12.6 6.7 5.6 37.0 7.1 3.9 4.9 6.7 5.3 4.0 8.2 7.1 6.9 4.5 13.9 5.4 3.8 4.3 1.4 4.3 0.0 0.8 0.4 1.9 1.0 7.7 10.4 6.6 15.5 2.8 1.8 5.9 9.1 2.8 10.8 7.7 19.2 7.0 13.5 11.6 3.1 16.2 7.3 7.2 3.6 8.8 18.3 9.5 10.0 9.7 5.1 11.5 9.9 3.4 3.3 14.5 2.4 4.3 12.1 3.9 4.3 9.1 9.9 8.4 6.7 9.7 21.1 11.3 11.0 3.8 4.2 15.8 11.9 7.2 17.6 7.8 5.4 7.3 3.9 13.0 11.3 14.2 17.0 6.6 5.4 12.1 9.0 19.0 11.4 0.0 0.8 0.0 1.1 0.6 0.6 1.4 1.4 1.9 1.1 1.1 1.0 0.7 0.0 0.4 0.4 4.3 1.8 1.0 9.6 9.4 8.7 11.9 9.3 7.9 9.4 8.3 7.9 7.1 TMEM229A ENSG00000234224 "Transmembrane protein 229A" B2RXF0 7 124030916-124033023 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.6;intestine: 16.4;testis: 10.6" "Cell line enriched" "Detected in some" 44 "SH-SY5Y: 54.6" "Cancer enhanced" "Detected in some" "glioma: 2.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA056391 Uncertain Approved "Plasma membrane" "Plasma membrane" "HPA056391: " "unprognostic (2.52e-2)" "unprognostic (3.04e-2)" "unprognostic (2.30e-1)" "unprognostic (2.50e-1)" "unprognostic (2.89e-2)" "unprognostic (8.21e-2)" "unprognostic (4.74e-2)" "unprognostic (2.31e-1)" "unprognostic (4.31e-3)" 0.4 1.5 6.9 0.5 7.6 0.4 0.4 1.3 9.0 0.8 0.5 7.6 0.0 16.4 0.7 1.2 0.4 1.7 0.6 0.9 8.0 4.6 0.5 0.4 0.5 0.4 10.6 4.9 1.0 0.4 2.5 1.0 0.6 5.6 0.8 0.6 0.6 0.7 0.5 0.4 0.4 7.7 0.7 7.3 0.6 3.7 10.6 8.7 0.0 0.5 0.0 0.4 1.1 0.1 0.0 0.0 0.3 0.0 0.2 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.3 0.2 0.0 0.0 0.1 0.0 6.9 7.6 1.3 6.1 8.0 4.6 10.6 4.9 5.6 8.7 TMEM236 "bA162I21.2, bA16O1.2, FAM23A, FAM23B" ENSG00000148483 "Transmembrane protein 236" Q5W0B7 10 17752252-17800868 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "intestine: 76.4" "Cell line enriched" "Detected in some" 10 "MOLT-4: 14.9" "Cancer enhanced" "Detected in some" "colorectal cancer: 1.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA045096 Enhanced "HPA045096: " "unprognostic (4.95e-2)" "unprognostic (2.48e-1)" "unprognostic (2.88e-3)" "unprognostic (2.47e-1)" "unprognostic (1.96e-1)" "unprognostic (3.36e-2)" "unprognostic (2.52e-3)" "unprognostic (1.37e-1)" "unprognostic (3.98e-1)" "unprognostic (1.42e-1)" "unprognostic (5.06e-3)" "unprognostic (1.75e-1)" "unprognostic (1.62e-2)" "unprognostic (1.72e-1)" "unprognostic (3.43e-2)" "unprognostic (3.16e-2)" "unprognostic (1.54e-2)" 0.5 0.3 0.3 4.9 0.3 0.0 0.3 0.3 0.3 0.4 32.0 0.1 0.1 13.7 0.5 0.1 0.4 0.2 0.1 0.3 0.3 0.3 0.5 0.4 0.6 0.1 0.3 0.1 0.3 0.7 0.0 0.3 0.6 0.1 0.3 9.1 0.1 0.3 0.1 0.5 0.3 76.4 0.3 0.3 0.3 0.3 0.5 0.1 0.1 0.3 0.1 0.1 0.3 0.3 1.3 0.9 2.6 0.6 1.0 0.6 0.1 0.3 0.2 0.4 0.5 0.1 0.1 0.5 0.3 0.0 0.1 0.3 0.5 0.5 0.2 0.2 0.2 0.3 0.2 0.2 0.8 0.2 0.5 0.6 0.5 0.5 0.1 0.5 1.5 0.2 0.4 0.1 0.2 0.4 0.2 0.4 0.2 0.3 14.9 0.3 0.3 0.1 0.6 0.4 0.3 0.1 0.3 0.3 0.2 0.2 0.1 0.5 0.2 0.0 0.7 0.5 0.6 0.2 0.2 0.3 0.2 0.3 0.2 0.2 0.2 2.6 0.6 0.9 0.6 0.4 0.4 0.7 0.5 0.4 0.4 1.3 0.5 0.6 2.2 1.0 0.4 0.9 0.4 0.1 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.1 0.1 0.1 TMEM241 "C18orf45, FLJ44259, MGC11386" ENSG00000134490 "Transmembrane protein 241" Q24JQ0 18 23197144-23437961 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 8.4" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029489, HPA059922" Uncertain Approved "Golgi apparatus,Vesicles" "Golgi apparatus" Vesicles "HPA029489: , HPA059922: " "unprognostic (1.44e-3)" "unprognostic (1.92e-1)" "unprognostic (7.80e-2)" "unprognostic (1.02e-2)" "unprognostic (1.37e-1)" "unprognostic (6.48e-2)" "unprognostic (1.15e-4)" "unprognostic (7.07e-2)" "unprognostic (6.65e-2)" "unprognostic (1.19e-1)" "unprognostic (1.81e-3)" "unprognostic (9.53e-3)" "unprognostic (1.15e-1)" "unprognostic (1.42e-1)" "unprognostic (2.95e-1)" "unprognostic (4.93e-1)" "prognostic unfavourable (5.80e-4)" 5.8 3.6 6.4 4.3 11.3 2.6 6.3 2.0 11.9 6.0 4.3 4.2 2.2 4.1 5.7 5.0 5.2 4.6 4.5 4.0 3.9 4.0 3.1 5.4 4.3 3.6 3.1 5.2 4.9 6.5 7.0 6.5 6.1 5.2 2.7 6.3 3.5 4.8 2.6 3.4 3.9 2.9 7.6 3.5 4.1 3.7 2.1 2.6 1.9 6.8 4.9 5.1 5.4 4.7 3.0 2.3 1.3 3.1 8.4 2.2 1.4 3.1 6.2 1.2 4.1 6.5 5.8 3.7 1.5 2.0 1.5 3.5 1.2 7.4 11.9 3.4 3.0 6.0 3.3 5.6 5.2 1.4 0.4 2.5 4.5 2.6 3.6 2.6 2.0 6.6 6.1 6.2 7.4 6.8 5.2 4.2 5.5 3.4 2.7 0.5 1.4 1.2 2.0 5.6 11.4 2.6 2.3 4.4 4.2 7.3 3.9 4.7 4.1 1.2 2.6 10.6 2.5 3.7 4.2 8.4 6.4 5.0 3.4 8.0 6.8 1.3 0.7 0.0 1.3 3.1 2.2 1.8 0.2 1.2 2.3 3.0 1.1 1.9 0.0 8.4 1.2 0.7 1.5 1.4 6.4 11.3 2.0 11.9 3.9 4.0 3.1 5.2 5.2 2.6 TMEM245 "C9orf5, CG-2" ENSG00000106771 "Transmembrane protein 245" Q9H330 9 109015152-109119945 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023892 Approved Approved "Plasma membrane,Cytosol" "Plasma membrane, Cytosol" "HPA023892: AB_1845828" "unprognostic (1.56e-2)" "unprognostic (1.65e-1)" "unprognostic (1.29e-1)" "unprognostic (9.58e-2)" "unprognostic (1.63e-1)" "unprognostic (6.43e-2)" "unprognostic (1.66e-1)" "unprognostic (5.96e-2)" "unprognostic (1.18e-1)" "unprognostic (1.03e-1)" "unprognostic (2.05e-1)" "unprognostic (1.85e-1)" "prognostic favourable (4.46e-9)" "unprognostic (6.11e-2)" "unprognostic (2.44e-1)" "unprognostic (2.41e-1)" "unprognostic (2.24e-2)" 16.5 35.5 14.4 7.2 18.1 4.0 24.2 15.7 20.6 14.0 19.2 14.7 22.0 7.7 18.4 17.3 14.6 18.7 15.3 25.2 12.6 14.9 29.0 16.2 20.5 12.3 14.5 14.8 29.0 20.3 43.2 14.9 17.5 13.7 16.4 10.7 22.1 14.5 22.3 29.8 9.2 16.8 23.1 13.6 10.4 17.2 12.2 14.3 12.3 52.1 8.9 7.5 20.8 11.2 3.5 3.5 6.3 3.3 5.4 9.0 2.7 13.5 18.1 13.4 4.5 31.6 18.2 29.6 19.6 15.2 21.2 16.8 24.3 27.3 12.3 20.2 14.9 21.5 17.0 12.6 25.1 15.9 7.3 15.2 15.1 14.3 13.8 11.5 12.0 19.4 12.9 20.6 19.1 17.7 10.1 13.6 24.0 8.9 15.3 5.3 14.9 16.4 8.8 26.6 7.6 22.6 13.3 7.4 7.3 13.0 13.0 13.0 17.3 6.5 19.4 16.5 12.4 15.4 22.3 9.1 23.4 3.9 23.0 6.2 23.9 6.3 2.6 2.2 4.0 1.8 4.9 2.7 6.8 5.6 2.5 3.5 9.0 6.2 1.0 5.4 3.3 3.5 6.5 2.7 14.4 18.1 15.7 20.6 12.6 14.9 14.5 14.8 13.7 14.3 TMEM259 "ASBABP1, C19orf6, MBRL, MGC4022" ENSG00000182087 "Transmembrane protein 259" Q4ZIN3 19 1009648-1021179 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042669, HPA054801" Approved Approved "Nuclear speckles,Endoplasmic reticulum" "Endoplasmic reticulum" "Nuclear speckles" "HPA042669: AB_10794916, HPA054801: " "unprognostic (1.35e-1)" "unprognostic (1.28e-1)" "unprognostic (1.41e-1)" "prognostic favourable (1.01e-4)" "unprognostic (4.12e-2)" "unprognostic (6.87e-3)" "unprognostic (2.77e-2)" "unprognostic (1.23e-1)" "unprognostic (2.20e-1)" "unprognostic (2.74e-1)" "unprognostic (4.85e-3)" "unprognostic (4.07e-2)" "unprognostic (4.81e-2)" "prognostic favourable (8.92e-6)" "unprognostic (2.47e-1)" "unprognostic (2.57e-1)" "unprognostic (4.10e-3)" 39.5 39.2 35.7 42.3 39.2 46.4 36.9 54.8 44.3 35.4 41.0 46.1 33.9 43.7 39.6 27.4 37.0 34.8 38.6 43.9 34.8 26.1 37.1 59.2 40.5 44.6 44.1 30.0 38.4 59.0 43.5 55.7 47.9 40.1 41.1 23.3 47.8 49.0 36.2 39.3 62.3 42.9 30.1 27.5 61.8 48.5 36.0 40.2 38.0 47.6 24.9 45.4 37.9 37.0 3.8 6.7 2.5 5.2 2.5 5.5 3.0 35.9 23.2 16.1 18.3 19.9 19.3 28.5 30.6 26.7 25.3 27.4 21.3 20.3 24.9 30.2 23.1 41.2 16.2 30.1 11.2 31.9 27.4 14.6 28.7 23.4 35.3 28.0 37.2 25.8 30.8 20.3 25.5 22.0 24.6 50.5 16.8 15.7 30.7 25.8 23.9 19.1 35.1 12.3 31.5 20.0 33.9 22.4 23.4 19.4 24.6 20.9 24.2 36.5 25.5 25.3 14.6 35.4 31.8 71.7 26.9 27.7 29.9 23.1 25.1 0.9 3.9 2.2 5.5 3.5 4.1 3.8 3.2 5.5 6.0 3.4 3.5 3.9 2.5 2.5 5.2 6.7 3.2 3.0 35.7 39.2 54.8 44.3 34.8 26.1 44.1 30.0 40.1 40.2 TMEM26 "Em:AC068892.1, MGC35010" ENSG00000196932 "Transmembrane protein 26" Q6ZUK4 10 61406643-61453450 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 30.2" "Cell line enhanced" "Detected in some" "BJ hTERT+: 9.1;fHDF/TERT166: 2.2;HSkMC: 3.9;HUVEC TERT2: 2.9;MOLT-4: 4.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in some" "hypothalamus: 2.7" "Low region specificity" "Detected in many" "unprognostic (1.21e-3)" "unprognostic (2.84e-1)" "unprognostic (7.34e-2)" "unprognostic (7.83e-2)" "unprognostic (1.38e-3)" "unprognostic (1.30e-1)" "unprognostic (7.56e-2)" "unprognostic (3.69e-2)" "unprognostic (3.13e-1)" "unprognostic (9.41e-2)" "unprognostic (5.38e-2)" "unprognostic (5.24e-2)" "unprognostic (2.29e-5)" "unprognostic (2.55e-2)" "unprognostic (1.51e-2)" "unprognostic (8.53e-2)" "unprognostic (1.95e-1)" 1.3 1.2 3.7 1.0 2.1 0.0 7.4 0.3 2.0 3.2 1.1 0.9 1.1 1.8 5.6 0.9 0.6 0.8 1.2 0.6 0.9 1.0 3.6 4.5 1.8 5.8 1.5 1.3 2.1 0.4 5.6 0.7 1.8 1.1 3.5 1.1 3.6 0.5 3.2 0.7 0.3 1.9 2.5 0.9 30.2 0.5 4.4 1.2 6.2 0.7 0.2 0.1 0.9 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 1.7 0.2 0.0 9.1 1.0 1.1 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 3.9 0.0 1.0 0.0 2.9 0.0 0.0 0.3 0.0 4.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 2.1 0.3 2.0 0.9 1.0 1.5 1.3 1.1 1.2 TMEM41A MGC15397 ENSG00000163900 "Transmembrane protein 41A" Q96HV5 3 185476496-185499057 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 54.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059101, HPA059790" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" Nucleoplasm "Golgi apparatus, Cytosol" "HPA059101: , HPA059790: " "unprognostic (2.17e-2)" "unprognostic (7.94e-2)" "unprognostic (1.99e-2)" "prognostic unfavourable (6.70e-6)" "unprognostic (2.67e-1)" "unprognostic (2.15e-1)" "prognostic unfavourable (1.04e-4)" "unprognostic (2.84e-1)" "unprognostic (1.39e-1)" "unprognostic (1.79e-1)" "prognostic unfavourable (4.72e-4)" "unprognostic (3.63e-2)" "unprognostic (2.56e-2)" "unprognostic (3.73e-1)" "unprognostic (3.68e-1)" "unprognostic (1.46e-2)" "unprognostic (1.02e-2)" 8.1 23.9 7.8 4.8 10.2 9.3 10.1 4.9 11.5 10.6 26.8 11.7 6.3 24.5 9.1 11.1 20.6 9.0 8.6 8.3 7.5 8.4 15.8 26.1 11.3 9.0 8.1 5.4 14.2 10.7 6.7 5.7 9.0 8.6 10.1 8.6 11.9 11.2 9.4 8.3 16.6 54.4 8.0 8.7 12.4 8.7 11.2 7.4 11.3 9.0 18.1 16.7 8.8 12.5 12.8 16.4 7.8 8.4 8.5 16.7 6.5 20.6 7.5 5.0 6.2 8.0 8.6 14.8 8.0 7.0 10.1 7.4 19.5 8.2 6.4 15.3 7.4 14.4 13.8 8.5 10.2 10.7 12.7 11.1 4.5 19.6 8.9 12.0 6.3 8.0 12.8 9.1 10.5 7.7 19.7 16.0 6.4 8.0 7.3 6.9 8.3 11.9 7.4 7.7 11.7 8.7 15.2 5.1 6.5 6.9 17.7 12.1 21.1 9.4 5.6 6.0 7.5 12.5 16.6 23.7 36.0 12.9 9.1 7.2 7.2 7.8 6.3 5.1 13.2 6.6 16.7 12.8 13.6 14.3 7.0 12.4 15.0 16.1 2.4 8.5 8.4 16.4 11.1 6.5 7.8 10.2 4.9 11.5 7.5 8.4 8.1 5.4 8.6 7.4 TMEM41B KIAA0033 ENSG00000166471 "Transmembrane protein 41B" Q5BJD5 11 9280654-9314780 "Predicted membrane proteins" "Autophagy, Neurogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CAPAN-2: 41.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014946 Uncertain Approved Peroxisomes Peroxisomes "HPA014946: AB_2205037" "unprognostic (1.21e-1)" "unprognostic (2.19e-1)" "unprognostic (1.35e-1)" "unprognostic (2.75e-3)" "unprognostic (5.78e-3)" "unprognostic (1.94e-1)" "prognostic unfavourable (9.18e-6)" "unprognostic (6.18e-2)" "unprognostic (9.37e-3)" "unprognostic (4.90e-3)" "unprognostic (1.36e-2)" "unprognostic (4.02e-2)" "unprognostic (1.29e-1)" "unprognostic (1.40e-1)" "unprognostic (2.20e-1)" "unprognostic (3.55e-2)" "unprognostic (8.18e-2)" 9.2 11.6 11.9 8.7 13.0 15.5 10.5 13.7 17.6 8.0 14.3 20.1 15.6 21.8 7.3 10.6 13.5 7.8 10.5 10.7 11.9 14.6 14.6 23.0 19.3 9.5 16.2 12.9 9.1 14.6 18.8 13.4 13.8 20.1 14.0 11.3 10.1 11.8 11.1 8.8 15.9 21.2 5.9 13.5 10.2 15.5 14.9 14.6 14.9 21.3 8.5 11.0 9.6 8.8 7.2 6.0 8.0 2.4 7.1 9.2 3.7 12.8 13.5 7.6 6.5 7.5 10.9 18.3 11.5 11.0 6.8 12.6 6.4 41.9 5.6 10.8 7.3 16.9 8.8 7.0 8.5 9.6 6.8 4.6 9.1 6.6 9.7 4.1 6.4 9.2 9.9 6.5 8.2 5.8 9.7 14.1 13.2 4.6 6.7 1.8 23.5 7.1 4.5 10.6 7.7 10.6 13.0 2.4 8.4 11.5 9.7 8.0 8.6 6.5 8.0 7.6 8.8 11.7 6.0 4.5 7.0 10.1 8.5 2.6 6.2 6.3 1.9 7.4 4.7 1.6 4.3 7.2 4.4 5.1 3.1 5.9 9.2 7.6 8.0 7.1 2.4 6.0 4.0 3.7 11.9 13.0 13.7 17.6 11.9 14.6 16.2 12.9 20.1 14.6 TMEM44 DKFZp686O18124 ENSG00000145014 "Transmembrane protein 44" Q2T9K0 3 194587673-194633689 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "basophil: 3.2;NK-cell: 11.5" "Group enriched" "Detected in many" 9 "granulocytes: 3.2;NK-cells: 11.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA043718 Uncertain Approved Cytosol "Intracellular and membrane" Cytosol "HPA043718: AB_10794662" "unprognostic (8.94e-2)" "unprognostic (1.01e-1)" "unprognostic (8.31e-3)" "unprognostic (4.53e-2)" "unprognostic (2.78e-3)" "unprognostic (9.29e-2)" "unprognostic (2.11e-3)" "unprognostic (1.17e-2)" "unprognostic (1.70e-2)" "unprognostic (3.37e-2)" "unprognostic (1.48e-2)" "unprognostic (4.75e-3)" "prognostic unfavourable (6.55e-13)" "unprognostic (1.23e-2)" "unprognostic (3.36e-1)" "unprognostic (1.65e-3)" "unprognostic (5.66e-2)" 13.2 2.8 4.8 6.2 11.8 10.6 21.2 1.9 7.3 6.6 11.8 2.4 9.2 4.6 6.8 22.9 5.1 4.9 7.9 5.9 6.1 6.3 5.6 3.6 15.1 6.3 5.2 7.8 5.1 3.3 1.3 2.3 12.0 6.7 4.8 11.9 3.3 7.0 5.8 6.7 3.4 6.0 5.6 3.7 9.0 6.7 4.1 3.3 4.1 5.3 5.5 3.7 5.0 6.7 0.3 0.6 3.2 0.4 11.5 0.8 0.0 6.3 5.2 7.9 8.4 3.0 10.0 7.0 5.0 9.3 4.1 6.6 2.9 12.7 1.1 23.5 5.8 7.4 2.6 3.8 2.7 10.6 3.8 7.2 5.4 2.1 5.4 2.2 11.4 6.4 4.2 9.4 4.1 16.8 2.0 0.3 13.4 5.9 3.3 5.7 4.1 8.5 6.4 5.0 0.2 4.3 3.6 2.2 4.8 3.5 1.1 7.3 5.3 4.8 19.9 12.4 4.6 3.8 6.4 0.9 0.7 2.2 18.7 8.7 6.2 3.2 0.3 0.3 0.5 0.2 0.1 0.2 0.2 0.8 0.0 0.3 0.1 0.3 0.8 11.5 0.4 0.6 0.0 0.0 4.8 11.8 1.9 7.3 6.1 6.3 5.2 7.8 6.7 3.3 TMEM56-RWDD3 ENSG00000271092 "TMEM56-RWDD3 readthrough" 1 95117923-95247225 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "liver: 42.6;retina: 25.5" "Cell line enhanced" "Detected in many" "RH-30: 15.1" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "unprognostic (1.80e-1)" "unprognostic (1.32e-1)" "unprognostic (9.43e-2)" "unprognostic (1.98e-1)" "unprognostic (1.80e-1)" "unprognostic (1.77e-3)" "unprognostic (4.35e-2)" "unprognostic (7.05e-2)" "unprognostic (1.70e-1)" "unprognostic (4.00e-1)" "unprognostic (2.93e-2)" "unprognostic (1.47e-1)" "unprognostic (1.29e-2)" "unprognostic (3.42e-1)" "unprognostic (2.72e-1)" "unprognostic (1.99e-1)" "unprognostic (1.42e-2)" 3.1 3.9 4.6 1.8 5.8 2.8 3.9 7.5 9.2 2.9 3.6 3.3 2.3 4.1 3.2 4.9 2.1 3.1 3.7 14.2 3.8 2.4 2.8 42.6 2.7 3.3 2.5 4.9 3.5 6.2 4.1 6.1 4.5 4.1 3.7 3.9 25.5 3.9 2.2 4.7 4.6 5.8 7.0 2.9 2.3 3.9 3.4 2.8 0.0 4.5 1.6 2.6 3.6 2.9 2.7 1.3 1.1 0.8 0.7 2.4 1.0 7.1 4.3 4.0 5.3 1.7 3.1 4.5 1.4 0.9 2.8 3.2 6.6 3.0 2.6 5.0 1.6 1.8 3.8 1.9 3.0 1.9 2.4 3.2 4.2 1.6 1.5 0.9 1.0 1.9 2.1 2.5 0.7 1.2 5.3 1.7 1.5 2.0 2.2 2.5 2.0 2.2 1.9 15.1 0.4 3.8 7.4 3.9 4.5 5.3 4.2 5.2 3.0 2.4 2.6 3.0 4.1 2.8 3.9 2.4 1.6 1.6 1.4 0.6 2.1 0.6 0.7 1.1 1.3 0.8 0.7 2.7 2.0 0.8 1.3 2.6 2.4 0.9 0.0 0.7 0.7 0.6 1.6 1.0 4.6 5.8 7.5 9.2 3.8 2.4 2.5 4.9 4.1 2.8 TMEM64 DKFZp762C1112 ENSG00000180694 "Transmembrane protein 64" Q6YI46 8 90621995-90791632 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "epididymis: 84.0" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB034221 Enhanced "CAB034221: AB_1567653" "unprognostic (3.61e-1)" "unprognostic (1.42e-1)" "unprognostic (1.58e-1)" "unprognostic (3.70e-2)" "unprognostic (1.14e-1)" "unprognostic (2.27e-1)" "unprognostic (2.55e-3)" "unprognostic (4.84e-1)" "unprognostic (2.04e-1)" "unprognostic (1.26e-2)" "unprognostic (3.30e-1)" "unprognostic (2.35e-1)" "unprognostic (2.59e-2)" "unprognostic (1.36e-1)" "unprognostic (1.19e-1)" "unprognostic (6.17e-2)" "unprognostic (1.97e-1)" 9.2 12.6 4.3 5.2 5.3 2.1 6.1 2.7 6.1 10.6 10.8 16.2 14.5 5.7 11.9 84.0 7.3 5.7 6.3 5.8 6.2 5.5 11.6 11.7 7.2 6.7 11.2 3.3 10.1 11.3 4.1 5.9 6.1 10.0 10.7 3.7 15.1 12.4 11.0 8.2 6.8 11.3 9.6 12.1 7.2 5.4 9.7 7.5 2.3 20.0 5.2 7.2 11.9 10.9 5.7 0.6 3.2 0.8 5.9 3.7 1.6 12.6 9.9 5.0 2.6 23.3 17.0 2.7 9.4 9.0 7.4 8.2 2.7 8.7 8.2 3.8 5.7 4.4 13.2 6.3 9.8 16.6 4.8 15.4 3.9 6.2 8.2 0.9 2.6 22.1 7.0 3.0 6.9 7.4 6.9 18.3 12.4 16.9 0.0 2.2 0.7 5.2 1.8 11.0 4.2 14.6 24.6 3.5 10.0 6.1 5.4 11.3 5.4 0.7 7.3 7.5 6.6 5.4 7.6 12.1 0.2 9.0 6.8 1.9 9.8 3.2 0.2 0.3 3.0 0.6 3.7 5.7 3.2 3.4 0.6 2.9 1.5 2.1 0.1 5.9 0.8 0.4 1.4 1.6 4.3 5.3 2.7 6.1 6.2 5.5 11.2 3.3 10.0 7.5 TMEM86B MGC30208 ENSG00000180089 "Transmembrane protein 86B" Q8N661 19 55226639-55229264 "Enzymes, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 15.1" "Low cell line specificity" "Detected in many" "Cancer enriched" "Detected in all" 5 "liver cancer: 10.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057689 Uncertain Uncertain Midbody,Centrosome Centrosome Midbody "HPA057689: " "unprognostic (2.36e-1)" "unprognostic (1.10e-1)" "unprognostic (2.76e-5)" "unprognostic (1.87e-1)" "unprognostic (1.29e-1)" "unprognostic (6.55e-2)" "prognostic favourable (3.13e-4)" "unprognostic (1.10e-2)" "unprognostic (2.00e-1)" "unprognostic (2.10e-1)" "prognostic favourable (9.97e-6)" "unprognostic (1.96e-2)" "unprognostic (6.63e-8)" "unprognostic (2.28e-1)" "unprognostic (1.07e-1)" "unprognostic (3.70e-1)" "unprognostic (3.19e-3)" 2.5 2.4 2.8 3.1 4.0 7.8 1.4 4.7 4.2 1.4 7.5 1.4 1.4 5.6 1.5 1.4 1.4 1.8 7.7 2.9 2.2 1.6 2.0 15.1 2.7 5.2 1.4 1.4 1.4 1.4 1.7 2.8 5.2 1.7 1.5 0.4 1.4 1.4 1.4 2.2 3.0 7.7 1.4 1.4 4.3 3.6 2.8 1.4 1.4 2.3 1.4 3.0 1.4 1.4 0.7 1.0 0.6 0.7 0.0 1.6 0.4 4.1 3.9 2.4 3.9 0.4 0.6 3.6 1.4 0.7 1.3 1.8 6.3 2.2 4.7 1.2 1.1 1.7 0.9 1.0 0.6 0.9 11.1 8.8 2.5 5.9 1.2 3.9 3.7 0.8 1.7 2.1 1.3 0.5 6.0 3.5 0.8 2.4 6.4 10.0 0.9 2.4 5.9 2.8 12.5 1.1 5.1 2.1 3.9 1.8 0.8 4.9 2.2 8.3 2.8 5.7 3.2 2.5 3.8 2.9 3.4 10.2 4.7 11.1 2.1 0.0 0.7 0.6 1.6 0.1 0.6 0.0 0.5 0.1 0.1 0.7 0.6 1.4 0.1 0.0 0.1 1.0 0.0 0.4 2.8 4.0 4.7 4.2 2.2 1.6 1.4 1.4 1.7 1.4 TMEM8A "M83, PGAP6, TMEM6, TMEM8" ENSG00000129925 "Transmembrane protein 8A" Q9HCN3 16 370773-387113 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 24.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051281, HPA064673" Approved Supported "Nucleoplasm,Cytokinetic bridge" Nucleoplasm "Cytokinetic bridge" "HPA051281: , HPA064673: " "unprognostic (5.84e-2)" "unprognostic (6.13e-2)" "unprognostic (3.85e-2)" "unprognostic (3.21e-2)" "unprognostic (5.77e-2)" "unprognostic (3.19e-2)" "unprognostic (1.13e-3)" "unprognostic (1.56e-2)" "unprognostic (8.89e-2)" "unprognostic (7.73e-2)" "unprognostic (3.43e-1)" "unprognostic (1.38e-2)" "prognostic favourable (1.29e-5)" "unprognostic (4.20e-3)" "unprognostic (3.19e-2)" "unprognostic (4.93e-2)" "unprognostic (2.48e-1)" 8.4 9.3 6.9 9.5 7.8 15.2 13.5 7.7 7.9 6.8 16.6 7.3 24.1 17.7 7.3 29.6 11.8 6.5 15.2 10.0 5.6 4.3 28.7 33.5 13.0 10.7 7.1 3.2 8.3 44.2 11.5 10.7 45.5 6.7 11.4 6.0 8.8 22.5 8.8 12.8 3.7 25.0 5.0 4.7 13.2 17.5 26.3 6.0 12.6 12.3 5.2 14.6 9.3 8.8 2.0 2.9 24.3 5.5 0.9 7.6 3.3 4.4 11.7 6.7 12.3 9.2 8.3 13.4 12.7 13.3 6.5 9.3 45.8 20.8 4.7 17.3 12.2 6.3 3.0 14.0 1.8 13.4 11.2 7.8 7.9 26.1 21.3 5.9 14.8 9.6 4.2 10.0 2.9 15.0 12.5 7.3 8.1 27.4 8.2 11.5 10.6 4.6 17.9 7.7 10.8 10.5 11.4 8.0 9.2 7.1 7.2 37.4 12.9 11.8 21.8 18.5 20.0 12.8 6.7 14.7 7.3 9.3 9.4 6.3 11.7 4.6 5.0 6.3 7.4 5.5 5.9 1.8 5.8 5.8 2.5 2.0 7.6 5.5 24.3 0.9 3.8 2.9 4.3 3.3 6.9 7.8 7.7 7.9 5.6 4.3 7.1 3.2 6.7 6.0 TMEM94 KIAA0195 ENSG00000177728 "Transmembrane protein 94" Q12767 17 75441159-75500090 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008423, HPA050660" Approved Supported "Nucleoplasm,Nuclear bodies" Nucleoplasm "Nuclear bodies" "HPA008423: AB_1852283, HPA050660: " "unprognostic (4.05e-2)" "unprognostic (3.43e-1)" "unprognostic (5.78e-2)" "unprognostic (4.32e-2)" "unprognostic (1.01e-1)" "unprognostic (1.97e-1)" "unprognostic (1.32e-3)" "unprognostic (1.70e-1)" "unprognostic (1.42e-1)" "unprognostic (7.27e-2)" "prognostic favourable (2.26e-4)" "unprognostic (9.71e-2)" "unprognostic (1.14e-1)" "unprognostic (1.21e-2)" "unprognostic (3.33e-1)" "unprognostic (1.44e-2)" "unprognostic (4.96e-2)" 14.6 25.6 26.6 11.2 32.0 13.9 9.8 24.4 32.7 11.7 16.7 30.3 8.2 15.4 13.0 8.5 14.5 27.4 13.7 21.1 21.7 13.3 14.0 9.6 17.0 10.6 24.0 23.0 17.1 13.9 17.2 18.6 18.6 21.9 12.5 11.5 25.4 11.8 12.5 40.4 16.2 15.2 9.4 15.9 14.3 14.8 16.5 23.4 10.7 18.4 9.6 9.2 13.7 7.1 4.6 6.2 5.5 4.6 4.3 7.1 4.5 7.5 19.7 16.3 25.6 8.2 9.3 23.4 4.5 10.0 7.7 7.9 6.6 11.8 10.6 15.1 7.9 9.9 7.8 12.5 4.3 9.5 11.1 10.8 8.8 9.9 11.1 12.0 23.5 16.1 7.0 7.7 6.7 14.0 11.2 12.4 10.1 8.8 24.8 7.5 6.8 7.7 17.6 19.3 9.8 7.6 19.9 14.5 15.4 5.4 23.5 13.5 14.5 14.3 8.1 7.7 9.8 8.0 6.4 27.0 7.7 5.8 9.1 11.1 10.5 0.2 4.6 5.5 7.1 2.9 5.4 2.0 3.3 4.7 4.6 4.6 2.8 4.4 1.2 4.3 2.7 6.2 4.1 4.5 26.6 32.0 24.4 32.7 21.7 13.3 24.0 23.0 21.9 23.4 TRAM1 "TRAM, TRAMP" ENSG00000067167 "Translocation associated membrane protein 1" Q15629 8 70573442-70608387 "Plasma proteins, Predicted membrane proteins" "Host-virus interaction, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023929 Approved "HPA023929: AB_1858239" "unprognostic (3.85e-2)" "prognostic unfavourable (2.06e-4)" "unprognostic (8.34e-3)" "unprognostic (1.31e-1)" "unprognostic (3.52e-2)" "unprognostic (5.93e-2)" "unprognostic (8.94e-2)" "unprognostic (2.21e-2)" "unprognostic (1.86e-1)" "unprognostic (2.12e-1)" "unprognostic (3.39e-3)" "unprognostic (3.61e-2)" "prognostic unfavourable (7.79e-4)" "unprognostic (7.45e-2)" "unprognostic (1.61e-1)" "unprognostic (2.31e-1)" "unprognostic (3.85e-2)" 38.0 31.3 14.6 22.8 15.5 20.8 33.4 10.3 13.0 36.6 36.0 18.5 37.7 21.6 32.9 37.7 26.6 28.7 28.7 30.7 15.7 15.0 59.4 123.7 58.6 31.9 19.0 10.4 32.9 89.0 23.6 30.9 45.9 14.6 32.2 19.4 23.5 84.4 45.1 16.1 19.2 40.0 23.2 24.0 46.8 24.9 26.9 16.0 49.1 60.9 19.0 31.5 33.0 30.6 34.2 59.3 35.4 33.2 40.0 51.0 63.5 26.5 26.2 11.5 7.0 55.8 58.8 16.5 47.8 46.4 36.1 43.9 16.5 42.2 25.5 10.4 39.5 34.2 10.4 39.7 34.8 17.3 11.7 18.5 9.3 18.7 82.0 13.9 10.5 69.9 38.7 17.8 65.2 30.0 11.8 66.7 44.2 7.0 31.1 9.7 7.5 12.9 15.4 8.8 16.7 94.9 24.3 8.4 9.1 30.7 61.0 26.7 22.8 15.1 30.6 22.1 19.5 25.3 15.5 54.6 21.8 13.1 25.2 14.2 16.3 35.4 30.4 19.5 39.8 32.7 51.0 34.2 43.3 44.8 36.5 27.0 41.0 41.8 8.7 40.0 33.2 59.3 44.1 63.5 14.6 15.5 10.3 13.0 15.7 15.0 19.0 10.4 14.6 16.0 TRPA1 ANKTM1 ENSG00000104321 "Transient receptor potential cation channel subfamily A member 1" O75762 8 72019917-72075617 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sensory transduction, Transport" "Ion channel" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 20.8;urinary bladder: 20.1;vagina: 12.1" "Cell line enriched" "Detected in some" 6 "HHSteC: 24.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory CD8 T-cell: 2.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "unprognostic (2.14e-2)" "unprognostic (2.50e-2)" "prognostic favourable (6.57e-4)" "unprognostic (1.28e-2)" "unprognostic (2.34e-1)" "unprognostic (1.95e-1)" "unprognostic (1.37e-2)" "unprognostic (8.11e-3)" "unprognostic (4.22e-2)" "unprognostic (2.47e-1)" "unprognostic (2.78e-3)" "unprognostic (1.49e-1)" "unprognostic (2.16e-4)" "unprognostic (2.37e-1)" "unprognostic (9.67e-2)" "unprognostic (1.57e-1)" "unprognostic (2.90e-1)" 0.3 0.2 0.2 9.1 0.2 0.0 0.2 0.2 0.4 0.4 16.8 0.3 0.0 4.8 0.2 0.3 2.2 0.2 5.7 0.3 0.2 0.2 0.2 0.2 0.3 0.8 0.3 0.0 0.4 0.2 0.0 0.2 0.3 0.1 4.7 7.5 0.0 0.2 0.0 0.2 0.2 20.8 3.8 0.2 0.4 7.9 0.4 0.0 0.6 0.2 0.3 1.4 20.1 12.1 0.5 0.6 0.1 1.1 0.3 2.6 0.2 0.0 2.4 0.7 0.0 0.0 0.1 0.0 0.3 2.2 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.4 1.3 0.1 0.0 0.5 0.0 24.1 0.0 0.2 1.6 0.0 1.1 0.2 0.0 0.0 0.0 2.9 0.0 0.0 0.1 0.5 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.1 0.4 0.0 2.3 0.0 0.3 0.0 0.1 3.8 1.1 0.0 0.3 0.2 0.0 1.8 0.0 1.7 0.0 0.0 0.0 0.3 0.0 1.1 0.5 0.5 2.6 0.0 0.5 0.0 0.4 0.1 0.3 1.1 0.6 1.0 0.2 0.2 0.2 0.2 0.4 0.2 0.2 0.3 0.0 0.1 0.0 TRPC7 ENSG00000069018 "Transient receptor potential cation channel subfamily C member 7" Q9HCX4 5 136213320-136365545 "Predicted membrane proteins, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 2.2;brain: 1.6;intestine: 1.3;kidney: 1.5;pituitary gland: 2.2;testis: 2.4" "Cell line enhanced" "Detected in some" "EFO-21: 1.7;SCLC-21H: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "CAB022592, HPA031126" Uncertain Uncertain "Actin filaments,Focal adhesion sites" "Focal adhesion sites" "Actin filaments" "CAB022592: , HPA031126: AB_10603221" "unprognostic (1.49e-1)" "unprognostic (2.08e-1)" "unprognostic (3.03e-2)" "unprognostic (2.89e-5)" "unprognostic (3.26e-1)" "unprognostic (2.75e-1)" "unprognostic (9.99e-2)" "unprognostic (1.77e-1)" "unprognostic (6.78e-2)" 0.0 2.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 2.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRPM4 FLJ20041 ENSG00000130529 "Transient receptor potential cation channel subfamily M member 4" Q8TD43 19 49157741-49211836 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Adaptive immunity, Immunity, Ion transport, Transport" "Calmodulin-binding, Ion channel" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 32.5;SK-BR-3: 21.4" "Cancer enhanced" "Detected in all" "prostate cancer: 85.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "dendritic cells: 5.4;granulocytes: 4.9;monocytes: 6.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA041169 Enhanced Supported "Nucleoplasm,Plasma membrane" 6500 "Nucleoplasm, Plasma membrane" "HPA041169: " "unprognostic (8.20e-3)" "unprognostic (1.41e-1)" "unprognostic (7.86e-2)" "prognostic favourable (2.88e-7)" "unprognostic (1.62e-2)" "unprognostic (9.78e-2)" "unprognostic (1.77e-2)" "unprognostic (2.90e-1)" "unprognostic (3.33e-2)" "unprognostic (3.38e-2)" "unprognostic (2.94e-2)" "unprognostic (2.79e-1)" "prognostic favourable (2.53e-7)" "unprognostic (8.46e-3)" "unprognostic (2.16e-1)" "unprognostic (5.70e-2)" "unprognostic (1.00e-2)" 6.7 3.8 3.5 13.7 3.7 4.3 8.5 3.0 6.8 8.2 25.2 4.5 8.6 20.6 7.9 9.1 7.7 5.4 24.8 9.3 2.7 2.2 14.2 23.6 9.4 3.5 2.6 5.7 2.7 17.4 3.4 3.3 5.0 6.9 20.2 11.4 10.6 16.2 13.2 16.4 16.1 26.8 9.4 2.5 3.4 18.3 4.2 2.2 0.4 10.1 11.5 6.8 9.9 8.6 1.1 5.4 4.9 6.8 1.0 0.7 2.1 6.0 4.5 1.1 5.1 3.8 3.6 3.6 5.1 3.0 1.4 1.9 3.3 9.5 0.2 1.3 3.4 8.0 0.7 1.5 0.6 0.1 1.6 1.0 1.9 2.0 3.4 0.1 6.6 4.3 7.0 2.6 1.2 2.4 2.4 1.2 3.5 9.1 0.4 0.5 0.6 6.9 2.2 1.0 0.3 2.4 32.5 0.4 1.1 2.1 21.4 1.1 11.6 2.0 6.1 7.6 4.3 4.2 0.1 2.2 2.2 0.2 4.3 4.0 2.8 2.7 6.8 1.1 0.6 4.0 0.5 0.8 0.5 0.4 5.4 1.1 0.6 0.7 4.9 1.0 1.5 4.9 0.3 2.1 3.5 3.7 3.0 6.8 2.7 2.2 2.6 5.7 6.9 2.2 TRPM5 "LTRPC5, MTR1" ENSG00000070985 "Transient receptor potential cation channel subfamily M member 5" Q9NZQ8 11 2404515-2423045 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor, Voltage-gated channel" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "epididymis: 4.1;intestine: 6.3;pancreas: 4.5;seminal vesicle: 4.0" "Cell line enhanced" "Detected in some" "MCF7: 3.2;RPMI-8226: 1.4" "Cancer enhanced" "Detected in some" "pancreatic cancer: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA043315 Uncertain "HPA043315: " "unprognostic (1.82e-1)" "unprognostic (1.98e-1)" "unprognostic (6.47e-5)" "unprognostic (6.81e-4)" "unprognostic (7.90e-3)" "unprognostic (1.18e-1)" "unprognostic (1.13e-2)" "unprognostic (2.24e-2)" "unprognostic (4.75e-1)" "unprognostic (1.53e-1)" "unprognostic (2.36e-1)" "unprognostic (3.19e-1)" "unprognostic (5.07e-3)" "unprognostic (2.40e-1)" "unprognostic (5.21e-1)" "unprognostic (5.72e-2)" "unprognostic (4.91e-2)" 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 6.1 0.0 4.1 0.0 0.0 0.1 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.5 0.0 0.2 0.5 0.0 4.0 0.0 0.0 6.3 0.0 0.0 0.0 0.5 0.9 3.1 0.0 0.2 0.0 0.0 0.1 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.1 0.0 0.1 0.0 0.0 1.4 0.0 0.0 0.6 0.0 0.0 0.6 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 TRPM7 "CHAK1, LTRPC7, TRP-PLIK" ENSG00000092439 "Transient receptor potential cation channel subfamily M member 7" Q96QT4 15 50552473-50686815 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Necrosis, Transport" "Calcium channel, Ion channel, Kinase, Serine/threonine-protein kinase, Transferase" "Amyotrophic lateral sclerosis, Neurodegeneration, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 91.8" "Cell line enhanced" "Detected in all" "U-2197: 49.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035522, HPA052173" Enhanced Approved "Vesicles,Plasma membrane,Cytosol" "Plasma membrane" "Vesicles, Cytosol" "HPA035522: , HPA052173: " "unprognostic (3.14e-2)" "unprognostic (1.86e-1)" "unprognostic (1.58e-1)" "unprognostic (1.42e-2)" "unprognostic (1.89e-1)" "unprognostic (1.60e-2)" "unprognostic (1.85e-2)" "unprognostic (2.59e-2)" "unprognostic (5.46e-3)" "unprognostic (2.64e-1)" "unprognostic (2.91e-1)" "unprognostic (1.59e-2)" "unprognostic (3.20e-2)" "unprognostic (2.08e-1)" "unprognostic (7.59e-2)" "unprognostic (9.45e-2)" "unprognostic (1.97e-1)" 13.3 10.8 6.6 14.7 9.0 12.8 12.1 19.5 9.3 11.8 11.7 8.1 9.7 9.9 16.5 10.7 9.4 11.0 8.2 19.1 5.5 4.9 16.0 20.0 10.8 10.6 12.4 5.2 16.6 11.6 91.8 14.6 14.3 10.2 9.7 10.3 28.6 11.5 13.5 10.8 11.7 12.8 12.8 9.8 11.1 10.3 6.9 10.0 14.5 12.6 6.9 12.6 12.9 12.3 7.0 4.7 4.4 3.4 5.7 7.6 2.0 8.3 8.3 7.0 7.7 20.2 15.2 8.5 10.6 14.7 6.7 8.9 11.4 4.6 18.2 5.2 12.2 14.1 9.3 7.8 9.7 10.1 5.6 14.5 12.8 6.0 18.4 15.0 11.3 14.1 9.2 7.6 14.4 5.4 16.4 14.0 12.2 13.1 9.6 7.3 5.3 5.1 10.6 9.7 8.9 9.4 19.8 5.8 7.4 7.3 11.6 14.2 7.3 16.3 8.2 10.7 5.1 49.9 12.1 9.5 21.0 17.5 11.7 30.7 9.9 3.8 3.4 3.9 6.6 3.2 7.6 5.6 4.8 4.4 3.7 7.0 4.4 5.2 4.4 5.7 3.2 4.7 4.8 2.0 6.6 9.0 19.5 9.3 5.5 4.9 12.4 5.2 10.2 10.0 TRPV1 VR1 ENSG00000196689 "Transient receptor potential cation channel subfamily V member 1" Q8NER1 17 3565444-3609411 "FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Calmodulin-binding, Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 11.7" "Cell line enhanced" "Detected in many" "HaCaT: 12.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in single" "unprognostic (3.96e-2)" "unprognostic (1.63e-1)" "unprognostic (1.18e-1)" "unprognostic (1.33e-2)" "unprognostic (6.83e-2)" "unprognostic (3.21e-4)" "unprognostic (9.90e-2)" "unprognostic (2.95e-1)" "unprognostic (2.03e-1)" "unprognostic (2.56e-2)" "unprognostic (3.43e-3)" "unprognostic (6.17e-3)" "unprognostic (6.97e-4)" "unprognostic (4.25e-1)" "unprognostic (4.78e-1)" "unprognostic (3.81e-2)" "unprognostic (5.12e-3)" 1.4 1.2 3.5 0.7 2.9 0.3 1.7 2.7 2.1 2.1 1.4 6.5 2.3 1.5 0.8 2.8 1.1 1.9 3.2 3.6 2.5 11.7 0.7 1.3 4.7 5.1 2.5 1.0 2.0 1.2 1.5 1.7 2.1 1.0 2.8 4.7 5.1 0.9 2.3 1.2 2.2 1.2 1.3 0.8 1.2 1.1 1.1 1.4 1.5 0.8 0.5 2.2 0.3 2.9 5.5 4.5 4.9 4.8 4.6 4.0 1.6 2.4 2.6 2.3 1.3 1.6 1.2 2.2 1.8 12.9 2.7 0.9 1.8 7.1 6.6 0.7 2.9 5.5 2.1 0.3 5.6 5.5 3.0 3.7 1.5 0.5 0.3 2.2 1.5 3.7 2.1 1.0 3.0 2.7 6.1 2.9 0.9 2.1 2.6 1.9 4.1 2.3 4.4 2.2 8.2 2.3 1.6 1.1 2.6 4.4 2.2 1.9 1.3 0.5 1.9 2.3 2.3 0.9 0.8 1.5 0.7 0.2 0.9 0.4 0.6 0.2 0.1 1.1 0.8 2.2 1.5 0.5 0.3 1.4 0.2 0.3 TRPV2 "VRL, VRL-1, VRL1" ENSG00000187688 "Transient receptor potential cation channel subfamily V member 2" Q9Y5S1 17 16415542-16437003 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 26.6;fHDF/TERT166: 34.8;HMC-1: 29.3;SK-MEL-30: 30.2;TIME: 27.2" "Cancer enriched" "Detected in all" 8 "melanoma: 59.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044993 Uncertain Supported "Plasma membrane" "Plasma membrane" "HPA044993: AB_10960889" "unprognostic (1.57e-1)" "unprognostic (4.34e-3)" "unprognostic (2.05e-2)" "unprognostic (1.58e-2)" "unprognostic (2.85e-2)" "unprognostic (6.16e-3)" "unprognostic (5.25e-2)" "unprognostic (1.25e-1)" "unprognostic (8.40e-3)" "unprognostic (2.43e-1)" "unprognostic (3.11e-2)" "unprognostic (1.02e-1)" "prognostic unfavourable (1.19e-6)" "unprognostic (7.94e-2)" "prognostic unfavourable (5.53e-4)" "unprognostic (8.07e-2)" "unprognostic (1.23e-1)" 25.4 17.6 5.9 14.3 4.9 15.6 11.3 1.9 7.6 6.7 6.0 4.2 0.5 5.4 8.2 6.1 5.7 6.8 6.7 8.9 5.0 8.1 4.4 4.5 25.8 24.9 6.0 4.2 8.9 8.4 7.7 1.8 15.6 8.1 6.3 5.0 4.9 4.4 2.1 3.8 5.0 8.8 9.2 4.1 23.4 5.3 2.8 2.5 23.4 5.7 4.2 18.0 8.1 6.7 9.0 25.9 20.4 22.3 26.5 29.8 17.4 0.0 0.5 0.0 0.0 8.5 26.6 1.6 2.6 3.0 3.0 2.9 0.1 0.0 3.0 0.7 34.8 0.0 0.0 0.0 1.7 13.5 0.2 3.3 0.0 8.2 10.2 4.6 29.3 11.8 0.0 17.9 0.2 1.2 11.4 8.5 14.1 0.1 5.9 6.4 0.0 0.0 3.5 0.1 1.3 13.2 0.3 0.4 0.0 0.0 0.0 30.2 0.0 4.0 27.2 0.0 0.1 0.1 0.3 0.0 0.1 1.5 2.7 6.8 4.1 20.4 12.2 15.2 29.8 22.3 25.9 9.0 21.9 27.6 25.9 8.7 12.5 21.7 3.0 26.5 19.8 22.7 21.2 17.4 5.9 4.9 1.9 7.6 5.0 8.1 6.0 4.2 8.1 2.5 TRPV3 VRL3 ENSG00000167723 "Transient receptor potential cation channel subfamily V member 3" Q8NET8 17 3510502-3557995 "Disease related genes, FDA approved drug targets, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Disease mutation, FDA approved drug targets, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 15.4;skeletal muscle: 29.1" "Cell line enhanced" "Detected in some" "A-431: 3.5;BEWO: 5.3;CACO-2: 4.2;RH-30: 13.0;T-47d: 5.5;U-266/70: 3.5" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in some" "basal ganglia: 2.4" "Cell type enhanced" "Detected in some" "basophil: 2.9" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in some" "Region enriched" "Detected in many" 6 "cerebellum: 14.0" HPA069550 Approved "Plasma membrane,Centrosome,Cytosol" "Plasma membrane" "Centrosome, Cytosol" "HPA069550: " "unprognostic (1.84e-4)" "unprognostic (2.25e-1)" "unprognostic (5.22e-2)" "unprognostic (3.92e-4)" "unprognostic (4.87e-3)" "unprognostic (2.96e-2)" "unprognostic (6.66e-2)" "unprognostic (4.88e-2)" "unprognostic (7.02e-2)" "unprognostic (2.68e-1)" "unprognostic (4.88e-2)" "unprognostic (3.69e-2)" "unprognostic (0.00e+0)" "unprognostic (1.12e-1)" "unprognostic (1.77e-1)" "unprognostic (8.64e-2)" "unprognostic (2.93e-2)" 0.4 0.2 0.4 3.2 2.4 0.9 4.1 0.3 1.2 0.6 10.6 0.1 0.3 3.2 0.2 0.2 2.3 0.3 0.8 0.3 0.4 0.3 0.2 1.1 0.3 0.5 0.4 0.2 0.3 0.9 0.0 0.7 0.4 0.0 0.2 2.9 0.3 0.5 0.4 29.1 8.4 15.4 0.5 0.5 0.4 1.6 0.8 0.0 0.0 0.2 9.7 3.0 0.7 2.1 0.7 0.6 2.9 0.6 0.6 0.7 0.1 3.5 0.0 0.5 0.1 0.2 0.6 5.3 0.2 0.0 0.0 0.0 4.2 0.9 0.2 1.0 0.1 0.4 0.0 0.1 0.0 0.1 0.1 0.0 0.3 0.6 0.1 0.2 0.8 0.3 0.0 0.7 1.8 0.0 0.1 0.1 0.0 0.7 0.1 0.2 0.1 0.5 0.1 13.0 0.2 0.0 0.2 0.1 0.0 0.2 0.6 0.0 5.5 0.2 0.1 0.1 0.2 0.1 0.1 3.5 2.7 0.0 0.1 0.1 0.0 2.9 0.4 0.4 0.7 0.2 0.5 0.7 0.4 0.7 0.1 0.5 0.4 0.6 1.0 0.6 0.6 0.6 0.2 0.1 0.4 2.4 0.3 1.2 0.4 0.3 0.4 0.2 0.0 0.0 TRPV4 "CMT2C, OTRPC4, TRP12, VR-OAC, VRL-2, VROAC" ENSG00000111199 "Transient receptor potential cation channel subfamily V member 4" Q9HBA0 12 109783085-109833401 "Disease related genes, Potential drug targets, Predicted membrane proteins, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Calmodulin-binding, Ion channel" "Charcot-Marie-Tooth disease, Disease mutation, Dwarfism, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 32.6" "Cell line enhanced" "Detected in many" "BEWO: 8.9;BJ hTERT+: 9.1;EFO-21: 8.0;HaCaT: 14.5;HUVEC TERT2: 8.3" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in some" 11 "pons and medulla: 15.0" "Cell type enriched" "Detected in single" 7 "classical monocyte: 3.0" "Lineage enriched" "Detected in single" 7 "monocytes: 3.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA007150 Uncertain "HPA007150: AB_1080393" "unprognostic (2.98e-2)" "unprognostic (1.12e-2)" "unprognostic (2.33e-2)" "unprognostic (4.20e-3)" "unprognostic (6.25e-3)" "unprognostic (1.09e-2)" "unprognostic (7.95e-2)" "unprognostic (2.03e-1)" "unprognostic (9.02e-2)" "prognostic unfavourable (8.10e-4)" "unprognostic (1.24e-1)" "unprognostic (1.68e-1)" "prognostic favourable (4.12e-5)" "unprognostic (1.20e-1)" "unprognostic (2.30e-1)" "unprognostic (1.72e-1)" "unprognostic (1.73e-2)" 1.3 0.9 0.3 0.9 0.4 0.1 3.3 0.2 0.6 2.3 0.4 3.2 0.0 0.6 0.8 3.7 9.5 5.6 5.2 1.6 1.3 0.2 11.6 7.8 2.6 1.8 0.2 0.0 0.6 7.1 0.1 4.3 11.1 15.0 6.2 0.3 12.6 32.6 1.4 0.2 6.5 0.3 0.9 0.3 3.5 0.9 0.7 0.1 0.2 0.9 2.6 8.7 2.6 1.7 0.0 0.4 0.0 3.0 0.0 0.0 0.4 2.5 0.1 0.0 0.0 1.9 1.8 8.9 4.2 9.1 1.2 0.5 0.0 6.3 0.0 8.0 5.4 14.5 1.1 0.0 0.3 0.0 2.1 0.0 0.0 3.6 0.7 0.0 0.0 3.3 2.0 3.3 0.0 8.3 0.8 0.0 0.4 5.3 0.0 0.0 1.6 0.2 0.0 0.5 0.0 0.0 5.1 0.0 0.0 0.3 0.6 2.5 1.2 0.4 5.1 0.0 3.6 0.1 0.0 0.1 0.0 0.0 0.0 0.0 4.8 0.0 3.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.4 0.2 0.6 1.3 0.2 0.2 0.0 15.0 0.1 TRPV5 "CaT2, ECAC1" ENSG00000127412 "Transient receptor potential cation channel subfamily V member 5" Q9NQA5 7 142908101-142933808 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Calmodulin-binding, Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "kidney: 26.0" "Cell line enhanced" "Detected in single" "RT4: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 5 "neutrophil: 1.2" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA063175 Uncertain "HPA063175: " "unprognostic (7.44e-2)" "unprognostic (3.93e-2)" "unprognostic (1.22e-2)" "unprognostic (4.20e-2)" "unprognostic (1.98e-1)" "unprognostic (3.26e-1)" "unprognostic (3.05e-1)" "unprognostic (2.78e-2)" "unprognostic (1.07e-1)" "unprognostic (7.95e-2)" "unprognostic (7.73e-4)" "unprognostic (4.87e-2)" "unprognostic (3.41e-1)" "unprognostic (4.58e-1)" "unprognostic (7.76e-3)" 0.1 0.0 0.8 0.4 0.7 0.5 0.5 0.1 0.8 0.1 0.1 0.1 0.1 0.7 0.1 0.3 0.1 0.1 0.1 0.1 1.1 0.7 26.0 0.1 0.1 0.2 1.6 0.4 0.1 0.3 0.0 0.1 0.1 0.7 0.1 0.0 0.1 0.3 0.1 0.2 0.1 0.1 0.1 3.5 0.2 0.0 0.8 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.2 0.1 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.8 0.7 0.1 0.5 1.1 0.7 1.6 0.4 0.7 0.1 TRPV6 "CaT1, ECAC2" ENSG00000165125 "Transient receptor potential cation channel subfamily V member 6" Q9H1D0 7 142871203-142885762 "Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Calmodulin-binding, Ion channel" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 26.1;placenta: 65.1;salivary gland: 34.2" "Cell line enhanced" "Detected in some" "BEWO: 5.5;HaCaT: 10.2;RT4: 18.3;SK-BR-3: 13.5;T-47d: 30.1" "Cancer enriched" "Detected in many" 5 "prostate cancer: 16.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA062864 Approved "HPA062864: " "unprognostic (9.85e-2)" "unprognostic (1.60e-2)" "unprognostic (6.29e-2)" "unprognostic (8.72e-2)" "unprognostic (1.08e-1)" "unprognostic (1.14e-1)" "unprognostic (7.11e-2)" "unprognostic (5.43e-2)" "unprognostic (3.50e-1)" "unprognostic (4.56e-2)" "unprognostic (3.89e-2)" "unprognostic (3.27e-2)" "unprognostic (8.49e-2)" "unprognostic (9.39e-3)" "unprognostic (1.69e-1)" "unprognostic (7.17e-3)" "unprognostic (3.53e-2)" 0.3 0.0 0.3 0.3 0.3 0.0 2.1 0.3 0.3 0.4 1.2 0.3 0.3 4.1 0.3 0.4 1.7 0.1 4.1 0.3 0.3 0.2 2.5 0.6 0.8 0.3 0.8 0.3 0.3 26.1 0.0 0.4 65.1 0.4 12.6 0.0 0.4 34.2 0.7 0.3 3.7 1.0 0.5 2.0 0.3 2.4 0.7 0.3 0.3 0.7 0.6 1.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 18.3 1.1 0.0 0.0 13.5 0.3 30.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.3 0.3 0.2 0.8 0.3 0.4 0.3 UNC50 "GMH1, UNCL, URP" ENSG00000115446 "Unc-50 inner nuclear membrane RNA binding protein" Q53HI1 2 98608579-98618515 "Predicted membrane proteins" "Protein transport, Transport" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027009 Approved "HPA027009: AB_1858620" "prognostic unfavourable (4.79e-4)" "unprognostic (3.28e-2)" "unprognostic (1.23e-1)" "unprognostic (1.74e-2)" "unprognostic (5.54e-2)" "unprognostic (1.86e-2)" "prognostic unfavourable (4.89e-5)" "unprognostic (1.34e-1)" "unprognostic (2.59e-1)" "unprognostic (5.31e-2)" "unprognostic (6.31e-2)" "unprognostic (1.58e-1)" "unprognostic (1.43e-1)" "unprognostic (2.14e-1)" "unprognostic (4.38e-1)" "unprognostic (7.12e-3)" "unprognostic (4.82e-3)" 25.8 34.1 26.4 22.3 34.6 20.0 29.9 23.1 30.9 26.0 22.5 29.3 38.4 23.6 30.0 46.2 23.2 28.0 24.5 26.1 25.6 25.9 33.8 29.0 24.5 23.2 34.7 29.9 29.6 39.0 42.8 35.1 44.4 27.1 27.4 28.1 31.3 33.7 41.0 22.5 25.0 23.2 25.8 29.8 28.7 30.4 44.3 27.8 22.4 42.2 14.8 25.8 24.6 37.0 39.0 39.6 46.4 40.7 38.2 41.8 29.7 20.2 13.4 25.0 16.9 37.6 32.7 28.2 19.3 27.2 23.8 21.1 20.6 24.2 6.2 29.3 16.4 19.7 17.4 15.6 19.7 20.8 18.5 13.8 17.9 33.1 40.6 26.4 22.0 21.4 35.7 12.7 23.4 20.8 22.3 19.2 24.1 14.5 11.5 29.6 19.0 16.0 7.4 18.2 21.6 26.3 18.2 9.3 13.9 13.6 18.1 30.8 15.5 34.1 16.1 26.2 16.2 13.2 12.9 29.5 22.7 16.5 24.7 19.2 22.8 35.5 40.7 46.4 39.4 38.6 34.0 39.0 33.3 36.8 39.6 34.7 36.6 41.8 32.7 38.2 34.7 37.3 26.4 29.7 26.4 34.6 23.1 30.9 25.6 25.9 34.7 29.9 27.1 27.8 VN1R1 "V1RL1, VNR19I1, ZVNH1, ZVNR1" ENSG00000178201 "Vomeronasal 1 receptor 1" Q9GZP7 19 57454790-57457142 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "Pheromone response" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 9.2" "Cell line enhanced" "Detected in some" "HEK 293: 6.1;U-266/70: 5.5;U-266/84: 6.5" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "naive B-cell: 2.3" "Low lineage specificity" "Detected in single" HPA062209 Uncertain Nucleoplasm,Vesicles Vesicles Nucleoplasm "HPA062209: " "unprognostic (7.11e-2)" "unprognostic (1.32e-1)" "unprognostic (2.52e-1)" "unprognostic (3.17e-2)" "unprognostic (1.61e-1)" "unprognostic (2.53e-1)" "unprognostic (1.51e-2)" "unprognostic (5.28e-2)" "unprognostic (1.01e-1)" "unprognostic (2.84e-2)" "unprognostic (1.65e-3)" "unprognostic (1.21e-2)" "unprognostic (5.41e-2)" "unprognostic (5.68e-2)" "unprognostic (2.73e-1)" "unprognostic (1.25e-2)" "unprognostic (4.59e-5)" 0.1 1.4 2.0 0.3 2.9 0.3 1.5 9.2 3.5 0.2 0.7 0.0 0.5 5.3 0.9 0.8 0.6 1.9 1.9 2.0 0.8 0.9 0.9 0.7 1.5 1.6 0.4 3.6 3.5 1.1 2.0 0.4 0.8 1.3 3.6 4.0 0.5 0.5 1.5 1.1 0.9 1.4 2.7 0.4 0.5 0.3 2.3 0.3 0.5 0.3 0.6 0.4 0.1 0.5 0.1 1.8 1.9 0.1 0.5 0.9 0.4 0.7 0.4 1.8 0.0 0.2 0.2 0.9 0.2 0.0 0.4 0.2 0.7 0.0 6.1 0.9 0.0 0.6 0.3 0.4 1.2 0.7 0.6 0.1 0.4 0.2 0.3 0.9 0.9 0.3 0.4 2.0 0.5 0.6 0.4 1.2 0.9 0.6 1.0 3.3 1.4 0.0 0.5 0.1 0.9 0.6 0.1 1.5 0.2 0.4 0.6 5.5 6.5 0.5 0.5 0.1 1.1 0.5 0.3 0.3 0.4 0.0 0.2 1.3 0.3 0.3 0.2 2.3 0.4 0.3 0.5 0.6 0.2 0.3 0.0 0.1 XKR5 ENSG00000275591 "XK related 5" 8 6808517-6835644 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 9.5" "Cell line enhanced" "Detected in some" "AF22: 5.9;NTERA-2: 3.9;SCLC-21H: 3.2;SH-SY5Y: 5.8;U-2 OS: 2.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.2" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in all" "unprognostic (8.95e-2)" "unprognostic (1.72e-1)" "unprognostic (2.26e-1)" "unprognostic (2.46e-2)" "unprognostic (1.78e-1)" "unprognostic (6.73e-2)" "unprognostic (9.91e-2)" "unprognostic (2.16e-3)" "unprognostic (1.30e-1)" "unprognostic (7.91e-3)" "unprognostic (3.13e-2)" "unprognostic (9.19e-2)" "unprognostic (1.03e-2)" "unprognostic (1.76e-1)" "unprognostic (2.77e-2)" "unprognostic (4.06e-2)" 0.0 0.0 0.0 0.9 0.0 2.0 0.0 0.3 0.6 2.7 0.0 0.2 0.0 0.0 1.3 0.6 0.4 0.6 0.7 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.7 0.6 0.0 0.0 0.0 1.4 0.0 0.0 0.6 0.1 0.5 0.0 0.0 1.8 0.0 9.5 0.0 0.0 0.5 0.0 0.0 0.2 1.2 0.4 0.1 0.1 0.1 0.0 0.0 0.0 5.9 1.1 0.0 0.0 0.0 2.0 0.9 1.1 1.7 0.1 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 3.9 0.0 0.0 0.1 0.0 0.0 0.5 3.2 5.8 0.4 0.0 0.0 0.0 0.2 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.3 0.1 0.0 1.2 0.0 0.0 XKR6 "C8orf21, C8orf5, C8orf7" ENSG00000171044 "XK related 6" Q5GH73 8 10896045-11201366 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.4" "Cell line enhanced" "Detected in many" "Karpas-707: 6.2;U-266/84: 10.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 1.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA024828, HPA064769" Uncertain Approved "Actin filaments" "Actin filaments" "HPA024828: AB_2215165, HPA064769: " "unprognostic (8.63e-3)" "unprognostic (8.45e-2)" "unprognostic (1.50e-1)" "unprognostic (9.92e-6)" "unprognostic (2.09e-1)" "unprognostic (2.51e-2)" "unprognostic (1.18e-1)" "unprognostic (8.75e-3)" "unprognostic (8.65e-2)" "unprognostic (7.09e-2)" "unprognostic (2.87e-1)" "unprognostic (1.31e-1)" "unprognostic (3.78e-2)" "unprognostic (3.86e-2)" "unprognostic (2.14e-1)" "unprognostic (1.58e-1)" "unprognostic (3.29e-3)" 2.0 2.9 3.0 4.8 13.1 4.1 2.5 21.4 6.3 1.9 2.7 1.4 1.9 1.7 2.4 1.3 3.8 2.2 2.0 1.5 3.4 1.6 2.3 1.0 2.7 3.9 1.3 4.4 0.9 5.1 3.3 8.8 1.2 5.3 3.2 2.1 1.1 5.2 5.0 0.8 3.9 3.3 1.6 1.4 3.8 3.3 7.5 2.4 0.1 3.0 0.2 3.6 3.0 2.3 1.3 0.6 0.0 0.0 1.2 0.3 0.1 0.0 0.0 1.3 0.0 0.0 0.1 0.0 2.0 0.6 0.6 1.7 0.0 0.5 4.9 0.0 1.0 0.2 2.2 2.7 0.9 0.1 0.6 1.6 0.2 0.0 0.9 0.0 4.2 0.5 1.8 0.0 2.1 1.1 0.1 6.2 0.8 0.5 0.0 0.0 3.2 1.2 0.0 0.0 1.2 2.3 1.8 3.2 1.8 1.0 0.1 0.0 0.0 0.8 0.0 2.6 1.2 0.0 0.9 1.7 10.0 4.6 1.0 0.0 2.1 0.0 0.0 0.0 0.3 0.0 0.2 1.0 0.0 0.1 0.0 1.3 0.2 0.0 0.0 1.2 0.0 0.6 0.2 0.1 3.0 13.1 21.4 6.3 3.4 1.6 1.3 4.4 5.3 2.4 YIPF7 "FinGER9, FLJ39576" ENSG00000177752 "Yip1 domain family member 7" Q8N8F6 4 44622065-44678556 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "skeletal muscle: 45.3;tongue: 14.8" "Cell line enhanced" "Detected in some" "BEWO: 1.5;fHDF/TERT166: 1.4;PC-3: 1.3;SCLC-21H: 2.8;WM-115: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 3.3" "Low lineage specificity" "Detected in many" "Region enriched" "Detected in single" 6 "cerebellum: 0.7" "Region enriched" "Detected in single" 28 "cerebellum: 14.8" HPA030642 Uncertain "HPA030642: AB_10601027" "unprognostic (9.41e-4)" "unprognostic (2.27e-1)" "unprognostic (2.90e-2)" "unprognostic (2.24e-1)" "unprognostic (2.63e-2)" "unprognostic (1.34e-1)" "unprognostic (9.46e-2)" "unprognostic (9.81e-2)" "unprognostic (2.32e-2)" "unprognostic (3.05e-2)" "unprognostic (1.52e-2)" "unprognostic (2.46e-2)" "unprognostic (1.35e-1)" "unprognostic (4.73e-2)" "unprognostic (2.98e-2)" 1.5 0.0 0.3 0.0 0.5 0.0 0.1 0.8 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.9 0.0 0.0 0.5 0.3 0.5 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.6 0.1 45.3 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 14.8 0.7 0.0 0.0 2.3 3.3 0.3 1.0 0.3 0.9 0.3 0.2 0.0 0.1 0.0 0.0 0.0 1.5 0.8 0.0 0.0 0.8 0.0 0.0 0.0 0.8 1.4 0.0 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 2.8 0.0 1.0 0.0 0.3 0.0 0.7 0.0 0.6 0.3 0.0 0.3 0.5 1.1 0.0 0.0 0.0 1.6 0.0 1.0 0.0 0.5 0.7 0.4 2.3 0.9 0.7 0.6 0.6 0.3 0.4 0.3 0.3 0.2 3.3 0.1 0.3 0.3 0.5 0.8 0.3 0.3 0.5 0.3 0.0 0.1 0.0 ZDHHC13 "FLJ10852, FLJ10941, HIP14L" ENSG00000177054 "Zinc finger DHHC-type containing 13" Q8IUH4 11 19117099-19176422 "Enzymes, Predicted membrane proteins, Transporters" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HUVEC TERT2: 53.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016759, HPA018791" Uncertain Enhanced Vesicles Vesicles "HPA016759: AB_1858993, HPA018791: AB_1858992" "unprognostic (1.43e-2)" "unprognostic (4.00e-3)" "unprognostic (1.08e-1)" "unprognostic (1.11e-3)" "unprognostic (2.95e-2)" "unprognostic (1.34e-2)" "unprognostic (1.55e-2)" "unprognostic (1.57e-1)" "unprognostic (3.57e-3)" "unprognostic (3.03e-2)" "unprognostic (1.63e-1)" "unprognostic (2.16e-1)" "unprognostic (6.95e-3)" "unprognostic (1.15e-1)" "unprognostic (7.93e-2)" "unprognostic (2.17e-1)" "unprognostic (2.76e-2)" 4.7 5.2 6.3 9.3 8.0 6.8 7.3 13.2 9.7 8.8 13.2 5.8 7.1 8.7 6.4 5.6 36.4 10.5 6.9 7.7 6.2 7.1 10.8 2.3 4.7 6.9 5.4 5.2 5.8 14.0 10.9 20.1 9.4 9.4 7.1 14.7 6.4 11.2 5.9 2.1 14.9 12.3 4.9 4.7 6.3 14.4 11.2 4.8 15.0 7.7 18.2 27.5 15.3 14.5 6.3 4.3 23.4 5.8 4.3 7.5 3.5 15.8 7.5 7.2 6.1 2.6 3.0 6.9 7.6 7.0 8.5 9.9 4.5 3.8 8.1 5.3 6.3 24.2 10.3 5.0 9.4 10.0 9.0 4.2 4.8 3.6 6.0 5.7 7.3 3.4 5.9 3.6 5.0 53.8 4.0 4.1 8.8 5.1 7.3 4.7 6.0 7.0 8.2 10.0 1.9 8.8 10.5 12.6 9.2 9.1 11.1 4.1 5.2 6.7 15.4 7.6 5.4 11.6 6.1 3.5 10.7 7.5 9.1 5.9 13.2 7.4 3.5 23.4 6.8 5.8 6.1 6.3 5.3 7.5 4.3 4.2 5.1 6.5 4.4 4.3 4.6 4.2 6.8 3.5 6.3 8.0 13.2 9.7 6.2 7.1 5.4 5.2 9.4 4.8 ZDHHC17 "HIP14, HYPH, KIAA0946" ENSG00000186908 "Zinc finger DHHC-type containing 17" Q8IUH5 12 76763588-76853696 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Acyltransferase, Transferase" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 16.3" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016807, HPA058674" Approved Supported "Golgi apparatus,Vesicles" "Golgi apparatus, Vesicles" "HPA016807: AB_1858999, HPA058674: " "unprognostic (1.06e-1)" "unprognostic (2.26e-2)" "unprognostic (2.63e-2)" "unprognostic (3.04e-1)" "unprognostic (6.12e-2)" "unprognostic (2.83e-2)" "unprognostic (2.35e-3)" "unprognostic (3.09e-1)" "unprognostic (8.38e-2)" "unprognostic (1.04e-1)" "unprognostic (1.56e-3)" "unprognostic (5.42e-2)" "prognostic unfavourable (7.11e-5)" "unprognostic (1.77e-2)" "unprognostic (2.69e-1)" "unprognostic (2.98e-1)" "unprognostic (1.71e-2)" 7.9 7.8 10.0 5.8 14.0 11.3 8.8 18.1 18.1 8.0 5.9 9.2 3.8 3.6 12.0 6.8 6.4 7.0 5.5 6.4 8.7 6.5 9.1 13.1 5.4 7.1 11.3 10.7 11.5 5.2 9.5 10.3 8.7 13.2 7.9 5.4 5.9 5.7 7.3 5.4 5.9 6.4 8.0 10.0 7.1 6.1 6.4 11.6 7.5 6.2 4.1 5.7 5.6 6.3 3.8 16.3 5.8 2.2 1.7 3.6 1.4 5.7 7.1 22.2 11.3 13.4 14.2 10.9 11.7 9.7 7.8 6.9 5.6 4.2 8.0 7.1 11.3 5.5 8.8 7.3 12.2 6.7 9.3 11.6 8.7 8.5 9.0 11.6 10.4 13.3 7.7 7.3 11.0 8.9 12.5 3.7 10.1 5.4 8.3 15.6 16.4 8.1 11.3 7.9 8.7 9.0 8.9 8.7 15.1 12.9 4.7 7.5 10.5 11.7 12.3 10.7 8.1 6.5 6.6 6.0 5.8 8.7 4.0 5.5 11.0 5.7 2.1 5.2 3.6 2.2 2.9 2.6 2.9 2.7 2.6 3.8 3.1 2.6 5.8 1.7 2.1 16.3 1.2 1.4 10.0 14.0 18.1 13.8 8.7 6.5 11.3 10.7 13.2 11.6